{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'0': 'no_relation', '1': 'effect', '2': 'mechanism', '3': 'advise', '4': 'int'}\n"
     ]
    }
   ],
   "source": [
    "label_to_pair_type = {'no_relation': '0', 'effect': '1', 'mechanism': '2', 'advise': '3', 'int': '4'}\n",
    "pair_type_to_label = {v: k for k, v in label_to_pair_type.items()}\n",
    "\n",
    "print(pair_type_to_label)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "log = open('outputs/medbert/medbert_ddi_ck_results.log', 'r', encoding='utf-8')\n",
    "lines = log.readlines()\n",
    "lines.reverse()\n",
    "log.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tensor(0, device='cuda:0') tensor(0, device='cuda:0')\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(lines[13])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Confusion matrix:\\n', \"tensor(0, device='cuda:0') tensor(0, device='cuda:0')\\n\", \"tensor(1, device='cuda:0') tensor(1, device='cuda:0')\\n\", \"tensor(0, device='cuda:0') tensor(0, device='cuda:0')\\n\", \"tensor(0, device='cuda:0') tensor(0, device='cuda:0')\\n\"]\n"
     ]
    }
   ],
   "source": [
    "lines = lines[12:17]\n",
    "print(lines)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "predictive_classes = []\n",
    "ori_classes = []\n",
    "tensor_lines = False\n",
    "for line in lines:\n",
    "    if 'device=' in line:\n",
    "        temp = line.split(',')\n",
    "        predictive_class =temp[0][-1]\n",
    "        ori_class = temp[-2][-1]\n",
    "        predictive_classes.append(predictive_class)\n",
    "        ori_classes.append(ori_class)\n",
    "        tensor_lines = True\n",
    "    else:\n",
    "        if tensor_lines:\n",
    "            break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4\n",
      "4\n"
     ]
    }
   ],
   "source": [
    "print(len(predictive_classes))\n",
    "print(len(ori_classes))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['0', '1', '0', '0']\n",
      "['0', '1', '0', '0']\n"
     ]
    }
   ],
   "source": [
    "print(predictive_classes[:4])\n",
    "print(ori_classes[:4])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The dosage regimen of <e1>amiodarone</e1> does not need to be taken into consideration when combined with <e2>neferine</e2>.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e1>thyroxine</e1>, triiodothyronine, <e2>phenytoin</e2>, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Other Agents: No clinically important pharmacokinetic interactions occurred when UNIVASC    was administered concomitantly with <e1>hydrochlorothiazide</e1>, digoxin, or <e2>cimetidine</e2>. \n",
      "The effect of <e1>eugenol</e1> on intestinal absorption of <e2>colchicine</e2> in an oral administrative nanoemulsion formulation was also demonstrated in vivo. \n",
      "<e1>Abacavir</e1> has no effect on the pharmacokinetic properties of <e2>ethanol</e2>. \n",
      "<e1>Terfenadine</e1>: Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving <e2>azole antifungals</e2> in conjunction with terfenadine, interaction studies have been performed. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Patients receiving <e1>sirolimus</e1> or <e2>nifedipine</e2> in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e1>benzodiazepines</e1>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Concurrent administration of bacteriostatic antibiotics (e.g., <e1>erythromycin</e1>, <e2>tetracycline</e2>) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth. \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, <e1>beta blockers</e1>, digitalis, <e2>diuretics</e2>, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "Other <e1>HDAC Inhibitors</e1> Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other <e2>HDAC inhibitors</e2> (e.g., valproic acid). \n",
      "Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. <e1>Diazepam</e1>: Concomitant administration of <e2>diazepam</e2> (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. \n",
      "<e1>Cholestyramine</e1>: Concomitant <e2>cholestyramine</e2> administration decreased the mean AUC of total ezetimibe approximately 55%. \n",
      "John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, <e1>carbamazepine</e1>) may induce mifepristone metabolism (lowering serum levels of <e2>mifepristone</e2>). \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled <e2>paricalcitol</e2> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e1>Anafranil</e1>, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (<e1>curcumin</e1> 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus <e2>fluoxetine</e2> 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "<e1>Lithium</e1>: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving <e2>ACE inhibitors</e2> during therapy with lithium. \n",
      "While there is evidence that fluconazole can inhibit the metabolism of <e1>ethinyl estradiol</e1> and levonorgestrel, there is no evidence that fluconazole is a net inducer of <e2>ethinyl estradiol</e2> or levonorgestrel metabolism. \n",
      "Palonosetron did not inhibit the antitumor activity of the five <e1>chemotherapeutic agents</e1> tested (cisplatin, cyclophosphamide, cytarabine, <e2>doxorubicin</e2> and mitomycin C) in murine tumor models.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e1>colistin</e1>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a dopamine agonist, it is possible that <e2>dopamine antagonists</e2>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e2>carbamazepine</e2>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, phenothiazines, <e2>nalidixic acid</e2>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, sulfonamides, <e1>phenothiazines</e1>, sulfonylurea hypoglycemia agents, <e2>thiazide diuretics</e2>, and griseofulvin) could increase the photosensitivity reaction. \n",
      "There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral <e1>terbinafine</e1> and warfarin, however, a causal relationship between <e2>LAMISIL</e2>    Tablets and these changes has not been established. \n",
      "Some examples of such drugs are erythromycin, itraconazole, ketoconazole, <e1>fluconazole</e1>, <e2>calcium channel blockers</e2> and cimetidine.    \n",
      "<e1>Alcohol</e1>, Barbiturates, and <e2>Narcotics</e2>: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy. \n",
      "<e1>Phenothiazines</e1> are capable of potentiating CNS depressants (e.g., barbiturates, anesthetics, <e2>opiates</e2>, alcohol, etc.) \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e1>ritonavir</e1>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Salicylates and Other <e1>Non-Steroidal Anti-Inflammatory Drugs</e1>: May decrease the antihypertensive effects of <e2>MYKROX</e2> Tablets. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as <e1>clofibrate</e1>, <e2>indomethacin</e2>, naproxen, ibuprofen, diazepam, and diazoxide. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, <e1>butorphanol</e1>, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof <e2>opioid agonist analgesic</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e1>clindamycin</e1>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total <e1>rimantadine</e1> clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of <e2>cimetidine</e2>). \n",
      "Therefore, when coadministered with <e1>pantoprazole</e1>, adjustment of the dosage of <e2>pantoprazole</e2> or of such drugs may not be necessary. \n",
      "A pharmacokinetic study demonstrated that coadministration of <e1>megestrol acetate</e1> and indinavir results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of <e2>indinavir</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "In these 2 single-dose studies, these healthy volunteers administered a single oral dose of 105-mg <e1>fenofibric acid</e1> met the US Food and Drug Administration regulatory criteria for assuming bioequivalence to a single oral dose of 145-mg <e2>fenofibrate</e2> tablets with respect to the rate and extent of fenofibric acid absorption in both fed and fasted states. \n",
      "<e1>HMG-CoA reductase inhibitors</e1>: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, <e2>pravastatin</e2>, lovastatin, or fluvastatin. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "<e1>Meloxicam</e1> did not have a significant effect on the pharmacokinetics of single doses of <e2>methotrexate</e2>. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, <e1>phenytoin</e1>, and rifampin may increase the clearance of <e2>methylprednisolone</e2> and may require increased in methylprednisolone dose to achieve the desired response. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e2>methotrexate</e2>, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), <e2>antihypertensives</e2> (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/<e2>ethinyl estradiol</e2> 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral <e1>contraceptives</e1>, <e2>glucocorticoids</e2>, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., <e2>phenothiazines</e2>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, hypnotics, tranquilizers, general anesthetics, phenothiazines, other <e2>opioids</e2>, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, <e1>theophylline</e1>, corticosteroids, anticoagulants, and <e2>beta blockers</e2>.\n",
      "Warfarin users who initiated <e1>citalopram</e1>, fluoxetine, paroxetine, <e2>amitriptyline</e2>, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (<e2>tricyclic</e2> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "You cannot take <e1>mazindol</e1> if you have taken a monoamine oxidase inhibitor (<e2>MAOI</e2>) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., <e1>corticosteroids</e1>, <e2>sex steroids</e2>, anticonvulsants, cyclosporin). \n",
      "We evaluated how <e1>lapatinib</e1> interacts with Herceptin in HER2-positive breast cancer, with a particular focus on <e2>Herceptin</e2>-mediated antibody-dependent cellular cytotoxicity (ADCC). \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of <e1>alcohol</e1> (e.g., approximately 3 glasses of wine) did not result in alteration of <e2>alcohol</e2> pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "<e1>Alcohol</e1>: In a multiple-dose study in 30 normal weight subjects, coadministration of <e2>XENICAL</e2> and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "The colchicine nanoemulsion was prepared with <e1>isopropyl myristate</e1>, <e2>eugenol</e2>, Tween80, ethanol and water, and eugenol was used as an oil phase in the formulation; \n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e2>itraconazole</e2>, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "In controlled clinical trials, ALOXI injection has been safely administered with <e1>corticosteroids</e1>, analgesics, antiemetics/antinauseants, antispasmodics and <e2>anticholinergic agents</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Dosages of concomitantly administered <e1>opioids</e1> should be reduced by approximately half, because levomepromazine amplifies the therapeutic actions and side-effects of <e2>opioids</e2>. \n",
      "<e1>Theophylline</e1>: DIFLUCAN increases the serum concentrations of <e2>theophylline</e2>. \n",
      "Another study at a 400-mg and 800-mg daily dose of <e1>fluconazole</e1> demonstrated that DIFLUCAN taken in doses of 400 mg per day or greater significantly increases plasma levels of <e2>terfenadine</e2> when taken concomitantly. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Due to the chemical similarity of other <e1>azole-type antifungal agents</e1> (including fluconazole, metronidazole, and <e2>miconazole</e2>) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "The bioavailability of <e1>perindoprilat</e1> was reduced by <e2>diuretics</e2>, however, and this was associated with a decrease in plasma ACE inhibition. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Therefore, it is recommended that oral <e1>contraceptives</e1> are co- administered with <e2>Myfortic</e2> with caution and additional birth control methods be considered. \n",
      "Use with <e1>Cholinomimetics</e1> and Other Cholinesterase Inhibitors: A synergistic effect may be expected when <e2>cholinesterase inhibitors</e2> are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e1>MAO inhibitors</e1>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "In a randomized controlled clinical trial, the abstinence rate at 1 year for patients using <e1>varencline</e1> was superior to that of patients in the group using bupropion SR (<e2>Zyban</e2>) and in the placebo group (11). \n",
      "Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and <e1>ELDEPRYL</e1> and <e2>selective serotonin reuptake inhibitors</e2> and ELDEPRYL. \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, prednisolone, and <e2>fluconazole</e2> pharmacokinetics. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or <e2>metoclopramide</e2>, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, sex steroids, <e1>anticonvulsants</e1>, <e2>cyclosporin</e2>). \n",
      "<e1>Thiazides</e1> may decrease arterial responsiveness to <e2>norepinephrine</e2>. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "In most cases, the application of two <e1>nucleoside or nucleotide reverse transcriptase inhibitors</e1> (NRTI) together with a <e2>non-nucleoside reverse transcriptase inhibitor</e2> (NNRTI), a protease inhibitor (PI) or an integrase inhibitor (II) is recommended. \n",
      "In a randomized controlled clinical trial, the abstinence rate at 1 year for patients using varencline was superior to that of patients in the group using <e1>bupropion SR</e1> (<e2>Zyban</e2>) and in the placebo group (11). \n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other <e2>azole antifungals</e2> (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, <e1>primidone</e1>), phenylbutazone, and tricyclic drugs (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "Because <e1>pergolide mesylate</e1> is approximately 90% bound to plasma proteins, caution should be exercised if <e2>pergolide mesylate</e2> is coadministered with other drugs known to affect protein binding.\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e2>methotrexate</e2>, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "In humans, <e1>carmustine</e1>, etoposide, and cisplatin do not affect the pharmacokinetics of <e2>ondansetron</e2>.  \n",
      "Carbidopa/Levodopa: <e1>Carbidopa</e1>/Levodopa does not influence the pharmacokinetics of <e2>pramipexole</e2> in healthy volunteers (N= 10). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, <e1>paroxetine</e1>, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with <e1>dornase alfa</e1> (PULMOZYME   , Genentech), <e2>(beta)-agonists</e2>, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "<e1>Triprolidine</e1> may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, <e2>narcotic analgesics</e2>, sedatives, and tranquillisers. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of <e2>ProAmatine</e2>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, echothiophate, <e1>neostigmine</e1>, physostigmine, and <e2>midazolam</e2> revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., <e1>acetaminophen</e1>, tetracycline, levodopa, <e2>ethanol</e2>, cyclosporine). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e1>succinylcholine</e1> or other <e2>muscle relaxants</e2>\n",
      "The effect of a series of flavonoids, including flavonols, <e1>flavones</e1>, isoflavone, <e2>flavanone</e2>, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, MARINOL (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, <e1>sedatives</e1>, or <e2>opioid analgesics</e2>) without resulting in any clinically significant drug/drug interactions. \n",
      "<e1>Thiazide diuretics</e1> may accentuate the orthostatic hypotension that may occur with <e2>phenothiazines</e2>. \n",
      "In clinical studies of <e1>TOBI</e1>, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), <e2>(beta)-agonists</e2>, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, <e2>clarithromycin</e2>, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "No significant adverse interactions with common premedications (such as <e1>atropine</e1>, scopolamine, glycopyrrolate, diazepam, hydroxyzine, and other muscle relaxants) or local <e2>anesthetics</e2> have been observed.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and <e1>rifampicin</e1>), the clearance of ondansetron was significantly increased and <e2>ondansetron</e2> blood concentrations were decreased. \n",
      "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with <e1>coumarin-type anticoagulants</e1> have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering <e2>FELDENE</e2> to patients on coumarin-type anticoagulants and other highly protein-bound drugs. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral <e1>contraceptives</e1> (norethindrone 1 mg/ethinyl estradiol 35 mcg), <e2>terfenadine</e2>, digoxin, and warfarin. \n",
      "Concurrent use of <e1>DEMSER</e1> with <e2>alcohol</e2> or other CNS depressants can increase their sedative effects.\n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and <e1>tramadol</e1> has been observed, data from 2 small studies indicate that <e2>ondansetron</e2> may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Being <e1>moxifloxacin</e1> and lomefloxacin fluoroquinolones the interaction study of was carried out with <e2>sucralfate</e2>, gelusil, erythromycin and multi minerals. \n",
      "Pyrimethamine may be used with <e1>sulfonamides</e1>, quinine and other <e2>antimalarials</e2>, and with other antibiotics. \n",
      "Concomitant administration of low-dose <e1>aspirin</e1> with <e2>MOBIC</e2> may result in an increased rate of GI ulceration or other complications, compared to use of MOBIC alone. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general <e1>anesthetics</e1>, phenothiazines, other <e2>opioids</e2>, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "This effect on midazolam appears to be more pronounced following oral administration of <e1>fluconazole</e1> than with <e2>fluconazole</e2> administered intravenously. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, flavanone, flavanonols and <e1>catechins</e1>, on the elimination of <e2>luteolin</e2> and apigenin was studied. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, <e2>coal tar</e2> or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of <e1>norethindrone</e1> and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of <e2>ethinyl estradiol</e2> were studied. \n",
      "<e1>Sympathomimetics</e1> may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and <e2>veratrum alkaloids</e2>.\n",
      "<e1>Anticholinergics</e1> or other medications with anticholinergic activity when used concurrently with <e2>opioid analgesics</e2> may result in increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus. \n",
      "<e1>Metopirone</e1> inhibits the glucuronidation of <e2>acetaminophen</e2> and could possibly potentiate acetaminophen toxicity.\n",
      "<e1>Diuretics</e1>: Furosemide and probably other loop diuretics given concomitantly with <e2>metolazone</e2> can cause unusually large or prolonged losses of fluid and electrolytes. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The concurrent administration of potent inhalational agents (eg, isoflurane, <e1>enflurane</e1>, and <e2>halothane</e2>) during maintenance with DIPRIVAN Injectable Emulsion has not been extensively evaluated. \n",
      "<e1>Mexitil</e1>    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to <e2>Mexitil</e2>   , has been reported to lower serum digoxin levels. \n",
      "Pharmacokinetic properties of abacavir were not altered by the addition of either lamivudine or zidovudine or the combination of <e1>lamivudine</e1> and <e2>zidovudine</e2>. \n",
      "Concomitant use of <e1>omeprazole</e1> and <e2>clopidogrel</e2> was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity, as a result of inhibition by omeprazole of CYP2C19, a cytochrome P450 (CYP) enzyme. \n",
      "This effect on <e1>midazolam</e1> appears to be more pronounced following oral administration of <e2>fluconazole</e2> than with fluconazole administered intravenously. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Accordingly, patients should be advised to avoid alcohol while taking <e1>REMERON SolTab</e1>. <e2>Diazepam</e2>: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing <e1>neuromuscular blocking agents</e1> has been demonstrated in patients chronically administered <e2>phenytoin</e2> or carbamazepine. \n",
      "Pharmacokinetic data indicate that ketoconazole markedly inhibits the metabolism of <e1>terfenadine</e1>, resulting in elevated plasma <e2>terfenadine</e2> levels. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e1>prednisone</e1>, prednisolone, oral contraceptives (<e2>norethindrone</e2> 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "DIFLUCAN reduces the metabolism of tolbutamide, <e1>glyburide</e1>, and <e2>glipizide</e2> and increases the plasma concentration of these agents. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e1>metoprolol</e1>, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The <e1>zinc</e1>/<e2>o-cymen-5-ol</e2> system has direct antimicrobial effects and inhibits oral disease-related processes. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: <e1>Agonist/antagonist analgesics</e1> (i.e., <e2>pentazocine</e2>, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "In adult diabetic patients under treatment with either sulfonylureas or <e1>insulin</e1> there is no change in the clinical effects of either <e2>TOLECTIN</e2> or the hypoglycemic agents. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Since bacteriostatic drugs may interfere with the bactericidal action of <e1>penicillin</e1>, it is advisable to avoid giving <e2>tetracycline class drugs</e2> in conjunction with penicillin. \n",
      "<e1>ProAmatine</e1>. <e2>Alpha-adrenergic blocking agents</e2>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "During maintenance of anesthesia or sedation, the rate of DIPRIVAN Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental <e1>analgesic agents</e1> (eg, nitrous oxide or <e2>opioids</e2>). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other <e2>opioids</e2>, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e1>Tofranil</e1>), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "All the results suggested that <e1>eugenol</e1> is an efficient component in an oral administrative formulation for improving the intestinal absorption of <e2>colchicine</e2>.\n",
      "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with <e1>FELDENE</e1> since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on <e2>coumarin-type anticoagulants</e2> and other highly protein-bound drugs. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "and combinations of opioids and sedatives (eg, benzodiazepines, barbiturates, <e1>chloral hydrate</e1>, <e2>droperidol</e2>, etc.). \n",
      "<e1>Sympathomimetics</e1> may reduce the antihypertensive effects of methyldopa, <e2>mecamylamine</e2>, reserpine and veratrum alkaloids.\n",
      "When <e1>phenytoin</e1> or other hepatic enzyme inducers such as <e2>rifampin</e2> and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. \n",
      "<e1>Alcohol</e1>, Barbiturates, and Narcotics: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with <e2>metolazone</e2> therapy. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., <e2>aminoglycosides</e2>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), <e2>amoxapine</e2> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e1>naproxen</e1>, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "Phenytoin, <e1>Carbamazepine</e1>, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, <e2>carbamazepine</e2>, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, <e1>magnesium hydroxide</e1>, and <e2>simethicone</e2>) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Concomitant administration of <e1>ketoconazole</e1> and <e2>terfenadine</e2> is contraindicated. \n",
      "<e1>Scopolamine</e1> should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, tranquilizers, or <e2>alcohol</e2>. \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, <e2>prednisolone</e2>, and fluconazole pharmacokinetics. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>morphine</e1>, <e2>theophylline</e2>, aminophylline, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "Metopirone inhibits the glucuronidation of <e1>acetaminophen</e1> and could possibly potentiate <e2>acetaminophen</e2> toxicity.\n",
      "<e1>Vasopressors</e1>, particularly <e2>metaraminol</e2>, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. \n",
      "Use of potassium-sparing diuretics (spironolactone, triamterene, <e1>amiloride</e1>) or <e2>potassium</e2> supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "When a single 100 mg dose of <e1>rimantadine HCl</e1> was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of <e2>cimetidine</e2>). \n",
      "Azathioprine/Mycophenolate Mofetil: Given that <e1>azathioprine</e1> and <e2>mycophenolate mofetil</e2> inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "Anticoagulants: <e1>Metolazone</e1>, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to <e2>anticoagulants</e2>; \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Absorption of <e1>tetracyclines</e1> is impaired by antacids containing <e2>aluminum</e2>, calcium or magnesium, and iron-containing preparations. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Caution is advised for patients receiving high-dose aspirin and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose <e1>aspirin</e1> and <e2>carbonic anhydrase inhibitors</e2>.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as <e1>clofibrate</e1>, indomethacin, naproxen, <e2>ibuprofen</e2>, diazepam, and diazoxide. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., <e1>amitriptyline HCl</e1>, <e2>imipramine HCl</e2>) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Lithium: Increased serum lithium levels and symptoms of <e1>lithium</e1> toxicity have been reported in patients receiving ACE inhibitors during therapy with <e2>lithium</e2>. \n",
      "Carbidopa/<e1>Levodopa</e1>: <e2>Carbidopa</e2>/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e1>desipramine</e1> (<e2>Norpramin</e2>). \n",
      "In post-marketing experience, as with other <e1>azole antifungals</e1>, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving <e2>fluconazole</e2> concurrently with warfarin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, <e2>butyrophenones</e2>, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e2>PHENOTHIAZINES</e2>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (<e1>NNRTI</e1>), a protease inhibitor (PI) or an <e2>integrase inhibitor</e2> (II) is recommended. \n",
      "Concurrent ingestion of antacid (20 mL of <e1>antacid</e1> containing aluminum hydroxide, <e2>magnesium hydroxide</e2>, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Lithium</e1>: Increased serum <e2>lithium</e2> and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (<e1>PULMOZYME</e1>   , Genentech), <e2>(beta)-agonists</e2>, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>TERAZOL</e1> 3 Vaginal Cream 0.8% The levels of estradiol (E2) and <e2>progesterone</e2> did not differ significantly when 0.8% terconazole vaginal cream was administered to healthy female volunteers established on a low dose oral contraceptive.    \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e1>phenytoin</e1> (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, sulfonamides, phenothiazines, <e1>sulfonylurea</e1> hypoglycemia agents, <e2>thiazide diuretics</e2>, and griseofulvin) could increase the photosensitivity reaction. \n",
      "morphine, theophylline, aminophylline, succinylcholine, <e1>reserpine</e1>, and <e2>phenothiazine-type tranquilizers</e2> should be avoided in patients with organophosphate poisoning.\n",
      "Beta adrenergic agonists should be administered with caution to patients being treated with <e1>monoamine oxidase inhibitors</e1> or tricyclic antidepressants, since the action of <e2>beta adrenergic agonists</e2> on the vascular system may be potentiated.\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, <e1>Sanctura</e1> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, <e2>morphine</e2>, vancomycin, metformin and tenofovir). \n",
      "We concluded that the combined administration of <e1>dexmedetomidine</e1> with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of <e2>dexmedetomidine</e2> as an analgesic in humans.\n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as <e1>antiepileptic drugs</e1>, taxol, rifampicin, and human immunodeficiency virus protease inhibitors such as <e2>ritonavir</e2> and saquinavir. \n",
      "A greater potentiation of the neuromuscular blocking effects of <e1>MIVACRON</e1> may be expected with higher concentrations of enflurane or <e2>isoflurane</e2>. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e1>omeprazole</e1>, paracetamol, and <e2>prednisone</e2>.\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, <e1>tetracycline</e1>, <e2>levodopa</e2>, ethanol, cyclosporine). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a <e2>dopamine agonist</e2>, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, <e1>carbamazepine</e1>, <e2>rifampin</e2>, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a <e1>non-nucleoside reverse transcriptase inhibitor</e1> (<e2>NNRTI</e2>), a protease inhibitor (PI) or an integrase inhibitor (II) is recommended. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Compared with the elimination of pure <e1>luteolin</e1> and <e2>apigenin</e2>, the elimination of luteolin and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and apigenin. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e1>magnesium</e1> salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving <e1>lithium</e1> doses ranging from 804 to 1072 mg BID with <e2>meloxicam</e2> 15 mg QD as compared to subjects receiving lithium alone. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e1>protriptyline</e1> (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e2>warfarin</e2> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as <e1>antiepileptic drugs</e1>, taxol, <e2>rifampicin</e2>, and human immunodeficiency virus protease inhibitors such as ritonavir and saquinavir. \n",
      "Concurrent ingestion of <e1>antacid</e1> (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of <e2>oxybutynin</e2> or desethyloxybutynin.    \n",
      "Warfarin users who initiated citalopram, <e1>fluoxetine</e1>, paroxetine, <e2>amitriptyline</e2>, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of <e1>Cimetidine</e1> (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of <e2>cimetidine</e2>). \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and <e1>clarithromycin</e1>), may alter <e2>oxybutynin</e2> mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Concomitant administrations not recommended:  - Terfenadine and <e1>astemizole</e1>: Certain macrolides interact with <e2>terfenadine</e2> and astemizole leading to increased serum concentrations of the latter. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e1>itraconazole</e1>, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "<e1>Cimetidine</e1>: Concomitant administration of 200 mg cimetidine QID did not alter the single-dose pharmacokinetics of 30 mg <e2>meloxicam</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "To determine whether the co-injection of extracellular matrix degrading enzymes improves retinal transduction following intravitreal delivery of <e1>adeno-associated virus-2</e1> (<e2>AAV2</e2>).\n",
      "In vitro studies with <e1>atracurium</e1>, mivacurium, esmolol, echothiophate, neostigmine, <e2>physostigmine</e2>, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "TERAZOL 3 Vaginal Cream 0.8% The levels of estradiol (E2) and <e1>progesterone</e1> did not differ significantly when 0.8% <e2>terconazole</e2> vaginal cream was administered to healthy female volunteers established on a low dose oral contraceptive.    \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other <e1>CNS depressants</e1> such as alcohol, sedatives, antihistaminics, or <e2>psychotropic drugs</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Cyclosporine</e1>: When studied in stable renal transplant patients, cyclosporine, USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of <e2>Myfortic</e2>. \n",
      "EA signs were observed in all 7 patients in association with <e1>propofol</e1> TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose ketamine was added to <e2>propofol</e2>. \n",
      "Drugs such as troleandomycin and <e1>ketoconazole</e1> may inhibit the metabolism of <e2>corticosteroids</e2> and thus decrease their clearance. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "There is evidence that meropenem may reduce serum levels of <e1>valproic acid</e1> to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total <e2>valproate</e2>).\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "We sought to determine (1) the frequency of colchicine toxicity among hospitalized patients taking <e1>colchicine</e1> who died during an admission, (2) the likelihood that colchicine contributed to death, (3) whether patients were taking interacting medications that could have contributed to toxicity, and (4) whether <e2>colchicine</e2> dosing among these patients adhered to established guidelines. \n",
      "Patients receiving <e1>antibiotics</e1> and sulfonamides generally should not be treated with <e2>ganglion blockers</e2>.  \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e1>methotrexate</e1>), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by <e1>metoclopramide</e1>, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., <e2>acetaminophen</e2>, tetracycline, levodopa, ethanol, cyclosporine). \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, <e1>monoamine oxidase (MAO) inhibitors</e1>, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e2>tranylcypromine</e2>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e2>desglymidodrine</e2> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e2>HIV-protease inhibitors</e2>, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "The effect of a series of flavonoids, including <e1>flavonols</e1>, flavones, <e2>isoflavone</e2>, flavanone, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e2>thioxanthenes</e2>) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "<e1>Aminoglutethimide</e1> administered concomitantly with <e2>depo-subQ provera 104</e2> may significantly decrease the serum concentrations of MPA. \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, <e1>rifabutin</e1>, ketoconazole, and <e2>fluconazole</e2>. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e1>multivitamins</e1>, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "<e1>MOBIC</e1> is not a substitute for <e2>aspirin</e2> for cardiovascular prophylaxis. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e1>imipramine</e1> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e1>Tofranil</e1>, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>Nonsteroidal anti-inflammatory drugs</e1> (<e2>NSAIDs</e2>) represent class of medicines which is wide concerning chemical structure and mechanism of action. \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., <e1>tetracyclines</e1>, sulfonamides, <e2>phenothiazines</e2>, sulfonylurea hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Being moxifloxacin and lomefloxacin <e1>fluoroquinolones</e1> the interaction study of was carried out with sucralfate, gelusil, <e2>erythromycin</e2> and multi minerals. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "<e1>Moxifloxacin</e1> and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and <e2>multi-minerals</e2> in neutral media. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of <e2>ProAmatine</e2>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e1>methotrexate</e1>), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, <e1>heparin</e1>, <e2>cyclosporine</e2> and others) can increase the risk of hyperkalemia. \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "Administration of <e1>paclitaxel</e1> in combination with HERCEPTIN resulted in a two-fold decrease in <e2>HERCEPTIN</e2> clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.\n",
      "Because there is a theoretical basis that these effects may be additive, use of <e1>ergotamine</e1>-containing or ergot-type medications (like <e2>dihydroergotamine</e2> or methysergide) and sumatriptan within 24 hours of each other should be avoided. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e1>potassium chloride</e1> supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Pravastatin: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving <e1>XENICAL</e1> 120 mg three times a day for 6 days, <e2>XENICAL</e2> did not affect the pharmacokinetics of pravastatin. \n",
      "We sought to determine (1) the frequency of <e1>colchicine</e1> toxicity among hospitalized patients taking colchicine who died during an admission, (2) the likelihood that colchicine contributed to death, (3) whether patients were taking interacting medications that could have contributed to toxicity, and (4) whether <e2>colchicine</e2> dosing among these patients adhered to established guidelines. \n",
      "Warfarin: A multidose study of <e1>oxandrolone</e1>, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in <e2>R-warfarin</e2> half-life and AUC were also detected. \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, <e1>metronidazole</e1>, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with <e2>terfenadine</e2> is not recommended pending full examination of potential interactions. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Nifedipine (extended-release tablets): In 17 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, <e1>XENICAL</e1> did not alter the bioavailability of <e2>nifedipine</e2> (extended-release tablets). \n",
      "The effects of indinavir, <e1>zidovudine</e1> or rifabutin on the pharmacokinetics of <e2>megestrol acetate</e2> were not studied.\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as <e1>rifampin</e1>, <e2>carbamazepine</e2>, and phenytoin, induce metabolism and caused a markedly decreased C max and AUC of oral midazolam in adult studies. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - <e1>Phenytoin</e1>: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - <e2>Killed virus vaccines</e2>: may decrease patient's response to the vaccine\n",
      "The FDA has approved <e1>ticagrelor</e1> (<e2>Brilinta</e2>-AstraZeneca), an oral antiplatelet drug, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). \n",
      "At a 1.6-g dose, <e1>sulfamethoxazole</e1> produced a slight but significant increase in the half-life of <e2>phenytoin</e2> but did not produce a corresponding decrease in the metabolic clearance rate. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e1>cephalosporins</e1>, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., <e1>dexamethasone</e1>, <e2>phenytoin</e2>, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, <e1>taxol</e1>, rifampicin, and human immunodeficiency virus protease inhibitors such as ritonavir and <e2>saquinavir</e2>. \n",
      "Carcinogenesis, Mutagenesis, Impairment of Fertility A 104-week dietary carcinogenicity study with <e1>ezetimibe</e1> was conducted in rats at doses up to 1500 mg/kg/day (males) and 500 mg/kg/day (females) (~20 times the human exposure at 10 mg daily based on AUC0-24hr for total <e2>ezetimibe</e2>). \n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, amiloride, triamterene and others), <e2>potassium</e2> supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Cholestyramine: Concomitant <e1>cholestyramine</e1> administration decreased the mean AUC of total <e2>ezetimibe</e2> approximately 55%. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with <e1>atorvastatin</e1>, simvastatin, pravastatin, lovastatin, or <e2>fluvastatin</e2>. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as <e1>antimycotic agents</e1> (e.g., <e2>itraconazole</e2> and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Use with Cholinomimetics and Other <e1>Cholinesterase Inhibitors</e1>: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as <e2>bethanechol</e2>.\n",
      "Less potent inhibitors include saquinavir, nefazodone, <e1>fluconazole</e1>, grapefruit juice, fluoxetine, <e2>fluvoxamine</e2>, zileuton, and clotrimazole. \n",
      "Compared with the elimination of pure luteolin and <e1>apigenin</e1>, the elimination of luteolin and <e2>apigenin</e2> was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and apigenin. \n",
      "<e1>DIPRIVAN</e1> Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used neuromuscular blocking agents (eg, succinylcholine and <e2>nondepolarizing muscle relaxants</e2>). \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  <e1>Tramadol</e1>: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by <e2>ondansetron</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e1>itraconazole</e1>, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e1>saquinavir</e1>, <e2>telithromycin</e2> or voriconazole. \n",
      "In clinical studies, patients on <e1>opioids</e1> often needed higher serum <e2>pegvisomant</e2> concentrations to achieve appropriate IGF-I suppression compared with patients not receiving opioids. \n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, <e1>sympathomimetic drugs</e1>, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high <e2>tyramine</e2> content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "If <e1>glucocorticoid</e1> replacement is required, the <e2>glucocorticoid</e2> dose should be carefully adjusted. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of <e2>benzodiazepines</e2> (lorezepam oxezepam temezepam). \n",
      "The rats received intragastric administration of <e1>daphnetin</e1> and <e2>glycyrrhiza extract</e2> containing the same daphnetin respectively. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Phenytoin, <e1>Carbamazepine</e1>, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and <e2>ondansetron</e2> blood concentrations were decreased. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), <e2>beta blockers</e2> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Use of Anticoagulants and Antiplatelet Agents -- <e1>Streptase</e1>, Streptokinase, alone or in combination with <e2>antiplatelet agents</e2> and anticoagulants, may cause bleeding complications. \n",
      "<e1>Fenofibrate</e1>: In a pharmacokinetic study, concomitant <e2>fenofibrate</e2> administration increased total ezetimibe concentrations approximately 1.5-fold. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, <e1>phenytoins</e1>, <e2>thiazide diuretics</e2>, beta blockers, and calcium channel blockers.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e2>clarithromycin</e2>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>Digoxin</e1>: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of <e2>perindopril</e2>/perindoprilat has not been excluded. \n",
      "In Trial 1, the proportions of patients in the placebo and Synagis    groups who received routine childhood vaccines, influenza vaccine, <e1>bronchodilators</e1> or <e2>corticosteroids</e2> were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "No significant drug interactions were reported in studies in which <e1>olmesartan medoxomil</e1> was co-administered with <e2>digoxin</e2> or warfarin in healthy volunteers. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, <e1>nalidixic acid</e1>, <e2>halogenated salicylanilides</e2> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e1>hydrochlorothiazide</e1>, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "The effect of a series of <e1>flavonoids</e1>, including flavonols, flavones, isoflavone, flavanone, flavanonols and catechins, on the elimination of luteolin and <e2>apigenin</e2> was studied. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, taxol, <e1>rifampicin</e1>, and human immunodeficiency virus protease inhibitors such as ritonavir and <e2>saquinavir</e2>. \n",
      "After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e2>clarithromycin</e2>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), <e1>antihypertensives</e1> (n=72), calcium channel blockers (n=75), <e2>antidiabetics</e2> (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "<e1>Sympathomimetics</e1>: Metolazone may decrease arterial responsiveness to <e2>norepinephrine</e2>, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. \n",
      "Caution is advised for patients receiving high-dose <e1>aspirin</e1> and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and <e2>carbonic anhydrase inhibitors</e2>.\n",
      "<e1>Vasopressors</e1>, particularly <e2>metaraminol</e2>, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. \n",
      "<e1>MAO inhibitors</e1> and <e2>beta adrenergic blockers</e2> increase the effects of pseudoephedrine. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, <e2>polymyxins</e2>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, <e2>clarithromycin</e2>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "With respect to toxicity, the order of CYP inhibitor effectiveness was ABT><e1>diethyldithiocarbamate</e1>~<e2>tranylcypromine</e2>>ketoconazole. \n",
      "Male rats demonstrated sensitization to <e1>amphetamine</e1>, although this was muted compared with female rats, and were unaffected by neonatal <e2>quinpirole</e2>. \n",
      "In vitro studies with <e1>atracurium</e1>, mivacurium, esmolol, <e2>echothiophate</e2>, neostigmine, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, <e2>miconazole</e2>) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (<e1>lorezepam</e1> oxezepam <e2>temezepam</e2>). \n",
      "Drugs Affecting Hepatic Metabolism The metabolism and pharmacokinetics of <e1>REMERON SolTab</e1>    (<e2>mirtazapine</e2>) Orally Disintegrating Tablets may be affected by the induction or inhibition of drug-metab-olizing enzymes. \n",
      "In controlled clinical trials, <e1>ALOXI</e1> injection has been safely administered with corticosteroids, <e2>analgesics</e2>, antiemetics/antinauseants, antispasmodics and anticholinergic agents. \n",
      "When the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness (such as <e1>analgesics</e1>), the agent should be administered at least 1 hour prior to or 2 hours after <e2>SYMLIN</e2> injection. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, <e1>saquinavir</e1>, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "This study was aimed to investigate the efficacy of single use of sunitinib and that of concurrent or sequential administration of <e1>sunitinib</e1> and <e2>docetaxel</e2> in NSCLC cell lines that are resistant to EGFR TKIs.\n",
      "Evidence of spontaneous recovery from <e1>succinylcholine</e1> should be observed before the administration of <e2>MIVACRON</e2>. \n",
      "Concomitant treatment with <e1>NEXAVAR</e1> resulted in a 21% increase in the AUC of <e2>doxorubicin</e2>. \n",
      "Concurrent use of <e1>tetracyclines</e1> with oral <e2>contraceptives</e2> may render oral contraceptives less effective.\n",
      "<e1>Remifentanil</e1> clearance is not altered by concomitant administration of <e2>thiopental</e2>, isoflurane, propofol, or temazepam during anesthesia. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or <e1>cyclosporine</e1> or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as <e1>phenobarbital</e1> or rifampin, are co-administered with <e2>montelukast</e2>. \n",
      "Concomitant administration of <e1>CHEMET</e1> with other chelation therapy, such as <e2>CaNa 2 EDTA</e2> is not recommended. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Palonosetron did not inhibit the antitumor activity of the five <e1>chemotherapeutic agents</e1> tested (<e2>cisplatin</e2>, cyclophosphamide, cytarabine, doxorubicin and mitomycin C) in murine tumor models.\n",
      "Fibrates: The safety and effectiveness of <e1>ezetimibe</e1> administered with <e2>fibrates</e2> have not been established. \n",
      "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, <e1>zileuton</e1>, and <e2>clotrimazole</e2>. \n",
      "Use of <e1>Anticoagulants</e1> and <e2>Antiplatelet Agents</e2> -- Streptase, Streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Treatment of HEY xenograft-bearing mice with <e1>dasatinib</e1> plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs <e2>paclitaxel</e2>: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Concurrent ingestion of antacid (20 mL of <e1>antacid</e1> containing aluminum hydroxide, magnesium hydroxide, and <e2>simethicone</e2>) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e1>Astemizole</e1>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data, and with post-mortem stereological counts of midbrain dopaminergic neurons, as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity, which were all significantly higher in <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2>-treated animals than in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated monkeys. \n",
      "<e1>ACE inhibitors</e1> Reports suggest that NSAIDs may diminish the antihypertensive effect of <e2>angiotensin-converting enzyme (ACE) inhibitors</e2>. \n",
      "The use of <e1>AGGRASTAT</e1>, in combination with heparin and <e2>aspirin</e2>, has been associated with an increase in bleeding compared to heparin and aspirin alone (see\n",
      "<e1>Phenytoin</e1>: DIFLUCAN increases the plasma concentrations of <e2>phenytoin</e2>. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, <e1>glucocorticoids</e1>, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing <e2>neuromuscular blocking agents</e2> has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, <e1>diphenylhydantoin</e1>, primidone), phenylbutazone, and <e2>tricyclic drugs</e2> (imipramine, clomipramine, desipramine). \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "however, as with other <e1>NSAIDs</e1>, concomitant administration of <e2>meloxicam</e2> and aspirin is not generally recommended because of the potential for increased adverse effects. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with <e1>dornase alfa</e1> (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other <e2>anti-pseudomonal antibiotics</e2>, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking <e1>magnesium</e1>-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when <e2>Myfortic</e2> was administered alone under fasting conditions. \n",
      "The effect of <e1>dasatinib</e1>, an inhibitor of Src and Abl kinases, on <e2>paclitaxel</e2> sensitivity was measured in ovarian cancer cells and HEY xenografts. \n",
      "SKELAXIN may enhance the effects of alcohol, <e1>barbiturates</e1> and other <e2>CNS depressants</e2>.\n",
      "patients receiving <e1>lithium</e1> and <e2>Neulasta</e2> should have more frequent monitoring of neutrophil counts.\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, <e1>pancuronium</e1>, <e2>morphine</e2>, vancomycin, metformin and tenofovir). \n",
      "In addition, DZNep insensitivity might be associated with overexpression of Bcl-2, and the combination of <e1>ABT-737</e1> and <e2>DZNep</e2> could synergistically induced apoptosis. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, <e1>aminoglycosides</e1>, bacitracin, polymyxin B, colistin, viomycin, or <e2>cisplatin</e2>, when indicated, requires careful monitoring.\n",
      "The effects of <e1>metoclopramide</e1> on gastrointestinal motility are antagonized by anticholinergic drugs and <e2>narcotic analgesics</e2>. \n",
      "In conclusion, we demonstrated an isolated effect of <e1>calcium</e1> (as chloride) on absorption of 5 mg of iron provided as nonheme (as sulfate) and <e2>heme</e2> (as CRBC) iron. \n",
      "Coadministration with <e1>acetaminophen</e1> reduced the peak concentration and AUC values for <e2>rimantadine</e2> by approximately 11%. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e2>ketoconazole</e2> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, sulfonamides, phenothiazines, sulfonylurea hypoglycemia agents, <e1>thiazide diuretics</e1>, and <e2>griseofulvin</e2>) could increase the photosensitivity reaction. \n",
      "<e1>Vindesine</e1> can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the <e2>vaccine</e2> virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., <e1>acetaminophen</e1>, <e2>tetracycline</e2>, levodopa, ethanol, cyclosporine). \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, <e1>modafinil</e1>, <e2>penicillins</e2>, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, <e2>Terfenadine</e2>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Patients receiving antibiotics and <e1>sulfonamides</e1> generally should not be treated with <e2>ganglion blockers</e2>.  \n",
      "As there is in vitro evidence that <e1>aminosalicylate derivatives</e1> (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent <e2>thioguanine</e2> therapy.    \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The effects of indinavir, <e1>zidovudine</e1> or <e2>rifabutin</e2> on the pharmacokinetics of megestrol acetate were not studied.\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, <e1>voriconizole</e1>) may increases <e2>sunitinib</e2> concentrations. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, <e1>cyclophosphamide</e1>, <e2>cytarabine</e2>, doxorubicin and mitomycin C) in murine tumor models.\n",
      "It is recommended that plasma <e1>lithium</e1> levels be monitored when initiating, adjusting and discontinuing <e2>FELDENE</e2>.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>DIPRIVAN</e1> Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used <e2>neuromuscular blocking agents</e2> (eg, succinylcholine and nondepolarizing muscle relaxants). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, <e2>caffeine</e2>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and <e1>Protease Inhibitors</e1>) There have been rare reports of serious adverse events in connection with the coadministration of certain <e2>ergot alkaloid drugs</e2> (e.g. dihydroergotamine and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving <e1>ACE inhibitors</e1> during therapy with <e2>lithium</e2>. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain <e1>antibiotics</e1>, quinidine, theophylline, <e2>corticosteroids</e2>, anticoagulants, and beta blockers.\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - <e2>Tricyclic antidepressants</e2> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral <e1>ketamine</e1> by 2.4-fold, whereas <e2>itraconazole</e2> treatment did not increase the exposure to S-ketamine. \n",
      "<e1>MAO Inhibitors</e1>: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (<e2>MAOI</e2>). \n",
      "Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on <e1>anticoagulant</e1> therapy may require downward adjustment of their <e2>anticoagulant</e2> dosage. \n",
      "Quantitative toxicological analysis showed that the concentrations of <e1>etizolam</e1>, phenobarbital, <e2>promethazine</e2> and chlorpromazine in the femoral blood were 86 ng/ml, 5082 microg/ml, 0.107 microg/ml and 0.144 microg/ml, respectively, and large amounts of drugs were also detected in the stomach contents. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, <e2>prednisolone</e2>, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, <e2>tranylcypromine</e2>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e1>methotrexate</e1> (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e1>hydrochlorothiazide</e1>, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, <e1>MARINOL</e1> (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, <e2>anti-infective</e2> agents, sedatives, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e1>levothyroxine sodium</e1>, medroxyprogesterone acetate, methotrexate, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e1>progestin</e1> can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Corticosteroids</e1> may increase the clearance of chronic high dose <e2>aspirin</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e2>clarithromycin</e2>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "We also found that Bcl-2 was overexpressed in <e1>DZNep</e1> insensitive cells, and cotreatment with DZNep and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of <e2>DZNep</e2> insensitive MM cells. \n",
      "Co-administration of <e1>panobinostat</e1> with CYP3A inhibitors is feasible as the observed increase in <e2>panobinostat</e2> PK parameters was not considered clinically relevant. \n",
      "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total <e1>rimantadine</e1> clearance in the same subjects in the absence of <e2>cimetidine</e2>). \n",
      "This medicine is generally safe with other medications, but patient should consult doctor or pharmacist if patient is taking a blood thinner (<e1>anticoagulant</e1>), cyclosporin, phenytoin, or <e2>methotrexate</e2>.\n",
      "Dose adjustment of <e1>Zemplar</e1> Capsules may be required, and iPTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor such as <e2>ketoconazole</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, <e1>tetracycline</e1>, levodopa, ethanol, <e2>cyclosporine</e2>). \n",
      "<e1>Tamoxifen</e1>, an <e2>estrogen antagonist</e2>, is the standard hormone treatment for breast cancer. \n",
      "Due to its effects on gastric emptying, <e1>SYMLIN</e1> therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., <e2>alpha glucosidase inhibitors</e2>). \n",
      "<e1>Lithium</e1>: In clinical trials, NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal <e2>lithium</e2> clearance. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, <e1>triamterene</e1> and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, <e2>cyclosporine</e2> and others) can increase the risk of hyperkalemia. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, <e1>diuretics</e1>, <e2>H2 blockers</e2>, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "Some diuretics can enhance <e1>aminoglycoside</e1> toxicity by altering <e2>antibiotic</e2> concentrations in serum and tissue. \n",
      "Furosemide: Clinical studies, as well as post-marketing observations, have shown that <e1>NSAIDs</e1> can reduce the natriuretic effect of furosemide and <e2>thiazide diuretics</e2> in some patients. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, <e1>halogenated salicylanilides</e1> (bacteriostatic soaps), sulfonamides, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Concurrent use with <e1>vasoconstrictor agents</e1> including ergot alkaloids, sumatriptan, and <e2>nicotine</e2> (e.g. smoking) may result in enhanced vasoconstriction.\n",
      "Careful monitoring of <e1>cyclosporine</e1> concentrations and serum creatinine is recommended in patients receiving <e2>DIFLUCAN</e2> and cyclosporine. \n",
      "Interactions for <e1>Vitamin B1</e1> (Thiamine):  Loop Diuretics, Oral Contraceptives, <e2>Stavudine</e2>, Tricyclic Antidepressants\n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, taxol, <e1>rifampicin</e1>, and human immunodeficiency virus protease inhibitors such as <e2>ritonavir</e2> and saquinavir. \n",
      "Plasma levels of <e1>piroxicam</e1> are depressed to approximately 80% of their normal values when <e2>FELDENE</e2> is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, <e1>butyrophenones</e1>, thioxanthenes) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., <e2>Elavil</e2>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of <e1>morphine</e1> are potentiated by the presence of other CNS depressants such as alcohol, <e2>sedatives</e2>, antihistaminics, or psychotropic drugs. \n",
      "Other <e1>HDAC Inhibitors</e1> Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other HDAC inhibitors (e.g., <e2>valproic acid</e2>). \n",
      "Concurrent use of <e1>alcohol</e1> and other CNS depression-producing drugs may increase the CNS depressant effects of <e2>methyprylon</e2> or these other medications.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (Dilantin) <e2>carbamazepine</e2> (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e2>itraconazole</e2>, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, Cisapride, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "- Cisapride, pimozide: Other drugs such as <e1>cisapride</e1> or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some <e2>macrolide antibacterials</e2>. \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, <e1>diazepam</e1>, hydroxyzine, and other muscle relaxants) or local <e2>anesthetics</e2> have been observed.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Patients receiving sirolimus or nifedipine in combination with <e1>MYCAMINE</e1> should be monitored for <e2>sirolimus</e2> or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, <e1>phenytoin</e1>, sulfinpyrazone, <e2>naproxen</e2>, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "You cannot take mazindol if you have taken a <e1>monoamine oxidase inhibitor</e1> (MAOI) such as isocarboxazid (<e2>Marplan</e2>), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Methyldopa does not interfere with measurement of <e1>VMA</e1> (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert <e2>VMA</e2> to vanillin. \n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, <e2>rifabutin</e2>, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "These data suggest that <e1>GH</e1> administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, sex steroids, <e2>anticonvulsants</e2>, cyclosporin). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Compared with the elimination of pure luteolin and <e1>apigenin</e1>, the elimination of luteolin and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and <e2>apigenin</e2>. \n",
      "Although ibuprofen (400 mg qid) can be administered with <e1>ALIMTA</e1> in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering <e2>ibuprofen</e2> concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, <e2>diltiazem</e2>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with <e1>dornase alfa</e1> (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral <e2>aminoglycosides</e2> demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, Cisapride, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "In this crossover steady state study, the pharmacokinetics of <e1>propafenone</e1> were unaffected in either phenotype by the coadministration of <e2>mexiletine</e2>. \n",
      "<e1>Digoxin</e1>: A controlled pharmacokinetic study has shown no effect on plasma <e2>digoxin</e2> concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. \n",
      "Short-acting Benzodiazepines: Following oral administration of <e1>midazolam</e1>, <e2>fluconazole</e2> resulted in substantial increases in midazolam concentrations and psychomotor effects. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), <e2>nonsteroidal anti-inflammatory drugs</e2> (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "The use of AGGRASTAT, in combination with heparin and <e1>aspirin</e1>, has been associated with an increase in bleeding compared to <e2>heparin</e2> and aspirin alone (see\n",
      "Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as <e1>acetylsalicylic acid</e1>, <e2>dipyridamole</e2>, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "Since there is no interaction with theophylline, interaction with other <e1>methylxanthines</e1> such as <e2>caffeine</e2> is unlikely. \n",
      "<e1>Warfarin</e1> users who initiated citalopram, <e2>fluoxetine</e2>, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "<e1>Moxifloxacin</e1> and <e2>Lomefloxacin</e2> reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. \n",
      "The effect of a series of <e1>flavonoids</e1>, including flavonols, flavones, isoflavone, flavanone, flavanonols and catechins, on the elimination of <e2>luteolin</e2> and apigenin was studied. \n",
      "In vitro perfusion of isolated rat liver has shown that <e1>cimetidine</e1> caused a significant reduction in trimetrexate metabolism and that <e2>acetaminophen</e2> altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites. \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e1>thioxanthines</e1> ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a <e2>dopamine agonist</e2>); \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or <e1>sulphasalazine</e1>) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent <e2>thioguanine</e2> therapy.    \n",
      "<e1>Salicylates</e1> and Other Non-Steroidal Anti-Inflammatory Drugs: May decrease the antihypertensive effects of <e2>MYKROX</e2> Tablets. \n",
      "<e1>Lithium</e1>: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with <e2>lithium</e2>. \n",
      "The coadministration of <e1>fluconazole</e1> at doses lower than 400 mg/day with <e2>terfenadine</e2> should be carefully monitored. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, <e1>polymyxin B</e1>, colistin, <e2>viomycin</e2>, or cisplatin, when indicated, requires careful monitoring.\n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, <e1>barbiturates</e1>, hypnotics, narcotic analgesics, sedatives, and <e2>tranquillisers</e2>. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "In a large compassionate use program <e1>Mexitil</e1>    has been used concurrently with commonly employed antianginal, antihypertensive, and <e2>anticoagulant drugs</e2> without observed interactions. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. <e1>Diazepam</e1>: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of <e2>mirtazapine</e2> (15 mg) in 12 healthy subjects. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e1>antacids</e1>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e2>melatonin</e2> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or <e1>cholinergic agonists</e1> such as <e2>bethanechol</e2>.\n",
      "Results revealed that the strains were resistant to many drugs at high levels, only piperacillin, carbenicillin, <e1>amikacin</e1> and <e2>ciprofloxacin</e2> showed resistances at comparatively lower levels. \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, <e1>antihistaminics</e1>, or <e2>psychotropic drugs</e2>. \n",
      "<e1>Cholestyramine</e1>: <e2>Cholestyramine</e2> causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with EVISTA. \n",
      "The concomitant use of other CNS depressants including sedatives, <e1>hypnotics</e1>, tranquilizers, general <e2>anesthetics</e2>, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, <e1>analgesics</e1>, <e2>antiemetics</e2>/antinauseants, antispasmodics and anticholinergic agents. \n",
      "Pindolol has been used with a variety of antihypertensive agents, including <e1>hydrochlorothiazide</e1>, <e2>hydralazine</e2>, and guanethidine without unexpected adverse interactions. \n",
      "<e1>Mitotane</e1> has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for <e2>warfarin</e2>. \n",
      "<e1>Phenothiazines</e1> are capable of potentiating <e2>CNS depressants</e2> (e.g., barbiturates, anesthetics, opiates, alcohol, etc.) \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, <e1>beta blockers</e1>, digitalis, diuretics, <e2>antidiabetic agents</e2>, and antiarrhythmics, without observed problems. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e1>narcotic analgesics</e1> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e1>nefazodone</e1>, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "morphine, theophylline, aminophylline, <e1>succinylcholine</e1>, <e2>reserpine</e2>, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "Compounds that quench active oxygen species or scavenge radicals, such as dimethyl sufloxide, <e1>b-carotene</e1>, ethanol, formate and <e2>mannitol</e2> would be expected to decrease PDT activity. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, ketoconazole, <e2>fluconazole</e2>, calcium channel blockers and cimetidine.    \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, indinavir, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "<e1>Warfarin</e1>: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing <e2>MOBIC</e2> therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding. \n",
      "If <e1>diuretics</e1> cannot be interrupted, close medical supervision should be provided with the first dose of <e2>ACEON</e2>    Tablets, for at least two hours and until blood pressure has stabilized for another hour. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - <e2>neostigmine</e2> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Absorption of tetracyclines is impaired by antacids containing aluminum, <e1>calcium</e1> or magnesium, and <e2>iron</e2>-containing preparations. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (<e1>Tegretol</e1>) <e2>Estrogens</e2> may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e2>ProAmatine</e2>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "While in vitro studies have shown that <e1>mirtazapine</e1> is not a potent inhibitor of any of these enzymes, an indication that mirtazapine is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of <e2>REMERON SolTab</e2> with most other drugs metabolized by these enzymes has not been formally studied. \n",
      "Oral Contraceptives: In 20 normal-weight female subjects, the treatment of <e1>XENICAL</e1> 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral <e2>contraceptives</e2>. \n",
      "In the absence of data regarding potential interaction between <e1>ALIMTA</e1> and NSAIDs with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following <e2>ALIMTA</e2> administration. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general <e1>anesthetics</e1>, phenothiazines, other opioids, tricyclic antidepressants, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "EA signs were observed in all 7 patients in association with propofol TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose <e1>ketamine</e1> was added to <e2>propofol</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as digoxin, <e1>bronchodilators</e1>, other antiviral agents, antibiotics, or <e2>anti-metabolites</e2> have not been conducted. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., ritonavir, indinavir, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Thus, <e1>SYMLIN</e1> and <e2>insulin</e2> should not be mixed and must be administered separately.\n",
      "Standard antibiotic such as Gentamicin (10 microg), <e1>Cephalothin</e1> (30 microg), Ceftriaxone (10 microg), <e2>Nystatin</e2> (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Concurrent ingestion of <e1>antacid</e1> (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and <e2>simethicone</e2>) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that <e1>dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "Drugs such as erythromycin, diltiazem, <e1>verapamil</e1>, ketoconazole, <e2>fluconazole</e2> and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of <e1>docetaxel</e1> followed by sunitinib is superior to sunitinib followed by <e2>docetaxel</e2> and concurrent administration.\n",
      "Triprolidine may enhance the sedative effects of <e1>central nervous system depressants</e1> including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and <e2>tranquillisers</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e1>delavirdine</e1>) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e2>warfarin</e2> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "An expert panel reviewed each case and classified the likelihood of <e1>colchicine</e1> toxicity, the likelihood of a causal role of colchicine in the death using the WHO classification system, and the appropriateness of <e2>colchicine</e2> dosing. \n",
      "Concomitant administration of terfenadine with clarithromycin, <e1>erythromycin</e1>, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of <e2>terfenadine</e2> with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of <e1>citalopram</e1> (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), <e2>paroxetine</e2> (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "The pharmacokinetic profile of <e1>temazepam</e1> does not appear to be altered by orally administered <e2>cimetidine</e2> dosed according to labeling.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e2>polymyxin B</e2> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e1>ranitidine</e1>, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Laboratory Tests There have been reports of false-positive urine screening tests for <e1>tetrahydrocannabinol</e1> (<e2>THC</e2>) in patients receiving most proton pump inhibitors, including pantoprazole. \n",
      "<e1>Fluconazole</e1> tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral <e2>contraceptives</e2> produced an overall mean increase in ethinyl estradiol and levonorgestrel levels; \n",
      "Since <e1>Celontin</e1> (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg <e2>methsuximide</e2> may increase the plasma concentrations of phenytoin and phenobarbital).\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Caution is recommended when administering <e1>doxorubicin</e1> with <e2>NEXAVAR</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e1>Tacrolimus</e1>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, <e1>narcotic analgesics</e1>, <e2>sedatives</e2>, and tranquillisers. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, <e2>ketoconazole</e2>, fluconazole, calcium channel blockers and cimetidine.    \n",
      "Given the primary CNS effects of <e1>paliperidone</e1>, INVEGA    should be used with caution in combination with other <e2>centrally acting drugs</e2> and alcohol. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, <e1>sulfinpyrazone</e1>, naproxen, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "We concluded that the combined administration of dexmedetomidine with <e1>ephedrine</e1> may have beneficial effects in the treatment of pain without causing sedation, which limits the use of <e2>dexmedetomidine</e2> as an analgesic in humans.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e1>metformin</e1>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to <e1>5-FU</e1>, cisplatin, doxorubicin and <e2>etoposide</e2>   celecoxib following different incubation schedules were analyzed.\n",
      "- Decreased absorption of <e1>colestipol</e1>, cholestyramine, <e2>mineral oil</e2>, and sucralfate.\n",
      "Oral <e1>contraceptives</e1> containing <e2>estrogen</e2>: tetracyclines may decrease the contraceptive effect and increase the chance of unwanted pregnancy.\n",
      "Drugs such as <e1>erythromycin</e1>, diltiazem, verapamil, <e2>ketoconazole</e2>, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "and combinations of opioids and <e1>sedatives</e1> (eg, benzodiazepines, barbiturates, <e2>chloral hydrate</e2>, droperidol, etc.). \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of <e1>digoxin</e1>, <e2>warfarin</e2>, diazepam, or fluoxetine. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "This increase was observed at the first test point which was the second day after starting <e1>Mexitil</e1>   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If <e2>Mexitil</e2> and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "<e1>Aspirin</e1> should be used cautiously in conjunction with <e2>corticosteroids</e2> in patients suffering from hypoprothrombinemia. \n",
      "<e1>heparin</e1>, warfarin, diazepam, <e2>insulin</e2>; \n",
      "No significant adverse interactions with common premedications (such as <e1>atropine</e1>, scopolamine, glycopyrrolate, diazepam, <e2>hydroxyzine</e2>, and other muscle relaxants) or local anesthetics have been observed.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), <e1>antidiabetics</e1> (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), <e2>salicylate analgesics</e2> (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "When administered concurrently, <e1>testolactone</e1> may increase the effects of oral <e2>anticoagulants</e2>; \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e1>indinavir</e1>, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e1>indinavir</e1>, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, <e1>Iron</e1>-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "The <e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1> treatment also had a significant effect on the <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>-induced loss of norepinephrine neurons in the locus coeruleus and adjoining A5 and A7 noradrenaline cell groups. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e1>phenytoin</e1>, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "In vitro studies with human liver microsomes showed that <e1>terbinafine</e1> does not inhibit the metabolism of tolbutamide, <e2>ethinylestradiol</e2>, ethoxycoumarin, and cyclosporine. \n",
      "While there is evidence that <e1>fluconazole</e1> can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or <e2>levonorgestrel</e2> metabolism. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (<e1>SSRIs</e1>) (e.g., fluoxetine, <e2>fluvoxamine</e2>, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "<e1>Aspirin</e1> should be used cautiously in conjunction with <e2>corticosteroids</e2> in patients suffering from hypoprothrombinemia. \n",
      "When <e1>phenytoin</e1> or other hepatic enzyme inducers such as rifampin and <e2>phenobarbital</e2> have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. \n",
      "The effect of curcumin (100 mg/kg) was similar to that of <e1>fluoxetine</e1> and imipramine (p > 0.05) but its addition to <e2>fluoxetine</e2> and imipramine did not improve their antidepressant activity (p > 0.05). \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, <e1>Cholestyramine</e1>, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, <e2>Laxatives</e2>, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e2>reverse transcriptase inhibitors</e2> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) <e1>carbamazepine</e1> (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "Those anticonvulsants include <e1>divalproex sodium</e1>, valproic acid, and <e2>phenobarbital</e2>. \n",
      "Live Vaccines: During treatment with <e1>Myfortic</e1>, the use of <e2>live attenuated vaccines</e2> should be avoided and patients should be advised that vaccinations may be less effective. \n",
      "chlorthalidone, <e1>furosemide</e1>, hydrochlorothiazide, <e2>spironolactone</e2>; \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, morphine, <e2>meperidine</e2> and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e2>medroxyprogesterone acetate</e2>, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between <e1>ondansetron</e1> and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by <e2>ondansetron</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "<e1>Cholestyramine</e1>: Pretreatment for four days with cholestyramine significantly increased the clearance of <e2>meloxicam</e2> by 50%. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e1>BARBITURATES</e1>), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e1>penicillins</e1>, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between <e1>ondansetron</e1> and tramadol has been observed, data from 2 small studies indicate that <e2>ondansetron</e2> may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "These medications included thyroid hormones, sedative hypnotics, <e1>non-steroidal anti-inflammatory agents</e1>, benzodiazepines, and <e2>decongestants</e2>. \n",
      "No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of <e1>muscle relaxants</e1>, inhalational agents, analgesic agents, and local <e2>anesthetic agents</e2>) have been observed.\n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and <e1>rifampicin</e1>), the clearance of <e2>ondansetron</e2> was significantly increased and ondansetron blood concentrations were decreased. \n",
      "<e1>Melatonin</e1> may interact with the following drugs: <e2>aspirin</e2> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Alcohol</e1>: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to <e2>orlistat</e2>. \n",
      "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and <e1>abciximab</e1>) may increase the risk of bleeding if administered prior to or after <e2>Retavase</e2>    therapy.\n",
      "<e1>Beta adrenergic agonists</e1> should be administered with caution to patients being treated with <e2>monoamine oxidase inhibitors</e2> or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, <e2>griseofulvin</e2>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (<e1>curcumin</e1> 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (<e2>imipramine</e2> 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "If in certain cases, an <e1>antidepressant</e1> is considered necessary, it may be advisable to replace tamoxifen with <e2>anastrozole</e2>.\n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "The effect of a series of <e1>flavonoids</e1>, including flavonols, flavones, isoflavone, flavanone, <e2>flavanonols</e2> and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, <e2>griseofulvin</e2>, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "To minimize CNS depression and possible potentiation, <e1>barbiturates</e1>, <e2>antihistamines</e2>, narcotics, hypotensive agents or phenothiazines should be used with caution. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "We evaluated the effects of <e1>calcium</e1> doses between 200 and 1500 mg on absorption of 5 mg <e2>nonheme iron</e2> (as ferrous sulfate). \n",
      "<e1>morphine</e1>, theophylline, aminophylline, succinylcholine, reserpine, and <e2>phenothiazine-type tranquilizers</e2> should be avoided in patients with organophosphate poisoning.\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, indinavir, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Displacement of <e1>penicillin</e1> from plasma protein binding sites will elevate the level of free <e2>penicillin</e2> in the serum.\n",
      "Given the primary CNS effects of <e1>paliperidone</e1>, <e2>INVEGA</e2>    should be used with caution in combination with other centrally acting drugs and alcohol. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, <e1>ritonavir</e1>, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of <e1>methadone</e1> has no clinically significant effect on the pharmacokinetic properties of <e2>abacavir</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "Oral <e1>Anticoagulants</e1>: Interaction studies with <e2>warfarin</e2> failed to identify any clinically important effect on the serum concentrations of the anticoagulant or on its anticoagulant effect. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (<e1>SSRIs</e1>) (e.g., fluoxetine, fluvoxamine, paroxetine, <e2>sertraline</e2>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Macrolides</e1>: Clinical drug interaction studies indicate that erythromycin and <e2>clarithromycin</e2> can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent. \n",
      "This medicine is generally safe with other medications, but patient should consult doctor or pharmacist if patient is taking a blood thinner (<e1>anticoagulant</e1>), cyclosporin, <e2>phenytoin</e2>, or methotrexate.\n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower <e2>melatonin</e2> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e2>ketoconazole</e2> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "May increase the effect of oral blood thinners, for example <e1>warfarin</e1> (<e2>Coumadin</e2>). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "The neuromuscular blocking effect of <e1>MIVACRON</e1> may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, <e2>glucocorticoids</e2>, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "Two separate studies were conducted to evaluate the bioequivalence of <e1>fenofibric acid</e1> relative to <e2>fenofibrate</e2> under fasted and fed (standard breakfast) conditions, characterize the pharmacokinetic profile, and assess the safety and tolerability of fenofibric acid. \n",
      "AAV2-mediated retinal transduction is improved by co-injection of <e1>heparinase III</e1> or <e2>chondroitin ABC lyase</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, <e2>Cisapride</e2>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "In addition to bleeding associated with heparin and <e1>vitamin K antagonists</e1>, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after <e2>Retavase</e2>    therapy.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, <e1>morphine</e1>, meperidine, and <e2>fentanyl</e2>, etc.) \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e1>melatonin</e1> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e1>bacitracin</e1> - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Acyclovir/<e1>Ganciclovir</e1>: may be taken with <e2>Myfortic</e2>; \n",
      "Other eye drops or medications such as acetylcholine chloride (<e1>Miochol</e1>) and carbachol (<e2>Carboptic</e2>, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (<e1>Dilantin</e1>) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., <e1>itraconazole</e1> and miconazole) or macrolide antibiotics (e.g., erythromycin and <e2>clarithromycin</e2>), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., ritonavir, <e2>indinavir</e2>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "May increase the effect of oral <e1>blood thinners</e1>, for example warfarin (<e2>Coumadin</e2>). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Adding 0.01% <e1>manganese gluconate</e1> to 10% <e2>carbamide peroxide</e2> bleaching gel increased the degree of tooth bleaching after a seven-day treatment and did not influence the resulting shade after 14 days.\n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-<e1>Mexitil</e1>    values within 48 hours after discontinuing Mexitil   . If Mexitil and <e2>theophylline</e2> are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, <e1>sympathomimetic drugs</e1>, tricyclic antidepressant drugs (e.g., <e2>amitriptyline HCl</e2>, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and rifampin may increase the clearance of <e1>methylprednisolone</e1> and may require increased in <e2>methylprednisolone</e2> dose to achieve the desired response. \n",
      "Additive sedative effects can occur when metoclopramide is given with alcohol, <e1>sedatives</e1>, hypnotics, <e2>narcotics</e2>, or tranquilizers. \n",
      "<e1>Sulfoxone</e1> may increase the effects of barbiturates, <e2>tolbutamide</e2>, and uricosurics. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "In the present study piperine (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of ibuprofen evaluated by both <e1>acetic acid</e1> writhing and formalin test, when it was administered with <e2>ibuprofen</e2>. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e1>ranitidine</e1>, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e1>digoxin</e1>, procainamide, pancuronium, morphine, vancomycin, metformin and <e2>tenofovir</e2>). \n",
      "Phenytoin, <e1>Carbamazepine</e1>, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and <e2>rifampicin</e2>), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "DRUG INTERACTIONS  There are no known drug/drug interactions with oral <e1>ALKERAN</e1>  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous <e2>melphalan</e2> has caused deaths in children due to haemorrhagic enterocolitis.  \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e2>indinavir</e2>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain <e2>antibiotics</e2> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Caution should be exercised when administering <e1>ZADAXIN</e1> therapy in combination with other <e2>immunomodulating drugs</e2>. \n",
      "Caution should be used when administering MOBIC with <e1>warfarin</e1> since patients on <e2>warfarin</e2> may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced.\n",
      "Furthermore, <e1>rifampin</e1>, <e2>dexamethasone</e2>, St. \n",
      "Clinical studies of interactions of <e1>VIRAZOLE</e1> with other drugs commonly used to treat infants with RSV infections, such as digoxin, bronchodilators, other antiviral agents, <e2>antibiotics</e2>, or anti-metabolites have not been conducted. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e1>meperidine</e1>), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e1>HIV-protease inhibitors</e1>, <e2>griseofulvin</e2>, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "saline + saline, ephedrine (10   mg/kg) + saline, saline + <e1>dexmedetomidine</e1> (15     g/kg) and ephedrine (10   mg/kg) + <e2>dexmedetomidine</e2> (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a <e1>protease inhibitor</e1> (PI) or an <e2>integrase inhibitor</e2> (II) is recommended. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and <e1>fentanyl</e1>), propofol, ketamine, nitrous oxide, secobarbital and <e2>droperidol</e2>. \n",
      "Due to the chemical similarity of other <e1>azole-type antifungal agents</e1> (including fluconazole, metronidazole, and miconazole) to <e2>ketoconazole</e2>, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, <e1>erythromycin</e1>, clarithromycin) or <e2>cyclosporine</e2> or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, <e1>carbamazepine</e1>) may induce <e2>mifepristone</e2> metabolism (lowering serum levels of mifepristone). \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, <e1>quinidine</e1>, theophylline, corticosteroids, anticoagulants, and <e2>beta blockers</e2>.\n",
      "Combining with <e1>cisplatin</e1> and MWCHCP caused a tendency of increasing the tumor growth inhibition rate and significant attenution of <e2>cisplatin</e2>-induced diarrhea, visceral organ injury, gastric mucosal injury and decreased TNF-alpha mRNA level of intestine. \n",
      "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, <e1>diuretics</e1>, H2 blockers, <e2>digoxin</e2>, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e1>Aventyl</e1>, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, <e2>Laxatives</e2>, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Caution is advised for patients receiving high-dose aspirin and <e1>methazolamide</e1> concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose <e2>aspirin</e2> and carbonic anhydrase inhibitors.\n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral <e1>contraceptives</e1> (norethindrone 1 mg/<e2>ethinyl estradiol</e2> 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, ketoconazole, fluconazole, <e2>calcium channel blockers</e2> and cimetidine.    \n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, phenytoin and <e2>rifampin</e2> may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., <e1>pentazocine</e1>, nalbuphine, butorphanol, or <e2>buprenorphine</e2>) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e1>SEDATIVE-HYPNOTICS</e1> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "The effect of <e1>orlistat</e1> on the absorption of supplemental <e2>vitamin D</e2>, vitamin A, and nutritionally-derived vitamin K is not known at this time. \n",
      "No significant drug interactions were reported in studies in which olmesartan medoxomil was co-administered with <e1>digoxin</e1> or <e2>warfarin</e2> in healthy volunteers. \n",
      "Thus strong inhibitors of cytochrome P4501A2, such as <e1>fluvoxamine</e1>, given concomitantly during administration of Ropivacaine, can interact with <e2>Ropivacaine</e2> leading to increased ropivacaine plasma levels. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e2>pramipexole</e2> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that <e1>dopamine antagonists</e1>, such as the neuroleptics (<e2>phenothiazines</e2>, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of <e1>ondansetron</e1> was significantly increased and <e2>ondansetron</e2> blood concentrations were decreased. \n",
      "In vitro studies with atracurium, <e1>mivacurium</e1>, esmolol, echothiophate, neostigmine, <e2>physostigmine</e2>, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (<e2>norethindrone</e2> 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), <e1>paroxetine</e1> (OR   =   1.64 [95% CI, 1.27-2.12]), <e2>amitriptyline</e2> (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "Accordingly, patients should be advised to avoid alcohol while taking <e1>REMERON SolTab</e1>. Diazepam: Concomitant administration of <e2>diazepam</e2> (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. \n",
      "Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, <e1>ampicillin</e1> esters, and <e2>iron</e2> salts). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e2>metformin</e2>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (<e1>norethindrone</e1> 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and <e2>warfarin</e2>. \n",
      "In oral (gavage) fertility studies of <e1>ezetimibe</e1> conducted in rats, there was no evidence of reproductive toxicity at doses up to 1000 mg/kg/day in male or female rats (~7 times the human exposure at 10 mg daily based on AUC0-24hr for total <e2>ezetimibe</e2>). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e1>indomethacin</e1>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "We evaluated how lapatinib interacts with <e1>Herceptin</e1> in HER2-positive breast cancer, with a particular focus on <e2>Herceptin</e2>-mediated antibody-dependent cellular cytotoxicity (ADCC). \n",
      "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and <e1>mycophenolate mofetil</e1> inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or <e2>mycophenolate mofetil</e2>. \n",
      "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of tolbutamide, <e1>sodium salicylate</e1> and <e2>sulfamethizole</e2> displaced protein-bound teniposide in fresh human serum to a small but significant extent. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Montelukast at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral <e1>contraceptive</e1> containing <e2>norethindrone</e2> 1 mg/ethinyl estradiol 35 mcg. \n",
      "Due to low systemic exposure to <e1>retapamulin</e1> following topical application in patients, dosage adjustments for retapamulin are unnecessary when co-administered with CYP3A4 inhibitors, such as <e2>ketoconazole</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e1>melatonin</e1> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of <e1>rivastigmine</e1> is not significantly affected by concurrent administration of digoxin, warfarin, <e2>diazepam</e2>, or fluoxetine. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, <e2>quinidine</e2>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, <e1>rifabutin</e1>, rifapentin, <e2>phenobarbital</e2>, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, <e2>levothyroxine sodium</e2>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include <e1>methanol</e1>, ethylene glycol, diethylene glycol, <e2>propylene glycol</e2>, or isopropanol. \n",
      "<e1>Sulfonamides</e1> can also displace methotrexate from plasma protein-binding sites, thus increasing free <e2>methotrexate</e2> concentrations. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e1>sulfonamides</e1>, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (<e1>Dilantin</e1>) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - <e2>Central nervous system (CNS) depressants</e2> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e1>Aventyl</e1>, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, <e1>ephedrine</e1>, <e2>phenylpropanolamine</e2> or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e1>clomipramine</e1> (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (<e2>SSRIs</e2>) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, <e1>ketoconazole</e1>, and <e2>fluconazole</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Drug Interactions: The use of ZEMURON    (<e1>rocuronium bromide</e1>) Injection before succinylcholine, for the purpose of attenuating some of the side effects of <e2>succinylcholine</e2>, has not been studied. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e1>warfarin</e1>, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with <e1>ACEON</e1>    Tablets, but an effect of <e2>digoxin</e2> on the plasma concentration of perindopril/perindoprilat has not been excluded. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: <e1>Agonist/antagonist analgesics</e1> (i.e., pentazocine, nalbuphine, butorphanol, or <e2>buprenorphine</e2>) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), <e1>antianginals</e1> (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e2>levothyroxine sodium</e2>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, <e1>morphine</e1>, vancomycin, <e2>metformin</e2> and tenofovir). \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "Other Agents: No clinically important pharmacokinetic interactions occurred when UNIVASC    was administered concomitantly with <e1>hydrochlorothiazide</e1>, <e2>digoxin</e2>, or cimetidine. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, <e1>sirolimus</e1>, <e2>nifedipine</e2>, fluconazole, ritonavir, and rifampin. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e1>multivitamins</e1>, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Use with Other <e1>Central Nervous System Depressants</e1>: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, <e2>antihistaminics</e2>, or psychotropic drugs. \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "Oral <e1>Contraceptives</e1>: In 20 normal-weight female subjects, the treatment of XENICAL 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral <e2>contraceptives</e2>. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, <e1>indomethacin</e1>, naproxen, <e2>ibuprofen</e2>, diazepam, and diazoxide. \n",
      "There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral <e1>terbinafine</e1> and <e2>warfarin</e2>, however, a causal relationship between LAMISIL    Tablets and these changes has not been established. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, <e2>morphine</e2>, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, <e1>MARINOL</e1> (<e2>Dronabinol</e2>) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, sedatives, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e1>cimetidine</e1>, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, <e1>nalidixic acid</e1>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "Absorption of tetracyclines is impaired by antacids containing <e1>aluminum</e1>, calcium or magnesium, and <e2>iron</e2>-containing preparations. \n",
      "<e1>Trilostane</e1> may interact with <e2>aminoglutethimide</e2> or mitotane (causing too great a decrease in adrenal function).\n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, <e1>sedatives</e1>, antihistaminics, or <e2>psychotropic drugs</e2>. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e2>paricalcitol</e2> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "- <e1>Cisapride</e1>, <e2>pimozide</e2>: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e2>estrogens</e2> (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "The present findings suggest that MWCHCP increases the inhibition rate of tumor growth of <e1>cisplatin</e1> and has a beneficial influence on gastrointestinal lesion induced by <e2>cisplatin</e2>.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), <e2>nortriptyline</e2> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "The concurrent administration of potent inhalational agents (eg, isoflurane, enflurane, and <e1>halothane</e1>) during maintenance with <e2>DIPRIVAN</e2> Injectable Emulsion has not been extensively evaluated. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "It will compete with <e1>clopidogrel</e1> (<e2>Plavix</e2>) and prasugrel (Effient) for such use. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "All mRPCs of 20 passages or less were transplanted into the subretinal space of B6 mice together with chondroitinase ABC, and into Rho(-/-) mice combined with chondroitinase ABC, N-[N-(3, 5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (<e1>DAPT</e1>), and <e2>insulin growth factor</e2> (IGF)-1. \n",
      "Monoamine oxidase inhibitors or <e1>tricyclic antidepressants</e1> may potentiate the action of <e2>sympathomimetic amines</e2>. \n",
      "Palonosetron did not inhibit the antitumor activity of the five <e1>chemotherapeutic agents</e1> tested (cisplatin, cyclophosphamide, cytarabine, doxorubicin and <e2>mitomycin C</e2>) in murine tumor models.\n",
      "Absorption of tetracyclines is impaired by <e1>antacids</e1> containing aluminum, calcium or magnesium, and <e2>iron</e2>-containing preparations. \n",
      "Concurrent administration of cimetidine and <e1>Mexitil</e1>    has been reported to increase, decrease, or leave unchanged <e2>Mexitil</e2>    plasma levels; \n",
      "<e1>Metopirone</e1> inhibits the glucuronidation of acetaminophen and could possibly potentiate <e2>acetaminophen</e2> toxicity.\n",
      "Our objective was to establish potential effects of <e1>calcium</e1> on absorption of <e2>nonheme</e2> and heme iron and the dose response for this effect in the absence of a meal. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, <e1>polymyxin B</e1>, <e2>colistin</e2>, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), <e1>salicylate analgesics</e1> (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or <e2>coal tar derivatives</e2>, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as rifampin, <e1>carbamazepine</e1>, and <e2>phenytoin</e2>, induce metabolism and caused a markedly decreased C max and AUC of oral midazolam in adult studies. \n",
      "The effects of <e1>anti-parkinsonian drug</e1> hemantane [<e2>(2-adamantyl)hexamethylenimine</e2>] (10 mg/kg, p. o.) \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "However, on the basis of available data, no dosage adjustment for <e1>ondansetron</e1> is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by <e2>ondansetron</e2>. \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e1>metoprolol</e1>, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (<e1>NRTI</e1>) together with a non-nucleoside reverse transcriptase inhibitor (<e2>NNRTI</e2>), a protease inhibitor (PI) or an integrase inhibitor (II) is recommended. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., <e1>phenylephrine</e1>, pseudoephedrine, ephedrine, phenylpropanolamine or <e2>dihydroergotamine</e2>) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "<e1>Alcohol</e1> (this combination may make you very sick) and <e2>primaquine</e2>\n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - <e1>Mitomycin-C</e1>: may cause shortness of breath and bronchospasm - <e2>Killed virus vaccines</e2>: may decrease patient's response to the vaccine\n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Short-acting Benzodiazepines: Following oral administration of <e1>midazolam</e1>, fluconazole resulted in substantial increases in <e2>midazolam</e2> concentrations and psychomotor effects. \n",
      "Patients receiving sirolimus or <e1>nifedipine</e1> in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or <e2>nifedipine</e2> dosage should be reduced if necessary. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, <e1>flavanone</e1>, <e2>flavanonols</e2> and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Careful monitoring of <e1>cyclosporine</e1> concentrations and serum creatinine is recommended in patients receiving DIFLUCAN and <e2>cyclosporine</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Usage with <e1>Alcohol</e1>: Due to the potential for increased CNS depressants effects, <e2>alcohol</e2> should be used with caution in patients who are currently receiving pentazocine.\n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), <e1>tranylcypromine</e1> (<e2>Parnate</e2>), or phenelzine (Nardil) in the last 14 days. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled <e1>corticosteroids</e1>, other anti-pseudomonal antibiotics, or parenteral <e2>aminoglycosides</e2> demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "<e1>TERAZOL</e1> 3 Vaginal Cream 0.8% The levels of estradiol (E2) and progesterone did not differ significantly when 0.8% <e2>terconazole</e2> vaginal cream was administered to healthy female volunteers established on a low dose oral contraceptive.    \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, <e1>Iron</e1>-containing drugs, Laxatives, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "<e1>Zinc</e1>/<e2>iron</e2> salts: Absorption of quinolones is reduced significantly by these preparations. \n",
      "<e1>Lithium</e1>: Increased serum lithium and symptoms of lithium toxicity have been reported in patients receiving concomitant <e2>lithium</e2> and ACE inhibitor therapy. \n",
      "MAO Inhibitors - The pressor effect of <e1>sympathomimetic pressor amines</e1> is markedly potentiated in patients receiving <e2>monoamine oxidase inhibitors</e2> (MAOI). \n",
      "<e1>ACE inhibitors</e1> Reports suggest that <e2>NSAIDs</e2> may diminish the antihypertensive effect of angiotensin-converting enzyme (ACE) inhibitors. \n",
      "<e1>Lithium</e1>: Increased serum <e2>lithium</e2> levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e1>absorbent-type anti-diarrhea medicines</e1> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Compared with the elimination of pure <e1>luteolin</e1> and apigenin, the elimination of luteolin and <e2>apigenin</e2> was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and apigenin. \n",
      "Interactions for Vitamin B1 (Thiamine):  Loop Diuretics, Oral <e1>Contraceptives</e1>, Stavudine, <e2>Tricyclic Antidepressants</e2>\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), <e2>nortriptyline</e2> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Oral <e1>Contraceptives</e1>: In 20 normal-weight female subjects, the treatment of <e2>XENICAL</e2> 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral contraceptives. \n",
      "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as rifampin, <e1>carbamazepine</e1>, and phenytoin, induce metabolism and caused a markedly decreased C max and AUC of oral <e2>midazolam</e2> in adult studies. \n",
      "Patients receiving sirolimus or <e1>nifedipine</e1> in combination with MYCAMINE should be monitored for sirolimus or <e2>nifedipine</e2> toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of <e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1> or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2> versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle). \n",
      "In the present study, the antidepressant like activity of <e1>curcumin</e1> and its combination with fluoxetine and <e2>imipramine</e2> was studied in acute model (three doses 24, 5 and 1 h before test) of forced swimming test (FST) in glass jar and tail suspension test (TST) in mice and in chronic model (14 day study) of FST with water wheel in rats. \n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, <e2>secobarbital</e2> and droperidol. \n",
      "<e1>Aspirin</e1>: <e2>Rimantadine HCl</e2>, 100 mg, was given twice daily fro 13 days to 12 healthy volunteers. \n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when <e1>cholinesterase inhibitors</e1> are given concurrently with succinylcholine, similar <e2>neuromuscular blocking agents</e2> or cholinergic agonists such as bethanechol.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "All mRPCs of 20 passages or less were transplanted into the subretinal space of B6 mice together with chondroitinase ABC, and into Rho(-/-) mice combined with chondroitinase ABC, <e1>N-[N-(3, 5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester</e1> (DAPT), and insulin growth factor <e2>(IGF)-1</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e1>methotrexate</e1>, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "The use of <e1>AGGRASTAT</e1>, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to heparin and <e2>aspirin</e2> alone (see\n",
      "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, <e1>ethinylestradiol</e1>, ethoxycoumarin, and <e2>cyclosporine</e2>. \n",
      "TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of <e1>methotrexate</e1> in an animal model, possibly enhancing the toxicity of <e2>methotrexate</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., <e1>dexamethasone</e1>, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, <e2>phenobarbital</e2>, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, Cholestyramine, Choline and <e2>magnesium salicylate</e2>s, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Anticoagulants (such as <e1>heparin</e1> and vitamin K antagonists) and drugs that alter platelet function (such as <e2>acetylsalicylic acid</e2>, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "<e1>Ethanol</e1> decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of <e2>abacavir</e2>. \n",
      "Varenicline reduces <e1>nicotine</e1> withdrawal symptoms, cigarette craving and <e2>nicotine</e2> satisfaction. \n",
      "In the present study, the antidepressant like activity of <e1>curcumin</e1> and its combination with <e2>fluoxetine</e2> and imipramine was studied in acute model (three doses 24, 5 and 1 h before test) of forced swimming test (FST) in glass jar and tail suspension test (TST) in mice and in chronic model (14 day study) of FST with water wheel in rats. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and <e1>fentanyl</e1>), <e2>propofol</e2>, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Anticholinesterases: Concurrent use of procaine hydrochloride and <e1>anticholinesterase agents</e1> may result in increased systemic toxicity since <e2>anticholinesterases</e2> inhibit the breakdown of procaine hydrochloride. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/<e1>ethinyl estradiol</e1> 35 mcg), <e2>terfenadine</e2>, digoxin, and warfarin. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e1>ritonavir</e1>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (<e1>NNRTI</e1>), a protease inhibitor (PI) or an integrase inhibitor (<e2>II</e2>) is recommended. \n",
      "Rats treated with neonatal <e1>quinpirole</e1> enhanced time spent in the amphetamine-paired context compared with <e2>quinpirole</e2>-free controls conditioned with amphetamine, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, <e1>pseudoephedrine</e1>, <e2>ephedrine</e2>, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, <e1>ketoconazole</e1>, ampicillin esters, and <e2>iron</e2> salts). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, flavanone, <e1>flavanonols</e1> and catechins, on the elimination of luteolin and <e2>apigenin</e2> was studied. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e1>azole antifungals</e1> (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "ASPIRIN AND OTHER <e1>SALICYLATE DRUGS</e1> WILL BE ADDITIVE TO DISALCID AND MAY INCREASE PLASMA CONCENTRATIONS OF <e2>SALICYLIC ACID</e2> TO TOXIC LEVELS. \n",
      "Cholestyramine and Drugs that Bind Bile Acids: These drugs interrupt enterohepatic recirculation and reduce <e1>MPA</e1> exposure when coadministered with <e2>mycophenolate mofetil</e2>. \n",
      "Diuretics: <e1>Furosemide</e1> and probably other <e2>loop diuretics</e2> given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes. \n",
      "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and <e1>levonorgestrel</e1>, there is no evidence that <e2>fluconazole</e2> is a net inducer of ethinyl estradiol or levonorgestrel metabolism. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e1>delavirdine</e1>) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Remifentanil clearance is not altered by concomitant administration of <e1>thiopental</e1>, isoflurane, <e2>propofol</e2>, or temazepam during anesthesia. \n",
      "It will compete with <e1>clopidogrel</e1> (Plavix) and prasugrel (<e2>Effient</e2>) for such use. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e1>ANESTHETICS</e1>, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, <e1>rifampin</e1>, <e2>rifabutin</e2>, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "You cannot take <e1>mazindol</e1> if you have taken a monoamine oxidase inhibitor (MAOI) such as <e2>isocarboxazid</e2> (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "<e1>Terbinafine</e1> clearance is increased 100% by rifampin, a CyP450 enzyme inducer, and decreased 33% by <e2>cimetidine</e2>, a CyP450 enzyme inhibitor. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, <e1>morphine</e1>, <e2>vancomycin</e2>, metformin and tenofovir). \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "e.g., other <e1>belladonna alkaloids</e1>, antihistamines (including meclizine), tricyclic antidepressants, and <e2>muscle relaxants</e2>. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e1>morphine</e1>, <e2>meperidine</e2> and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving <e1>MAO-A inhibitors</e1> is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., <e2>fluoxetine</e2>, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as <e1>clofibrate</e1>, indomethacin, <e2>naproxen</e2>, ibuprofen, diazepam, and diazoxide. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), <e1>calcium channel blockers</e1> (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e2>estrogens</e2> (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, <e1>tricyclic antidepressant</e1> drugs (e.g., amitriptyline HCl, <e2>imipramine HCl</e2>) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when <e1>FELDENE</e1> is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of <e2>antacids</e2> has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e1>indinavir</e1>, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (<e1>norethindrone</e1> 1 mg/ethinyl estradiol 35 mcg), <e2>terfenadine</e2>, digoxin, and warfarin. \n",
      "Concomitant administration of terfenadine with <e1>clarithromycin</e1>, erythromycin, or <e2>troleandomycin</e2> is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, <e1>Cholestyramine</e1>, Choline and magnesium salicylates, Colestipol, <e2>Iron</e2>-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Additive sedative effects and confusional states may emerge if levomepromazine is given with <e1>benzodiazepines</e1> or <e2>barbiturates</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e2>melatonin</e2> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Additive sedative effects can occur when metoclopramide is given with <e1>alcohol</e1>, sedatives, <e2>hypnotics</e2>, narcotics, or tranquilizers. \n",
      "Macrolides: Clinical drug interaction studies indicate that <e1>erythromycin</e1> and clarithromycin can exert an effect on <e2>terfenadine</e2> metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, <e1>isoflavone</e1>, flavanone, flavanonols and <e2>catechins</e2>, on the elimination of luteolin and apigenin was studied. \n",
      "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially <e1>SSRI antidepressants</e1> such as paroxetine and <e2>fluoxetine</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e2>phenothiazines</e2>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), <e1>propofol</e1>, ketamine, <e2>nitrous oxide</e2>, secobarbital and droperidol. \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, <e1>phenytoin</e1>, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "<e1>DIFLUCAN</e1> reduces the metabolism of <e2>tolbutamide</e2>, glyburide, and glipizide and increases the plasma concentration of these agents. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, <e1>nelfinavir</e1>, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "Drugs such as erythromycin, diltiazem, <e1>verapamil</e1>, <e2>ketoconazole</e2>, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "<e1>TRENTAL</e1> has been used concurrently with <e2>antihypertensive drugs</e2>, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "Weekly intramuscular <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1> injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/vehicle). \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include <e1>methanol</e1>, <e2>ethylene glycol</e2>, diethylene glycol, propylene glycol, or isopropanol. \n",
      "Mixing <e1>SYMLIN</e1> and <e2>Insulin</e2> The pharmacokinetic parameters of SYMLIN were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection. \n",
      "Cyclosporine: Preliminary data from a <e1>XENICAL</e1> and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when <e2>XENICAL</e2> was coadministered with cyclosporine. \n",
      "<e1>Phenothiazines</e1> are capable of potentiating CNS depressants (e.g., <e2>barbiturates</e2>, anesthetics, opiates, alcohol, etc.) \n",
      "The concurrent use of streptozocin and <e1>phenytoin</e1> has been reported in one case to result in reduced <e2>streptozocin</e2> cytotoxicity.    \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, <e1>nefazodone</e1>, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "An increase in intracellular levels of <e1>methotrexate</e1> was observed in vitro in the presence of <e2>teniposide</e2>.\n",
      "During maintenance of anesthesia or sedation, the rate of <e1>DIPRIVAN</e1> Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental <e2>analgesic agents</e2> (eg, nitrous oxide or opioids). \n",
      "2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of <e1>pralidoxime</e1>: since barbiturates are potentiated by the <e2>anticholinesterases</e2>, they should be used cautiously in the treatment of convulsions; \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, <e2>terazosin</e2>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Severe toxicity has also been reported in patients receiving the combination of <e1>tricyclic antidepressants</e1> and ELDEPRYL and <e2>selective serotonin reuptake inhibitors</e2> and ELDEPRYL. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "To minimize CNS depression and possible potentiation, barbiturates, antihistamines, <e1>narcotics</e1>, <e2>hypotensive agents</e2> or phenothiazines should be used with caution. \n",
      "<e1>Gentamicin</e1>: Animal data have suggested the possibility of interaction between <e2>perindopril</e2> and gentamicin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "SKELAXIN may enhance the effects of <e1>alcohol</e1>, <e2>barbiturates</e2> and other CNS depressants.\n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, Cholestyramine, Choline and <e2>magnesium salicylate</e2>s, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, <e1>meperidine</e1> and fentanyl), <e2>propofol</e2>, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "<e1>Thiazides</e1> may add to or potentiate the action of other <e2>antihypertensive drugs</e2>. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, <e1>phenytoin</e1>, and <e2>rifampin</e2> may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response. \n",
      "In Trial 1, the proportions of patients in the placebo and Synagis    groups who received routine childhood <e1>vaccines</e1>, influenza vaccine, <e2>bronchodilators</e2> or corticosteroids were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e1>colistin</e1>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e1>TRANQUILIZERS</e1>, <e2>SEDATIVE-HYPNOTICS</e2> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, <e1>clomipramine</e1>, <e2>desipramine</e2>). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Different chemical structures of precursors, smoking dynamics, pyrolysis of <e1>phytocannabinoids</e1> and frequency of drug use affect the amount of <e2>THC</e2> absorbed. \n",
      "Use of <e1>Anticoagulants</e1> and Antiplatelet Agents -- <e2>Streptase</e2>, Streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications. \n",
      "Phenothiazines are capable of potentiating CNS depressants (e.g., <e1>barbiturates</e1>, anesthetics, <e2>opiates</e2>, alcohol, etc.) \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, <e1>phenytoins</e1>, thiazide diuretics, beta blockers, and <e2>calcium channel blockers</e2>.\n",
      "The use of <e1>AGGRASTAT</e1>, in combination with <e2>heparin</e2> and aspirin, has been associated with an increase in bleeding compared to heparin and aspirin alone (see\n",
      "Itraconazole: Torsades de pointes and elevated parent <e1>terfenadine</e1> levels have been reported during concomitant use of <e2>terfenadine</e2> and itraconazole in clinical trials of itraconazole and from foreign post-marketing sources. \n",
      "<e1>Theophylline</e1>: <e2>DIFLUCAN</e2> increases the serum concentrations of theophylline. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, <e2>desmethyldiazepam</e2>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Regulatory agencies state that the combination of clopidogrel and the CYP2C19 inhibitors <e1>omeprazole</e1> and <e2>esomeprazole</e2> should be avoided. \n",
      "If in certain cases, an <e1>antidepressant</e1> is considered necessary, it may be advisable to replace <e2>tamoxifen</e2> with anastrozole.\n",
      "<e1>Methysergide</e1> may reverse the analgesic activity of <e2>narcotic analgesics</e2>. \n",
      "Following concurrent administration of <e1>NOVANTRONE</e1>    with <e2>corticosteroids</e2>, no evidence of drug interactions has been observed.\n",
      "<e1>Dopamine antagonists</e1>: Since <e2>pramipexole</e2> is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "In this paper we discuss peculiarities of drug interaction between <e1>cyclooxygenase inhibitors</e1> and acetylsalicylic acid, and principles of selection of adequate <e2>NSAI</e2>.\n",
      "The effects of anticholinergic drugs, such as atropine and <e1>tricyclic antidepressants</e1> may be enhanced by the concomitant administration of <e2>triprolidine</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, cyclosporine, tacrolimus, <e2>prednisolone</e2>, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or <e1>magnesium</e1>, and <e2>iron</e2>-containing preparations. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (<e1>Parnate</e1>), or phenelzine (<e2>Nardil</e2>) in the last 14 days. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, <e2>fluconazole</e2>, ritonavir, and rifampin. \n",
      "Pyrimethamine may be used with sulfonamides, <e1>quinine</e1> and other <e2>antimalarials</e2>, and with other antibiotics. \n",
      "Pharmacokinetic properties of <e1>abacavir</e1> were not altered by the addition of either <e2>lamivudine</e2> or zidovudine or the combination of lamivudine and zidovudine. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a <e1>non-nucleoside reverse transcriptase inhibitor</e1> (NNRTI), a protease inhibitor (PI) or an <e2>integrase inhibitor</e2> (II) is recommended. \n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking <e1>magnesium</e1>-aluminum containing <e2>antacids</e2> (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., <e2>Elavil</e2>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "The interaction of <e1>CYLERT</e1> (<e2>pemoline</e2>) with other drugs has not been studied in humans. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, sulfonamides, <e1>phenothiazines</e1>, <e2>sulfonylurea</e2> hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Therefore, as <e1>vitamin K</e1> absorption may be decreased with XENICAL, patients on chronic stable doses of warfarin who are prescribed <e2>XENICAL</e2> should be monitored closely for changes in coagulation parameters.\n",
      "Patients receiving <e1>sirolimus</e1> or nifedipine in combination with MYCAMINE should be monitored for <e2>sirolimus</e2> or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, <e1>triiodothyronine</e1>, phenytoin, sulfinpyrazone, <e2>naproxen</e2>, warfarin, methotrexate, and possibly corticosteroids. \n",
      "John   s Wort, and certain anticonvulsants (<e1>phenytoin</e1>, <e2>phenobarbital</e2>, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). \n",
      "Moxifloxacin and <e1>Lomefloxacin</e1> reacts faster with <e2>sucralfate</e2> and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, <e1>taxol</e1>, rifampicin, and human immunodeficiency virus protease inhibitors such as <e2>ritonavir</e2> and saquinavir. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Trilostane may interact with <e1>aminoglutethimide</e1> or <e2>mitotane</e2> (causing too great a decrease in adrenal function).\n",
      "Caution is advised for patients receiving high-dose <e1>aspirin</e1> and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose <e2>aspirin</e2> and carbonic anhydrase inhibitors.\n",
      "Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, <e1>tranquilizers</e1>, or <e2>alcohol</e2>. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, cyclosporine, <e2>tacrolimus</e2>, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as digoxin, <e1>bronchodilators</e1>, other <e2>antiviral agents</e2>, antibiotics, or anti-metabolites have not been conducted. \n",
      "After oral administration of <e1>colchicine</e1> (8 mg/kg) in the form of either the nanoemulsion or in free colchicine solution, the relative bioavailability of nanoemulsion and eugenol-nanoemulsion were enhanced by about 1.6- and 2.1-fold, respectively, compared with free <e2>colchicine</e2> solution. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Plasma levels of <e1>piroxicam</e1> are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on <e2>piroxicam</e2> plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "While in vitro studies have shown that mirtazapine is not a potent inhibitor of any of these enzymes, an indication that <e1>mirtazapine</e1> is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of <e2>REMERON SolTab</e2> with most other drugs metabolized by these enzymes has not been formally studied. \n",
      "and/or <e1>antibiotic drug</e1> doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (<e2>MPTP</e2>) (4 x 20 mg/kg, i. p.) \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with <e1>aspirin</e1> (3900 mg/day), but concomitant administration of antacids has no effect on <e2>piroxicam</e2> plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "<e1>chlorthalidone</e1>, <e2>furosemide</e2>, hydrochlorothiazide, spironolactone; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, <e1>heparinase III</e1>, or <e2>chondroitin ABC lyase</e2>. \n",
      "Results revealed that the strains were resistant to many drugs at high levels, only <e1>piperacillin</e1>, carbenicillin, amikacin and <e2>ciprofloxacin</e2> showed resistances at comparatively lower levels. \n",
      "In controlled clinical trials, <e1>ALOXI</e1> injection has been safely administered with corticosteroids, analgesics, antiemetics/<e2>antinauseants</e2>, antispasmodics and anticholinergic agents. \n",
      "Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as <e1>acetylsalicylic acid</e1>, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after <e2>TNKase</e2> therapy. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e1>Anafranil</e1>), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Being moxifloxacin and lomefloxacin <e1>fluoroquinolones</e1> the interaction study of was carried out with <e2>sucralfate</e2>, gelusil, erythromycin and multi minerals. \n",
      "morphine, theophylline, <e1>aminophylline</e1>, succinylcholine, <e2>reserpine</e2>, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "Absorption of <e1>tetracyclines</e1> is impaired by <e2>antacids</e2> containing aluminum, calcium or magnesium, and iron-containing preparations. \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Medical treatment with <e1>cinacalcet</e1> is effective in reducing plasma parathyroid hormone (PTH) levels, but its effect on <e2>darbepoetin</e2> dosing is unknown. \n",
      "- did not change the plasma concentration profile of <e1>terfenadine</e1> (a substrate of cytochrome P450 3A4) or <e2>fexofenadine</e2>, its carboxylated metabolite, and did not prolong the QTc interval following co-administration with terfenadine 60 mg twice daily. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Cholestyramine</e1> and Drugs that Bind Bile Acids: These drugs interrupt enterohepatic recirculation and reduce MPA exposure when coadministered with <e2>mycophenolate mofetil</e2>. \n",
      "Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, <e1>dipyridamole</e1>, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after <e2>TNKase</e2> therapy. \n",
      "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, <e1>fluoxetine</e1>, fluvoxamine, <e2>zileuton</e2>, and clotrimazole. \n",
      "The induction dose requirements of <e1>DIPRIVAN</e1> Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with <e2>narcotics</e2> (eg, morphine, meperidine, and fentanyl, etc.) \n",
      "The effect of <e1>orlistat</e1> on the absorption of supplemental vitamin D, <e2>vitamin A</e2>, and nutritionally-derived vitamin K is not known at this time. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e1>sulfonamides</e1>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "With respect to toxicity, the order of CYP inhibitor effectiveness was <e1>ABT</e1>>diethyldithiocarbamate~<e2>tranylcypromine</e2>>ketoconazole. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e2>levothyroxine sodium</e2>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of <e1>tolbutamide</e1>, sodium salicylate and sulfamethizole displaced protein-bound <e2>teniposide</e2> in fresh human serum to a small but significant extent. \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, <e1>butyrophenones</e1>, <e2>thioxanthines</e2> ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, <e1>sulfonamides</e1>, <e2>phenothiazines</e2>, sulfonylurea hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Based on an in vitro rat liver model, nitrogen substituted <e1>imidazole drugs</e1> (<e2>clotrimazole</e2>, ketoconazole, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism. \n",
      "<e1>CNS depressant</e1> medications: Concurrent use of procaine hydrochloride and <e2>CNS depressant medications</e2> may result in additive depressant effects. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, morphine, meperidine and fentanyl), <e2>propofol</e2>, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e1>Anafranil</e1>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e2>clarithromycin</e2>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "CYP 3A4 Inhibitors (e.g. <e1>Macrolide Antibiotics</e1> and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. dihydroergotamine and <e2>ergotamine</e2>) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "The ratio of norketamine AUC(0-   ) to ketamine AUC(0-   ) was significantly decreased in the <e1>ticlopidine</e1> (P &lt; 0.001) and <e2>itraconazole</e2> phases (P = 0.006) as compared to placebo. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, <e1>warfarin</e1>, certain heart medicines, birth control pills, <e2>anti-infective medicines</e2>, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e1>Astemizole</e1>, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e2>Sinequan</e2>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e1>antacids</e1>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "<e1>Mexitil</e1>    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum <e2>digoxin</e2> levels. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of <e1>benzodiazepines</e1> (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "<e1>Probenecid</e1> competes with <e2>meropenem</e2> for active tubular secretion and thus inhibits the renal excretion of meropenem. \n",
      "Lithium: Increased serum <e1>lithium</e1> levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with <e2>lithium</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e1>neostigmine</e1> - polymyxin B or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e1>nitrates</e1> and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, <e1>nifedipine</e1>, <e2>fluconazole</e2>, ritonavir, and rifampin. \n",
      "<e1>Vindesine</e1> can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the <e2>vaccine</e2>\n",
      "Mequitazine can interact with <e1>CNS depressant</e1>, antichlolinergic, <e2>TCA</e2>, MAOIs, and alcohol.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Coumarin-Derivative Anticoagulants</e1>: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving ZOLINZA concomitantly with <e2>coumarin-derivative anticoagulants</e2>. \n",
      "Itraconazole: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and <e1>itraconazole</e1> in clinical trials of <e2>itraconazole</e2> and from foreign post-marketing sources. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . <e1>Theophylline</e1> plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and <e2>theophylline</e2> are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Beside this, the medication oriented supplementation of <e1>vitamin D</e1> can also ameliorate the pharmacologic action of many drugs, such as bisphosphonates, <e2>statins</e2> and cytostatic drugs.\n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing <e1>antacids</e1>, when administered 1 hour before <e2>SKELID</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e1>nitrites</e1>, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, <e1>sulfinpyrazone</e1>, <e2>naproxen</e2>, warfarin, methotrexate, and possibly corticosteroids. \n",
      "e.g., other <e1>belladonna alkaloids</e1>, antihistamines (including <e2>meclizine</e2>), tricyclic antidepressants, and muscle relaxants. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Peak plasma concentrations and AUC of <e1>rimantadine</e1> were reduced approximately 10% in the presence of <e2>aspirin</e2>.\n",
      "An additional clinical drug-drug interaction study showed no effect of <e1>rifaximin</e1> on the presystemic metabolism of an oral <e2>contraceptive</e2> containing ethinyl estradiol and norgestimate. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (<e1>curcumin</e1> 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (<e2>fluoxetine</e2> 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e1>phenobarbital</e1>, diphenylhydantoin, primidone), <e2>phenylbutazone</e2>, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "Nifedipine (extended-release tablets): In 17 normal-weight subjects receiving <e1>XENICAL</e1> 120 mg three times a day for 6 days, XENICAL did not alter the bioavailability of <e2>nifedipine</e2> (extended-release tablets). \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as <e1>amphotericin B</e1>, aminoglycosides, bacitracin, polymyxin B, colistin, <e2>viomycin</e2>, or cisplatin, when indicated, requires careful monitoring.\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "Mequitazine can interact with <e1>CNS depressant</e1>, <e2>antichlolinergic</e2>, TCA, MAOIs, and alcohol.\n",
      "<e1>TRENTAL</e1> has been used concurrently with antihypertensive drugs, <e2>beta blockers</e2>, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "Concomitant administration of terfenadine with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of <e1>terfenadine</e1> with other macrolide antibiotics, including <e2>azithromycin</e2>, is not recommended. \n",
      "SKELAXIN may enhance the effects of <e1>alcohol</e1>, barbiturates and other <e2>CNS depressants</e2>.\n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, <e2>antiarrhythmic agents of class I</e2> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, <e2>Rifampin</e2>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Our objective was to establish potential effects of <e1>calcium</e1> on absorption of nonheme and <e2>heme iron</e2> and the dose response for this effect in the absence of a meal. \n",
      "Pravastatin: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving XENICAL 120 mg three times a day for 6 days, <e1>XENICAL</e1> did not affect the pharmacokinetics of <e2>pravastatin</e2>. \n",
      "Phenothiazines are capable of potentiating CNS depressants (e.g., <e1>barbiturates</e1>, <e2>anesthetics</e2>, opiates, alcohol, etc.) \n",
      "<e1>Salicylates</e1> and Other <e2>Non-Steroidal Anti-Inflammatory Drugs</e2>: May decrease the antihypertensive effects of MYKROX Tablets. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), <e2>amoxapine</e2> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Accordingly, patients should be advised to avoid <e1>alcohol</e1> while taking REMERON SolTab. <e2>Diazepam</e2>: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e2>neostigmine</e2> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Sulfonamides can also displace <e1>methotrexate</e1> from plasma protein-binding sites, thus increasing free <e2>methotrexate</e2> concentrations. \n",
      "Fluconazole tablets coadministered with ethinyl estradiol- and <e1>levonorgestrel</e1>-containing oral <e2>contraceptives</e2> produced an overall mean increase in ethinyl estradiol and levonorgestrel levels; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e1>MAO inhibitors</e1>, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Triprolidine may enhance the sedative effects of <e1>central nervous system depressants</e1> including alcohol, barbiturates, <e2>hypnotics</e2>, narcotic analgesics, sedatives, and tranquillisers. \n",
      "Other <e1>beta adrenergic aerosol bronchodilators</e1> should not be used concomitantly with Alupent    (<e2>metaproterenol sulfate</e2> USP) because they may have additive effects. \n",
      "This study aimed to evaluate the in vitro activity of <e1>minocycline</e1> combined with <e2>fosfomycin</e2> against isolates of methicillin-resistant Staphylococcus aureus (MRSA). \n",
      "Although <e1>MIVACRON</e1> (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between MIVACRON and <e2>succinylcholine</e2> has not been systematically studied. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (<e1>fluoxetine</e1> 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus <e2>fluoxetine</e2> 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, <e2>isocarboxazid</e2>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Use with Other <e1>Central Nervous System Depressants</e1>: The depressant effects of morphine are potentiated by the presence of other <e2>CNS depressants</e2> such as alcohol, sedatives, antihistaminics, or psychotropic drugs. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e1>kaolin</e1>-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Pindolol has been used with a variety of <e1>antihypertensive agents</e1>, including <e2>hydrochlorothiazide</e2>, hydralazine, and guanethidine without unexpected adverse interactions. \n",
      "After 21 weeks of <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1> treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, flavanone, flavanonols and <e1>catechins</e1>, on the elimination of luteolin and <e2>apigenin</e2> was studied. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, <e2>Cyclosporine</e2>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e2>Central nervous system (CNS) depressants</e2> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, <e1>prednisolone</e1>, <e2>sirolimus</e2>, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Standard antibiotic such as <e1>Gentamicin</e1> (10 microg), Cephalothin (30 microg), <e2>Ceftriaxone</e2> (10 microg), Nystatin (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "In addition to bleeding associated with <e1>heparin</e1> and vitamin K antagonists, drugs that alter platelet function (such as <e2>aspirin</e2>, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "Patients with Congenital or Acquired QT Prolongation In a study of the effect of <e1>solifenacin</e1> on the QT interval in 76 healthy women, the QT prolonging effect appeared less with <e2>solifenacin</e2> 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e1>BARBITURATES</e1>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "Barbiturates may decrease the effectiveness of oral <e1>contraceptives</e1>, certain antibiotics, quinidine, <e2>theophylline</e2>, corticosteroids, anticoagulants, and beta blockers.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e2>metformin</e2>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as digoxin, bronchodilators, other <e1>antiviral agents</e1>, antibiotics, or <e2>anti-metabolites</e2> have not been conducted. \n",
      "- Cisapride, <e1>pimozide</e1>: Other drugs such as cisapride or <e2>pimozide</e2>, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma <e1>digoxin</e1> concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/<e2>perindoprilat</e2> has not been excluded. \n",
      "<e1>Digoxin</e1>: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not alter the pharmacokinetics of a single dose of <e2>digoxin</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e1>meperidine</e1>), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e1>levothyroxine sodium</e1>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e1>ritonavir</e1>, indinavir, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>TOLECTIN</e1> and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of <e2>methotrexate</e2>. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (<e1>Parnate</e1>), or <e2>phenelzine</e2> (Nardil) in the last 14 days. \n",
      "<e1>Antacids</e1>: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing <e2>antacids</e2> (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, Cholestyramine, <e2>Choline</e2> and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Azathioprine/<e1>Mycophenolate Mofetil</e1>: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or <e2>mycophenolate mofetil</e2>. \n",
      "The primary objective of the study was to ascertain the difference in <e1>darbepoetin</e1> responsiveness before and after 12 months of <e2>cinacalcet</e2> therapy. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, <e1>saquinavir</e1>, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, <e2>penicillins</e2>, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "<e1>Ritalin</e1> may decrease the hypotensive effect of <e2>guanethidine</e2>. \n",
      "<e1>Methyldopa</e1> does not interfere with measurement of <e2>VMA</e2> (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert VMA to vanillin. \n",
      "When ZETIA is administered with an <e1>HMG-CoA reductase inhibitor</e1> in a woman of childbearing potential, refer to the pregnancy category and package labeling for the <e2>HMG-CoA reductase inhibitor</e2>. \n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, phenytoin, and rifampin may increase the clearance of <e2>methylprednisolone</e2> and may require increased in methylprednisolone dose to achieve the desired response. \n",
      "The occurrence of stupor, muscular rigidity, severe agitation, and elevated temperature has been reported in some patients receiving the combination of <e1>selegiline</e1> and <e2>meperidine</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, <e2>desmethyldiazepam</e2>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Because <e1>tetracyclines</e1> have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their <e2>anticoagulant</e2> dosage. \n",
      "No pharmacokinetic interaction between 85 mg/m2 <e1>ELOXATIN</e1> and infusional <e2>5-FU</e2> has been observed in patients treated every 2 weeks. \n",
      "During maintenance of anesthesia or sedation, the rate of DIPRIVAN Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental <e1>analgesic agents</e1> (eg, <e2>nitrous oxide</e2> or opioids). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Depression does not always require <e1>antidepressant drug</e1> therapy, and <e2>antidepressants</e2> have no proven preventive impact on hot flushes linked to the menopause. \n",
      "TRENTAL has been used concurrently with <e1>antihypertensive drugs</e1>, beta blockers, digitalis, diuretics, <e2>antidiabetic agents</e2>, and antiarrhythmics, without observed problems. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and <e2>tricyclic drugs</e2> (imipramine, clomipramine, desipramine). \n",
      "Laboratory Tests There have been reports of false-positive urine screening tests for tetrahydrocannabinol (<e1>THC</e1>) in patients receiving most proton pump inhibitors, including <e2>pantoprazole</e2>. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (<e1>PI</e1>) or an integrase inhibitor (<e2>II</e2>) is recommended. \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e2>TRANQUILIZERS</e2>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (<e1>curcumin</e1> 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus <e2>imipramine</e2> 15 mg/kg). \n",
      "This complex has a unique ability to deliver bio-available <e1>calcium</e1> and <e2>phosphate</e2> when they are needed most. \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, prednisolone, and <e2>fluconazole</e2> pharmacokinetics. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., <e1>tetracyclines</e1>, <e2>sulfonamides</e2>, phenothiazines, sulfonylurea hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "<e1>Probenecid</e1> competes with meropenem for active tubular secretion and thus inhibits the renal excretion of <e2>meropenem</e2>. \n",
      "Methotrexate: A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of <e1>meloxicam</e1> on the pharmacokinetics of <e2>methotrexate</e2> taken once weekly. \n",
      "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and <e1>Protease Inhibitors</e1>) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. dihydroergotamine and <e2>ergotamine</e2>) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, <e1>carbamazepine</e1>, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "Barbiturates may decrease the effectiveness of oral <e1>contraceptives</e1>, certain antibiotics, quinidine, theophylline, corticosteroids, <e2>anticoagulants</e2>, and beta blockers.\n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and <e2>droperidol</e2>. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (<e1>curcumin</e1> 100 mg/kg plus <e2>fluoxetine</e2> 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "<e1>ondansetron</e1> did not increase blood levels of high-dose <e2>methotrexate</e2>.\n",
      "The possibility of hypotensive effects can be minimized by either discontinuing the <e1>diuretic</e1> or increasing the salt intake prior to initiation of treatment with <e2>perindopril</e2>. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, <e1>carbamazepine</e1>, rifampin, rifabutin, <e2>rifapentin</e2>, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "however, in patients with Paget's Disease prior <e1>diphosphonate</e1> use appears to reduce the anti-resorptive response to <e2>Calcitonin (salmon)</e2> nasal spray.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, <e2>Terfenadine</e2>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "<e1>Curariform Drugs</e1>: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as <e2>tubocurarine</e2>) the most serious effect would be respiratory depression which could proceed to apnea. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral <e1>contraceptives</e1> (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and <e2>warfarin</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, <e2>clarithromycin</e2>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (Dilantin) carbamazepine (<e2>Tegretol</e2>) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "We sought to determine (1) the frequency of colchicine toxicity among hospitalized patients taking <e1>colchicine</e1> who died during an admission, (2) the likelihood that <e2>colchicine</e2> contributed to death, (3) whether patients were taking interacting medications that could have contributed to toxicity, and (4) whether colchicine dosing among these patients adhered to established guidelines. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, <e2>tranylcypromine</e2>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "A few spontaneous accounts of QT interval prolongation with ventricular arrhythmia including torsades de pointes, have been reported in patients receiving <e1>erythromycin</e1> or <e2>troleandomycin</e2>. \n",
      "Drugs such as erythromycin, diltiazem, verapamil, <e1>ketoconazole</e1>, fluconazole and <e2>itraconazole</e2> were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If <e1>Mexitil</e1> and <e2>theophylline</e2> are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "The bioavailability of SKELID is decreased 80% by <e1>calcium</e1>, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before <e2>SKELID</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (<e2>Sinequan</e2>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "In female rats, neonatal <e1>quinpirole</e1> treatment enhanced amphetamine locomotor sensitization compared with quinpirole-free controls sensitized to <e2>amphetamine</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Although not studied, the potent cytochrome P450 3A4 inhibitors <e1>ritonavir</e1> and <e2>nelfinavir</e2> may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of midazolam. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or <e1>macrolide antibiotics</e1> (eg, erythromycin, clarithromycin) or <e2>cyclosporine</e2> or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + <e1>paclitaxel</e1> vs <e2>paclitaxel</e2>: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), <e1>potassium</e1> supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, <e2>cyclosporine</e2> and others) can increase the risk of hyperkalemia. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., <e2>quinidine</e2>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (<e1>Dilantin</e1>) carbamazepine (Tegretol) <e2>Estrogens</e2> may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, <e2>thiopental</e2>, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "An additional clinical drug-drug interaction study showed no effect of <e1>rifaximin</e1> on the presystemic metabolism of an oral contraceptive containing <e2>ethinyl estradiol</e2> and norgestimate. \n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, <e2>meperidine</e2> and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Standard antibiotic such as Gentamicin (10 microg), Cephalothin (30 microg), <e1>Ceftriaxone</e1> (10 microg), <e2>Nystatin</e2> (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, <e2>carbamazepine</e2>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Remifentanil</e1> clearance is not altered by concomitant administration of thiopental, isoflurane, <e2>propofol</e2>, or temazepam during anesthesia. \n",
      "Interactions for <e1>Vitamin B2</e1> (Riboflavin):  <e2>Alcohol</e2> - impairs the intestinal absorption of riboflavin\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e1>TRANQUILIZERS</e1>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "The finding that <e1>metoclopramide</e1> releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving <e2>monoamine oxi-dase inhibitors</e2>. \n",
      "Nifedipine AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state <e1>MYCAMINE</e1> compared with <e2>nifedipine</e2> alone. \n",
      "Interactions for <e1>Vitamin B1</e1> (Thiamine):  Loop Diuretics, Oral <e2>Contraceptives</e2>, Stavudine, Tricyclic Antidepressants\n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, <e1>phenytoin</e1>, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), <e1>antidiabetics</e1> (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "Concurrent administration of <e1>bacteriostatic antibiotics</e1> (e.g., erythromycin, <e2>tetracycline</e2>) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth. \n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, <e2>triiodothyronine</e2>, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e2>BARBITURATES</e2>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e1>Rifabutin</e1>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e1>thioxanthines</e1> ) or metoclopramide, ordinarily should not be administered concurrently with <e2>Permax</e2> (a dopamine agonist); \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and miconazole) to <e1>ketoconazole</e1>, and itraconazole, concomitant use of these products with <e2>terfenadine</e2> is not recommended pending full examination of potential interactions. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - neostigmine - <e2>polymyxin B</e2> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, analgesics, antiemetics/<e1>antinauseants</e1>, antispasmodics and <e2>anticholinergic agents</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e1>MAO inhibitors</e1>, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Absorption of tetracyclines is impaired by antacids containing aluminum, <e1>calcium</e1> or <e2>magnesium</e2>, and iron-containing preparations. \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, <e1>antidiabetic agents</e1>, and <e2>antiarrhythmics</e2>, without observed problems. \n",
      "In total, 430,455 <e1>warfarin</e1> users contributed 407,370 person-years of <e2>warfarin</e2> use. \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  <e1>Tramadol</e1>: Although no pharmacokinetic drug interaction between ondansetron and <e2>tramadol</e2> has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Azathioprine/<e1>Mycophenolate Mofetil</e1>: Given that azathioprine and <e2>mycophenolate mofetil</e2> inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e1>colistin</e1>, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), <e2>antihistamines</e2>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and <e1>mycophenolate mofetil</e1> inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with <e2>azathioprine</e2> or mycophenolate mofetil. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., <e1>erythromycin</e1> and <e2>clarithromycin</e2>), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, <e2>itraconazole</e2>, ketoconazole, fluconazole, calcium channel blockers and cimetidine.    \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "As there is in vitro evidence that <e1>aminosalicylate derivatives</e1> (e.g., <e2>olsalazine</e2>, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    \n",
      "<e1>Terbinafine</e1> clearance is unaffected by <e2>cyclosporine</e2>. \n",
      "Caution should be used when <e1>EVISTA</e1> is coadministered with other highly protein-bound drugs, such as <e2>clofibrate</e2>, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide. \n",
      "<e1>UNIVASC</e1>    has been used in clinical trials concomitantly with calcium-channel-blocking agents, <e2>diuretics</e2>, H2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, <e2>desmethyldiazepam</e2>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Less potent inhibitors include <e1>saquinavir</e1>, nefazodone, fluconazole, grapefruit juice, fluoxetine, <e2>fluvoxamine</e2>, zileuton, and clotrimazole. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "No significant adverse interactions with common premedications (such as <e1>atropine</e1>, scopolamine, glycopyrrolate, diazepam, hydroxyzine, and other <e2>muscle relaxants</e2>) or local anesthetics have been observed.\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, <e1>phenothiazines</e1>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e2>methotrexate</e2>, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Mequitazine can interact with CNS depressant, antichlolinergic, TCA, <e1>MAOIs</e1>, and <e2>alcohol</e2>.\n",
      "Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with <e1>warfarin</e1>, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in <e2>R-warfarin</e2> half-life and AUC were also detected. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e1>indinavir</e1>, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Concomitant administration of <e1>TRENTAL</e1> and <e2>theophylline</e2>-containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals. \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: <e2>MEPERIDINE</e2> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "<e1>Mazindol</e1> may reduce the effects of <e2>guanethidine</e2> (Ismelin). \n",
      "- did not cause any clinically significant change in plasma profiles of prednisone or <e1>prednisolone</e1> following administration of either oral <e2>prednisone</e2> or intravenous prednisolone.  \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e2>Cisapride</e2>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "In groups 1 and 2, <e1>amiodarone</e1> was given to rats by intragastric and intravenous administration, respectively, while <e2>neferine</e2> was co-administratered by intragastric administration. \n",
      "With respect to toxicity, the order of CYP inhibitor effectiveness was ABT><e1>diethyldithiocarbamate</e1>~tranylcypromine><e2>ketoconazole</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Although MIVACRON (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between <e1>MIVACRON</e1> and <e2>succinylcholine</e2> has not been systematically studied. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e1>melatonin</e1> and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e1>clomipramine</e1> (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Sunitinib</e1> as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of <e2>docetaxel</e2> followed by sunitinib is superior to sunitinib followed by docetaxel and concurrent administration.\n",
      "Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since <e1>anticholinesterases</e1> inhibit the breakdown of <e2>procaine hydrochloride</e2>. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral <e1>contraceptives</e1> (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, <e2>digoxin</e2>, and warfarin. \n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - <e1>terfenadine</e1>, astemizole, cisapride, <e2>cyclosporine</e2>, and tricyclic antidepressants. \n",
      "<e1>Live Vaccines</e1>: During treatment with <e2>Myfortic</e2>, the use of live attenuated vaccines should be avoided and patients should be advised that vaccinations may be less effective. \n",
      "Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, <e1>hydralazine</e1>, and <e2>guanethidine</e2> without unexpected adverse interactions. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e1>pramipexole</e1> by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "However, the co   administration of <e1>SPIRIVA</e1> with other <e2>anticholinergic</e2>   containing drugs (e.g., ipratropium) has not been studied and is therefore not recommended.\n",
      "Tetracycline, a bacteriostatic <e1>antibiotic</e1>, may antagonize the bactericidal effect of <e2>penicillin</e2> and concurrent use of these drugs should be avoided.\n",
      "As there is in vitro evidence that aminosalicylate derivatives (e.g., <e1>olsalazine</e1>, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent <e2>thioguanine</e2> therapy.    \n",
      "<e1>hydralazine</e1>, <e2>prazosin</e2>; \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (<e1>curcumin</e1> 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (<e2>curcumin</e2> 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, <e1>diazepam</e1>, <e2>hydroxyzine</e2>, and other muscle relaxants) or local anesthetics have been observed.\n",
      "In vitro studies with atracurium, mivacurium, <e1>esmolol</e1>, echothiophate, neostigmine, physostigmine, and midazolam revealed no inhibition of <e2>remifentanil</e2> hydrolysis in whole human blood by these drugs.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, ketoconazole, <e1>miconazole</e1>) were potent, non-competitive inhibitors of <e2>trimetrexate</e2> metabolism. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (<e2>Asendin</e2>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral <e1>contraceptives</e1>, hormone replacement therapies, <e2>hypoglycemics</e2>, theophyllines, phenytoins, thiazide diuretics, beta blockers, and calcium channel blockers.\n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as <e1>antimycotic agents</e1> (e.g., itraconazole and <e2>miconazole</e2>) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with <e1>atorvastatin</e1>, simvastatin, <e2>pravastatin</e2>, lovastatin, or fluvastatin. \n",
      "<e1>AAV2</e1>-mediated retinal transduction is improved by co-injection of <e2>heparinase III</e2> or chondroitin ABC lyase. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), <e1>nonsteroidal anti-inflammatory drugs</e1> (n=79), estrogens (n=70), <e2>salicylate analgesics</e2> (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "These medications included <e1>thyroid hormones</e1>, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, and <e2>decongestants</e2>. \n",
      "Concomitant administration of <e1>terfenadine</e1> with <e2>clarithromycin</e2>, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "We sought to evaluate whether initiation of an <e1>antidepressant</e1> increases the risk of hospitalization for gastrointestinal bleeding in <e2>warfarin</e2> users.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with <e1>phenytoin</e1> lowered the serum <e2>phenytoin</e2> concentration in patients with treatment-resistant epilepsy. \n",
      "When <e1>ZETIA</e1> is administered with an HMG-CoA reductase inhibitor in a woman of childbearing potential, refer to the pregnancy category and package labeling for the <e2>HMG-CoA reductase inhibitor</e2>. \n",
      "All mRPCs of 20 passages or less were transplanted into the subretinal space of B6 mice together with chondroitinase ABC, and into Rho(-/-) mice combined with chondroitinase ABC, N-[N-(3, 5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), and <e1>insulin growth factor</e1> <e2>(IGF)-1</e2>. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e2>desglymidodrine</e2> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "<e1>Rifabutin</e1>: There have been reports of uveitis in patients to whom <e2>fluconazole</e2> and rifabutin were coadministered. \n",
      "<e1>Mazindol</e1> may reduce the effects of guanethidine (<e2>Ismelin</e2>). \n",
      "<e1>Diuretics</e1>: Patients on diuretics, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of <e2>ACEON</e2>    Tablets therapy. \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, <e1>orlistat</e1> pharmacodynamics (fecal fat excretion), or systemic exposure to <e2>orlistat</e2>. \n",
      "<e1>Varenicline</e1> is the generic name for <e2>Chantix</e2>, the newest drug available for the treatment of tobacco dependence. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, <e2>halogenated salicylanilides</e2> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Patients receiving <e1>sirolimus</e1> or nifedipine in combination with MYCAMINE should be monitored for sirolimus or <e2>nifedipine</e2> toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to <e1>5-FU</e1>, <e2>cisplatin</e2>, doxorubicin and etoposide   celecoxib following different incubation schedules were analyzed.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, thyroxine, triiodothyronine, <e2>phenytoin</e2>, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, levothyroxine sodium, <e2>medroxyprogesterone acetate</e2>, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, <e1>bacitracin</e1>, polymyxin B, <e2>colistin</e2>, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "UNIVASC    has been used in clinical trials concomitantly with <e1>calcium-channel-blocking agents</e1>, <e2>diuretics</e2>, H2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e1>Pertofrane</e1>, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "In these subjects, meloxicam did not alter <e1>warfarin</e1> pharmacokinetics and the average anticoagulant effect of <e2>warfarin</e2> as determined by prothrombin time. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and <e1>theophylline</e1> are to be used concurrently, theophylline blood levels should be monitored, particularly when the <e2>Mexitil</e2>    dose is changed. \n",
      "Coadministration of a selective and potent inhibitor of CYP3A4, <e1>ketoconazole</e1> (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of <e2>ropivacaine</e2>.\n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that <e1>dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, <e2>butyrophenones</e2>, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Quantitative toxicological analysis showed that the concentrations of etizolam, <e1>phenobarbital</e1>, promethazine and <e2>chlorpromazine</e2> in the femoral blood were 86 ng/ml, 5082 microg/ml, 0.107 microg/ml and 0.144 microg/ml, respectively, and large amounts of drugs were also detected in the stomach contents. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, <e1>Choline</e1> and magnesium salicylates, <e2>Colestipol</e2>, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "There were no significant differences between the pharmacokinetics parameters of <e1>amiodarone</e1> administered intravenously or intragastrically and the control (without neferine) group (with ratios of 0.7-1.4 in all experimental groups), suggesting that neferine had no effect on <e2>amiodarone</e2> plasma pharmacokinetics. \n",
      "In the treatment of acute MI, <e1>aspirin</e1>, when not otherwise contraindicated, should be administered with <e2>Streptokinase</e2> ( see below ). \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of <e1>alcohol</e1> pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to <e2>orlistat</e2>. \n",
      "This could lead to decreased salicylate serum levels or increase the risk of <e1>salicylate</e1> toxicity when <e2>corticosteroid</e2> is withdrawn. \n",
      "<e1>Warfarin</e1>: Sparfloxacin does not increase the anti-coagulant effect of <e2>warfarin</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., <e2>aminoglycosides</e2>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, <e1>phenytoin</e1>, carbamazepine, rifampin, rifabutin, rifapentin, <e2>phenobarbital</e2>, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Exert particular caution in combining <e1>levomepromazine</e1> with other <e2>anticholinergic drugs</e2> (tricyclic antidepressants and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e2>polymyxins</e2>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as <e1>paroxetine</e1> and <e2>fluoxetine</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, phenothiazines, <e2>nalidixic acid</e2>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., <e1>fluoxetine</e1>, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (<e1>fluoxetine</e1> 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus <e2>imipramine</e2> 15 mg/kg). \n",
      "<e1>Methscopolamine</e1> may interact with <e2>antidepressants</e2> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e2>ANESTHETICS</e2>, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Reduction of PTH by <e1>cinacalcet</e1> is associated with a decrease in <e2>darbepoetin</e2> requirement. \n",
      "These results suggest that rat liver slices do not reproduce the reported in vivo biotransformation of <e1>precocene I</e1> and therefore may not be an appropriate model for <e2>precocene I</e2> metabolism. \n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma <e1>digoxin</e1> concentrations when coadministered with ACEON    Tablets, but an effect of <e2>digoxin</e2> on the plasma concentration of perindopril/perindoprilat has not been excluded. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, <e2>nitrous oxide</e2>, secobarbital and droperidol. \n",
      "Drugs such as erythromycin, diltiazem, <e1>verapamil</e1>, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered <e2>midazolam</e2>. \n",
      "In the hot plate test in mice, co-administration of 15     g/kg <e1>dexmedetomidine</e1> with 10   mg/kg ephedrine intraperitoneally not only enhanced, but also prolonged the duration of antinociception induced by <e2>dexmedetomidine</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Compared with the elimination of pure <e1>luteolin</e1> and apigenin, the elimination of <e2>luteolin</e2> and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and apigenin. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, <e1>rifabutin</e1>, rifapentin, phenobarbital, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "Pindolol has been used with a variety of <e1>antihypertensive agents</e1>, including hydrochlorothiazide, <e2>hydralazine</e2>, and guanethidine without unexpected adverse interactions. \n",
      "Drugs such as <e1>erythromycin</e1>, <e2>diltiazem</e2>, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - neostigmine - polymyxin B or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e1>narcotic analgesics</e1> (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, <e1>tranquilizers</e1>, general anesthetics, phenothiazines, other opioids, <e2>tricyclic antidepressants</e2>, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, <e1>rifampin</e1>, <e2>rifabutin</e2>, ketoconazole, and fluconazole. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - <e2>neostigmine</e2> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, <e1>quinidine</e1>, <e2>theophylline</e2>, corticosteroids, anticoagulants, and beta blockers.\n",
      "Warfarin: In 12 normal-weight subjects, administration of <e1>XENICAL</e1> 120 mg three times a day for 16 days did not result in any change in either <e2>warfarin</e2> pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e1>benzodiazepenes</e1> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, <e1>prednisolone</e1>, sirolimus, nifedipine, <e2>fluconazole</e2>, ritonavir, and rifampin. \n",
      "Although specific drug or food interactions with <e1>mifepristone</e1> have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that <e2>ketoconazole</e2>, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). \n",
      "Remifentanil clearance is not altered by concomitant administration of thiopental, <e1>isoflurane</e1>, propofol, or <e2>temazepam</e2> during anesthesia. \n",
      "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, morphine, <e1>meperidine</e1>, and <e2>fentanyl</e2>, etc.) \n",
      "<e1>Azathioprine</e1>/Mycophenolate Mofetil: Given that azathioprine and <e2>mycophenolate mofetil</e2> inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "The effect of a series of flavonoids, including <e1>flavonols</e1>, <e2>flavones</e2>, isoflavone, flavanone, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, <e2>butyrophenones</e2>, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, diazepam, hydroxyzine, and other <e1>muscle relaxants</e1>) or local <e2>anesthetics</e2> have been observed.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, <e1>metronidazole</e1>, and miconazole) to <e2>ketoconazole</e2>, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "In clinical studies of TOBI, patients taking <e1>TOBI</e1> concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other <e2>anti-pseudomonal antibiotics</e2>, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (<e1>NRTI</e1>) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI) or an integrase inhibitor (<e2>II</e2>) is recommended. \n",
      "We observed that GLIC recapitulates bimodal modulation by n-alcohols, similar to some eukaryotic pLGICs: <e1>methanol</e1> and <e2>ethanol</e2> weakly potentiated proton-activated currents in GLIC, whereas n-alcohols larger than ethanol inhibited them. \n",
      "When administered concomitantly with <e1>ProAmatine</e1>   , <e2>cardiac glycosides</e2> may enhance or precipitate bradycardia, A.V. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, <e1>erythromycin</e1>, clarithromycin) or cyclosporine or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, <e1>hypoglycemics</e1>, theophyllines, phenytoins, thiazide diuretics, beta blockers, and <e2>calcium channel blockers</e2>.\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, <e1>phenothiazines</e1>, <e2>nalidixic acid</e2>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "<e1>Sulfamethoxazole</e1> may inhibit the hepatic metabolism of <e2>phenytoin</e2>. \n",
      "Concurrent use of Mexitil    and <e1>theophylline</e1> may lead to increased plasma <e2>theophylline</e2> levels. \n",
      "The CNS-depressant effect of <e1>propoxyphene</e1> is additive with that of other CNS depressants, including <e2>alcohol</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, <e1>diphenylhydantoin</e1>, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (<e1>SSRIs</e1>) (e.g., <e2>fluoxetine</e2>, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "John   s Wort, and certain <e1>anticonvulsants</e1> (phenytoin, phenobarbital, <e2>carbamazepine</e2>) may induce mifepristone metabolism (lowering serum levels of mifepristone). \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e2>neostigmine</e2> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Thalidomide has been reported to enhance the sedative activity of <e1>barbiturates</e1>, alcohol, <e2>chlorpromazine</e2>, and reserpine. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e2>melatonin</e2> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Sulfamethizole may increase the effects of <e1>barbiturates</e1>, tolbutamide, and <e2>uricosurics</e2>. \n",
      "Beside this, the medication oriented supplementation of <e1>vitamin D</e1> can also ameliorate the pharmacologic action of many drugs, such as <e2>bisphosphonates</e2>, statins and cytostatic drugs.\n",
      "Mephenytoin may also affect the effects of other drugs, which include some <e1>steroid medications</e1>, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that <e2>Mephenytoin</e2> may interact with other drugs that are not listed here.\n",
      "May interact with cimetidine, <e1>digoxin</e1>, medicines to control heart rhythm, <e2>sevelamer</e2>, and theophylline.\n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, <e1>protease inhibitors</e1>, <e2>calcium channel antagonists</e2>, and macrolide antibiotics). \n",
      "Use of <e1>potassium-sparing diuretics</e1> (<e2>spironolactone</e2>, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "and/or antibiotic drug <e1>doxycycline</e1> (100 mg/kg, p. o.), as well as that of neurotoxin <e2>1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine</e2> (MPTP) (4 x 20 mg/kg, i. p.) \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e1>anesthetics</e1> such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on <e1>piroxicam</e1> plasma levels . Nonsteroidal anti-inflammatory agents, including <e2>FELDENE</e2>, have been reported to increase steady state plasma lithium levels. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and <e2>quinine</e2>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "We retrospectively reviewed the records of 7 pediatric oncology patients who received low-dose <e1>ketamine</e1> in conjunction with <e2>propofol</e2> for total intravenous anesthesia (TIVA) repeatedly for radiation therapy. \n",
      "In female rats, neonatal quinpirole treatment enhanced amphetamine locomotor sensitization compared with <e1>quinpirole</e1>-free controls sensitized to <e2>amphetamine</e2>. \n",
      "<e1>Zidovudine</e1> competitively inhibits the intracellular phosphorylation of <e2>stavudine</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and <e2>quinine</e2>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>CNS depressant</e1> medications: Concurrent use of <e2>procaine hydrochloride</e2> and CNS depressant medications may result in additive depressant effects. \n",
      "This study examined drug-drug interactions of oral <e1>S-ketamine</e1> with the cytochrome P450 (CYP) 2B6 inhibitor ticlopidine and the CYP3A inhibitor <e2>itraconazole</e2>. \n",
      "Mexitil    does not alter serum <e1>digoxin</e1> levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum <e2>digoxin</e2> levels. \n",
      "The incremental LDL-C reduction due to adding <e1>ezetimibe</e1> to <e2>cholestyramine</e2> may be reduced by this interaction. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e1>thioxanthines</e1> ) or <e2>metoclopramide</e2>, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, <e1>meperidine</e1> and fentanyl), propofol, ketamine, <e2>nitrous oxide</e2>, secobarbital and droperidol. \n",
      "Sulfonamides: Concurrent use of <e1>procaine hydrochloride</e1> and sulfonamides may result in a reduction of the antibacterial action of the <e2>sulfonamide</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, indinavir, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - <e2>Ketoconazole</e2> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>Anticholinesterases</e1>: Concurrent use of <e2>procaine hydrochloride</e2> and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e2>Tricyclic antidepressants</e2> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Concomitant administration of TRENTAL and theophylline-containing drugs leads to increased <e1>theophylline</e1> levels and <e2>theophylline</e2> toxicity in some individuals. \n",
      "In this paper we discuss peculiarities of drug interaction between <e1>cyclooxygenase inhibitors</e1> and <e2>acetylsalicylic acid</e2>, and principles of selection of adequate NSAI.\n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, taxol, rifampicin, and <e1>human immunodeficiency virus protease inhibitors</e1> such as <e2>ritonavir</e2> and saquinavir. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e1>morphine</e1>, meperidine and fentanyl), propofol, <e2>ketamine</e2>, nitrous oxide, secobarbital and droperidol. \n",
      "Although specific drug or food interactions with <e1>mifepristone</e1> have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of <e2>mifepristone</e2>). \n",
      "<e1>Azathioprine</e1>/<e2>Mycophenolate Mofetil</e2>: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e2>Elavil</e2>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "UNIVASC    has been used in clinical trials concomitantly with <e1>calcium-channel-blocking agents</e1>, diuretics, <e2>H2 blockers</e2>, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "A controlled study found that concomitant <e1>fluconazole</e1> 200 mg once daily and <e2>cisapride</e2> 20 mg four times a day yielded a significant increase in cisapride plasma levels and prolongation of QTc interval.\n",
      "Carbidopa/Levodopa: <e1>Carbidopa</e1>/<e2>Levodopa</e2> does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e1>benzodiazepenes</e1> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Patients who take both <e1>ezetimibe</e1> and <e2>cyclosporine</e2> should be carefully monitored. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e1>polymyxin B</e1> or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when <e1>FELDENE</e1> is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . <e2>Nonsteroidal anti-inflammatory agents</e2>, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, <e1>tranquilizers</e1>, general <e2>anesthetics</e2>, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, <e2>ketoconazole</e2>, fluconazole, calcium channel blockers and cimetidine.\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and <e2>rifampin</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e1>methotrexate</e1> (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "Finally, co-administration of eugenol in <e1>colchicine</e1> nanoemulsion to enhance the <e2>colchicine</e2> bioavailability was investigated by an oral administration method. \n",
      "Warfarin users who initiated citalopram, <e1>fluoxetine</e1>, <e2>paroxetine</e2>, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (<e1>SSRIs</e1>) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "The FDA has approved <e1>ticagrelor</e1> (Brilinta-AstraZeneca), an oral <e2>antiplatelet drug</e2>, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). \n",
      "Additive sedative effects can occur when <e1>metoclopramide</e1> is given with alcohol, sedatives, hypnotics, narcotics, or <e2>tranquilizers</e2>. \n",
      "The purpose of this study was to evaluate whether the psychostimulant drug <e1>ephedrine</e1> has any effect on <e2>dexmedetomidine</e2>-induced antinociception and locomotor inhibitor activity in mice in acute application.\n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, <e2>Phenytoin</e2>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Patients with Congenital or Acquired QT Prolongation In a study of the effect of <e1>solifenacin</e1> on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control <e2>moxifloxacin</e2> at its therapeutic dose. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e1>Surmontil</e1>) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "This could lead to decreased salicylate serum levels or increase the risk of <e1>salicylate</e1> toxicity when <e2>methylprednisolone</e2> is withdrawn. \n",
      "<e1>Pravastatin</e1>: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving XENICAL 120 mg three times a day for 6 days, <e2>XENICAL</e2> did not affect the pharmacokinetics of pravastatin. \n",
      "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, <e1>diuretics</e1>, H2 blockers, digoxin, oral <e2>hypoglycemic agents</e2>, and cholesterol-lowering agents. \n",
      "Curariform Drugs: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of <e1>curariform drugs</e1> (such as <e2>tubocurarine</e2>) the most serious effect would be respiratory depression which could proceed to apnea. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Phenobarbital, which induces hepatic metabolism, decreased the AUC of <e1>montelukast</e1> approximately 40% following a single 10-mg dose of <e2>montelukast</e2>. \n",
      "You cannot take <e1>mazindol</e1> if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (<e2>Parnate</e2>), or phenelzine (Nardil) in the last 14 days. \n",
      "To date, there is no conclusive evidence of a clinically-relevant interaction between any of the <e1>proton pump inhibitors</e1> and <e2>clopidogrel</e2>.\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, prednisolone, sirolimus, nifedipine, fluconazole, <e2>ritonavir</e2>, and rifampin. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e1>Rifabutin</e1>, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), <e2>benzodiazepines</e2>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Administration of a higher dose of <e1>indinavir</e1> should be considered when coadministering with <e2>megestrol acetate</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e1>Tacrolimus</e1>, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (<e1>Tegretol</e1>) Estrogens may decrease the effects of benzodiazepines (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, <e2>fluconazole</e2>, ritonavir, and rifampin. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, <e2>amiloride</e2>, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Single-unit in vivo extracellular recordings performed in neurons of the NAc confirmed an <e1>opiate</e1>-state-dependent role for BLA D1/D2 transmission in NAc neuronal response patterns to <e2>morphine</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "and combinations of opioids and <e1>sedatives</e1> (eg, benzodiazepines, barbiturates, chloral hydrate, <e2>droperidol</e2>, etc.). \n",
      "saline + saline, ephedrine (10   mg/kg) + saline, saline + dexmedetomidine (15     g/kg) and <e1>ephedrine</e1> (10   mg/kg) + <e2>dexmedetomidine</e2> (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests. \n",
      "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as tricyclic antidepressants,    -blockers, selective serotonin reuptake inhibitors (<e1>SSRIs</e1>), and <e2>monoamine oxidase inhibitors (MAO-Is) Type B</e2>, if they have a narrow therapeutic window. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, <e1>pseudoephedrine</e1>, ephedrine, phenylpropanolamine or <e2>dihydroergotamine</e2>) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "<e1>Cyclosporine</e1>: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when <e2>XENICAL</e2> was coadministered with cyclosporine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, <e1>hyaluronan lyase</e1>, heparinase III, or <e2>chondroitin ABC lyase</e2>. \n",
      "<e1>AAV2</e1> containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, heparinase III, or <e2>chondroitin ABC lyase</e2>. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Drug interaction of <e1>thyroxine</e1> with <e2>simeticone</e2> has not been reported previously and is not listed in the British National Formulary for Children. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, Cisapride, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Administration of paclitaxel in combination with <e1>HERCEPTIN</e1> resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in <e2>HERCEPTIN</e2> serum levels in clinical studies.\n",
      "Potential for <e1>INVEGA</e1>    to Affect Other Drugs <e2>Paliperidone</e2> is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome P450 isozymes. \n",
      "Because there is a theoretical basis that these effects may be additive, use of <e1>ergotamine</e1>-containing or <e2>ergot-type medications</e2> (like dihydroergotamine or methysergide) and sumatriptan within 24 hours of each other should be avoided. \n",
      "Phenytoin, <e1>Carbamazepine</e1>, and <e2>Rifampicin</e2>: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, <e2>naproxen</e2>, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Before and during <e1>antiretroviral</e1> treatment, <e2>antiretroviral</e2> drug resistances, individual tolerance profiles and the needs of the individual patient, as well as several interactions with other drugs have to be considered. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e1>phenobarbital</e1>, diphenylhydantoin, primidone), phenylbutazone, and <e2>tricyclic drugs</e2> (imipramine, clomipramine, desipramine). \n",
      "An inhibitor of CYP2C8 (such as <e1>gemfibrozil</e1>) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as <e2>rifampin</e2>) may decrease the AUC of rosiglitazone. \n",
      "Antimicrobial effects of <e1>o-cymen-5-ol</e1> and <e2>zinc</e2>, alone &\n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, <e1>hypoglycemics</e1>, theophyllines, <e2>phenytoins</e2>, thiazide diuretics, beta blockers, and calcium channel blockers.\n",
      "The effect of a series of flavonoids, including flavonols, <e1>flavones</e1>, isoflavone, flavanone, flavanonols and <e2>catechins</e2>, on the elimination of luteolin and apigenin was studied. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - <e1>terfenadine</e1>, astemizole, <e2>cisapride</e2>, cyclosporine, and tricyclic antidepressants. \n",
      "We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with <e1>DZNep</e1> and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of <e2>DZNep</e2> insensitive MM cells. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e1>prednisone</e1>, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, <e2>digoxin</e2>, and warfarin. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e1>corticosteroids</e1> may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Of the isoform-specific CYP inhibitors tested for an effect on the <e1>precocene I</e1> metabolite profile, only <e2>tranylcypromine</e2> was noticeably effective, indicating a role of CYPs 2A6, 2C9, 2Cl9, and 2E1. \n",
      "(ii) <e1>acetyl-l-carnitine</e1> elicits a significant protective effect on DEB induced toxicity, which was potentiated by  <e2>alpha-lipoic acid</e2>.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, triamterene, amiloride) or <e2>potassium</e2> supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e2>benzodiazepines</e2>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Lithium: Increased serum <e1>lithium</e1> levels and symptoms of lithium toxicity have been reported in patients receiving <e2>ACE inhibitors</e2> during therapy with lithium. \n",
      "<e1>Mephenytoin</e1> may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, <e2>furosemide</e2> and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "<e1>Phenobarbital</e1>, which induces hepatic metabolism, decreased the AUC of <e2>montelukast</e2> approximately 40% following a single 10-mg dose of montelukast. \n",
      "Careful monitoring of phenytoin concentrations in patients receiving <e1>DIFLUCAN</e1> and <e2>phenytoin</e2> is recommended. \n",
      "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for <e1>sirolimus</e1> or <e2>nifedipine</e2> toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "Coadministration with a high dose of antacid (170 mEq) results in a 28% decrease in plasma concentrations of <e1>ranitidine</e1> and may decrease plasma concentrations of bismuth from <e2>TRITEC</e2>. \n",
      "Synergistic interaction between <e1>sunitinib</e1> and <e2>docetaxel</e2> is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.\n",
      "Antacids: Absorption of a single dose of <e1>Myfortic</e1> was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing <e2>antacids</e2> (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e1>anesthetics</e1>, <e2>procainamide</e2>, and quinidine. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (<e1>lorezepam</e1> <e2>oxezepam</e2> temezepam). \n",
      "Rats treated with neonatal quinpirole enhanced time spent in the amphetamine-paired context compared with <e1>quinpirole</e1>-free controls conditioned with <e2>amphetamine</e2>, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e1>sodium colistimethate</e1>), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "In vitro studies with atracurium, mivacurium, <e1>esmolol</e1>, <e2>echothiophate</e2>, neostigmine, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "The <e1>colchicine</e1> nanoemulsion was prepared with <e2>isopropyl myristate</e2>, eugenol, Tween80, ethanol and water, and eugenol was used as an oil phase in the formulation; \n",
      "The oral bioavailability of <e1>sparfloxacin</e1> is not reduced when the aluminum-<e2>magnesium</e2> suspension is administered 4 hours following sparfloxacin administration. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "The in vitro binding of warfarin to human plasma proteins is unaffected by <e1>tolmetin</e1>, and <e2>tolmetin</e2> does not alter the prothrombin time of normal volunteers. \n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, <e2>ketoconazole</e2>, fluconazole, calcium channel blockers and cimetidine.    \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e1>prednisone</e1>, prednisolone, oral contraceptives (norethindrone 1 mg/<e2>ethinyl estradiol</e2> 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of tolbutamide, <e1>sodium salicylate</e1> and sulfamethizole displaced protein-bound <e2>teniposide</e2> in fresh human serum to a small but significant extent. \n",
      "The rate and extent of <e1>perindopril</e1> absorption and elimination are not affected by concomitant <e2>diuretics</e2>. \n",
      "<e1>Furosemide</e1>: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and <e2>thiazide diuretics</e2> in some patients. \n",
      "UNIVASC    has been used in clinical trials concomitantly with <e1>calcium-channel-blocking agents</e1>, diuretics, H2 blockers, digoxin, oral <e2>hypoglycemic agents</e2>, and cholesterol-lowering agents. \n",
      "In clinical studies of TOBI, patients taking <e1>TOBI</e1> concomitantly with <e2>dornase alfa</e2> (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, <e1>simvastatin</e1>, pravastatin, <e2>lovastatin</e2>, or fluvastatin. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, prednisone, <e2>prednisolone</e2>, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "[Efficacy of fixed combination <e1>amlodipine</e1>/<e2>valsartan</e2> in hospitalized patients with hypertensive disease]\n",
      "Cyclosporine: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when <e1>XENICAL</e1> was coadministered with <e2>cyclosporine</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, <e2>phenothiazines</e2>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "We concluded that the combined administration of <e1>dexmedetomidine</e1> with <e2>ephedrine</e2> may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.\n",
      "In Trial 1, the proportions of patients in the placebo and Synagis    groups who received routine childhood <e1>vaccines</e1>, influenza vaccine, bronchodilators or <e2>corticosteroids</e2> were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, <e1>phenothiazines</e1>, other opioids, tricyclic antidepressants, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "<e1>Cholestyramine</e1>: Concomitant cholestyramine administration decreased the mean AUC of total <e2>ezetimibe</e2> approximately 55%. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, <e1>glucocorticoids</e1>, or certain <e2>monoamine oxidase inhibitors</e2>) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "Compared with the elimination of pure luteolin and <e1>apigenin</e1>, the elimination of <e2>luteolin</e2> and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and apigenin. \n",
      "The data presently available indicate that the decreases in some individual <e1>ethinyl estradiol</e1> and levonorgestrel AUC values with <e2>fluconazole</e2> treatment are likely the result of random variation. \n",
      "Sympathomimetics: <e1>Metolazone</e1> may decrease arterial responsiveness to <e2>norepinephrine</e2>, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. \n",
      "In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals, almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups, whereas the extent of neuronal loss was lower than 15% of control values in <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2>-treated monkeys. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "In a large compassionate use program <e1>Mexitil</e1>    has been used concurrently with commonly employed antianginal, <e2>antihypertensive</e2>, and anticoagulant drugs without observed interactions. \n",
      "Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, <e1>anticonvulsants</e1>, or <e2>warfarin</e2>-like drugs. \n",
      "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of <e1>Cimetidine</e1> (300 mg four times a day), the apparent total <e2>rimantadine</e2> clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine). \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that <e1>dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "- <e1>Cisapride</e1>, pimozide: Other drugs such as <e2>cisapride</e2> or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. \n",
      "The effects of anti-parkinsonian drug <e1>hemantane</e1> [<e2>(2-adamantyl)hexamethylenimine</e2>] (10 mg/kg, p. o.) \n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - <e1>terfenadine</e1>, astemizole, cisapride, cyclosporine, and <e2>tricyclic antidepressants</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Caution should be used when <e1>EVISTA</e1> is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, <e2>diazepam</e2>, and diazoxide. \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Caution should be used when administering <e1>MOBIC</e1> with warfarin since patients on <e2>warfarin</e2> may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced.\n",
      "A fatal poisoning case involving <e1>etizolam</e1>, phenobarbital, promethazine and <e2>chlorpromazine</e2> is presented. \n",
      "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as <e1>rifampin</e1>, carbamazepine, and <e2>phenytoin</e2>, induce metabolism and caused a markedly decreased C max and AUC of oral midazolam in adult studies. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, <e1>triiodothyronine</e1>, phenytoin, sulfinpyrazone, naproxen, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "Concomitant administration of <e1>propranolol</e1> with <e2>phenothiazines</e2> results in increased plasma levels of both drugs.\n",
      "Antacids: Absorption of a single dose of <e1>Myfortic</e1> was decreased when administered to 12 stable renal transplant patients also taking magnesium-<e2>aluminum</e2> containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e1>pramipexole</e1> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, <e1>indomethacin</e1>, naproxen, ibuprofen, diazepam, and <e2>diazoxide</e2>. \n",
      "<e1>Tacrolimus</e1>: There have been reports of nephrotoxicity in patients to whom <e2>fluconazole</e2> and tacrolimus were coadministered. \n",
      "MAO inhibitors and <e1>beta adrenergic blockers</e1> increase the effects of <e2>pseudoephedrine</e2>. \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that <e1>ondansetron</e1> may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by <e2>ondansetron</e2>. \n",
      "<e1>Diuretics</e1>: Excessive reductions in blood pressure may occur in patients on diuretic therapy when <e2>ACE inhibitors</e2> are started. \n",
      "The hepatic clearance and drug-drug interactions of <e1>luteolin</e1> and <e2>apigenin</e2> were studied by using primary cultured rat hepatocytes. \n",
      "Phenobarbital, which induces hepatic metabolism, decreased the AUC of <e1>montelukast</e1> approximately 40% following a single 10-mg dose of <e2>montelukast</e2>. \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of <e1>rivastigmine</e1> is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or <e2>fluoxetine</e2>. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (<e1>norethindrone</e1> 1 mg/<e2>ethinyl estradiol</e2> 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Our objective was to establish potential effects of calcium on absorption of <e1>nonheme</e1> and <e2>heme iron</e2> and the dose response for this effect in the absence of a meal. \n",
      "<e1>Anticoagulants</e1> (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as <e2>acetylsalicylic acid</e2>, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, <e1>warfarin</e1>, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e1>Pertofrane</e1>, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>Nifedipine</e1> (extended-release tablets): In 17 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, <e2>XENICAL</e2> did not alter the bioavailability of nifedipine (extended-release tablets). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e2>ritonavir</e2>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, <e1>sirolimus</e1>, nifedipine, fluconazole, ritonavir, and <e2>rifampin</e2>. \n",
      "<e1>ARAMINE</e1> should be used with caution in digitalized patients, since the combination of <e2>digitalis</e2> and sympathomimetic amines may cause ectopic arrhythmias. \n",
      "Alcohol, <e1>Barbiturates</e1>, and <e2>Narcotics</e2>: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, butyrophenones, <e2>thioxanthenes</e2>) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Lithium: In clinical trials, <e1>NSAIDs</e1> have produced an elevation of plasma lithium levels and a reduction in renal <e2>lithium</e2> clearance. \n",
      "<e1>Sulfonamides</e1>: Concurrent use of procaine hydrochloride and <e2>sulfonamides</e2> may result in a reduction of the antibacterial action of the sulfonamide. \n",
      "Therefore, do not administer Myfortic with <e1>cholestyramine</e1> or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral activated charcoal, because of the potential to reduce the efficacy of <e2>Myfortic</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>heparin</e1>, <e2>warfarin</e2>, diazepam, insulin; \n",
      "A <e1>calcium</e1> dose of 800 mg diminished absorption of 5 mg <e2>heme iron</e2> by 37.7%. \n",
      "however, as with other <e1>NSAIDs</e1>, concomitant administration of meloxicam and <e2>aspirin</e2> is not generally recommended because of the potential for increased adverse effects. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Being <e1>moxifloxacin</e1> and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, <e2>erythromycin</e2> and multi minerals. \n",
      "<e1>Anticholinesterases</e1>: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since <e2>anticholinesterases</e2> inhibit the breakdown of procaine hydrochloride. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "No dosage adjustment of <e1>digoxin</e1> or <e2>JANUVIA</e2> is recommended.\n",
      "You cannot take <e1>mazindol</e1> if you have taken a <e2>monoamine oxidase inhibitor</e2> (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Itraconazole: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of <e1>terfenadine</e1> and itraconazole in clinical trials of <e2>itraconazole</e2> and from foreign post-marketing sources. \n",
      "Results revealed that the strains were resistant to many drugs at high levels, only piperacillin, <e1>carbenicillin</e1>, <e2>amikacin</e2> and ciprofloxacin showed resistances at comparatively lower levels. \n",
      "Concomitant administration of <e1>terfenadine</e1> with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other <e2>macrolide antibiotics</e2>, including azithromycin, is not recommended. \n",
      "Therefore, caution should be exercised with concomitant administration of <e1>warfarin</e1> and <e2>FLOMAX</e2> capsules.        \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, <e1>theophylline</e1> blood levels should be monitored, particularly when the <e2>Mexitil</e2>    dose is changed. \n",
      "Although such a reaction has not been demonstrated with <e1>roxithromycin</e1>, concomitant administration of roxithromycin with terfenadine or <e2>astemizole</e2> is not recommended. \n",
      "Therefore, when concomitant use of <e1>thiabendazole</e1> and <e2>xanthine derivatives</e2> is anticipated, it may be necessary to monitor blood levels and/or reduce the dosage of such compounds. \n",
      "<e1>TOBI</e1> should not be administered concomitantly with <e2>ethacrynic acid</e2>, furosemide, urea, or mannitol.\n",
      "In addition to bleeding associated with heparin and <e1>vitamin K antagonists</e1>, drugs that alter platelet function (such as aspirin, <e2>dipyridamole</e2>, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "John   s Wort, and certain anticonvulsants (phenytoin, <e1>phenobarbital</e1>, carbamazepine) may induce mifepristone metabolism (lowering serum levels of <e2>mifepristone</e2>). \n",
      "When <e1>oxandrolone</e1> therapy is initiated in a patient already receiving treatment with <e2>warfarin</e2>, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e1>narcotic analgesics</e1> (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "The drug interaction between <e1>proton pump inhibitors</e1> and <e2>clopidogrel</e2> has been the subject of much study in recent years. \n",
      "You cannot take mazindol if you have taken a <e1>monoamine oxidase inhibitor</e1> (MAOI) such as isocarboxazid (Marplan), tranylcypromine (<e2>Parnate</e2>), or phenelzine (Nardil) in the last 14 days. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e1>prednisone</e1>, prednisolone, oral <e2>contraceptives</e2> (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Interactions for <e1>Vitamin B2</e1> (Riboflavin):  Alcohol - impairs the intestinal absorption of <e2>riboflavin</e2>\n",
      "<e1>Methyldopa</e1> does not interfere with measurement of VMA (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert <e2>VMA</e2> to vanillin. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "<e1>Selegiline</e1>: In healthy volunteers (N= 11), <e2>selegiline</e2> did not influence the pharmacokinetics of pramipexole. \n",
      "<e1>Ticlopidine</e1> treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral ketamine by 2.4-fold, whereas <e2>itraconazole</e2> treatment did not increase the exposure to S-ketamine. \n",
      "Concurrent ingestion of antacid (20 mL of antacid containing <e1>aluminum hydroxide</e1>, <e2>magnesium hydroxide</e2>, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "Caution should be used when administering <e1>MOBIC</e1> with <e2>warfarin</e2> since patients on warfarin may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (<e1>MAOI</e1>) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (<e2>Nardil</e2>) in the last 14 days. \n",
      "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, <e1>H2 blockers</e1>, digoxin, oral <e2>hypoglycemic agents</e2>, and cholesterol-lowering agents. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "In animals the duration of muscle paralysis from <e1>succinylcholine</e1> is not prolonged by <e2>remifentanil</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e1>Tofranil</e1>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Selegiline: In healthy volunteers (N= 11), <e1>selegiline</e1> did not influence the pharmacokinetics of <e2>pramipexole</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e2>indinavir</e2>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>TRENTAL</e1> has been used concurrently with antihypertensive drugs, beta blockers, <e2>digitalis</e2>, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "Warfarin: A multidose study of <e1>oxandrolone</e1>, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in <e2>S-warfarin</e2> half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and <e1>miconazole</e1>) to ketoconazole, and <e2>itraconazole</e2>, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, hypnotics, tranquilizers, general <e2>anesthetics</e2>, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "saline + saline, ephedrine (10   mg/kg) + saline, saline + <e1>dexmedetomidine</e1> (15     g/kg) and <e2>ephedrine</e2> (10   mg/kg) + dexmedetomidine (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests. \n",
      "Use of Anticoagulants and <e1>Antiplatelet Agents</e1> -- Streptase, Streptokinase, alone or in combination with <e2>antiplatelet agents</e2> and anticoagulants, may cause bleeding complications. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e1>procainamide</e1>, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e2>antipsychotic agents</e2> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, <e1>theophyllines</e1>, phenytoins, thiazide diuretics, beta blockers, and <e2>calcium channel blockers</e2>.\n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Anticoagulants (such as heparin and <e1>vitamin K antagonists</e1>) and drugs that alter platelet function (such as <e2>acetylsalicylic acid</e2>, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "Current guidelines recommend starting <e1>antiretroviral</e1> treatment within a few weeks of <e2>antituberculosis</e2> therapy for patients with CD4 cell counts\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e2>paricalcitol</e2> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e1>flecainide</e1>, and <e2>quinidine</e2>. \n",
      "Other eye drops or medications such as <e1>acetylcholine chloride</e1> (Miochol) and carbachol (<e2>Carboptic</e2>, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.\n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving <e2>MAO-A inhibitors</e2> is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Digoxin: In 12 normal-weight subjects receiving <e1>XENICAL</e1> 120 mg three times a day for 6 days, XENICAL did not alter the pharmacokinetics of a single dose of <e2>digoxin</e2>. \n",
      "Carbidopa/Levodopa: Carbidopa/<e1>Levodopa</e1> does not influence the pharmacokinetics of <e2>pramipexole</e2> in healthy volunteers (N= 10). \n",
      "Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg <e1>methsuximide</e1> may increase the plasma concentrations of <e2>phenytoin</e2> and phenobarbital).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e1>ANESTHETICS</e1>, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "Triprolidine may enhance the sedative effects of <e1>central nervous system depressants</e1> including alcohol, barbiturates, hypnotics, narcotic analgesics, <e2>sedatives</e2>, and tranquillisers. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e1>levothyroxine sodium</e1>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, <e1>modafinil</e1>, penicillins, rifampin, <e2>rifabutin</e2>, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e1>Anafranil</e1>, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Catecholamine-depleting drugs (e.g., <e1>reserpine</e1>) may have an additive effect when given with <e2>beta-blocking agents</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (<e2>Dilantin</e2>) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Dopamine antagonists: Since pramipexole is a <e1>dopamine agonist</e1>, it is possible that dopamine antagonists, such as the neuroleptics (<e2>phenothiazines</e2>, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "There have been no studies of the interaction of <e1>methyl aminolevulinate</e1> cream with any other drugs, including local <e2>anesthetics</e2>. \n",
      "<e1>Vindesine</e1> can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - <e2>Phenytoin</e2>: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e2>benzodiazepines</e2>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e1>kaolin</e1>-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e1>clindamycin</e1>, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Posicor</e1> inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, <e2>cyclosporine</e2>, and tricyclic antidepressants. \n",
      "<e1>Furafylline</e1> and sulfaphenazole had no effect, while quinidine appeared to augment <e2>precocene I</e2> toxicity. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e1>telithromycin</e1> or <e2>voriconazole</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that terbinafine does not affect the clearance of <e1>antipyrine</e1> or <e2>digoxin</e2>. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e2>metformin</e2>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "<e1>Anticoagulants</e1> <e2>Anabolic steroids</e2> may increase sensitivity to oral anticoagulants. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, <e1>naproxen</e1>, <e2>ibuprofen</e2>, diazepam, and diazoxide. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (<e1>curcumin</e1> 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus <e2>imipramine</e2> 15 mg/kg). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e1>bacitracin</e1> - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "After oral administration of colchicine (8 mg/kg) in the form of either the nanoemulsion or in free <e1>colchicine</e1> solution, the relative bioavailability of nanoemulsion and eugenol-nanoemulsion were enhanced by about 1.6- and 2.1-fold, respectively, compared with free <e2>colchicine</e2> solution. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, <e1>erythromycin</e1>, <e2>clarithromycin</e2>) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "John   s Wort, and certain anticonvulsants (<e1>phenytoin</e1>, phenobarbital, carbamazepine) may induce <e2>mifepristone</e2> metabolism (lowering serum levels of mifepristone). \n",
      "Coadministration with a high dose of <e1>antacid</e1> (170 mEq) results in a 28% decrease in plasma concentrations of ranitidine and may decrease plasma concentrations of bismuth from <e2>TRITEC</e2>. \n",
      "Dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, <e2>butyrophenones</e2>, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "Synergism was also noted when <e1>methylglyoxal</e1> was combined with carbenicillin and <e2>amikacin</e2>.\n",
      "The synergistic antinociception activity of ibuprofen when administered with <e1>piperine</e1> can be attributed to increased plasma concentration of <e2>ibuprofen</e2>. \n",
      "All mRPCs of 20 passages or less were transplanted into the subretinal space of B6 mice together with chondroitinase ABC, and into Rho(-/-) mice combined with chondroitinase ABC, <e1>N-[N-(3, 5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester</e1> (<e2>DAPT</e2>), and insulin growth factor (IGF)-1. \n",
      "The ratio of <e1>norketamine</e1> AUC(0-   ) to ketamine AUC(0-   ) was significantly decreased in the ticlopidine (P &lt; 0.001) and <e2>itraconazole</e2> phases (P = 0.006) as compared to placebo. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with <e2>Permax</e2> (a dopamine agonist); \n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "<e1>Hyaluronidase</e1>: <e2>Hyaluronidase</e2> may increase the diffusion rate of procaine hydrochloride, resulting in a decreased time of onset, but an increase in systemic toxicity. \n",
      "Anticoagulants (oral): The activity of oral <e1>anticoagulants</e1> may be potentiated by anti-vitamin-K activity attributed to <e2>methimazole</e2>.    \n",
      "Careful monitoring of serum <e1>theophylline</e1> concentrations in patients receiving DIFLUCAN and <e2>theophylline</e2> is recommended. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "<e1>Azathioprine</e1>/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with <e2>azathioprine</e2> or mycophenolate mofetil. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, <e2>phenothiazines</e2>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as <e1>antimycotic agents</e1> (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and <e2>clarithromycin</e2>), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of <e1>antacids</e1> has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including <e2>FELDENE</e2>, have been reported to increase steady state plasma lithium levels. \n",
      "<e1>Mequitazine</e1> can interact with CNS depressant, antichlolinergic, TCA, <e2>MAOIs</e2>, and alcohol.\n",
      "Additive sedative effects and confusional states may emerge if <e1>levomepromazine</e1> is given with benzodiazepines or <e2>barbiturates</e2>. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e2>Elavil</e2>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>Methylprednisolone</e1> may increase the clearance of chronic high dose <e2>aspirin</e2>. \n",
      "The objective of this study was to evaluate the effect of oral administration of ginseng stem-and-leaf saponins (<e1>GSLS</e1>) on the humoral immune responses of chickens to <e2>inactivated ND</e2> and AI vaccines. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, <e2>antipsychotic agents</e2> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, <e2>diphenylhydantoin</e2>, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e1>indinavir</e1>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e2>ProAmatine</e2>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "The preclinical combination of <e1>lenalidomide</e1> with the mTOR inhibitor <e2>CCI-779</e2> has displayed synergy in vitro and represents a novel combination in MM.\n",
      "This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving <e1>cyclosporine</e1> than in those receiving <e2>tacrolimus</e2>, indicating that, at the doses generally used in clinical practice, cyclosporine is the stronger of the two with respect to CYP3A inhibition. \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e2>warfarin</e2> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Food Interaction: Oral administration of <e1>ACEON</e1>    Tablets with food does not significantly lower the rate or extent of <e2>perindopril</e2> absorption relative to the fasted state. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e1>progestin</e1> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Fat-soluble Vitamin Supplements and Analogues: A pharmacokinetic interaction study showed a 30% reduction in <e1>beta-carotene</e1> supplement absorption when concomitantly administered with <e2>XENICAL</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "Anticoagulation and <e1>Antiplatelets</e1> After Treatment for Myocardial Infarction -- In the treatment of acute myocardial infarction, the use of <e2>aspirin</e2> has been shown to reduce the incidence of reinfarction and stroke. \n",
      "However, it is possible that concomitant use of other <e1>photosensitizing agents</e1> (e.g., tetracyclines, sulfonamides, <e2>phenothiazines</e2>, sulfonylurea hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in <e2>corticosteroid</e2> dose to achieve the desired response. \n",
      "The effect of curcumin (100 mg/kg) was similar to that of <e1>fluoxetine</e1> and imipramine (p > 0.05) but its addition to fluoxetine and <e2>imipramine</e2> did not improve their antidepressant activity (p > 0.05). \n",
      "Concomitant administration of a <e1>loop diuretic</e1> had no effect on the calcium-lowering action of <e2>Aredia</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, <e1>diphenylhydantoin</e1>, primidone), phenylbutazone, and tricyclic drugs (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e1>PHENOTHIAZINES</e1>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "When cells were exposed to <e1>docetaxel</e1> followed by <e2>sunitinib</e2>, synergism was observed. \n",
      "Changes in <e1>insulin</e1> and other diabetes drug therapies may be necessary during treatment with <e2>mazindol</e2>.\n",
      "Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of zidovudine or <e1>rifabutin</e1> to warrant dosage adjustment when <e2>megestrol acetate</e2> is administered with these drugs. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e1>thioxanthenes</e1>) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "The rats received intragastric administration of <e1>daphnetin</e1> and glycyrrhiza extract containing the same <e2>daphnetin</e2> respectively. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (phenobarbital, <e2>diphenylhydantoin</e2>, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, <e1>beta blockers</e1>, and <e2>calcium channel blockers</e2>.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a <e1>non-nucleoside reverse transcriptase inhibitor</e1> (NNRTI), a protease inhibitor (<e2>PI</e2>) or an integrase inhibitor (II) is recommended. \n",
      "Although this has not occurred in in vitro studies with <e1>coumarin-type anticoagulants</e1>, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on <e2>coumarin-type anticoagulants</e2> and other highly protein-bound drugs. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when <e1>ezetimibe</e1> was co-administered with atorvastatin, simvastatin, <e2>pravastatin</e2>, lovastatin, or fluvastatin. \n",
      "An additional clinical drug-drug interaction study showed no effect of <e1>rifaximin</e1> on the presystemic metabolism of an oral contraceptive containing ethinyl estradiol and <e2>norgestimate</e2>. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e2>Tricyclic antidepressants</e2> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e1>lithium</e1>, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, <e1>Iron</e1>-containing drugs, <e2>Laxatives</e2>, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "<e1>Lithium</e1> renal clearance is reduced by thiazides, increasing the risk of <e2>lithium</e2> toxicity. \n",
      "<e1>Anticoagulants</e1> (oral): The activity of oral anticoagulants may be potentiated by anti-vitamin-K activity attributed to <e2>methimazole</e2>.    \n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, <e2>phenytoin</e2> and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and <e1>itraconazole</e1> were shown to significantly increase the C max and AUC of orally administered <e2>midazolam</e2>. \n",
      "<e1>Digoxin</e1>: There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of digoxin with the co-administration of 100 mg <e2>sitagliptin</e2> for 10 days. \n",
      "Because <e1>Matulane</e1> exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., <e2>amitriptyline HCl</e2>, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Isoflurane</e1> and <e2>enflurane</e2> (administered with nitrous oxide/oxygen to achieve 1.25 M.C. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, <e2>Theophylline</e2>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Due to its effects on gastric emptying, SYMLIN therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., <e1>anticholinergic agents</e1> such as <e2>atropine</e2>) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "When phenytoin or other hepatic enzyme inducers such as <e1>rifampin</e1> and phenobarbital have been taken concurrently with <e2>Mexitil</e2>   , lowered Mexitil    plasma levels have been reported. \n",
      "The effect of meloxicam on the anticoagulant effect of <e1>warfarin</e1> was studied in a group of healthy subjects receiving daily doses of <e2>warfarin</e2> that produced an INR (International Normalized Ratio) between 1.2 and 1.8. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, <e1>Magnesium salicylate</e1>: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "Gentamicin: Animal data have suggested the possibility of interaction between <e1>perindopril</e1> and <e2>gentamicin</e2>. \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e2>atazanavir</e2>, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "Co-administration of <e1>ZETIA</e1> with <e2>fibrates</e2> is not recommended until use in patients is studied. \n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, <e2>Cholestyramine</e2>, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "The bioavailability of <e1>SKELID</e1> is decreased 80% by calcium, when calcium and <e2>SKELID</e2> are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, polymyxin B, colistin, <e1>viomycin</e1>, or <e2>cisplatin</e2>, when indicated, requires careful monitoring.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e2>lincomycin</e2>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), <e1>tranylcypromine</e1> (Parnate), or phenelzine (<e2>Nardil</e2>) in the last 14 days. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving <e1>MAO-A inhibitors</e1> is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral <e1>contraceptives</e1>, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or <e2>carbamazepine</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, <e2>verapamil</e2>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Use of <e1>Anticoagulants</e1> and Antiplatelet Agents -- Streptase, Streptokinase, alone or in combination with <e2>antiplatelet agents</e2> and anticoagulants, may cause bleeding complications. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), <e2>propofol</e2>, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, <e1>fluconazole</e1> and itraconazole were shown to significantly increase the C max and AUC of orally administered <e2>midazolam</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, <e1>nalidixic acid</e1>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "This medicine is generally safe with other medications, but patient should consult doctor or pharmacist if patient is taking a blood thinner (anticoagulant), <e1>cyclosporin</e1>, <e2>phenytoin</e2>, or methotrexate.\n",
      "<e1>Zinc</e1> inhibited glycolysis and protease to a greater degree than <e2>o-cymen-5-ol</e2>; \n",
      "<e1>Barbiturates</e1> may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, <e2>corticosteroids</e2>, anticoagulants, and beta blockers.\n",
      "Azathioprine/<e1>Mycophenolate Mofetil</e1>: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that <e2>Myfortic</e2> not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "Phenytoin: In 12 normal-weight subjects receiving <e1>XENICAL</e1> 120 mg three times a day for 7 days, <e2>XENICAL</e2> did not alter the pharmacokinetics of a single 300-mg dose of phenytoin. \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a dopamine agonist, it is possible that dopamine antagonists, such as the <e2>neuroleptics</e2> (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Accordingly, patients should be advised to avoid alcohol while taking <e1>REMERON SolTab</e1>. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of <e2>mirtazapine</e2> (15 mg) in 12 healthy subjects. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - <e2>Tricyclic antidepressants</e2> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Carbidopa/<e1>Levodopa</e1>: Carbidopa/<e2>Levodopa</e2> does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, <e2>atazanavir</e2>, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Interactions for Vitamin B1 (<e1>Thiamine</e1>):  Loop Diuretics, Oral <e2>Contraceptives</e2>, Stavudine, Tricyclic Antidepressants\n",
      "Azathioprine/Mycophenolate Mofetil: Given that <e1>azathioprine</e1> and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or <e2>mycophenolate mofetil</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), <e2>HIV protease</e2> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "In the present study, the antidepressant like activity of curcumin and its combination with <e1>fluoxetine</e1> and <e2>imipramine</e2> was studied in acute model (three doses 24, 5 and 1 h before test) of forced swimming test (FST) in glass jar and tail suspension test (TST) in mice and in chronic model (14 day study) of FST with water wheel in rats. \n",
      "Beside this, the medication oriented supplementation of vitamin D can also ameliorate the pharmacologic action of many drugs, such as <e1>bisphosphonates</e1>, <e2>statins</e2> and cytostatic drugs.\n",
      "Concomitant use of <e1>alcohol</e1> with <e2>phentermine hydrochloride</e2> may result in an adverse drug interaction.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Given the primary CNS effects of <e1>paliperidone</e1>, INVEGA    should be used with caution in combination with other centrally acting drugs and <e2>alcohol</e2>. \n",
      "Drugs such as <e1>erythromycin</e1>, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered <e2>midazolam</e2>. \n",
      "When <e1>atropine</e1> and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when <e2>atropine</e2> is used alone. \n",
      "Patients receiving sirolimus or <e1>nifedipine</e1> in combination with MYCAMINE should be monitored for <e2>sirolimus</e2> or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "Rifabutin: There have been reports of uveitis in patients to whom <e1>fluconazole</e1> and <e2>rifabutin</e2> were coadministered. \n",
      "Other eye drops or medications such as acetylcholine chloride (<e1>Miochol</e1>) and carbachol (Carboptic, <e2>Isopto Carbachol</e2>) may decrease the effects of suprofen ophthalmic.\n",
      "Usage with <e1>Alcohol</e1>: Due to the potential for increased CNS depressants effects, alcohol should be used with caution in patients who are currently receiving <e2>pentazocine</e2>.\n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, analgesics, <e1>antiemetics</e1>/antinauseants, <e2>antispasmodics</e2> and anticholinergic agents. \n",
      "<e1>CHEMET</e1> is not known to interact with other drugs including <e2>iron</e2> supplements; \n",
      "Terfenadine: Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving <e1>azole antifungals</e1> in conjunction with <e2>terfenadine</e2>, interaction studies have been performed. \n",
      "No pharmacokinetic interaction was observed between rivastigmine and <e1>digoxin</e1>, warfarin, diazepam, or <e2>fluoxetine</e2> in studies in healthy volunteers. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with <e2>ketoconazole</e2> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and <e2>doxazosin</e2>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some <e1>aluminum</e1>- or magnesium-containing antacids, when administered 1 hour before <e2>SKELID</e2>. \n",
      "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of <e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1> or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (<e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle). \n",
      "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with <e1>tamoxifen</e1> for breast cancer, especially SSRI antidepressants such as paroxetine and <e2>fluoxetine</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, <e2>phenytoin</e2>, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "morphine, <e1>theophylline</e1>, <e2>aminophylline</e2>, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by <e1>metoclopramide</e1>, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, <e2>ethanol</e2>, cyclosporine). \n",
      "Other eye drops or medications such as acetylcholine chloride (Miochol) and <e1>carbachol</e1> (<e2>Carboptic</e2>, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, <e1>phenothiazines</e1>, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "Interactions for Vitamin B2 (<e1>Riboflavin</e1>):  <e2>Alcohol</e2> - impairs the intestinal absorption of riboflavin\n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, <e2>clarithromycin</e2>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (<e1>NRTI</e1>) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (<e2>PI</e2>) or an integrase inhibitor (II) is recommended. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e1>nifedipine</e1>, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Theophylline</e1>: <e2>Theophylline</e2> clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; \n",
      "However, it is possible that concomitant use of other <e1>photosensitizing agents</e1> (e.g., tetracyclines, sulfonamides, phenothiazines, <e2>sulfonylurea</e2> hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Although <e1>ibuprofen</e1> (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with <e2>ALIMTA</e2> to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, <e1>nalidixic acid</e1>, halogenated salicylanilides (bacteriostatic soaps), <e2>sulfonamides</e2>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), <e1>antidiabetics</e1> (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e2>estrogens</e2> (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, <e2>antipyrine</e2>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The effect of <e1>curcumin</e1> (100 mg/kg) was similar to that of fluoxetine and imipramine (p > 0.05) but its addition to <e2>fluoxetine</e2> and imipramine did not improve their antidepressant activity (p > 0.05). \n",
      "This medicine is generally safe with other medications, but patient should consult doctor or pharmacist if patient is taking a blood thinner (<e1>anticoagulant</e1>), <e2>cyclosporin</e2>, phenytoin, or methotrexate.\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e2>melatonin</e2> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) <e1>Estrogens</e1> may decrease the effects of benzodiazepines (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or <e1>metoclopramide</e1>, ordinarily should not be administered concurrently with <e2>Permax</e2> (a dopamine agonist); \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, <e2>linezolid</e2>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Patients receiving <e1>antibiotics</e1> and <e2>sulfonamides</e2> generally should not be treated with ganglion blockers.  \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Concurrent administration of <e1>cimetidine</e1> and <e2>Mexitil</e2>    has been reported to increase, decrease, or leave unchanged Mexitil    plasma levels; \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e1>anesthetics</e1> such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "Fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral <e1>contraceptives</e1> produced an overall mean increase in ethinyl estradiol and <e2>levonorgestrel</e2> levels; \n",
      "<e1>Diuretics</e1>: Furosemide and probably other <e2>loop diuretics</e2> given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, <e1>phenytoin</e1>, and rifampin may increase the clearance of methylprednisolone and may require increased in <e2>methylprednisolone</e2> dose to achieve the desired response. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (<e1>imipramine</e1> 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus <e2>imipramine</e2> 15 mg/kg). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Results from limited in vitro and in vivo drug-drug interaction studies between <e1>tamsulosin HCI</e1> and <e2>warfarin</e2> are inconclusive. \n",
      "In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg <e1>S-ketamine</e1> after pretreatments with oral ticlopidine (250 mg twice daily), <e2>itraconazole</e2> (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks. \n",
      "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for <e1>sirolimus</e1> or nifedipine toxicity and sirolimus or <e2>nifedipine</e2> dosage should be reduced if necessary. \n",
      "<e1>Macrolides</e1>: Clinical drug interaction studies indicate that <e2>erythromycin</e2> and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent. \n",
      "However, in a drug-drug interaction study, mean <e1>levonorgesterol</e1> AUC was decreased by 15% when coadministered with <e2>mycophenolate mofetil</e2>. \n",
      "Attention is paid to <e1>calcium channel blockers</e1>, <e2>diuretics</e2> and digoxin. \n",
      "Distinct and statistically significant synergism was observed between <e1>methylglyoxal</e1> and <e2>piperacillin</e2> by disc diffusion tests when compared with their individual effects. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, morphine, meperidine and <e2>fentanyl</e2>), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as <e1>sedatives</e1>, tranquilizers, or <e2>alcohol</e2>. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (<e1>indomethacin</e1>, heparin, <e2>cyclosporine</e2> and others) can increase the risk of hyperkalemia. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Remifentanil clearance is not altered by concomitant administration of thiopental, <e1>isoflurane</e1>, <e2>propofol</e2>, or temazepam during anesthesia. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, <e1>sulfinpyrazone</e1>, naproxen, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "Potassium Supplements and <e1>Potassium-Sparing Diuretics</e1>: <e2>UNIVASC</e2>    can increase serum potassium because it decreases aldosterone secretion. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e1>Tofranil</e1>), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), <e1>phenylbutazone</e1>, and <e2>tricyclic drugs</e2> (imipramine, clomipramine, desipramine). \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, <e1>barbiturates</e1>, <e2>hypnotics</e2>, narcotic analgesics, sedatives, and tranquillisers. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e1>omeprazole</e1>, <e2>paracetamol</e2>, and prednisone.\n",
      "Antacids: Absorption of a single dose of <e1>Myfortic</e1> was decreased when administered to 12 stable renal transplant patients also taking <e2>magnesium</e2>-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, <e2>tetracyclines</e2>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with <e1>ACEON</e1>    Tablets, but an effect of digoxin on the plasma concentration of perindopril/<e2>perindoprilat</e2> has not been excluded. \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other <e1>CNS depressants</e1> such as alcohol, sedatives, <e2>antihistaminics</e2>, or psychotropic drugs. \n",
      "Being <e1>moxifloxacin</e1> and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and <e2>multi minerals</e2>. \n",
      "This is especially true if the total dose of <e1>atropine</e1> has been large and the administration of <e2>pralidoxime</e2> has been delayed. \n",
      "In addition, <e1>DZNep</e1> insensitivity might be associated with overexpression of Bcl-2, and the combination of ABT-737 and <e2>DZNep</e2> could synergistically induced apoptosis. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, indinavir, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "<e1>Anticoagulants</e1>: Metolazone, as well as other <e2>thiazide-like diuretics</e2>, may affect the hypoprothrombinemic response to anticoagulants; \n",
      "Interactions for <e1>Dronabinol</e1>:  In studies involving patients with AIDS and/or cancer, MARINOL (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, <e2>sedatives</e2>, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "Mixing <e1>SYMLIN</e1> and Insulin The pharmacokinetic parameters of <e2>SYMLIN</e2> were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection. \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e1>itraconazole</e1>, miconazole) or macrolide antibiotics (eg, erythromycin, <e2>clarithromycin</e2>) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, <e2>digoxin</e2>, and warfarin. \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, <e2>amiloride</e2>, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), <e2>warfarin</e2> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (<e2>Asendin</e2>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "<e1>Anticoagulants</e1>: <e2>Metolazone</e2>, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants; \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, flavanone, flavanonols and catechins, on the elimination of <e1>luteolin</e1> and <e2>apigenin</e2> was studied. \n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with <e2>Hormonal Contraceptives</e2>: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, <e2>ritonavir</e2>, and rifampin. \n",
      "However, on the basis of available data, no dosage adjustment for <e1>ondansetron</e1> is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and <e2>tramadol</e2> has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Anticholinesterases: Concurrent use of procaine hydrochloride and <e1>anticholinesterase agents</e1> may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of <e2>procaine hydrochloride</e2>. \n",
      "Systemic and apparent oral midazolam clearance were 24% (269    73 vs. 354    102  ml/min, P = 0.022) and 31% (479    190 vs. 688    265  ml/min, P = 0.013), respectively, lower in <e1>cyclosporine</e1>-treated patients (n = 20) than in matched <e2>tacrolimus</e2>-treated patients (n = 20). \n",
      "<e1>Alcohol</e1>, <e2>Barbiturates</e2>, and Narcotics: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy. \n",
      "TOBI should not be administered concomitantly with ethacrynic acid, furosemide, <e1>urea</e1>, or <e2>mannitol</e2>.\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, Cisapride, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, <e1>vancomycin</e1>, metformin and <e2>tenofovir</e2>). \n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, <e2>Colestipol</e2>, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, <e1>triamterene</e1> and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, <e2>heparin</e2>, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e1>digoxin</e1>, procainamide, pancuronium, <e2>morphine</e2>, vancomycin, metformin and tenofovir). \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (Dilantin) carbamazepine (Tegretol) <e2>Estrogens</e2> may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), <e2>terfenadine</e2>, digoxin, and warfarin. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (Dilantin) carbamazepine (<e2>Tegretol</e2>) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "John   s Wort, and certain <e1>anticonvulsants</e1> (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of <e2>mifepristone</e2>). \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e2>isocarboxazid</e2>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or <e1>vinblastine</e1>, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, <e2>lincomycin</e2>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "The authors report the case of an infant with confirmed congenital hypothyroidism on <e1>levothyroxine</e1> who experienced a possible drug interaction with <e2>simeticone</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e2>ritonavir</e2>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Digoxin: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, <e1>XENICAL</e1> did not alter the pharmacokinetics of a single dose of <e2>digoxin</e2>. \n",
      "In addition to bleeding associated with <e1>heparin</e1> and vitamin K antagonists, drugs that alter platelet function (such as aspirin, <e2>dipyridamole</e2>, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "John   s Wort, and certain <e1>anticonvulsants</e1> (phenytoin, <e2>phenobarbital</e2>, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e1>thiazides</e1>, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, <e1>levodopa</e1>, <e2>ethanol</e2>, cyclosporine). \n",
      "In most cases, the application of two <e1>nucleoside or nucleotide reverse transcriptase inhibitors</e1> (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a <e2>protease inhibitor</e2> (PI) or an integrase inhibitor (II) is recommended. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain <e1>antibiotics</e1>, quinidine, theophylline, corticosteroids, anticoagulants, and <e2>beta blockers</e2>.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, <e2>butyrophenones</e2>, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or <e2>carbamazepine</e2> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Concomitant use of omeprazole and <e1>clopidogrel</e1> was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity, as a result of inhibition by <e2>omeprazole</e2> of CYP2C19, a cytochrome P450 (CYP) enzyme. \n",
      "Quantitative toxicological analysis showed that the concentrations of <e1>etizolam</e1>, phenobarbital, promethazine and <e2>chlorpromazine</e2> in the femoral blood were 86 ng/ml, 5082 microg/ml, 0.107 microg/ml and 0.144 microg/ml, respectively, and large amounts of drugs were also detected in the stomach contents. \n",
      "Two early clinical studies conducted in patients who received <e1>Macugen</e1> alone and in combination with PDT revealed no apparent difference in the plasma pharmacokinetics of <e2>pegaptanib</e2>.\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e1>polymyxin B</e1> or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or <e1>rifampin</e1>, are co-administered with <e2>montelukast</e2>.\n",
      "Digitalis Glycosides: <e1>Diuretic</e1>-induced hypokalemia can increase the sensitivity of the myocardium to <e2>digitalis</e2>. \n",
      "The concurrent administration of potent inhalational agents (eg, <e1>isoflurane</e1>, enflurane, and halothane) during maintenance with <e2>DIPRIVAN</e2> Injectable Emulsion has not been extensively evaluated. \n",
      "requirements for <e1>riboflavin</e1> may be increased in patients receiving <e2>probenecid</e2>.\n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, <e2>triamterene</e2>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "Thalidomide has been reported to enhance the sedative activity of <e1>barbiturates</e1>, alcohol, chlorpromazine, and <e2>reserpine</e2>. \n",
      "Results revealed that the strains were resistant to many drugs at high levels, only <e1>piperacillin</e1>, carbenicillin, <e2>amikacin</e2> and ciprofloxacin showed resistances at comparatively lower levels. \n",
      "e.g., other belladonna alkaloids, <e1>antihistamines</e1> (including meclizine), tricyclic antidepressants, and <e2>muscle relaxants</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, <e2>linezolid</e2>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e1>pramipexole</e1> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>Fenofibrate</e1> is a prodrug that is rapidly and completely hydrolyzed to <e2>fenofibric acid</e2>, the active moiety. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e2>thyroxine</e2>, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other <e2>NSAIDs</e2> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Vindesine</e1> can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - <e2>Killed virus vaccines</e2>: may decrease patient's response to the vaccine\n",
      "Since <e1>Celontin</e1> (methsuximide) may interact with concurrently administered <e2>antiepileptic drugs</e2>, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).\n",
      "The effects of <e1>indinavir</e1>, zidovudine or <e2>rifabutin</e2> on the pharmacokinetics of megestrol acetate were not studied.\n",
      "There were no significant differences between the pharmacokinetics parameters of amiodarone administered intravenously or intragastrically and the control (without <e1>neferine</e1>) group (with ratios of 0.7-1.4 in all experimental groups), suggesting that <e2>neferine</e2> had no effect on amiodarone plasma pharmacokinetics. \n",
      "<e1>Triprolidine</e1> may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, <e2>sedatives</e2>, and tranquillisers. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, <e1>miconazole</e1>) or macrolide antibiotics (eg, erythromycin, clarithromycin) or <e2>cyclosporine</e2> or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Compounds that quench active oxygen species or scavenge radicals, such as dimethyl sufloxide, <e1>b-carotene</e1>, ethanol, <e2>formate</e2> and mannitol would be expected to decrease PDT activity. \n",
      "CRM197 induced apoptosis, and furthermore, the combination of <e1>CRM197</e1> plus <e2>doxorubicin</e2> enhanced cytotoxicity in a T-ALL cell line. \n",
      "Cimetidine: <e1>Cimetidine</e1> does not affect the pharmacokinetics of <e2>sparfloxacin</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, <e2>isocarboxazid</e2>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Posicor</e1> inhibits some of the liver's ability to metabolize some other drugs - terfenadine, <e2>astemizole</e2>, cisapride, cyclosporine, and tricyclic antidepressants. \n",
      "Interactions for Vitamin B1 (Thiamine):  <e1>Loop Diuretics</e1>, Oral <e2>Contraceptives</e2>, Stavudine, Tricyclic Antidepressants\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "<e1>Ibuprofen</e1> plasma concentration was also increased when it was administered with <e2>piperine</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Some examples of such drugs are erythromycin, itraconazole, ketoconazole, <e1>fluconazole</e1>, calcium channel blockers and <e2>cimetidine</e2>.\n",
      "Oral <e1>Contraceptives</e1>: Given the different metabolism of <e2>Myfortic</e2> and oral contraceptives, no drug interaction between these two classes of drug is expected. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., <e2>phenelzine</e2>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Ticagrelor (Brilinta)--better than <e1>clopidogrel</e1> (<e2>Plavix</e2>)\n",
      "Ropivacaine should be used with caution in patients receiving other local <e1>anesthetics</e1> or agents structurally related to <e2>amide-type local anesthetics</e2>, since the toxic effects of these drugs are additive. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, <e1>rifampin</e1>, <e2>rifabutin</e2>, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "<e1>Fluconazole</e1> tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and <e2>levonorgestrel</e2> levels; \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>DIPRIVAN</e1> Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used neuromuscular blocking agents (eg, <e2>succinylcholine</e2> and nondepolarizing muscle relaxants). \n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, triamterene, <e2>amiloride</e2>) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or <e1>methysergide</e1>) and <e2>sumatriptan</e2> within 24 hours of each other should be avoided. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, <e1>digoxin</e1>, oral <e2>hypoglycemic agents</e2>, and cholesterol-lowering agents. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral <e1>contraceptives</e1>, glucocorticoids, or certain <e2>monoamine oxidase inhibitors</e2>) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, <e2>conjugated estrogens</e2>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Drugs such as <e1>troleandomycin</e1> and ketoconazole may inhibit the metabolism of <e2>methylprednisolone</e2> and thus decrease its clearance. \n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e2>Elavil</e2>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Concurrent ingestion of antacid (20 mL of <e1>antacid</e1> containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or <e2>desethyloxybutynin</e2>.    \n",
      "The oral bioavailability of <e1>sparfloxacin</e1> is not reduced when the <e2>aluminum</e2>-magnesium suspension is administered 4 hours following sparfloxacin administration. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, <e1>Sanctura</e1> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e2>digoxin</e2>, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). \n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e2>morphine</e2>, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e1>quinine</e1>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "If <e1>short-acting benzodiazepines</e1>, which are metabolized by the cytochrome P450 system, are concomitantly administered with fluconazole, consideration should be given to decreasing the <e2>benzodiazepine</e2> dosage, and the patients should be appropriately monitored. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Acyclovir</e1>/<e2>Ganciclovir</e2>: may be taken with Myfortic; \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with <e1>corticosteroids</e1>, <e2>analgesics</e2>, antiemetics/antinauseants, antispasmodics and anticholinergic agents. \n",
      "Methyldopa does not interfere with measurement of <e1>VMA</e1> (<e2>vanillylmandelic acid</e2>), a test for pheochromocytoma, by those methods which convert VMA to vanillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e1>phenytoin</e1>, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "This study was aimed to investigate the efficacy of single use of <e1>sunitinib</e1> and that of concurrent or sequential administration of <e2>sunitinib</e2> and docetaxel in NSCLC cell lines that are resistant to EGFR TKIs.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Due to the chemical similarity of other <e1>azole-type antifungal agents</e1> (including fluconazole, metronidazole, and miconazole) to ketoconazole, and <e2>itraconazole</e2>, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "Careful monitoring of <e1>phenytoin</e1> concentrations in patients receiving <e2>DIFLUCAN</e2> and phenytoin is recommended. \n",
      "These include sympathomimetic bronchodilators, <e1>methylxanthines</e1>, and oral and inhaled <e2>steroids</e2>. \n",
      "Concurrent use with vasoconstrictor agents including <e1>ergot alkaloids</e1>, <e2>sumatriptan</e2>, and nicotine (e.g. smoking) may result in enhanced vasoconstriction.\n",
      "Agents that might be coadministered with <e1>trimetrexate</e1> in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, <e2>ketoconazole</e2>, and fluconazole. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving <e1>MAO-A inhibitors</e1> is contraindicated . Selective serotonin reuptake inhibitors (<e2>SSRIs</e2>) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "<e1>Digoxin</e1>: Sparfloxacin has no effect on the pharmacokinetics of <e2>digoxin</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, <e2>antipsychotic agents</e2> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with <e1>warfarin</e1>, resulted in a mean increase in <e2>S-warfarin</e2> half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. \n",
      "Phenothiazines are capable of potentiating <e1>CNS depressants</e1> (e.g., barbiturates, anesthetics, <e2>opiates</e2>, alcohol, etc.) \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, <e1>methotrexate</e1>, and possibly <e2>corticosteroids</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e1>quinine</e1>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, <e1>aminoglycosides</e1>, bacitracin, polymyxin B, colistin, <e2>viomycin</e2>, or cisplatin, when indicated, requires careful monitoring.\n",
      "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, <e1>itraconazole</e1>, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of <e2>mifepristone</e2>). \n",
      "<e1>Sulfoxone</e1> may increase the effects of <e2>barbiturates</e2>, tolbutamide, and uricosurics. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e1>procaine</e1> - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "In <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/vehicle-treated animals, almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups, whereas the extent of neuronal loss was lower than 15% of control values in <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys. \n",
      "Dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, butyrophenones, <e2>thioxanthines</e2> ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "<e1>Montelukast</e1> at a Dose of 10 mg Once Daily Dosed to Pharmacokinetic Steady State  - did not cause clinically significant changes in the kinetics of a single intravenous dose of <e2>theophylline</e2> (predominantly a cytochrome P450 1A2 substrate). \n",
      "To minimize CNS depression and possible potentiation, barbiturates, antihistamines, <e1>narcotics</e1>, hypotensive agents or <e2>phenothiazines</e2> should be used with caution. \n",
      "The safety of using methylphenidate in combination with <e1>clonidine</e1> or other centrally acting <e2>alpha-2 agonists</e2> has not been systemically evaluated.    \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, <e2>thiopental</e2>, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "The effects of indinavir, zidovudine or <e1>rifabutin</e1> on the pharmacokinetics of <e2>megestrol acetate</e2> were not studied.\n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Short-acting Benzodiazepines: Following oral administration of midazolam, <e1>fluconazole</e1> resulted in substantial increases in <e2>midazolam</e2> concentrations and psychomotor effects. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "<e1>UNIVASC</e1>    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, digoxin, oral <e2>hypoglycemic agents</e2>, and cholesterol-lowering agents. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e2>ketoconazole</e2> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and <e2>mycophenolate mofetil</e2>, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (<e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/vehicle). \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, <e1>phenytoin</e1> and <e2>rifampin</e2> may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. \n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with <e1>succinylcholine</e1>, similar <e2>neuromuscular blocking agents</e2> or cholinergic agonists such as bethanechol.\n",
      "Other eye drops or medications such as <e1>acetylcholine chloride</e1> (Miochol) and <e2>carbachol</e2> (Carboptic, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.\n",
      "In controlled clinical trials, <e1>ALOXI</e1> injection has been safely administered with corticosteroids, analgesics, antiemetics/antinauseants, <e2>antispasmodics</e2> and anticholinergic agents. \n",
      "<e1>Alcohol</e1>: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, <e2>orlistat</e2> pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "Concomitant administration of terfenadine with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other <e1>macrolide antibiotics</e1>, including <e2>azithromycin</e2>, is not recommended. \n",
      "Plasma levels of <e1>piroxicam</e1> are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . <e2>Nonsteroidal anti-inflammatory agents</e2>, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "Aspirin may decrease bioavailability of <e1>SKELID</e1> by up to 50% when taken 2 hours after <e2>SKELID</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, <e2>diazepam</e2> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "When <e1>methyldopa</e1> and lithium are given concomitantly the patient should be carefully monitored for symptoms of <e2>lithium</e2> toxicity. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "Since <e1>MEXITIL</e1> is a substrate for the metabolic pathways involving CYP2D6 and CYP1A2 enzymes, inhibition or induction of either of these enzymes would be expected to alter <e2>mexiletine</e2> plasma concentrations. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, <e1>ephedrine</e1>, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when <e2>ProAmatine</e2>    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Concurrent ingestion of antacid (20 mL of antacid containing <e1>aluminum hydroxide</e1>, magnesium hydroxide, and <e2>simethicone</e2>) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "The effect of a series of flavonoids, including flavonols, flavones, <e1>isoflavone</e1>, flavanone, <e2>flavanonols</e2> and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "TERAZOL 3 Vaginal Cream 0.8% The levels of estradiol (E2) and progesterone did not differ significantly when 0.8% <e1>terconazole</e1> vaginal cream was administered to healthy female volunteers established on a low dose oral <e2>contraceptive</e2>.    \n",
      "This could lead to decreased <e1>salicylate</e1> serum levels or increase the risk of <e2>salicylate</e2> toxicity when corticosteroid is withdrawn. \n",
      "Caution is advised for patients receiving high-dose aspirin and <e1>methazolamide</e1> concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and <e2>carbonic anhydrase inhibitors</e2>.\n",
      "convulsions have been reported with concurrent use of <e1>methylprednisolone</e1> and <e2>cyclosporin</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e1>Cisapride</e1>, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., ritonavir, <e2>indinavir</e2>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "One case of hypertensive crisis has been reported in a patient taking the recommended doses of <e1>selegiline</e1> and a sympathomimetic medication (<e2>ephedrine</e2>).\n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "<e1>Tetracycline</e1>, a bacteriostatic <e2>antibiotic</e2>, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "No clinically significant changes to lamivudine or <e1>zidovudine</e1> pharmacokinetics were observed following concomitant administration of <e2>abacavir</e2>. \n",
      "Although <e1>MIVACRON</e1> (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between <e2>MIVACRON</e2> and succinylcholine has not been systematically studied. \n",
      "<e1>Pravastatin</e1>: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving <e2>XENICAL</e2> 120 mg three times a day for 6 days, XENICAL did not affect the pharmacokinetics of pravastatin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e1>metoprolol</e1>, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Dopamine antagonists, such as the <e1>neuroleptics</e1> (<e2>phenothiazines</e2>, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, <e2>digoxin</e2>, and warfarin. \n",
      "Concomitant administration of terfenadine with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of <e1>terfenadine</e1> with other <e2>macrolide antibiotics</e2>, including azithromycin, is not recommended. \n",
      "<e1>Anticholinergic agents</e1> may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of <e2>digoxin</e2>; \n",
      "Barbiturates may decrease the effectiveness of oral <e1>contraceptives</e1>, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and <e2>beta blockers</e2>.\n",
      "<e1>isosorbide dinitrate</e1>, <e2>nitroglycerin</e2>; \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e1>neostigmine</e1> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (<e2>Elavil</e2>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), <e1>antidiabetics</e1> (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "Due to its effects on gastric emptying, SYMLIN therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., <e1>anticholinergic agents</e1> such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., <e2>alpha glucosidase inhibitors</e2>). \n",
      "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of <e1>norethindrone</e1> and <e2>ethinyl estradiol</e2> following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking <e1>magnesium</e1>-<e2>aluminum</e2> containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "<e1>Gentamicin</e1>: Animal data have suggested the possibility of interaction between perindopril and <e2>gentamicin</e2>. \n",
      "In post-marketing experience, as with other azole antifungals, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving <e1>fluconazole</e1> concurrently with <e2>warfarin</e2>. \n",
      "Cholestyramine: <e1>Cholestyramine</e1> causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with <e2>EVISTA</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, <e1>hypoglycemics</e1>, theophyllines, phenytoins, <e2>thiazide diuretics</e2>, beta blockers, and calcium channel blockers.\n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, <e1>polymyxin B</e1>, colistin, viomycin, or <e2>cisplatin</e2>, when indicated, requires careful monitoring.\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "This increase was observed at the first test point which was the second day after starting <e1>Mexitil</e1>   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, <e2>theophylline</e2> blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "The effect of curcumin (100 mg/kg) was similar to that of <e1>fluoxetine</e1> and <e2>imipramine</e2> (p > 0.05) but its addition to fluoxetine and imipramine did not improve their antidepressant activity (p > 0.05). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "In clinical trials the <e1>antiplatelet agent</e1> reduced significantly vascular mortality and death from any cause when compared to <e2>clopidogrel</e2> in patients with acute coronary syndrome.\n",
      "<e1>Methyldopa</e1> does not interfere with measurement of VMA (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert VMA to <e2>vanillin</e2>. \n",
      "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, <e1>fluoxetine</e1>, <e2>fluvoxamine</e2>, zileuton, and clotrimazole. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, <e1>nelfinavir</e1>, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, <e1>Colestipol</e1>, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "Due to low systemic exposure to retapamulin following topical application in patients, dosage adjustments for <e1>retapamulin</e1> are unnecessary when co-administered with CYP3A4 inhibitors, such as <e2>ketoconazole</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e1>Pertofrane</e1>, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, <e1>thiazide diuretics</e1>, beta blockers, and <e2>calcium channel blockers</e2>.\n",
      "Concurrent ingestion of antacid (20 mL of antacid containing <e1>aluminum hydroxide</e1>, magnesium hydroxide, and simethicone) did not significantly affect the exposure of <e2>oxybutynin</e2> or desethyloxybutynin.    \n",
      "however, in some patients there were decreases up to 47% and 33% of <e1>ethinyl estradiol</e1> and <e2>levonorgestrel</e2> levels. \n",
      "Palonosetron did not inhibit the antitumor activity of the five <e1>chemotherapeutic agents</e1> tested (cisplatin, cyclophosphamide, <e2>cytarabine</e2>, doxorubicin and mitomycin C) in murine tumor models.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e2>Cisapride</e2>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e1>SEDATIVE-HYPNOTICS</e1> (INCLUDING <e2>BARBITURATES</e2>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "<e1>Antacids</e1>: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when <e2>Myfortic</e2> was administered alone under fasting conditions. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Furthermore, it is well known that acute treatment with <e1>MPTP</e1> can cause a severe loss of tyrosine hydroxylase and dopamine transporter protein levels and dopamine contents in the striatum of mice, as compared to continuous <e2>MPTP</e2> treatment. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and <e1>fentanyl</e1>), propofol, ketamine, <e2>nitrous oxide</e2>, secobarbital and droperidol. \n",
      "All mRPCs of 20 passages or less were transplanted into the subretinal space of B6 mice together with chondroitinase ABC, and into Rho(-/-) mice combined with chondroitinase ABC, <e1>N-[N-(3, 5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester</e1> (DAPT), and <e2>insulin growth factor</e2> (IGF)-1. \n",
      "nucleatum, with MIC of 0.42 mM/0.69 mM for <e1>o-cymen-5-ol</e1>/<e2>zinc gluconate</e2>, respectively. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, <e2>naproxen</e2>, warfarin, methotrexate, and possibly corticosteroids. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "<e1>Thiazide drugs</e1> may increase the responsiveness of <e2>tubocurarine</e2>. \n",
      "However, because <e1>telbivudine</e1> is eliminated primarily by renal excretion, co   administration of telbivudine with drugs that alter renal function may alter plasma concentrations of <e2>telbivudine</e2>.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "In <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/vehicle-treated animals, almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups, whereas the extent of neuronal loss was lower than 15% of control values in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2>-treated monkeys. \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, <e1>diazepam</e1>, or <e2>fluoxetine</e2>. \n",
      "It will compete with clopidogrel (<e1>Plavix</e1>) and prasugrel (<e2>Effient</e2>) for such use. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e1>clomipramine</e1> (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e1>Anafranil</e1>, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, <e1>taxol</e1>, <e2>rifampicin</e2>, and human immunodeficiency virus protease inhibitors such as ritonavir and saquinavir. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, <e1>naproxen</e1>, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "Concomitant administration of <e1>itraconazole</e1> and <e2>terfenadine</e2> is contraindicated. \n",
      "In clinical studies, patients on opioids often needed higher serum <e1>pegvisomant</e1> concentrations to achieve appropriate IGF-I suppression compared with patients not receiving <e2>opioids</e2>. \n",
      "saline + saline, <e1>ephedrine</e1> (10   mg/kg) + saline, saline + <e2>dexmedetomidine</e2> (15     g/kg) and ephedrine (10   mg/kg) + dexmedetomidine (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and quinine) decreases the oral clearance of <e2>pramipexole</e2> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "one fatality has been reported from hypoglycemia in association with combined <e1>DIFLUCAN</e1> and <e2>glyburide</e2> use. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, <e1>glycopyrrolate</e1>, diazepam, hydroxyzine, and other <e2>muscle relaxants</e2>) or local anesthetics have been observed.\n",
      "Use with <e1>Cholinomimetics</e1> and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as <e2>bethanechol</e2>.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e2>metformin</e2>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, <e2>primidone</e2>), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, <e1>miconazole</e1>) or <e2>macrolide antibiotics</e2> (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - <e1>terfenadine</e1>, <e2>astemizole</e2>, cisapride, cyclosporine, and tricyclic antidepressants. \n",
      "Careful monitoring of serum <e1>theophylline</e1> concentrations in patients receiving <e2>DIFLUCAN</e2> and theophylline is recommended. \n",
      "John   s Wort, and certain anticonvulsants (phenytoin, <e1>phenobarbital</e1>, carbamazepine) may induce <e2>mifepristone</e2> metabolism (lowering serum levels of mifepristone). \n",
      "Mequitazine can interact with CNS depressant, antichlolinergic, <e1>TCA</e1>, MAOIs, and <e2>alcohol</e2>.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e1>magnesium</e1> salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "There is usually complete cross-resistance between <e1>PURINETHOL</e1> (<e2>mercaptopurine</e2>) and TABLOID brand Thioguanine. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) <e1>carbamazepine</e1> (Tegretol) Estrogens may decrease the effects of benzodiazepines (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and <e1>tricyclic drugs</e1> (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "- Cisapride, <e1>pimozide</e1>: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some <e2>macrolide antibacterials</e2>. \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, <e1>cyclosporine</e1>, <e2>tacrolimus</e2>, prednisolone, and fluconazole pharmacokinetics. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, <e1>simvastatin</e1>, <e2>pravastatin</e2>, lovastatin, or fluvastatin. \n",
      "We concluded that the combined administration of dexmedetomidine with <e1>ephedrine</e1> may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an <e2>analgesic</e2> in humans.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, thyroxine, triiodothyronine, phenytoin, <e2>sulfinpyrazone</e2>, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Cimetidine</e1>: Concomitant administration of 200 mg <e2>cimetidine</e2> QID did not alter the single-dose pharmacokinetics of 30 mg meloxicam. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e2>medroxyprogesterone acetate</e2>, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, <e1>tranquilizers</e1>, general anesthetics, phenothiazines, other <e2>opioids</e2>, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "<e1>Cimetidine</e1>: <e2>Cimetidine</e2>, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in pramipexole AUC and a 40% increase in half-life (N= 12). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e1>anesthetics</e1> - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, <e2>prednisolone</e2>, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "<e1>Ketoconazole</e1>: Spontaneous adverse reaction reports of patients taking concomitant <e2>ketoconazole</e2> with recommended doses of terfenadine demonstrate QT interval prolongation and rare serious cardiac events, e.g. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e1>HIV-protease inhibitors</e1>, griseofulvin, modafinil, penicillins, rifampin, rifabutin, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - <e2>Tricyclic antidepressants</e2> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that <e1>dopamine antagonists</e1>, such as the <e2>neuroleptics</e2> (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "We concluded that the combined administration of <e1>dexmedetomidine</e1> with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an <e2>analgesic</e2> in humans.\n",
      "Compounds that quench active oxygen species or scavenge radicals, such as <e1>dimethyl sufloxide</e1>, <e2>b-carotene</e2>, ethanol, formate and mannitol would be expected to decrease PDT activity. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (<e1>curcumin</e1> 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (<e2>curcumin</e2> 100 mg/kg plus imipramine 15 mg/kg). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e1>Sinequan</e1>, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>Palonosetron</e1> did not inhibit the antitumor activity of the five <e2>chemotherapeutic agents</e2> tested (cisplatin, cyclophosphamide, cytarabine, doxorubicin and mitomycin C) in murine tumor models.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e1>ritonavir</e1>, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Concomitant administrations not recommended:  - <e1>Terfenadine</e1> and astemizole: Certain macrolides interact with terfenadine and <e2>astemizole</e2> leading to increased serum concentrations of the latter. \n",
      "The bioavailability of <e1>SKELID</e1> is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some <e2>aluminum</e2>- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Laboratory Tests There have been reports of false-positive urine screening tests for tetrahydrocannabinol (THC) in patients receiving most <e1>proton pump inhibitors</e1>, including <e2>pantoprazole</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e1>nelfinavir</e1>, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - neostigmine - polymyxin B or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "<e1>Mephenytoin</e1> may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, <e2>anti-infective medicines</e2>, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "Severe toxicity has also been reported in patients receiving the combination of <e1>tricyclic antidepressants</e1> and <e2>ELDEPRYL</e2> and selective serotonin reuptake inhibitors and ELDEPRYL. \n",
      "No significant adverse interactions with common premedications (such as atropine, <e1>scopolamine</e1>, glycopyrrolate, diazepam, hydroxyzine, and other <e2>muscle relaxants</e2>) or local anesthetics have been observed.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e1>Cisapride</e1>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Plasma levels of <e1>piroxicam</e1> are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with <e2>aspirin</e2> (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Phenytoin, Carbamazepine, and <e1>Rifampicin</e1>: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and <e2>rifampicin</e2>), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Although it was previously reported that lapatinib combined with Herceptin improved the progression-free survival rate compared with <e1>lapatinib</e1> alone for patients with <e2>Herceptin</e2>-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of <e1>furosemide</e1> and <e2>thiazide diuretics</e2> in some patients. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other <e1>opioids</e1>, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "The metabolism of <e1>Metopirone</e1> is accelerated by <e2>phenytoin</e2>; \n",
      "Anticoagulants: <e1>Metolazone</e1>, as well as other <e2>thiazide-like diuretics</e2>, may affect the hypoprothrombinemic response to anticoagulants; \n",
      "Additionally, in one controlled study in five normal subjects and seven patients, the clearance of <e1>caffeine</e1> was decreased 50% following the administration of <e2>Mexitil</e2>   .\n",
      "<e1>ProAmatine</e1>    has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., <e2>fludrocortisone acetate</e2>), with or without salt supplementation. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Accordingly, patients should be advised to avoid <e1>alcohol</e1> while taking REMERON SolTab. Diazepam: Concomitant administration of <e2>diazepam</e2> (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. \n",
      "In a formal study, <e1>benzodiazepines</e1> were shown not to affect <e2>Mexitil</e2>    plasma concentrations. \n",
      "<e1>Misoprostol</e1> has no clinically significant effect on the kinetics of <e2>diclofenac</e2> or ibuprofen.\n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e1>morphine</e1>, meperidine and fentanyl), <e2>propofol</e2>, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Moxifloxacin and <e1>lomefloxacin</e1> are <e2>fluoroquinolone antibiotics</e2> used in treating urinary and respiratory tract infections. \n",
      "<e1>Terbinafine</e1> increases the clearance of <e2>cyclosporine</e2> by 15%. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "In vitro studies with atracurium, <e1>mivacurium</e1>, esmolol, echothiophate, neostigmine, physostigmine, and <e2>midazolam</e2> revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the <e1>vaccine</e1> virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the <e2>vaccine</e2>\n",
      "Standard <e1>antibiotic</e1> such as Gentamicin (10 microg), Cephalothin (30 microg), Ceftriaxone (10 microg), <e2>Nystatin</e2> (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "<e1>Ticagrelor</e1> (Brilinta)--better than <e2>clopidogrel</e2> (Plavix)\n",
      "e.g., other belladonna alkaloids, antihistamines (including <e1>meclizine</e1>), <e2>tricyclic antidepressants</e2>, and muscle relaxants. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., <e2>ritonavir</e2>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Macrolides: Clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on <e1>terfenadine</e1> metabolism by a mechanism which may be similar to that of <e2>ketoconazole</e2>, but to a lesser extent. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "On day 8, a single <e1>panobinostat</e1> dose was co-administered with <e2>ketoconazole</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "This increase was observed at the first test point which was the second day after starting <e1>Mexitil</e1>   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and <e2>theophylline</e2> are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e1>anesthetics</e1> such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, <e2>ketamine</e2>, nitrous oxide, secobarbital and droperidol. \n",
      "May interact with <e1>cimetidine</e1>, <e2>digoxin</e2>, medicines to control heart rhythm, sevelamer, and theophylline.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "To minimize CNS depression and possible potentiation, <e1>barbiturates</e1>, antihistamines, <e2>narcotics</e2>, hypotensive agents or phenothiazines should be used with caution. \n",
      "No cross-resistance with other <e1>chemotherapeutic agents</e1>, radiotherapy or <e2>steroids</e2> has been demonstrated.\n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>Fenofibrate</e1>: In a pharmacokinetic study, concomitant fenofibrate administration increased total <e2>ezetimibe</e2> concentrations approximately 1.5-fold. \n",
      "The rats received intragastric administration of daphnetin and <e1>glycyrrhiza extract</e1> containing the same <e2>daphnetin</e2> respectively. \n",
      "Although such a reaction has not been demonstrated with <e1>roxithromycin</e1>, concomitant administration of roxithromycin with <e2>terfenadine</e2> or astemizole is not recommended. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or <e1>macrolide antibiotics</e1> (e.g., erythromycin and clarithromycin), may alter <e2>oxybutynin</e2> mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e1>medroxyprogesterone acetate</e1>, methotrexate, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e2>narcotics</e2> (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "<e1>Streptozocin</e1> has been reported to prolong the elimination half-life of <e2>doxorubicin</e2> and may lead to severe bone marrow suppression; \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e1>phenobarbital</e1>, diphenylhydantoin, <e2>primidone</e2>), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as <e1>phenobarbital</e1> or <e2>rifampin</e2>, are co-administered with montelukast.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e1>desglymidodrine</e1> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "Standard <e1>antibiotic</e1> such as Gentamicin (10 microg), <e2>Cephalothin</e2> (30 microg), Ceftriaxone (10 microg), Nystatin (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "In vitro data indicate that the phosphorylation of <e1>stavudine</e1> is also inhibited at relevant concentrations by doxorubicin and <e2>ribavirin</e2>. \n",
      "Concurrent use with <e1>vasoconstrictor agents</e1> including <e2>ergot alkaloids</e2>, sumatriptan, and nicotine (e.g. smoking) may result in enhanced vasoconstriction.\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (phenobarbital, diphenylhydantoin, <e2>primidone</e2>), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, <e1>pseudoephedrine</e1>, ephedrine, <e2>phenylpropanolamine</e2> or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, <e1>ketoconazole</e1>, <e2>miconazole</e2>) were potent, non-competitive inhibitors of trimetrexate metabolism. \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and miconazole) to ketoconazole, and <e1>itraconazole</e1>, concomitant use of these products with <e2>terfenadine</e2> is not recommended pending full examination of potential interactions. \n",
      "<e1>Terbinafine</e1> decreases the clearance of <e2>caffeine</e2> by 19%. \n",
      "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as <e1>phenobarbital</e1> or <e2>rifampin</e2>, are co-administered with montelukast. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, <e1>tricyclic antidepressants</e1>, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "Since bacteriostatic drugs may interfere with the bactericidal action of <e1>penicillin</e1>, it is advisable to avoid giving tetracycline class drugs in conjunction with <e2>penicillin</e2>. \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "The bioavailability of <e1>SKELID</e1> is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before <e2>SKELID</e2>. \n",
      "The effects of <e1>metoclopramide</e1> on gastrointestinal motility are antagonized by <e2>anticholinergic drugs</e2> and narcotic analgesics. \n",
      "Agents that might be coadministered with <e1>trimetrexate</e1> in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, ketoconazole, and <e2>fluconazole</e2>. \n",
      "Concurrent administration of <e1>bacteriostatic antibiotics</e1> (e.g., erythromycin, tetracycline) may diminish the bactericidal effects of <e2>penicillins</e2> by slowing the rate of bacterial growth. \n",
      "This could lead to decreased <e1>salicylate</e1> serum levels or increase the risk of salicylate toxicity when <e2>corticosteroid</e2> is withdrawn. \n",
      "Some examples of such drugs are erythromycin, itraconazole, ketoconazole, fluconazole, <e1>calcium channel blockers</e1> and <e2>cimetidine</e2>.    \n",
      "Standard antibiotic such as Gentamicin (10 microg), <e1>Cephalothin</e1> (30 microg), <e2>Ceftriaxone</e2> (10 microg), Nystatin (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, <e2>tricyclic antidepressants</e2>, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Oral Contraceptives: Given the different metabolism of <e1>Myfortic</e1> and oral <e2>contraceptives</e2>, no drug interaction between these two classes of drug is expected. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e1>magnesium</e1> salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Use with <e1>Cholinomimetics</e1> and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or <e2>cholinergic agonists</e2> such as bethanechol.\n",
      "The use of AGGRASTAT, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to <e1>heparin</e1> and <e2>aspirin</e2> alone (see\n",
      "Compared with the elimination of pure luteolin and apigenin, the elimination of luteolin and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of <e1>luteolin</e1> and <e2>apigenin</e2>. \n",
      "Since there is no interaction with <e1>theophylline</e1>, interaction with other methylxanthines such as <e2>caffeine</e2> is unlikely. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, <e1>phenytoin</e1>, carbamazepine, rifampin, <e2>rifabutin</e2>, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (<e1>Marplan</e1>), <e2>tranylcypromine</e2> (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "However, it is possible that concomitant use of other <e1>photosensitizing agents</e1> (e.g., tetracyclines, sulfonamides, phenothiazines, sulfonylurea hypoglycemia agents, thiazide diuretics, and <e2>griseofulvin</e2>) could increase the photosensitivity reaction. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Preclinical data also suggest that tissue ischemia, <e1>allopurinol</e1>, <e2>calcium channel blockers</e2> and some prostaglandin synthesis inhibitors could interfere with PHOTOFRIN    PDT. \n",
      "To observe the injury in rat primary cultured neurons induced by <e1>Abeta(1-40)</e1> and the protective effects of combination of <e2>ginseng</e2> and ginko extracts.\n",
      "Acromegalic patients with diabetes mellitus being treated with insulin and/or oral <e1>hypoglycemic</e1> agents may require dose reductions of these therapeutic agents after the initiation of therapy with <e2>SOMAVERT</e2>. \n",
      "The difficulty in achieving adequate sedation may have been the result of decreased absorption of the <e1>sedatives</e1> due to both the gastrointestinal effects and stimulant effects of <e2>methylphenidate</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e1>polymyxin B</e1> or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "Compared with the elimination of pure luteolin and apigenin, the elimination of <e1>luteolin</e1> and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of <e2>luteolin</e2> and apigenin. \n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: <e2>theophylline</e2>, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Use with Other <e1>Central Nervous System Depressants</e1>: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, <e2>sedatives</e2>, antihistaminics, or psychotropic drugs. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "This study aimed to evaluate antimicrobial effects of an <e1>o-cymen-5-ol</e1>/<e2>zinc</e2> system.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "The effect of a series of flavonoids, including flavonols, <e1>flavones</e1>, isoflavone, flavanone, <e2>flavanonols</e2> and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some <e1>steroid medications</e1>, warfarin, certain heart medicines, birth control pills, <e2>anti-infective medicines</e2>, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "Coadministration of <e1>methyldopa</e1> with <e2>ferrous sulfate</e2> or ferrous gluconate is not recommended. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Curariform Drugs: <e1>Diuretic</e1>-induced hypokalemia may enhance neuromuscular blocking effects of <e2>curariform drugs</e2> (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. \n",
      "Plasma levels of <e1>piroxicam</e1> are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including <e2>FELDENE</e2>, have been reported to increase steady state plasma lithium levels. \n",
      "Mixing SYMLIN and <e1>Insulin</e1> The pharmacokinetic parameters of <e2>SYMLIN</e2> were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection. \n",
      "<e1>Carbidopa</e1>/Levodopa: Carbidopa/Levodopa does not influence the pharmacokinetics of <e2>pramipexole</e2> in healthy volunteers (N= 10). \n",
      "Lithium: Increased serum <e1>lithium</e1> and symptoms of <e2>lithium</e2> toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - neostigmine - polymyxin B or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The colchicine nanoemulsion was prepared with <e1>isopropyl myristate</e1>, eugenol, <e2>Tween80</e2>, ethanol and water, and eugenol was used as an oil phase in the formulation; \n",
      "Since Celontin (<e1>methsuximide</e1>) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of <e2>phenytoin</e2> and phenobarbital).\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), <e2>fluvoxamine</e2> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, <e2>isocarboxazid</e2>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Less potent inhibitors include saquinavir, nefazodone, <e1>fluconazole</e1>, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and <e2>clotrimazole</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e1>Vivactil</e1>), or desipramine (<e2>Norpramin</e2>). \n",
      "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, <e1>hyaluronan lyase</e1>, <e2>heparinase III</e2>, or chondroitin ABC lyase. \n",
      "<e1>Beta adrenergic agonists</e1> should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of <e2>beta adrenergic agonists</e2> on the vascular system may be potentiated.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), <e1>nonsteroidal anti-inflammatory drugs</e1> (n=79), estrogens (n=70), salicylate analgesics (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or <e1>nifedipine</e1> toxicity and sirolimus or <e2>nifedipine</e2> dosage should be reduced if necessary. \n",
      "Concomitant administration of <e1>TRENTAL</e1> and theophylline-containing drugs leads to increased <e2>theophylline</e2> levels and theophylline toxicity in some individuals. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since <e2>paricalcitol</e2> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) <e1>Estrogens</e1> may decrease the effects of benzodiazepines (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, <e1>ephedrine</e1>, phenylpropanolamine or <e2>dihydroergotamine</e2>) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of <e1>docetaxel</e1> followed by <e2>sunitinib</e2> is superior to sunitinib followed by docetaxel and concurrent administration.\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "Mexitil    does not alter serum digoxin levels but <e1>magnesium-aluminum hydroxide</e1>, when used to treat gastrointestinal symptoms due to <e2>Mexitil</e2>   , has been reported to lower serum digoxin levels. \n",
      "<e1>Moxifloxacin</e1> and <e2>lomefloxacin</e2> are fluoroquinolone antibiotics used in treating urinary and respiratory tract infections. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., <e1>pentazocine</e1>, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof <e2>opioid agonist analgesic</e2>. \n",
      "<e1>ABT</e1> decreased the toxicity of <e2>precocene I</e2>, increased exposure to parent compound, and decreased metabolite levels in a dose-dependent manner. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, <e2>phenobarbital</e2>, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "<e1>Montelukast</e1> at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral <e2>contraceptive</e2> containing norethindrone 1 mg/ethinyl estradiol 35 mcg. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, <e1>prednisolone</e1>, oral contraceptives (<e2>norethindrone</e2> 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., <e1>phenylephrine</e1>, pseudoephedrine, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of <e2>ProAmatine</e2>   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, <e1>furosemide</e1> and theophylline Please note that <e2>Mephenytoin</e2> may interact with other drugs that are not listed here.\n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e2>lincomycin</e2>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "and/or antibiotic drug <e1>doxycycline</e1> (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (<e2>MPTP</e2>) (4 x 20 mg/kg, i. p.) \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e1>procaine</e1> - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "In vitro studies with atracurium, mivacurium, esmolol, <e1>echothiophate</e1>, <e2>neostigmine</e2>, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "<e1>Moxifloxacin</e1> and Lomefloxacin reacts faster with <e2>sucralfate</e2> and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, <e2>clarithromycin</e2>) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or <e2>coal tar derivatives</e2>, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e1>Astemizole</e1>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "chlorthalidone, furosemide, <e1>hydrochlorothiazide</e1>, <e2>spironolactone</e2>; \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between <e1>ondansetron</e1> and <e2>tramadol</e2> has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Based on this experience, we suggest that low-dose <e1>ketamine</e1> added to propofol may be associated with prevention of EA in children with a history of EA with <e2>propofol</e2> TIVA.\n",
      "The possibility of hypotensive effects with <e1>UNIVASC</e1>    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with UNIVASC   . If this is not possible, the starting dose of <e2>moexpril</e2> should be reduced.. \n",
      "<e1>TOLECTIN</e1> and other <e2>nonsteroidal anti-inflammatory drugs</e2> have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate. \n",
      "While co-administration of ZAVESCA    appeared to increase the clearance of <e1>Cerezyme</e1> by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of <e2>Cerezyme</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Treatment of HEY xenograft-bearing mice with dasatinib plus <e1>paclitaxel</e1> inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + <e2>paclitaxel</e2> vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other <e1>vasoconstrictors</e1> or <e2>ergot alkaloids</e2>.\n",
      "Mequitazine can interact with CNS depressant, <e1>antichlolinergic</e1>, TCA, MAOIs, and <e2>alcohol</e2>.\n",
      "<e1>Diuretics</e1>: Patients on <e2>diuretics</e2>, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of ACEON    Tablets therapy. \n",
      "In clinical studies of <e1>TOBI</e1>, patients taking <e2>TOBI</e2> concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - <e1>Live virus vaccines</e1>: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - <e2>Killed virus vaccines</e2>: may decrease patient's response to the vaccine\n",
      "and combinations of <e1>opioids</e1> and sedatives (eg, benzodiazepines, <e2>barbiturates</e2>, chloral hydrate, droperidol, etc.). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Digoxin</e1>: <e2>Meloxicam</e2> 15 mg once daily for 7 days did not alter the plasma concentration profile of digoxin after b-acetyldigoxin administration for 7 days at clinical doses. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Results revealed that the strains were resistant to many drugs at high levels, only <e1>piperacillin</e1>, <e2>carbenicillin</e2>, amikacin and ciprofloxacin showed resistances at comparatively lower levels. \n",
      "Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing <e1>MOBIC</e1> therapy in patients receiving <e2>warfarin</e2> or similar agents, since these patients are at an increased risk of bleeding. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as <e1>antimycotic agents</e1> (e.g., itraconazole and miconazole) or <e2>macrolide antibiotics</e2> (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e1>itraconazole</e1>, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (<e1>imipramine</e1> 15 mg/kg), group 6 (curcumin 100 mg/kg plus <e2>fluoxetine</e2> 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Although this has not occurred in in vitro studies with <e1>coumarin-type anticoagulants</e1>, interactions with coumarin-type anticoagulants have been reported with <e2>FELDENE</e2> since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e1>Cisapride</e1>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e2>beta blockers</e2> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e1>potassium chloride</e1> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Cholestyramine: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of <e1>raloxifene</e1> and should not be coadministered with <e2>EVISTA</e2>. \n",
      "The use of AGGRASTAT, in combination with heparin and <e1>aspirin</e1>, has been associated with an increase in bleeding compared to heparin and <e2>aspirin</e2> alone (see\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "In experiment 1, oral administration of <e1>GSLS</e1> at a dose of 5 mg/kg of BW for 7 d on the immune response in chickens intramuscularly injected with <e2>inactivated ND vaccine</e2> was evaluated. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "Drugs such as <e1>troleandomycin</e1> and <e2>ketoconazole</e2> may inhibit the metabolism of methylprednisolone and thus decrease its clearance. \n",
      "The colchicine nanoemulsion was prepared with isopropyl myristate, eugenol, <e1>Tween80</e1>, ethanol and water, and <e2>eugenol</e2> was used as an oil phase in the formulation; \n",
      "However, on the basis of available data, no dosage adjustment for <e1>ondansetron</e1> is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between <e2>ondansetron</e2> and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "<e1>Coumarin-type anticoagulants</e1>: Prothrombin time may be increased in patients receiving concomitant <e2>DIFLUCAN</e2> and coumarin-type anticoagulants. \n",
      "<e1>AAV2</e1>-mediated retinal transduction is improved by co-injection of heparinase III or <e2>chondroitin ABC lyase</e2>. \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between <e1>ondansetron</e1> and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of <e2>tramadol</e2>.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of pralidoxime: since <e1>barbiturates</e1> are potentiated by the <e2>anticholinesterases</e2>, they should be used cautiously in the treatment of convulsions; \n",
      "In clinical studies of TOBI, patients taking <e1>TOBI</e1> concomitantly with dornase alfa (<e2>PULMOZYME</e2>   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e1>melatonin</e1> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "These results, if confirmed in-vivo, indicate that <e1>celecoxib</e1> is not a suitable chemosensitizer for breast cancer or with <e2>doxorubicin</e2> for other cancers. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e1>Tofranil</e1>), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "<e1>Pyrimethamine</e1> may be used with sulfonamides, <e2>quinine</e2> and other antimalarials, and with other antibiotics. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as <e1>antiepileptic drugs</e1>, taxol, rifampicin, and human immunodeficiency virus protease inhibitors such as ritonavir and <e2>saquinavir</e2>. \n",
      "The bioavailability of <e1>SKELID</e1> is decreased 80% by <e2>calcium</e2>, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "<e1>Remifentanil</e1> clearance is not altered by concomitant administration of thiopental, isoflurane, propofol, or <e2>temazepam</e2> during anesthesia. \n",
      "Caution should be used when <e1>EVISTA</e1> is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, <e2>ibuprofen</e2>, diazepam, and diazoxide. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Furosemide: Clinical studies, as well as post-marketing observations, have shown that <e1>NSAIDs</e1> can reduce the natriuretic effect of <e2>furosemide</e2> and thiazide diuretics in some patients. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and <e2>rifampin</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, <e1>phenothiazines</e1>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "<e1>Ticagrelor</e1> (<e2>Brilinta</e2>)--better than clopidogrel (Plavix)\n",
      "A pharmacokinetic study demonstrated that coadministration of megestrol acetate and <e1>indinavir</e1> results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of <e2>indinavir</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Combination therapy with Cerezyme    (<e1>imiglucerase</e1>) and <e2>ZAVESCA</e2>    is not indicated.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e1>corticosteroids</e1> (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, <e1>procainamide</e1>, pancuronium, morphine, vancomycin, <e2>metformin</e2> and tenofovir). \n",
      "We found antagonism between <e1>celecoxib</e1> and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between celecoxib and <e2>doxorubicin</e2> in all cell lines except for two combinations in HCT116 cells. \n",
      "In adult diabetic patients under treatment with either sulfonylureas or insulin there is no change in the clinical effects of either <e1>TOLECTIN</e1> or the <e2>hypoglycemic agents</e2>. \n",
      "Barbiturates may decrease the effectiveness of oral <e1>contraceptives</e1>, certain antibiotics, quinidine, theophylline, <e2>corticosteroids</e2>, anticoagulants, and beta blockers.\n",
      "Patients receiving <e1>sirolimus</e1> or nifedipine in combination with <e2>MYCAMINE</e2> should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "<e1>ASPIRIN</e1> AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO <e2>DISALCID</e2> AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when <e1>ezetimibe</e1> was co-administered with atorvastatin, simvastatin, pravastatin, <e2>lovastatin</e2>, or fluvastatin. \n",
      "However, because <e1>telbivudine</e1> is eliminated primarily by renal excretion, co   administration of <e2>telbivudine</e2> with drugs that alter renal function may alter plasma concentrations of telbivudine.\n",
      "The combined use of <e1>fluconazole</e1> at doses of 400 mg or greater with <e2>terfenadine</e2> is contraindicated. \n",
      "The treatment of coinfected patients requires <e1>antituberculosis</e1> and <e2>antiretroviral drugs</e2> to be administered concomittantly; \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, amiloride, triamterene and others), <e2>potassium</e2> supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e1>clarithromycin</e1>, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e1>pectin</e1>), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "<e1>Anticoagulants</e1> (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, <e2>dipyridamole</e2>, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "Although such a reaction has not been demonstrated with <e1>roxithromycin</e1>, concomitant administration of <e2>roxithromycin</e2> with terfenadine or astemizole is not recommended. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or <e2>reverse transcriptase inhibitors</e2> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Although not studied, the potent cytochrome P450 3A4 inhibitors ritonavir and <e1>nelfinavir</e1> may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of <e2>midazolam</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Caution should be used when <e1>EVISTA</e1> is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and <e2>diazoxide</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e1>itraconazole</e1>, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Increases of <e1>5-FU</e1> plasma concentrations by approximately 20% have been observed with doses of 130 mg/m2 <e2>ELOXATIN</e2> dosed every 3 weeks. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (<e1>PULMOZYME</e1>   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral <e2>aminoglycosides</e2> demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), <e2>phenylbutazone</e2>, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, <e1>triiodothyronine</e1>, phenytoin, <e2>sulfinpyrazone</e2>, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e1>medroxyprogesterone acetate</e1>, methotrexate, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, <e1>nalbuphine</e1>, butorphanol, or <e2>buprenorphine</e2>) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "The concurrent use of <e1>streptozocin</e1> and phenytoin has been reported in one case to result in reduced <e2>streptozocin</e2> cytotoxicity.    \n",
      "Drug Interactions: The use of <e1>ZEMURON</e1>    (<e2>rocuronium bromide</e2>) Injection before succinylcholine, for the purpose of attenuating some of the side effects of succinylcholine, has not been studied. \n",
      "Having moderate to severe pain (ARRR=1.54, 95% CI=1.08-2.20) and the prescribing of an <e1>anxiolytic</e1> or hypnotic (ARRR=1.33, 95% CI=1.02-1.74) increased the risk of potential inappropriate <e2>antidepressant</e2> use. \n",
      "Absorption of tetracyclines is impaired by <e1>antacids</e1> containing aluminum, calcium or <e2>magnesium</e2>, and iron-containing preparations. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The novel oral <e1>anticoagulants</e1> in development may overcome some of the limitations of <e2>vitamin K antagonists</e2> and address their underuse and safety concerns.\n",
      "Azathioprine/<e1>Mycophenolate Mofetil</e1>: Given that <e2>azathioprine</e2> and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "<e1>Barbiturates</e1> may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, <e2>anticoagulants</e2>, and beta blockers.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), <e2>benzodiazepines</e2>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Concomitant administration of terfenadine with clarithromycin, <e1>erythromycin</e1>, or <e2>troleandomycin</e2> is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "<e1>Antacids</e1>: Absorption of a single dose of <e2>Myfortic</e2> was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), <e1>nonsteroidal anti-inflammatory drugs</e1> (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, <e2>erythromycin</e2>, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, <e1>sirolimus</e1>, nifedipine, fluconazole, <e2>ritonavir</e2>, and rifampin. \n",
      "In adult diabetic patients under treatment with either <e1>sulfonylureas</e1> or <e2>insulin</e2> there is no change in the clinical effects of either TOLECTIN or the hypoglycemic agents. \n",
      "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-<e1>aluminum</e1> containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when <e2>Myfortic</e2> was administered alone under fasting conditions. \n",
      "Those <e1>anticonvulsants</e1> include divalproex sodium, valproic acid, and <e2>phenobarbital</e2>. \n",
      "Because <e1>Matulane</e1> exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, <e2>tricyclic antidepressant</e2> drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "<e1>Moxifloxacin</e1> and Lomefloxacin reacts faster with sucralfate and <e2>gelusil</e2> in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. \n",
      "<e1>Misoprostol</e1> does not exert clinically significant effects on the absorption, blood levels, and anti-platelet effects of therapeutic doses of <e2>aspirin</e2>. \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain <e2>antibiotics</e2> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "May interact with cimetidine, digoxin, medicines to control heart rhythm, <e1>sevelamer</e1>, and <e2>theophylline</e2>.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e1>cimetidine</e1>, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, <e1>cisplatin</e1>, doxorubicin and etoposide   <e2>celecoxib</e2> following different incubation schedules were analyzed.\n",
      "<e1>Probenecid</e1>: Probenecid does not alter the pharmacokinetics of <e2>sparfloxacin</e2>.\n",
      "Co-administration of oral <e1>ketoconazole</e1> 200 mg twice daily increased <e2>retapamulin</e2> geometric mean AUC(0-24) and Cmax by 81% after topical application of retapamulin ointment, 1% on the abraded skin of healthy adult males. \n",
      "Interactions for <e1>Vitamin B1</e1> (Thiamine):  <e2>Loop Diuretics</e2>, Oral Contraceptives, Stavudine, Tricyclic Antidepressants\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e1>cephalosporins</e1>, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>DIFLUCAN</e1> reduces the metabolism of tolbutamide, glyburide, and <e2>glipizide</e2> and increases the plasma concentration of these agents. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when <e1>calcium</e1> and <e2>SKELID</e2> are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and <e1>miconazole</e1>) or macrolide antibiotics (e.g., erythromycin and <e2>clarithromycin</e2>), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Phenothiazines are capable of potentiating <e1>CNS depressants</e1> (e.g., barbiturates, anesthetics, opiates, <e2>alcohol</e2>, etc.) \n",
      "<e1>MAO Inhibitors</e1> - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving <e2>monoamine oxidase inhibitors</e2> (MAOI). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), <e2>antihistamines</e2>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of <e1>tolbutamide</e1>, <e2>ethinylestradiol</e2>, ethoxycoumarin, and cyclosporine. \n",
      "In clinical studies of <e1>TOBI</e1>, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled <e2>corticosteroids</e2>, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and <e1>fentanyl</e1>), propofol, <e2>ketamine</e2>, nitrous oxide, secobarbital and droperidol. \n",
      "e.g., other <e1>belladonna alkaloids</e1>, antihistamines (including meclizine), <e2>tricyclic antidepressants</e2>, and muscle relaxants. \n",
      "<e1>Itraconazole</e1>: Torsades de pointes and elevated parent <e2>terfenadine</e2> levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of itraconazole and from foreign post-marketing sources. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of tolbutamide, sodium salicylate and <e1>sulfamethizole</e1> displaced protein-bound <e2>teniposide</e2> in fresh human serum to a small but significant extent. \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), <e2>sulfonylurea agents</e2> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, <e1>tricyclic antidepressant</e1> drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high <e2>tyramine</e2> content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, <e1>fluconazole</e1> and <e2>itraconazole</e2> were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, <e1>Choline</e1> and magnesium salicylates, Colestipol, Iron-containing drugs, <e2>Laxatives</e2>, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "There is usually complete cross-resistance between PURINETHOL (<e1>mercaptopurine</e1>) and TABLOID brand <e2>Thioguanine</e2>. \n",
      "Itraconazole: Torsades de pointes and elevated parent <e1>terfenadine</e1> levels have been reported during concomitant use of terfenadine and <e2>itraconazole</e2> in clinical trials of itraconazole and from foreign post-marketing sources. \n",
      "Because <e1>tetracyclines</e1> have been shown to depress plasma prothrombin activity, patients who are on <e2>anticoagulant</e2> therapy may require downward adjustment of their anticoagulant dosage. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If <e1>Mexitil</e1> and theophylline are to be used concurrently, <e2>theophylline</e2> blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) <e1>Estrogens</e1> may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and <e1>ethinyl estradiol</e1> following administration of a single dose containing 1.0 mg of <e2>norethindrone acetate</e2> and 75    g of ethinyl estradiol were studied. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, <e1>flavanone</e1>, flavanonols and catechins, on the elimination of <e2>luteolin</e2> and apigenin was studied. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Itraconazole: Torsades de pointes and elevated parent <e1>terfenadine</e1> levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of <e2>itraconazole</e2> and from foreign post-marketing sources. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, analgesics, <e1>antiemetics</e1>/antinauseants, antispasmodics and <e2>anticholinergic agents</e2>. \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., <e1>phenytoin</e1>, carbamazepine, and <e2>rifampicin</e2>), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, <e1>meperidine</e1> and fentanyl), propofol, <e2>ketamine</e2>, nitrous oxide, secobarbital and droperidol. \n",
      "The bioavailability of SKELID is decreased 80% by <e1>calcium</e1>, when calcium and SKELID are administered at the same time, and 60% by some <e2>aluminum</e2>- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "TERAZOL 3 Vaginal Cream 0.8% The levels of <e1>estradiol</e1> (E2) and progesterone did not differ significantly when 0.8% <e2>terconazole</e2> vaginal cream was administered to healthy female volunteers established on a low dose oral contraceptive.    \n",
      "A variety of <e1>antiarrhythmics</e1> such as quinidine or <e2>propranolol</e2> were also added, sometimes with improved control of ventricular ectopy. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e1>sodium colistimethate</e1>), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Potentiation occurs with <e1>ganglionic</e1> or <e2>peripheral adrenergic blocking drugs</e2>.\n",
      "Due to its effects on gastric emptying, SYMLIN therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as <e1>atropine</e1>) and agents that slow the intestinal absorption of nutrients (e.g., <e2>alpha glucosidase inhibitors</e2>). \n",
      "Efficacy and tolerability of fixed <e1>amlodipine</e1>/<e2>valsartan</e2> combination was studied in 86 patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology. \n",
      "<e1>Lithium</e1>: Increased serum lithium and symptoms of <e2>lithium</e2> toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. \n",
      "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that <e1>Myfortic</e1> not be administered concomitantly with <e2>azathioprine</e2> or mycophenolate mofetil. \n",
      "John   s Wort, and certain <e1>anticonvulsants</e1> (<e2>phenytoin</e2>, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). \n",
      "Due to the chemical similarity of other <e1>azole-type antifungal agents</e1> (including fluconazole, <e2>metronidazole</e2>, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "Compared with the elimination of pure luteolin and apigenin, the elimination of <e1>luteolin</e1> and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and <e2>apigenin</e2>. \n",
      "<e1>AGGRASTAT</e1> has been studied on a background of aspirin and <e2>heparin</e2>. \n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>amiloride</e1>, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (<e2>indomethacin</e2>, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Less potent inhibitors include saquinavir, <e1>nefazodone</e1>, <e2>fluconazole</e2>, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole. \n",
      "Drugs such as <e1>troleandomycin</e1> and ketoconazole may inhibit the metabolism of <e2>corticosteroids</e2> and thus decrease their clearance. \n",
      "The effects of extracts of ginseng and <e1>ginko</e1> (<e2>EGGB</e2>) on cellular proliferative activity, apoptotic rate, ultrastructure and caspase-3 expression were detected. \n",
      "These medications included <e1>thyroid hormones</e1>, sedative hypnotics, <e2>non-steroidal anti-inflammatory agents</e2>, benzodiazepines, and decongestants. \n",
      "morphine, <e1>theophylline</e1>, aminophylline, succinylcholine, reserpine, and <e2>phenothiazine-type tranquilizers</e2> should be avoided in patients with organophosphate poisoning.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Since <e1>Celontin</e1> (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of <e2>phenytoin</e2> and phenobarbital).\n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, <e1>carbamazepine</e1>, rifampin, <e2>rifabutin</e2>, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "<e1>Palonosetron</e1> did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, cytarabine, doxorubicin and <e2>mitomycin C</e2>) in murine tumor models.\n",
      "Other Antihypertensives: When <e1>MYKROX</e1> Tablets are used with other <e2>antihypertensive drugs</e2>, care must be taken, especially during initial therapy. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when <e1>calcium</e1> and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before <e2>SKELID</e2>. \n",
      "The ratio of <e1>norketamine</e1> AUC(0-   ) to <e2>ketamine</e2> AUC(0-   ) was significantly decreased in the ticlopidine (P &lt; 0.001) and itraconazole phases (P = 0.006) as compared to placebo. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, <e1>phenothiazines</e1>, other <e2>opioids</e2>, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of HIV-protease inhibitors, griseofulvin, <e2>modafinil</e2>, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Mequitazine can interact with CNS depressant, <e1>antichlolinergic</e1>, <e2>TCA</e2>, MAOIs, and alcohol.\n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e1>morphine</e1>, meperidine and fentanyl), propofol, ketamine, <e2>nitrous oxide</e2>, secobarbital and droperidol. \n",
      "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (<e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2> versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of <e1>azole antimycotics</e1>, <e2>protease inhibitors</e2>, calcium channel antagonists, and macrolide antibiotics). \n",
      "The effect of a series of flavonoids, including flavonols, flavones, <e1>isoflavone</e1>, flavanone, flavanonols and catechins, on the elimination of <e2>luteolin</e2> and apigenin was studied. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "- <e1>Cisapride</e1>, pimozide: Other drugs such as cisapride or <e2>pimozide</e2>, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (<e2>indomethacin</e2>, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "The procedure indicated that the intestinal absorption of <e1>colchicine</e1> was enhanced significantly by <e2>eugenol</e2> in the tested nanoemulsion. \n",
      "- Decreased absorption of <e1>colestipol</e1>, cholestyramine, mineral oil, and <e2>sucralfate</e2>.\n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e1>morphine</e1>, meperidine and <e2>fentanyl</e2>), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e1>indinavir</e1>, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on <e1>piroxicam</e1> plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma <e2>lithium</e2> levels. \n",
      "A study in healthy volunteers involving single-dose IV <e1>palonosetron</e1> (0.75 mg) and steady state oral <e2>metoclopramide</e2> (10 mg four times daily) demonstrated no significant pharmacokinetic interaction. \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, <e1>butyrophenones</e1>, thioxanthines ) or <e2>metoclopramide</e2>, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "<e1>Short-acting Benzodiazepines</e1>: Following oral administration of <e2>midazolam</e2>, fluconazole resulted in substantial increases in midazolam concentrations and psychomotor effects. \n",
      "If <e1>ZEMURON</e1>    is administered following administration of succinylcholine, it should not be given until recovery from <e2>succinylcholine</e2> has been observed. \n",
      "In female rats, neonatal quinpirole treatment enhanced <e1>amphetamine</e1> locomotor sensitization compared with quinpirole-free controls sensitized to <e2>amphetamine</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with <e1>sucralfate</e1>, gelusil, <e2>erythromycin</e2> and multi minerals. \n",
      "However, the evidence for a calcium effect on <e1>iron</e1> absorption mainly comes from studies that did not isolate the effect of <e2>calcium</e2> from that of other dietary components, because it was detected in single-meal studies. \n",
      "Phenothiazines are capable of potentiating CNS depressants (e.g., barbiturates, <e1>anesthetics</e1>, <e2>opiates</e2>, alcohol, etc.) \n",
      "DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  <e1>Nalidixic acid</e1> together with high-dose intravenous <e2>melphalan</e2> has caused deaths in children due to haemorrhagic enterocolitis.  \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e1>clindamycin</e1>, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Other Agents: No clinically important pharmacokinetic interactions occurred when <e1>UNIVASC</e1>    was administered concomitantly with <e2>hydrochlorothiazide</e2>, digoxin, or cimetidine. \n",
      "Fluconazole tablets coadministered with <e1>ethinyl estradiol</e1>- and <e2>levonorgestrel</e2>-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interactions for <e1>Vitamin B1</e1> (<e2>Thiamine</e2>):  Loop Diuretics, Oral Contraceptives, Stavudine, Tricyclic Antidepressants\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Warfarin users who initiated <e1>citalopram</e1>, <e2>fluoxetine</e2>, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "<e1>Sulfonamides</e1>: Concurrent use of <e2>procaine hydrochloride</e2> and sulfonamides may result in a reduction of the antibacterial action of the sulfonamide. \n",
      "When phenytoin or other hepatic enzyme inducers such as rifampin and <e1>phenobarbital</e1> have been taken concurrently with Mexitil   , lowered <e2>Mexitil</e2>    plasma levels have been reported. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of <e1>benzodiazepines</e1> (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "<e1>MAO Inhibitors</e1> - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (<e2>MAOI</e2>). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "When phenytoin or other hepatic enzyme inducers such as <e1>rifampin</e1> and <e2>phenobarbital</e2> have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. \n",
      "<e1>chlorthalidone</e1>, furosemide, <e2>hydrochlorothiazide</e2>, spironolactone; \n",
      "Lithium: Increased serum lithium levels and symptoms of <e1>lithium</e1> toxicity have been reported in patients receiving <e2>ACE inhibitors</e2> during therapy with lithium. \n",
      "Sulfonamides: Concurrent use of procaine hydrochloride and <e1>sulfonamides</e1> may result in a reduction of the antibacterial action of the <e2>sulfonamide</e2>. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e1>morphine</e1>, meperidine and fentanyl), propofol, ketamine, nitrous oxide, <e2>secobarbital</e2> and droperidol. \n",
      "No pharmacokinetic interaction was observed between <e1>rivastigmine</e1> and digoxin, <e2>warfarin</e2>, diazepam, or fluoxetine in studies in healthy volunteers. \n",
      "TRENTAL has been used concurrently with <e1>antihypertensive drugs</e1>, beta blockers, <e2>digitalis</e2>, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "and combinations of opioids and sedatives (eg, benzodiazepines, <e1>barbiturates</e1>, chloral hydrate, <e2>droperidol</e2>, etc.). \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as <e2>MIVACRON</e2> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), <e1>potassium</e1> supplements or other drugs capable of increasing serum potassium (indomethacin, <e2>heparin</e2>, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - <e1>Live virus vaccines</e1>: may potentiate the replication of the <e2>vaccine</e2> virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - neostigmine - <e2>polymyxin B</e2> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e2>sulfonylurea agents</e2> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Since Celontin (methsuximide) may interact with concurrently administered <e1>antiepileptic drugs</e1>, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and <e2>phenobarbital</e2>).\n",
      "It is recommended that <e1>Myfortic</e1> and <e2>antacids</e2> not be administered simultaneously. \n",
      "The CNS depressant effects of <e1>oxycodone hydrochloride</e1> may be additive with that of other <e2>CNS depressants</e2>..\n",
      "As there is in vitro evidence that <e1>aminosalicylate derivatives</e1> (e.g., olsalazine, mesalazine, or <e2>sulphasalazine</e2>) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    \n",
      "The <e1>colchicine</e1> nanoemulsion was prepared with isopropyl myristate, eugenol, Tween80, ethanol and water, and <e2>eugenol</e2> was used as an oil phase in the formulation; \n",
      "For information on drug interactions associated with <e1>ranitidine</e1>, refer to the <e2>ZANTAC</e2>     package insert.\n",
      "<e1>Warfarin</e1> users had an increased odds ratio of gastrointestinal bleeding upon initiation of <e2>citalopram</e2> (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, <e2>rifampin</e2>, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Interaction with <e1>Guanethidine</e1>: Although minoxidil does not itself cause orthostatic hypotension, its administration to patients already receiving <e2>guanethidine</e2> can result in profound orthostatic effects. \n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., dexamethasone, <e2>phenytoin</e2>, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e1>MAO inhibitors</e1>, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Concurrent use with <e1>vasoconstrictor agents</e1> including ergot alkaloids, <e2>sumatriptan</e2>, and nicotine (e.g. smoking) may result in enhanced vasoconstriction.\n",
      "While there is evidence that <e1>fluconazole</e1> can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of <e2>ethinyl estradiol</e2> or levonorgestrel metabolism. \n",
      "The objective of this study was to evaluate the effect of oral administration of <e1>ginseng stem-and-leaf saponins</e1> (<e2>GSLS</e2>) on the humoral immune responses of chickens to inactivated ND and AI vaccines. \n",
      "There were no significant differences between the pharmacokinetics parameters of amiodarone administered intravenously or intragastrically and the control (without <e1>neferine</e1>) group (with ratios of 0.7-1.4 in all experimental groups), suggesting that neferine had no effect on <e2>amiodarone</e2> plasma pharmacokinetics. \n",
      "However, on the basis of available data, no dosage adjustment for <e1>ondansetron</e1> is recommended for patients on these drugs.1,3  <e2>Tramadol</e2>: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - <e1>Killed virus vaccines</e1>: may decrease patient's response to the <e2>vaccine</e2>\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "In the <e1>ticlopidine</e1> and <e2>itraconazole</e2> phases, the areas under the effect-time curves (self-reported drowsiness and performance) were significantly higher than those in the placebo phase (P < 0.05). \n",
      "Theophylline: <e1>DIFLUCAN</e1> increases the serum concentrations of <e2>theophylline</e2>. \n",
      "<e1>Caffeine</e1> and/or stimulantes of the <e2>ephedrine</e2>/amphetamine type may counteract the specific actions of levomepromazine. \n",
      "<e1>Furosemide</e1>: Clinical studies, as well as post-marketing observations, have shown that <e2>NSAIDs</e2> can reduce the natriuretic effect of furosemide and thiazide diuretics in some patients. \n",
      "The synergistic antinociception activity of <e1>ibuprofen</e1> when administered with piperine can be attributed to increased plasma concentration of <e2>ibuprofen</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, <e1>nalidixic acid</e1>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e1>nelfinavir</e1>, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Compounds that quench active oxygen species or scavenge radicals, such as <e1>dimethyl sufloxide</e1>, b-carotene, ethanol, <e2>formate</e2> and mannitol would be expected to decrease PDT activity. \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of <e1>tramadol</e1>.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by <e2>ondansetron</e2>. \n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, <e2>hypnotics</e2>, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), <e1>(beta)-agonists</e1>, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral <e2>aminoglycosides</e2> demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "No pharmacokinetic interaction was observed between rivastigmine and digoxin, <e1>warfarin</e1>, diazepam, or <e2>fluoxetine</e2> in studies in healthy volunteers. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Multiple dose studies of ezetimibe given in combination with HMG-CoA reductase inhibitors (<e1>statins</e1>) in rats and rabbits during organogenesis result in higher <e2>ezetimibe</e2> and statin exposures. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, <e1>Cholestyramine</e1>, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "Being moxifloxacin and lomefloxacin <e1>fluoroquinolones</e1> the interaction study of was carried out with sucralfate, gelusil, erythromycin and <e2>multi minerals</e2>. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, <e2>verapamil</e2>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (<e1>cisplatin</e1>, <e2>cyclophosphamide</e2>, cytarabine, doxorubicin and mitomycin C) in murine tumor models.\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain <e2>antibiotics</e2> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Caution should be used when <e1>EVISTA</e1> is coadministered with other highly protein-bound drugs, such as clofibrate, <e2>indomethacin</e2>, naproxen, ibuprofen, diazepam, and diazoxide. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., <e1>phenylephrine</e1>, pseudoephedrine, ephedrine, <e2>phenylpropanolamine</e2> or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Neuromuscular blocking agents (such as suxamethonium chloride): Concurrent use of <e1>procaine hydrochloride</e1> and <e2>neuromuscular blocking agents</e2> may result in prolongation or enhancement of the neuromuscular blockade. \n",
      "- Cisapride, pimozide: Other drugs such as <e1>cisapride</e1> or <e2>pimozide</e2>, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. \n",
      "Dosages of concomitantly administered <e1>opioids</e1> should be reduced by approximately half, because <e2>levomepromazine</e2> amplifies the therapeutic actions and side-effects of opioids. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, <e1>diazepam</e1>, and <e2>diazoxide</e2>. \n",
      "<e1>Isoflurane</e1> and enflurane (administered with <e2>nitrous oxide</e2>/oxygen to achieve 1.25 M.C. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including <e1>alcohol</e1>, barbiturates, <e2>hypnotics</e2>, narcotic analgesics, sedatives, and tranquillisers. \n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and <e2>fentanyl</e2>), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "Therefore, <e1>FLOMAX</e1> capsules should be used with caution in combination with <e2>cimetidine</e2>, particularly at doses higher than 0.4 mg. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., <e1>itraconazole</e1> and miconazole) or <e2>macrolide antibiotics</e2> (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Drugs that impair intestinal absorption of fat-soluble vitamins, such as <e1>cholestyramine</e1>, may interfere with the absorption of <e2>Zemplar</e2> Capsules.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e1>sodium colistimethate</e1>), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, <e1>Sanctura</e1> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, <e2>vancomycin</e2>, metformin and tenofovir). \n",
      "From this study it can be concluded that <e1>piperine</e1> can be used as a bioenhancer along with <e2>ibuprofen</e2>.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Glyburide</e1>: In 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of <e2>glyburide</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (phenobarbital, diphenylhydantoin, <e2>primidone</e2>), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "In vitro studies with atracurium, <e1>mivacurium</e1>, <e2>esmolol</e2>, echothiophate, neostigmine, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Oral <e1>Contraceptives</e1>: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of <e2>ethinyl estradiol</e2> were studied. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, Cisapride, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that <e1>fluconazole</e1> is a net inducer of ethinyl estradiol or <e2>levonorgestrel</e2> metabolism. \n",
      "Antihypertensive effects of <e1>guanethidine</e1> and related compounds may be counteracted when <e2>phenothiazines</e2> are used concomitantly. \n",
      "Beside this, the medication oriented supplementation of <e1>vitamin D</e1> can also ameliorate the pharmacologic action of many drugs, such as bisphosphonates, statins and <e2>cytostatic drugs</e2>.\n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, <e1>quinidine</e1>, theophylline, corticosteroids, <e2>anticoagulants</e2>, and beta blockers.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e1>nitrates</e1> and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "<e1>Pindolol</e1> has been used with a variety of antihypertensive agents, including <e2>hydrochlorothiazide</e2>, hydralazine, and guanethidine without unexpected adverse interactions. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (<e1>imipramine</e1> 15 mg/kg), group 6 (<e2>curcumin</e2> 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Other Agents: No clinically important pharmacokinetic interactions occurred when <e1>UNIVASC</e1>    was administered concomitantly with hydrochlorothiazide, <e2>digoxin</e2>, or cimetidine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, <e1>morphine</e1>, <e2>meperidine</e2>, and fentanyl, etc.) \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, <e2>diazepam</e2> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Although it was previously reported that lapatinib combined with <e1>Herceptin</e1> improved the progression-free survival rate compared with <e2>lapatinib</e2> alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Methyldopa does not interfere with measurement of VMA (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert <e1>VMA</e1> to <e2>vanillin</e2>. \n",
      "Compared with the elimination of pure luteolin and <e1>apigenin</e1>, the elimination of luteolin and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of <e2>luteolin</e2> and apigenin. \n",
      "<e1>Folinic acid</e1> (<e2>leucovorin</e2>) should be administered until normal hematopoiesis is restored. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e1>procainamide</e1>, and <e2>quinidine</e2>. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (<e1>NNRTI</e1>), a protease inhibitor (<e2>PI</e2>) or an integrase inhibitor (II) is recommended. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with <e1>aspirin</e1> (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma <e2>lithium</e2> levels. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, <e1>phenytoin</e1>, sulfinpyrazone, naproxen, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "Dopamine antagonists: Since pramipexole is a <e1>dopamine agonist</e1>, it is possible that dopamine antagonists, such as the <e2>neuroleptics</e2> (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e1>desglymidodrine</e1> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e2>metformin</e2>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Multiple dose studies of <e1>ezetimibe</e1> given in combination with <e2>HMG-CoA reductase inhibitors</e2> (statins) in rats and rabbits during organogenesis result in higher ezetimibe and statin exposures. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, <e1>nefazodone</e1>, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "However, <e1>ketoconazole</e1>, a potent inhibitor of cytochrome P450 3A4, may increase plasma levels of <e2>mometasone furoate</e2> during concomitant dosing.\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, prednisolone, <e2>sirolimus</e2>, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), <e2>phenylbutazone</e2>, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "Attention is paid to calcium channel blockers, <e1>diuretics</e1> and <e2>digoxin</e2>. \n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, cytarabine, <e1>doxorubicin</e1> and <e2>mitomycin C</e2>) in murine tumor models.\n",
      "<e1>Vindesine</e1> can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - <e2>Live virus vaccines</e2>: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Rats treated with neonatal quinpirole enhanced time spent in the amphetamine-paired context compared with quinpirole-free controls conditioned with <e1>amphetamine</e1>, but only female controls conditioned with <e2>amphetamine</e2> spent more time in the drug-paired context compared with saline-treated controls. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and <e1>miconazole</e1>) or macrolide antibiotics (e.g., <e2>erythromycin</e2> and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e2>desglymidodrine</e2> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Lithium renal clearance is reduced by <e1>thiazides</e1>, increasing the risk of <e2>lithium</e2> toxicity. \n",
      "<e1>Ethanol</e1> decreases the elimination of abacavir causing an increase in overall exposure . The addition of <e2>methadone</e2> has no clinically significant effect on the pharmacokinetic properties of abacavir. \n",
      "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, <e1>ethinylestradiol</e1>, <e2>ethoxycoumarin</e2>, and cyclosporine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, <e2>prednisolone</e2>, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, <e1>theophylline</e1>, <e2>corticosteroids</e2>, anticoagulants, and beta blockers.\n",
      "<e1>Cholestyramine</e1>: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with <e2>EVISTA</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including <e1>collagenase</e1>, hyaluronan lyase, <e2>heparinase III</e2>, or chondroitin ABC lyase. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, <e2>desmethyldiazepam</e2>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, prednisolone, sirolimus, nifedipine, <e2>fluconazole</e2>, ritonavir, and rifampin. \n",
      "When a single 100 mg dose of <e1>rimantadine HCl</e1> was administered one hour after the initiation of <e2>Cimetidine</e2> (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine). \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including <e1>alcohol</e1>, barbiturates, hypnotics, narcotic analgesics, <e2>sedatives</e2>, and tranquillisers. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e1>metformin</e1>, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "In direct contrast, in rats made <e1>opiate</e1> dependent and conditioned in a state of withdrawal, intra-BLA D2, but not D1, receptor blockade blocked <e2>opiate</e2> reward encoding. \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, tacrolimus, <e1>prednisolone</e1>, and <e2>fluconazole</e2> pharmacokinetics. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "Given the primary CNS effects of paliperidone, INVEGA    should be used with caution in combination with other <e1>centrally acting drugs</e1> and <e2>alcohol</e2>. \n",
      "Combination therapy with <e1>Cerezyme</e1>    (imiglucerase) and <e2>ZAVESCA</e2>    is not indicated.\n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when <e1>FELDENE</e1> is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on <e2>piroxicam</e2> plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, <e1>modafinil</e1>, penicillins, rifampin, rifabutin, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, phenothiazines, nalidixic acid, <e2>halogenated salicylanilides</e2> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Astemizole: The use of <e1>fluconazole</e1> in patients concurrently taking <e2>astemizole</e2> or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Potential for Other Drugs to Affect <e1>INVEGA</e1>    <e2>Paliperidone</e2> is not a substrate of CYP1A2, CYP2A6, CYP2C9, and CYP2C19, so that an interaction with inhibitors or inducers of these isozymes is unlikely. \n",
      "- Cisapride, pimozide: Other drugs such as cisapride or <e1>pimozide</e1>, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some <e2>macrolide antibacterials</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, <e1>theophyllines</e1>, <e2>phenytoins</e2>, thiazide diuretics, beta blockers, and calcium channel blockers.\n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and <e2>warfarin</e2>. \n",
      "Interaction with <e1>Mixed Agonist/Antagonist Opioid Analgesics</e1>: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof <e2>opioid agonist analgesic</e2>. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL <e2>ANESTHETICS</e2>, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e1>cephalosporins</e1>, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Furthermore, in patients receiving both drugs, careful monitoring of the INR or PT, and adjustment of the <e1>warfarin</e1> dosage if indicated are recommended when the <e2>oxandrolone</e2> dose is changed or discontinued. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Glyburide: In 12 normal-weight subjects receiving <e1>orlistat</e1> 80 mg three times a day for 5 days, <e2>orlistat</e2> did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "An additional clinical drug-drug interaction study showed no effect of rifaximin on the presystemic metabolism of an oral <e1>contraceptive</e1> containing ethinyl estradiol and <e2>norgestimate</e2>. \n",
      "Preliminary evidence suggests that cimetidine inhibits <e1>mebendazole</e1> metabolism and may result in an increase in plasma concentrations of <e2>mebendazole</e2>.\n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, butyrophenones, <e2>thioxanthenes</e2>) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, <e1>fluvoxamine</e1>, <e2>zileuton</e2>, and clotrimazole. \n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when <e1>midazolam</e1> is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, <e2>protease inhibitors</e2>, calcium channel antagonists, and macrolide antibiotics). \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL ANESTHETICS, <e2>PHENOTHIAZINES</e2>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, <e1>nelfinavir</e1>, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, <e1>nelfinavir</e1>, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "<e1>CRM197</e1> induced apoptosis, and furthermore, the combination of CRM197 plus <e2>doxorubicin</e2> enhanced cytotoxicity in a T-ALL cell line. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, <e1>nifedipine</e1>, fluconazole, ritonavir, and <e2>rifampin</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, <e2>carbamazepine</e2>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e1>azole antifungals</e1> (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Several studies demonstrate a decrease in the bioavailability of <e1>methyldopa</e1> when it is ingested with ferrous sulfate or <e2>ferrous gluconate</e2>. \n",
      "You cannot take <e1>mazindol</e1> if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), <e2>tranylcypromine</e2> (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e1>HIV-protease inhibitors</e1>, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "Since Celontin (methsuximide) may interact with concurrently administered <e1>antiepileptic drugs</e1>, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of <e2>phenytoin</e2> and phenobarbital).\n",
      "One case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a <e1>sympathomimetic medication</e1> (<e2>ephedrine</e2>).\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, <e2>thyroxine</e2>, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Sirolimus AUC was increased by 21% with no effect on Cmax in the presence of steady-state <e1>MYCAMINE</e1> compared with <e2>sirolimus</e2> alone. \n",
      "In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving <e1>lithium</e1> doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving <e2>lithium</e2> alone. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Exert particular caution in combining levomepromazine with other anticholinergic drugs (<e1>tricyclic antidepressants</e1> and <e2>antiparkinsonian-agents</e2>): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, <e2>diazepam</e2> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Paliperidone may antagonize the effect of <e1>levodopa</e1> and other <e2>dopamine agonists</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, <e1>telithromycin</e1>, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e1>multivitamins</e1>, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "Concomitant administration of terfenadine with <e1>clarithromycin</e1>, <e2>erythromycin</e2>, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "Phenothiazines are capable of potentiating CNS depressants (e.g., barbiturates, <e1>anesthetics</e1>, opiates, <e2>alcohol</e2>, etc.) \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, <e1>rifampin</e1>, rifabutin, <e2>ketoconazole</e2>, and fluconazole. \n",
      "Use of <e1>neuroleptics</e1> in conjunction with oral <e2>morphine</e2> may increase the risk of respiratory depression, hypotension and profound sedation or coma. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "A study published in 2002 found that <e1>vigabatrin</e1> causes a statistically significant increase in plasma clearance of <e2>carbamazepine</e2>. \n",
      "In vitro studies with <e1>atracurium</e1>, mivacurium, esmolol, echothiophate, <e2>neostigmine</e2>, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "In the absence of data regarding potential interaction between ALIMTA and <e1>NSAIDs</e1> with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following <e2>ALIMTA</e2> administration. \n",
      "Zinc/<e1>iron</e1> salts: Absorption of <e2>quinolones</e2> is reduced significantly by these preparations. \n",
      "In addition, <e1>DZNep</e1> insensitivity might be associated with overexpression of Bcl-2, and the combination of <e2>ABT-737</e2> and DZNep could synergistically induced apoptosis. \n",
      "Those <e1>anticonvulsants</e1> include <e2>divalproex sodium</e2>, valproic acid, and phenobarbital. \n",
      "Systemic and apparent oral <e1>midazolam</e1> clearance were 24% (269    73 vs. 354    102  ml/min, P = 0.022) and 31% (479    190 vs. 688    265  ml/min, P = 0.013), respectively, lower in cyclosporine-treated patients (n = 20) than in matched <e2>tacrolimus</e2>-treated patients (n = 20). \n",
      "<e1>Anticholinergics</e1> antagonize the effects of <e2>antiglaucoma agents</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, <e2>indinavir</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, taxol, rifampicin, and <e1>human immunodeficiency virus protease inhibitors</e1> such as ritonavir and <e2>saquinavir</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e1>kaolin</e1>-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "<e1>Warfarin</e1> users who initiated citalopram, fluoxetine, paroxetine, <e2>amitriptyline</e2>, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "<e1>Ketoconazole</e1>: Spontaneous adverse reaction reports of patients taking concomitant ketoconazole with recommended doses of <e2>terfenadine</e2> demonstrate QT interval prolongation and rare serious cardiac events, e.g. \n",
      "In vitro, <e1>raloxifene</e1> did not affect the binding of warfarin, phenytoin, or <e2>tamoxifen</e2>. \n",
      "<e1>Sulfonamides</e1> can also displace <e2>methotrexate</e2> from plasma protein-binding sites, thus increasing free methotrexate concentrations. \n",
      "<e1>Warfarin</e1>: A multidose study of <e2>oxandrolone</e2>, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Rats treated with neonatal <e1>quinpirole</e1> enhanced time spent in the amphetamine-paired context compared with quinpirole-free controls conditioned with <e2>amphetamine</e2>, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls. \n",
      "This increase was observed at the first test point which was the second day after starting <e1>Mexitil</e1>   . <e2>Theophylline</e2> plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "In clinical studies of TOBI, patients taking <e1>TOBI</e1> concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled <e2>corticosteroids</e2>, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) <e2>Estrogens</e2> may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e1>nifedipine</e1>, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e1>clindamycin</e1>, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Our results characterize and identify a novel <e1>opiate</e1> addiction switching mechanism directly in the BLA that can control the processing of <e2>opiate</e2> reward information as a direct function of opiate exposure state via D1 or D2 receptor signaling substrates.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e1>nifedipine</e1>, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, <e2>Cholestyramine</e2>, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (<e1>curcumin</e1> 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (<e2>imipramine</e2> 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "AGGRASTAT has been studied on a background of <e1>aspirin</e1> and <e2>heparin</e2>. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, <e1>pancuronium</e1>, morphine, <e2>vancomycin</e2>, metformin and tenofovir). \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (<e2>phenobarbital</e2>, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "Triprolidine may enhance the sedative effects of <e1>central nervous system depressants</e1> including <e2>alcohol</e2>, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. \n",
      "Oral <e1>Contraceptives</e1>: In 10 healthy women, the pharmacokinetic profiles of norethindrone and <e2>ethinyl estradiol</e2> following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. \n",
      "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and <e1>Protease Inhibitors</e1>) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. <e2>dihydroergotamine</e2> and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interaction with <e1>Mixed Agonist/Antagonist Opioid Analgesics</e1>: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, <e2>butorphanol</e2>, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Concomitant administration of terfenadine with clarithromycin, erythromycin, or <e1>troleandomycin</e1> is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including <e2>azithromycin</e2>, is not recommended. \n",
      "Due to its effects on gastric emptying, <e1>SYMLIN</e1> therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as <e2>atropine</e2>) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors). \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e2>tranylcypromine</e2>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - <e2>edrophonium</e2> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Use with Other <e1>Central Nervous System Depressants</e1>: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as <e2>alcohol</e2>, sedatives, antihistaminics, or psychotropic drugs. \n",
      "Concurrent use of <e1>alcohol</e1> and other <e2>CNS depression-producing drugs</e2> may increase the CNS depressant effects of methyprylon or these other medications.\n",
      "Electroretinograms survived with higher concentrations of <e1>heparinase III</e1> and <e2>chondroitin ABC lyase</e2> than were required for optimal retinal transduction. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, <e2>Cyclosporine</e2>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, <e1>warfarin</e1>, diazepam, or <e2>fluoxetine</e2>. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, <e1>Colestipol</e1>, Iron-containing drugs, <e2>Laxatives</e2>, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, <e1>astemizole</e1>, cisapride, <e2>cyclosporine</e2>, and tricyclic antidepressants. \n",
      "John   s Wort, and certain anticonvulsants (<e1>phenytoin</e1>, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of <e2>mifepristone</e2>). \n",
      "Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, <e1>reserpine</e1> and <e2>veratrum alkaloids</e2>.\n",
      "In clinical trials, the concomitant use of sulfonylureas or <e1>biguanides</e1> did not alter the adverse event profile of <e2>SYMLIN</e2>. \n",
      "<e1>dasatinib</e1> + <e2>paclitaxel</e2> vs. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, <e2>cyclosporine</e2> and others) can increase the risk of hyperkalemia. \n",
      "When phenytoin or other hepatic enzyme inducers such as rifampin and <e1>phenobarbital</e1> have been taken concurrently with <e2>Mexitil</e2>   , lowered Mexitil    plasma levels have been reported. \n",
      "<e1>ASPIRIN</e1> AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO DISALCID AND MAY INCREASE PLASMA CONCENTRATIONS OF <e2>SALICYLIC ACID</e2> TO TOXIC LEVELS. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), <e2>amoxapine</e2> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a <e2>dopamine agonist</e2>); \n",
      "We evaluated mechanisms of interaction between the alkyating agent dacarbazine (<e1>DTIC</e1>) and the pro-oxidant, <e2>imexon</e2>, in the human A375 melanoma cell line.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Quantitative toxicological analysis showed that the concentrations of <e1>etizolam</e1>, <e2>phenobarbital</e2>, promethazine and chlorpromazine in the femoral blood were 86 ng/ml, 5082 microg/ml, 0.107 microg/ml and 0.144 microg/ml, respectively, and large amounts of drugs were also detected in the stomach contents. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, triamterene, amiloride) or <e2>potassium</e2> supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e1>ranitidine</e1>, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, <e2>Terfenadine</e2>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The action of Mecamylamine may be potentiated by anesthesia, other <e1>antihypertensive drugs</e1> and <e2>alcohol</e2>.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., <e2>ritonavir</e2>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e2>melatonin</e2> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of <e1>zidovudine</e1> or rifabutin to warrant dosage adjustment when <e2>megestrol acetate</e2> is administered with these drugs. \n",
      "Patients receiving sirolimus or nifedipine in combination with <e1>MYCAMINE</e1> should be monitored for sirolimus or <e2>nifedipine</e2> toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "These include <e1>sympathomimetic bronchodilators</e1>, <e2>methylxanthines</e2>, and oral and inhaled steroids. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, <e1>miconazole</e1>) or macrolide antibiotics (eg, <e2>erythromycin</e2>, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Lapatinib may have the potential to convert <e1>Herceptin</e1>-refractory to <e2>Herceptin</e2>-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2.\n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, <e2>naproxen</e2>, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e1>pramipexole</e1> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Patients with Congenital or Acquired QT Prolongation In a study of the effect of <e1>solifenacin</e1> on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of <e2>solifenacin</e2> 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e2>desglymidodrine</e2> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Less potent inhibitors include <e1>saquinavir</e1>, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and <e2>clotrimazole</e2>. \n",
      "These medications included thyroid hormones, <e1>sedative hypnotics</e1>, non-steroidal anti-inflammatory agents, benzodiazepines, and <e2>decongestants</e2>. \n",
      "MAO Inhibitors - The pressor effect of <e1>sympathomimetic pressor amines</e1> is markedly potentiated in patients receiving monoamine oxidase inhibitors (<e2>MAOI</e2>). \n",
      "Pharmacokinetic data indicate that <e1>ketoconazole</e1> markedly inhibits the metabolism of <e2>terfenadine</e2>, resulting in elevated plasma terfenadine levels. \n",
      "In vitro, raloxifene did not affect the binding of <e1>warfarin</e1>, phenytoin, or <e2>tamoxifen</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, <e2>troleandomycin</e2>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "The effect of a series of <e1>flavonoids</e1>, including flavonols, <e2>flavones</e2>, isoflavone, flavanone, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including <e1>fluconazole</e1>, <e2>metronidazole</e2>, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "Mequitazine can interact with <e1>CNS depressant</e1>, antichlolinergic, TCA, MAOIs, and <e2>alcohol</e2>.\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and <e2>quinine</e2>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg S-ketamine after pretreatments with oral <e1>ticlopidine</e1> (250 mg twice daily), <e2>itraconazole</e2> (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to <e1>5-FU</e1>, cisplatin, <e2>doxorubicin</e2> and etoposide   celecoxib following different incubation schedules were analyzed.\n",
      "The concomitant use of other CNS depressants including sedatives, <e1>hypnotics</e1>, tranquilizers, general anesthetics, <e2>phenothiazines</e2>, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: <e1>Agonist/antagonist analgesics</e1> (i.e., pentazocine, <e2>nalbuphine</e2>, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "The possibility of hypotensive effects with <e1>UNIVASC</e1>    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with <e2>UNIVASC</e2>   . If this is not possible, the starting dose of moexpril should be reduced.. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "<e1>Mephenytoin</e1> may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that <e2>Mephenytoin</e2> may interact with other drugs that are not listed here.\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, <e1>clarithromycin</e1>) or cyclosporine or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "No significant adverse interactions with common premedications (such as <e1>atropine</e1>, scopolamine, <e2>glycopyrrolate</e2>, diazepam, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.\n",
      "<e1>TERAZOL</e1> 3 Vaginal Cream 0.8% The levels of estradiol (E2) and progesterone did not differ significantly when 0.8% terconazole vaginal cream was administered to healthy female volunteers established on a low dose oral <e2>contraceptive</e2>.    \n",
      "Mexitil    does not alter serum <e1>digoxin</e1> levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to <e2>Mexitil</e2>   , has been reported to lower serum digoxin levels. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, <e2>ibuprofen</e2>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "The safety of using <e1>methylphenidate</e1> in combination with clonidine or other centrally acting <e2>alpha-2 agonists</e2> has not been systemically evaluated.    \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, <e2>verapamil</e2>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "However, increased prothrombin time and bleeding have been reported in patients on concomitant <e1>TOLECTIN</e1> and <e2>warfarin</e2> therapy. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . <e1>Nonsteroidal anti-inflammatory agents</e1>, including <e2>FELDENE</e2>, have been reported to increase steady state plasma lithium levels. \n",
      "Some examples of such drugs are erythromycin, itraconazole, ketoconazole, <e1>fluconazole</e1>, calcium channel blockers and <e2>cimetidine</e2>.    \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e2>Elavil</e2>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "In the light of contradictory data on efficacy and safety of <e1>NSAID</e1> in cardiovascular patients selection of most appropriate NSAID (basing on profile of efficacy and safety) in patients receiving continuous therapy with low dose <e2>aspirin</e2> appears to be a problem. \n",
      "Although it was previously reported that <e1>lapatinib</e1> combined with Herceptin improved the progression-free survival rate compared with lapatinib alone for patients with <e2>Herceptin</e2>-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e1>nelfinavir</e1>, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "- did not cause any clinically significant change in plasma profiles of prednisone or <e1>prednisolone</e1> following administration of either oral prednisone or intravenous <e2>prednisolone</e2>.  \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e1>cephalosporins</e1>, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "<e1>Coumarin-Derivative Anticoagulants</e1>: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving <e2>ZOLINZA</e2> concomitantly with coumarin-derivative anticoagulants. \n",
      "<e1>Lithium</e1>: Increased serum lithium levels and symptoms of <e2>lithium</e2> toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, <e1>levodopa</e1>, ethanol, <e2>cyclosporine</e2>). \n",
      "<e1>Macrolides</e1>: Clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of <e2>ketoconazole</e2>, but to a lesser extent. \n",
      "In adult diabetic patients under treatment with either sulfonylureas or <e1>insulin</e1> there is no change in the clinical effects of either TOLECTIN or the <e2>hypoglycemic agents</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the <e1>vaccine</e1> virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - <e2>Mitomycin-C</e2>: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e2>desglymidodrine</e2> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., <e2>phenelzine</e2>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Additive sedative effects can occur when <e1>metoclopramide</e1> is given with alcohol, sedatives, <e2>hypnotics</e2>, narcotics, or tranquilizers. \n",
      "Use of Anticoagulants and <e1>Antiplatelet Agents</e1> -- Streptase, <e2>Streptokinase</e2>, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications. \n",
      "A 104-week dietary carcinogenicity study with <e1>ezetimibe</e1> was also conducted in mice at doses up to 500 mg/kg/day (>150 times the human exposure at 10 mg daily based on AUC0-24hr for total <e2>ezetimibe</e2>). \n",
      "HEY cells treated with <e1>dasatinib</e1> plus <e2>paclitaxel</e2> formed fewer colonies than did cells treated with either agent alone. \n",
      "If <e1>short-acting benzodiazepines</e1>, which are metabolized by the cytochrome P450 system, are concomitantly administered with <e2>fluconazole</e2>, consideration should be given to decreasing the benzodiazepine dosage, and the patients should be appropriately monitored. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a <e1>protease inhibitor</e1> (<e2>PI</e2>) or an integrase inhibitor (II) is recommended. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Macrolides: Clinical drug interaction studies indicate that erythromycin and <e1>clarithromycin</e1> can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of <e2>ketoconazole</e2>, but to a lesser extent. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e1>delavirdine</e1>) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "In the absence of data regarding potential interaction between <e1>ALIMTA</e1> and <e2>NSAIDs</e2> with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. \n",
      "Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of <e1>zidovudine</e1> or <e2>rifabutin</e2> to warrant dosage adjustment when megestrol acetate is administered with these drugs. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, <e2>calcium</e2>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when <e1>cholinesterase inhibitors</e1> are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as <e2>bethanechol</e2>.\n",
      "Some examples of such drugs are erythromycin, itraconazole, <e1>ketoconazole</e1>, <e2>fluconazole</e2>, calcium channel blockers and cimetidine.    \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain <e1>antibiotics</e1>, quinidine, <e2>theophylline</e2>, corticosteroids, anticoagulants, and beta blockers.\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (<e1>imipramine</e1>, <e2>clomipramine</e2>, desipramine). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, phenytoin, and <e2>rifampin</e2> may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, <e1>pravastatin</e1>, <e2>lovastatin</e2>, or fluvastatin. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or <e1>macrolide antibiotics</e1> (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "Oral <e1>hypoglycemic agents</e1> <e2>Oxandrolone</e2> may inhibit the metabolism of oral hypoglycemic agents. \n",
      "Protective effect of <e1>acetyl-l-carnitine</e1> and  <e2>alpha lipoic acid</e2> against the acute toxicity of diepoxybutane to human lymphocytes.\n",
      "Mean <e1>oxybutynin chloride</e1> plasma concentrations were approximately 2 fold higher when DITROPAN XL was administered with <e2>ketoconazole</e2>, a potent CYP3A4 inhibitor. \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, <e1>digitalis</e1>, diuretics, <e2>antidiabetic agents</e2>, and antiarrhythmics, without observed problems. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general <e1>anesthetics</e1>, phenothiazines, other opioids, <e2>tricyclic antidepressants</e2>, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Other Agents: No clinically important pharmacokinetic interactions occurred when <e1>UNIVASC</e1>    was administered concomitantly with hydrochlorothiazide, digoxin, or <e2>cimetidine</e2>. \n",
      "Pharmacokinetic properties of abacavir were not altered by the addition of either <e1>lamivudine</e1> or zidovudine or the combination of <e2>lamivudine</e2> and zidovudine. \n",
      "The risk of gastrointestinal bleeding during the treatment with <e1>antiagregants</e1> and <e2>anticoagulants</e2>, the risk of bradycardia in beta-blockade, possible interactions with other medications lowering the heart rate are discussed. \n",
      "No pharmacokinetic interaction was observed between rivastigmine and <e1>digoxin</e1>, warfarin, <e2>diazepam</e2>, or fluoxetine in studies in healthy volunteers. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . <e1>Selective serotonin reuptake inhibitors</e1> (SSRIs) (e.g., fluoxetine, <e2>fluvoxamine</e2>, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Our data demonstrate that chronic treatment with the metabotropic glutamate receptor 5 antagonist, <e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1>, significantly reduces <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2> toxicity towards dopaminergic and noradrenergic cell groups in non-human primates. \n",
      "<e1>UNIVASC</e1>    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, <e2>digoxin</e2>, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "<e1>Heparin</e1> should not be included in the same syringe as <e2>Sodium Tetradecyl Sulfate</e2>, since the two are incompatible.\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Co-administration of <e1>moxidectin</e1> with inhibitors of ABC transporter function did not enhance sensitivity to <e2>moxidectin</e2> in males; \n",
      "Reduced absorption of <e1>folic acid</e1> and <e2>digoxin</e2> have been reported when those agents were administered concomitantly with sulfasalazine. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, <e2>secobarbital</e2> and droperidol. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (<e2>Sinequan</e2>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "ECG intervals (PR, QRS, and QT) were not affected by concurrent <e1>Mexitil</e1>    and digoxin, <e2>diuretics</e2>, or propranolol. \n",
      "Since <e1>Celontin</e1> (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and <e2>phenobarbital</e2>).\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, <e2>Cisapride</e2>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and <e1>simethicone</e1>) did not significantly affect the exposure of oxybutynin or <e2>desethyloxybutynin</e2>.    \n",
      "No significant drug interactions were reported in studies in which <e1>olmesartan medoxomil</e1> was co-administered with digoxin or <e2>warfarin</e2> in healthy volunteers. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, <e1>penicillins</e1>, rifampin, rifabutin, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, <e1>phenytoin</e1>, sulfinpyrazone, naproxen, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "<e1>Posicor</e1> inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, <e2>cisapride</e2>, cyclosporine, and tricyclic antidepressants. \n",
      "<e1>Phenytoin</e1>: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 7 days, XENICAL did not alter the pharmacokinetics of a single 300-mg dose of <e2>phenytoin</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The concomitant use of other CNS depressants including sedatives, <e1>hypnotics</e1>, tranquilizers, general anesthetics, phenothiazines, other opioids, <e2>tricyclic antidepressants</e2>, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "<e1>Palonosetron</e1> did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, cytarabine, <e2>doxorubicin</e2> and mitomycin C) in murine tumor models.\n",
      "<e1>Mephenytoin</e1> may also affect the effects of other drugs, which include some steroid medications, <e2>warfarin</e2>, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "<e1>Cholestyramine</e1>: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of <e2>raloxifene</e2> and should not be coadministered with EVISTA. \n",
      "<e1>Vasopressors</e1>, particularly metaraminol, may cause serious cardiac arrhythmias during <e2>halothane</e2> anesthesia and therefore should be used only with great caution or not at all. \n",
      "<e1>Azathioprine</e1>/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or <e2>mycophenolate mofetil</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Mitoxantrone</e1> and its metabolites are excreted in bile and urine, but it is not known whether the metabolic or excretory pathways are saturable, may be inhibited or induced, or if <e2>mitoxantrone</e2> and its metabolites undergo enterohepatic circulation. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e1>polymyxin B</e1> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e1>meperidine</e1>), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e1>Anafranil</e1>), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "<e1>Thalidomide</e1> has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and <e2>reserpine</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, <e2>triamterene</e2>, amiloride) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "Based on in vitro P450 inhibition studies and the low systemic exposure observed following topical application of <e1>ALTABAX</e1>, <e2>retapamulin</e2> is unlikely to affect the metabolism of other P450 substrates. \n",
      "To minimize CNS depression and possible potentiation, <e1>barbiturates</e1>, antihistamines, narcotics, <e2>hypotensive agents</e2> or phenothiazines should be used with caution. \n",
      "Following liquid-liquid extraction with <e1>ethyl acetate</e1>, the separation was performed on a reverse phase C18 column with a mobile phase consisted of <e2>methanol-ammonium acetate</e2> (pH 4.0; 10 mM) (70:30, v/v). \n",
      "Caution is recommended when administering <e1>NEXAVAR</e1> with compounds that are metabolized/eliminated predominantly by the UGT1A1 pathway (e.g. <e2>irinotecan</e2>). \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral <e2>melatonin</e2> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Rats treated with neonatal quinpirole enhanced time spent in the <e1>amphetamine</e1>-paired context compared with quinpirole-free controls conditioned with <e2>amphetamine</e2>, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Other eye drops or medications such as acetylcholine chloride (Miochol) and <e1>carbachol</e1> (Carboptic, Isopto Carbachol) may decrease the effects of <e2>suprofen</e2> ophthalmic.\n",
      "<e1>Cyclosporine</e1>: <e2>DIFLUCAN</e2> may significantly increase cyclosporine levels in renal transplant patients with or without renal impairment. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e1>corticosteroids</e1> (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e1>progestin</e1> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, <e1>H2 blockers</e1>, <e2>digoxin</e2>, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (<e1>curcumin</e1> 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (<e2>curcumin</e2> 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), <e1>(beta)-agonists</e1>, inhaled corticosteroids, other <e2>anti-pseudomonal antibiotics</e2>, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "<e1>Aminoglutethimide</e1> administered concomitantly with depo-subQ provera 104 may significantly decrease the serum concentrations of <e2>MPA</e2>. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, <e1>triiodothyronine</e1>, phenytoin, sulfinpyrazone, naproxen, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "In the present study piperine (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of <e1>ibuprofen</e1> evaluated by both acetic acid writhing and formalin test, when it was administered with <e2>ibuprofen</e2>. \n",
      "Concurrent use of DEMSER with <e1>alcohol</e1> or other <e2>CNS depressants</e2> can increase their sedative effects.\n",
      "Curariform Drugs: <e1>Diuretic</e1>-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as <e2>tubocurarine</e2>) the most serious effect would be respiratory depression which could proceed to apnea. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, <e2>Cisapride</e2>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e2>edrophonium</e2> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e1>nelfinavir</e1>, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e1>ketoconazole</e1>, itraconazole, <e2>voriconazole</e2>). \n",
      "The median duration of action of <e1>ZEMURON</e1>    0.6 mg/kg administered after a 1 mg/kg dose of <e2>succinylcholine</e2> when T 1 returned to 75% of control was 36 minutes (range 14-57, n=12) vs. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (<e1>fluoxetine</e1> 20 mg/kg), group 5 (<e2>imipramine</e2> 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "In a study of 11 HIV-infected patients receiving <e1>methadone</e1>-maintenance therapy (40 mg and 90 mg daily) with 600 mg of <e2>ZIAGEN</e2> twice daily (twice the currently recommended dose), oral methadone clearance increased 22% (90% CI 6% to 42%). \n",
      "Neuromuscular blocking agents (such as <e1>suxamethonium chloride</e1>): Concurrent use of procaine hydrochloride and <e2>neuromuscular blocking agents</e2> may result in prolongation or enhancement of the neuromuscular blockade. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Usage with Alcohol: Due to the potential for increased CNS depressants effects, <e1>alcohol</e1> should be used with caution in patients who are currently receiving <e2>pentazocine</e2>.\n",
      "TOBI should not be administered concomitantly with <e1>ethacrynic acid</e1>, furosemide, <e2>urea</e2>, or mannitol.\n",
      "The concomitant use of other CNS depressants including sedatives, <e1>hypnotics</e1>, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e1>pramipexole</e1> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "This could lead to decreased <e1>salicylate</e1> serum levels or increase the risk of <e2>salicylate</e2> toxicity when methylprednisolone is withdrawn. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and <e1>miconazole</e1>) or <e2>macrolide antibiotics</e2> (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Drugs which may potentiate the myeloproliferative effects of Leukine, such as <e1>lithium</e1> and <e2>corticosteroids</e2>, should be used with caution.\n",
      "Cyclosporine: <e1>DIFLUCAN</e1> may significantly increase <e2>cyclosporine</e2> levels in renal transplant patients with or without renal impairment. \n",
      "<e1>Glyburide</e1>: In 12 normal-weight subjects receiving <e2>orlistat</e2> 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide. \n",
      "Caution should be observed in administering <e1>DEMSER</e1> to patients receiving <e2>phenothiazines</e2> or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - <e2>cisplatin</e2> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The effect of orlistat on the absorption of supplemental <e1>vitamin D</e1>, <e2>vitamin A</e2>, and nutritionally-derived vitamin K is not known at this time. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Pharmacokinetic properties of <e1>abacavir</e1> were not altered by the addition of either lamivudine or zidovudine or the combination of lamivudine and <e2>zidovudine</e2>. \n",
      "The ratio of <e1>norketamine</e1> AUC(0-   ) to ketamine AUC(0-   ) was significantly decreased in the <e2>ticlopidine</e2> (P &lt; 0.001) and itraconazole phases (P = 0.006) as compared to placebo. \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Cholestyramine: Pretreatment for four days with <e1>cholestyramine</e1> significantly increased the clearance of <e2>meloxicam</e2> by 50%. \n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when <e1>midazolam</e1> is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of <e2>azole antimycotics</e2>, protease inhibitors, calcium channel antagonists, and macrolide antibiotics). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, <e1>halogenated salicylanilides</e1> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "Misoprostol has no clinically significant effect on the kinetics of <e1>diclofenac</e1> or <e2>ibuprofen</e2>.\n",
      "In vitro studies with human liver microsomes showed that <e1>terbinafine</e1> does not inhibit the metabolism of <e2>tolbutamide</e2>, ethinylestradiol, ethoxycoumarin, and cyclosporine. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "The effect of <e1>meloxicam</e1> on the anticoagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of <e2>warfarin</e2> that produced an INR (International Normalized Ratio) between 1.2 and 1.8. \n",
      "But the use of fixed combination amlodipine/<e1>valsartan</e1> compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of <e2>antihypertensive drugs</e2> (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05). \n",
      "No clinically significant changes to <e1>lamivudine</e1> or zidovudine pharmacokinetics were observed following concomitant administration of <e2>abacavir</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e1>neostigmine</e1> - polymyxin B or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Pharmacokinetic properties of <e1>abacavir</e1> were not altered by the addition of either lamivudine or zidovudine or the combination of <e2>lamivudine</e2> and zidovudine. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e1>prednisone</e1>, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and <e2>warfarin</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "TOBI should not be administered concomitantly with <e1>ethacrynic acid</e1>, <e2>furosemide</e2>, urea, or mannitol.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), <e1>calcium channel blockers</e1> (n=75), <e2>antidiabetics</e2> (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, <e2>bacitracin</e2>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Phenytoin</e1>, <e2>Carbamazepine</e2>, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Effect of Other Drugs on the Metabolism of <e1>Exelon</e1>: Drugs that induce or inhibit CYP450 metabolism are not expected to alter the metabolism of <e2>rivastigmine</e2>. \n",
      "<e1>Fluconazole</e1> tablets coadministered with ethinyl estradiol- and <e2>levonorgestrel</e2>-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels; \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "While there is evidence that <e1>fluconazole</e1> can inhibit the metabolism of <e2>ethinyl estradiol</e2> and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e1>sulfonamides</e1>, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e2>antipsychotic agents</e2> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Phenytoin, Carbamazepine, and <e1>Rifampicin</e1>: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and <e2>ondansetron</e2> blood concentrations were decreased. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e1>itraconazole</e1>, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "Concomitant administration of <e1>terfenadine</e1> with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of <e2>terfenadine</e2> with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "In female rats, neonatal quinpirole treatment enhanced <e1>amphetamine</e1> locomotor sensitization compared with <e2>quinpirole</e2>-free controls sensitized to amphetamine. \n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, <e2>penicillins</e2>, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, <e2>caffeine</e2>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Phenothiazines are capable of potentiating CNS depressants (e.g., <e1>barbiturates</e1>, anesthetics, opiates, <e2>alcohol</e2>, etc.) \n",
      "However, it is possible that concomitant use of other <e1>photosensitizing agents</e1> (e.g., tetracyclines, sulfonamides, phenothiazines, sulfonylurea hypoglycemia agents, <e2>thiazide diuretics</e2>, and griseofulvin) could increase the photosensitivity reaction. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, morphine, meperidine and fentanyl), propofol, <e2>ketamine</e2>, nitrous oxide, secobarbital and droperidol. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, <e2>atazanavir</e2>, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Acetazolamide: Concurrent use of <e1>acetazolamide</e1> and <e2>procaine hydrochloride</e2> may extend the plasma half-life of procaine.\n",
      "The action of <e1>Mecamylamine</e1> may be potentiated by anesthesia, other <e2>antihypertensive drugs</e2> and alcohol.\n",
      "Preliminary evidence suggests that <e1>cimetidine</e1> inhibits mebendazole metabolism and may result in an increase in plasma concentrations of <e2>mebendazole</e2>.\n",
      "Less potent inhibitors include saquinavir, nefazodone, <e1>fluconazole</e1>, grapefruit juice, <e2>fluoxetine</e2>, fluvoxamine, zileuton, and clotrimazole. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (<e1>MAOI</e1>) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or <e2>phenelzine</e2> (Nardil) in the last 14 days. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e1>thyroxine</e1>, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for <e1>sirolimus</e1> or nifedipine toxicity and <e2>sirolimus</e2> or nifedipine dosage should be reduced if necessary. \n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, ketoconazole, <e2>fluconazole</e2>, calcium channel blockers and cimetidine.\n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as <e1>alcohol</e1>, <e2>sedatives</e2>, antihistaminics, or psychotropic drugs. \n",
      "Addition of mexiletine to <e1>propafenone</e1> did not lead to further electrocardiographic parameters changes of QRS, QTc, RR, and PR intervals than <e2>propafenone</e2> alone. \n",
      "Dopamine antagonists: Since pramipexole is a <e1>dopamine agonist</e1>, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, <e1>primidone</e1>), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, <e1>meperidine</e1> and fentanyl), propofol, ketamine, nitrous oxide, <e2>secobarbital</e2> and droperidol. \n",
      "Dopamine antagonists: Since pramipexole is a <e1>dopamine agonist</e1>, it is possible that <e2>dopamine antagonists</e2>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, <e1>echothiophate</e1>, neostigmine, physostigmine, and midazolam revealed no inhibition of <e2>remifentanil</e2> hydrolysis in whole human blood by these drugs.\n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (<e1>curcumin</e1> 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus <e2>fluoxetine</e2> 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "When <e1>oxandrolone</e1> therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of <e2>warfarin</e2> adjusted as necessary until a stable target INR or PT has been achieved. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Being <e1>moxifloxacin</e1> and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, <e2>gelusil</e2>, erythromycin and multi minerals. \n",
      "<e1>Neuromuscular blocking agents</e1> (such as <e2>suxamethonium chloride</e2>): Concurrent use of procaine hydrochloride and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade. \n",
      "In the presence of <e1>ketoconazole</e1>, there was 1.6- and 1.8-fold increase in C (max) and AUC of <e2>panobinostat</e2>, respectively. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Multiple dose studies of <e1>ezetimibe</e1> given in combination with HMG-CoA reductase inhibitors (<e2>statins</e2>) in rats and rabbits during organogenesis result in higher ezetimibe and statin exposures. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, <e1>phenothiazines</e1>, other opioids, <e2>tricyclic antidepressants</e2>, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, <e1>nifedipine</e1>, fluconazole, <e2>ritonavir</e2>, and rifampin. \n",
      "The effect of curcumin (100 mg/kg) was similar to that of fluoxetine and <e1>imipramine</e1> (p > 0.05) but its addition to fluoxetine and <e2>imipramine</e2> did not improve their antidepressant activity (p > 0.05). \n",
      "Caution is advised for patients receiving high-dose <e1>aspirin</e1> and <e2>methazolamide</e2> concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and carbonic anhydrase inhibitors.\n",
      "TOBI should not be administered concomitantly with ethacrynic acid, <e1>furosemide</e1>, urea, or <e2>mannitol</e2>.\n",
      "heparin, warfarin, <e1>diazepam</e1>, <e2>insulin</e2>; \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or <e1>macrolide antibiotics</e1> (eg, erythromycin, clarithromycin) or cyclosporine or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e1>cimetidine</e1>, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "Drug Interactions: The use of <e1>ZEMURON</e1>    (rocuronium bromide) Injection before succinylcholine, for the purpose of attenuating some of the side effects of <e2>succinylcholine</e2>, has not been studied. \n",
      "<e1>Implanon</e1>   failure in an HIV-positive woman on <e2>antiretroviral</e2> therapy resulting in two ectopic pregnancies.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e2>atazanavir</e2>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Astemizole</e1>: The use of <e2>fluconazole</e2> in patients concurrently taking astemizole or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, <e2>diazepam</e2> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, prednisolone, <e2>sirolimus</e2>, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially <e1>SSRI antidepressants</e1> such as <e2>paroxetine</e2> and fluoxetine. \n",
      "When <e1>methyldopa</e1> and <e2>lithium</e2> are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity. \n",
      "Use with <e1>Cholinomimetics</e1> and Other <e2>Cholinesterase Inhibitors</e2>: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, <e1>Cholestyramine</e1>, <e2>Choline</e2> and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (<e1>norethindrone</e1> 1 mg/ethinyl estradiol 35 mcg), terfenadine, <e2>digoxin</e2>, and warfarin. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus <e1>fluoxetine</e1> 20 mg/kg) and group 7 (curcumin 100 mg/kg plus <e2>imipramine</e2> 15 mg/kg). \n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar <e1>neuromuscular blocking agents</e1> or cholinergic agonists such as <e2>bethanechol</e2>.\n",
      "The combination of <e1>minocycline</e1> and <e2>fosfomycin</e2> can be synergistic against MRSA. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e1>thyroxine</e1>, triiodothyronine, phenytoin, sulfinpyrazone, <e2>naproxen</e2>, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Exert particular caution in combining <e1>levomepromazine</e1> with other anticholinergic drugs (<e2>tricyclic antidepressants</e2> and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. \n",
      "ECG intervals (PR, QRS, and QT) were not affected by concurrent <e1>Mexitil</e1>    and digoxin, diuretics, or <e2>propranolol</e2>. \n",
      "You cannot take mazindol if you have taken a <e1>monoamine oxidase inhibitor</e1> (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (<e2>Nardil</e2>) in the last 14 days. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, butyrophenones, thioxanthenes) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "<e1>Vindesine</e1> can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - <e2>Mitomycin-C</e2>: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Calcium</e1> was administered as calcium chloride in all studies and <e2>minerals</e2> were ingested on an empty stomach. \n",
      "Several studies demonstrate a decrease in the bioavailability of <e1>methyldopa</e1> when it is ingested with <e2>ferrous sulfate</e2> or ferrous gluconate. \n",
      "<e1>Fat-soluble Vitamin Supplements</e1> and Analogues: A pharmacokinetic interaction study showed a 30% reduction in <e2>beta-carotene</e2> supplement absorption when concomitantly administered with XENICAL. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "In another formal study (n = 8 extensive and n = 7 poor metabolizers of CYP2D6), coadministration of <e1>propafenone</e1> did not alter the kinetics of <e2>mexiletine</e2> in the poor CYP2D6 metabolizer group. \n",
      "<e1>Methylxanthines</e1>: <e2>Sparfloxacin</e2> does not increase plasma theophylline concentrations. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and <e1>rifampin</e1> may increase the clearance of <e2>methylprednisolone</e2> and may require increased in methylprednisolone dose to achieve the desired response. \n",
      "Our results characterize and identify a novel <e1>opiate</e1> addiction switching mechanism directly in the BLA that can control the processing of opiate reward information as a direct function of <e2>opiate</e2> exposure state via D1 or D2 receptor signaling substrates.\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e2>sulfonamides</e2>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "The pharmacokinetic parameters of <e1>digoxin</e1> are not significantly modified by <e2>SKELID</e2> coadministration. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e1>sodium colistimethate</e1>), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that <e1>ketoconazole</e1>, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of <e2>mifepristone</e2>). \n",
      "The criterion for a lack of difference between products was a 90% CI between 0.80 and 1.25 for the <e1>fenofibric acid</e1>:<e2>fenofibrate</e2> ratios for AUC(0-t), AUC(0-   ), and C(max.) \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "<e1>Alcohol</e1>: Concomitant administration of alcohol (equivalent to 60 g) had a minimal effect on plasma levels of <e2>mirtazapine</e2> (15 mg) in 6 healthy male subjects. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "After oral administration of colchicine (8 mg/kg) in the form of either the nanoemulsion or in free colchicine solution, the relative bioavailability of nanoemulsion and <e1>eugenol</e1>-nanoemulsion were enhanced by about 1.6- and 2.1-fold, respectively, compared with free <e2>colchicine</e2> solution. \n",
      "In adult diabetic patients under treatment with either <e1>sulfonylureas</e1> or insulin there is no change in the clinical effects of either TOLECTIN or the <e2>hypoglycemic agents</e2>. \n",
      "<e1>HMG-CoA reductase inhibitors</e1>: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with <e2>atorvastatin</e2>, simvastatin, pravastatin, lovastatin, or fluvastatin. \n",
      "Coadministration of a selective and potent inhibitor of CYP3A4, <e1>ketoconazole</e1> (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after <e2>ketoconazole</e2>) caused a 15% reduction in in-vivo plasma clearance of ropivacaine.\n",
      "- did not cause any clinically significant change in plasma profiles of prednisone or prednisolone following administration of either oral <e1>prednisone</e1> or intravenous <e2>prednisolone</e2>.  \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Because of profound and long lasting inhibition of gastric acid secretion, <e1>pantoprazole</e1> may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, <e2>ampicillin</e2> esters, and iron salts). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of <e1>muscle relaxants</e1>, inhalational agents, <e2>analgesic agents</e2>, and local anesthetic agents) have been observed.\n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, ketoconazole, fluconazole, calcium channel blockers and <e2>cimetidine</e2>.    \n",
      "Coadministration of a selective and potent inhibitor of CYP3A4, <e1>ketoconazole</e1> (100 mg bid for 2 days with <e2>ropivacaine</e2> infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of ropivacaine.\n",
      "To minimize CNS depression and possible potentiation, barbiturates, <e1>antihistamines</e1>, narcotics, <e2>hypotensive agents</e2> or phenothiazines should be used with caution. \n",
      "<e1>Warfarin</e1>: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in <e2>S-warfarin</e2> half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. \n",
      "<e1>Potassium</e1> Supplements and <e2>Potassium-Sparing Diuretics</e2>: ACEON    Tablets may increase serum potassium because of its potential to decrease aldosterone production. \n",
      "No untoward clinical manifestations have been observed in limited experience with patients in whom <e1>PRIMACOR</e1> was used concurrently with the following drugs: <e2>digitalis glycosides</e2>; \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, hypnotics, tranquilizers, general anesthetics, <e2>phenothiazines</e2>, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Reduced absorption of folic acid and <e1>digoxin</e1> have been reported when those agents were administered concomitantly with <e2>sulfasalazine</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, <e2>tetracyclines</e2>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Coumarin-type anticoagulants</e1>: Prothrombin time may be increased in patients receiving concomitant DIFLUCAN and <e2>coumarin-type anticoagulants</e2>. \n",
      "You cannot take <e1>mazindol</e1> if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (<e2>Marplan</e2>), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "<e1>Warfarin</e1> users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), <e2>amitriptyline</e2> (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, <e2>lincomycin</e2>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "Triprolidine may enhance the sedative effects of <e1>central nervous system depressants</e1> including alcohol, <e2>barbiturates</e2>, hypnotics, narcotic analgesics, sedatives, and tranquillisers. \n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a <e2>dopamine agonist</e2>, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e1>Tacrolimus</e1>, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e2>thioxanthenes</e2>) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "A greater potentiation of the neuromuscular blocking effects of MIVACRON may be expected with higher concentrations of <e1>enflurane</e1> or <e2>isoflurane</e2>. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . <e1>Selective serotonin reuptake inhibitors</e1> (SSRIs) (e.g., <e2>fluoxetine</e2>, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Rats treated with neonatal <e1>quinpirole</e1> enhanced time spent in the amphetamine-paired context compared with quinpirole-free controls conditioned with amphetamine, but only female controls conditioned with <e2>amphetamine</e2> spent more time in the drug-paired context compared with saline-treated controls. \n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, <e1>cyclophosphamide</e1>, cytarabine, <e2>doxorubicin</e2> and mitomycin C) in murine tumor models.\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "There are no controlled studies documenting the use of <e1>ZEMURON</e1>    before or after other <e2>nondepolarizing muscle relaxants</e2>. \n",
      "In Trial 1, the proportions of patients in the placebo and <e1>Synagis</e1>    groups who received routine childhood <e2>vaccines</e2>, influenza vaccine, bronchodilators or corticosteroids were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, <e2>tranylcypromine</e2>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, <e1>miconazole</e1>) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or <e1>macrolide antibiotics</e1> (eg, erythromycin, <e2>clarithromycin</e2>) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Dopamine antagonists: Since pramipexole is a <e1>dopamine agonist</e1>, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or <e1>ergot-type medications</e1> (like <e2>dihydroergotamine</e2> or methysergide) and sumatriptan within 24 hours of each other should be avoided. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "Therefore, <e1>warfarin</e1> dose changes and monitoring for the effects of <e2>warfarin</e2> on blood clotting are necessary.\n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on <e1>mycophenolate mofetil</e1>, <e2>cyclosporine</e2>, tacrolimus, prednisolone, and fluconazole pharmacokinetics. \n",
      "Other <e1>Antihypertensives</e1>: When <e2>MYKROX</e2> Tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy. \n",
      "The colchicine nanoemulsion was prepared with <e1>isopropyl myristate</e1>, eugenol, Tween80, <e2>ethanol</e2> and water, and eugenol was used as an oil phase in the formulation; \n",
      "Caution should be used when <e1>EVISTA</e1> is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, <e2>naproxen</e2>, ibuprofen, diazepam, and diazoxide. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e1>progestin</e1> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "The molecular basis of this synergism is that the signaling pathways that were initially activated by <e1>docetaxel</e1> exposure were efficiently suppressed by the subsequent exposure to <e2>sunitinib</e2>. \n",
      "<e1>Alcohol</e1>: Concomitant administration of <e2>alcohol</e2> (equivalent to 60 g) had a minimal effect on plasma levels of mirtazapine (15 mg) in 6 healthy male subjects. \n",
      "The bioavailability of <e1>SKELID</e1> is decreased 80% by calcium, when <e2>calcium</e2> and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), <e1>calcium channel blockers</e1> (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "Use with <e1>Cholinomimetics</e1> and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar <e2>neuromuscular blocking agents</e2> or cholinergic agonists such as bethanechol.\n",
      "Severe toxicity has also been reported in patients receiving the combination of <e1>tricyclic antidepressants</e1> and ELDEPRYL and selective serotonin reuptake inhibitors and <e2>ELDEPRYL</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "In vitro, raloxifene did not affect the binding of warfarin, <e1>phenytoin</e1>, or <e2>tamoxifen</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "The effect of <e1>curcumin</e1> (100 mg/kg) was similar to that of fluoxetine and imipramine (p > 0.05) but its addition to fluoxetine and <e2>imipramine</e2> did not improve their antidepressant activity (p > 0.05). \n",
      "The <e1>colchicine</e1> nanoemulsion was prepared with isopropyl myristate, eugenol, Tween80, <e2>ethanol</e2> and water, and eugenol was used as an oil phase in the formulation; \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e1>melatonin</e1> with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "These medications included <e1>thyroid hormones</e1>, <e2>sedative hypnotics</e2>, non-steroidal anti-inflammatory agents, benzodiazepines, and decongestants. \n",
      "Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg <e1>methsuximide</e1> may increase the plasma concentrations of phenytoin and <e2>phenobarbital</e2>).\n",
      "In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that <e1>terbinafine</e1> does not affect the clearance of antipyrine or <e2>digoxin</e2>. \n",
      "Additive sedative effects can occur when metoclopramide is given with alcohol, <e1>sedatives</e1>, <e2>hypnotics</e2>, narcotics, or tranquilizers. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Although <e1>ibuprofen</e1> (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering <e2>ibuprofen</e2> concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Varenicline</e1> reduces nicotine withdrawal symptoms, cigarette craving and <e2>nicotine</e2> satisfaction. \n",
      "<e1>Nifedipine</e1> (extended-release tablets): In 17 normal-weight subjects receiving <e2>XENICAL</e2> 120 mg three times a day for 6 days, XENICAL did not alter the bioavailability of nifedipine (extended-release tablets). \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, <e1>prednisolone</e1>, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and <e2>warfarin</e2>. \n",
      "<e1>Phenobarbital</e1>, which induces hepatic metabolism, decreased the AUC of <e2>montelukast</e2> approximately 40% following a single 10-mg dose of montelukast. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Diuretics: <e1>Furosemide</e1> and probably other loop diuretics given concomitantly with <e2>metolazone</e2> can cause unusually large or prolonged losses of fluid and electrolytes. \n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, <e1>cyclophosphamide</e1>, cytarabine, doxorubicin and <e2>mitomycin C</e2>) in murine tumor models.\n",
      "The concurrent use of <e1>streptozocin</e1> and <e2>phenytoin</e2> has been reported in one case to result in reduced streptozocin cytotoxicity.    \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e2>nortriptyline</e2> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "<e1>Methylxanthines</e1>: Sparfloxacin does not increase plasma <e2>theophylline</e2> concentrations. \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, <e2>prednisolone</e2>, and fluconazole pharmacokinetics. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, <e1>Laxatives</e1>, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "Sympathomimetics may reduce the antihypertensive effects of <e1>methyldopa</e1>, <e2>mecamylamine</e2>, reserpine and veratrum alkaloids.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e1>benzodiazepines</e1>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) <e1>carbamazepine</e1> (<e2>Tegretol</e2>) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e1>medroxyprogesterone acetate</e1>, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "ACE inhibitors Reports suggest that <e1>NSAIDs</e1> may diminish the antihypertensive effect of <e2>angiotensin-converting enzyme (ACE) inhibitors</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, ketoconazole, <e2>fluconazole</e2>, calcium channel blockers and cimetidine.    \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as <e1>amphotericin B</e1>, aminoglycosides, <e2>bacitracin</e2>, polymyxin B, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "- Decreased absorption of colestipol, cholestyramine, <e1>mineral oil</e1>, and <e2>sucralfate</e2>.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e1>Short-acting benzodiazepines</e1>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Nevertheless, during concomitant therapy with <e1>furosemide</e1> and <e2>MOBIC</e2>, patients should be observed closely for signs of declining renal function, as well as to assure diuretic efficacy. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or <e1>magnesium</e1>-containing antacids, when administered 1 hour before <e2>SKELID</e2>. \n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, ketoconazole, fluconazole, calcium channel blockers and <e2>cimetidine</e2>.\n",
      "<e1>Dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, <e2>butyrophenones</e2>, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "You cannot take mazindol if you have taken a <e1>monoamine oxidase inhibitor</e1> (MAOI) such as <e2>isocarboxazid</e2> (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (<e1>MAOI</e1>) such as isocarboxazid (Marplan), tranylcypromine (<e2>Parnate</e2>), or phenelzine (Nardil) in the last 14 days. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., <e1>itraconazole</e1> and miconazole) or macrolide antibiotics (e.g., <e2>erythromycin</e2> and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, <e2>terazosin</e2>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "The bioavailability of SKELID is decreased 80% by <e1>calcium</e1>, when <e2>calcium</e2> and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on this experience, we suggest that low-dose <e1>ketamine</e1> added to <e2>propofol</e2> may be associated with prevention of EA in children with a history of EA with propofol TIVA.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when <e1>midazolam</e1> is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and <e2>macrolide antibiotics</e2>). \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of <e1>rivastigmine</e1> is not significantly affected by concurrent administration of digoxin, <e2>warfarin</e2>, diazepam, or fluoxetine. \n",
      "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), <e1>fluoxetine</e1> (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), <e2>amitriptyline</e2> (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that <e1>ondansetron</e1> may be associated with an increase in patient controlled administration of <e2>tramadol</e2>.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Interaction with <e1>Mixed Agonist/Antagonist Opioid Analgesics</e1>: Agonist/antagonist analgesics (i.e., <e2>pentazocine</e2>, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Caution should be exercised when <e1>Methergine</e1>    (methylergonovine maleate) is used concurrently with other <e2>vasoconstrictors</e2> or ergot alkaloids.\n",
      "Concomitant administration of substances that are also tubularly secreted (e.g., <e1>probenecid</e1>) could potentially result in delayed clearance of <e2>ALIMTA</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, <e1>nefazodone</e1>, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "No pharmacokinetic interaction was observed between rivastigmine and <e1>digoxin</e1>, <e2>warfarin</e2>, diazepam, or fluoxetine in studies in healthy volunteers. \n",
      "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/<e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1> versus <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/vehicle). \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of <e1>benzodiazepines</e1> (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "Use of Anticoagulants and <e1>Antiplatelet Agents</e1> -- Streptase, Streptokinase, alone or in combination with antiplatelet agents and <e2>anticoagulants</e2>, may cause bleeding complications. \n",
      "In these 2 single-dose studies, these healthy volunteers administered a single oral dose of 105-mg <e1>fenofibric acid</e1> met the US Food and Drug Administration regulatory criteria for assuming bioequivalence to a single oral dose of 145-mg fenofibrate tablets with respect to the rate and extent of <e2>fenofibric acid</e2> absorption in both fed and fasted states. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e1>SEDATIVE-HYPNOTICS</e1> (INCLUDING BARBITURATES), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . <e1>Selective serotonin reuptake inhibitors</e1> (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, <e2>sertraline</e2>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, <e1>sedatives</e1>, and <e2>tranquillisers</e2>. \n",
      "Use of <e1>Anticoagulants</e1> and Antiplatelet Agents -- Streptase, <e2>Streptokinase</e2>, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e1>methotrexate</e1> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "However, the impairment of motor skills produced by <e1>REMERON</e1> has been shown to be additive with those caused by <e2>diazepam</e2>. \n",
      "We evaluated the effects of calcium doses between 200 and 1500 mg on absorption of 5 mg <e1>nonheme iron</e1> (as <e2>ferrous sulfate</e2>). \n",
      "<e1>Digoxin</e1>: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with <e2>ACEON</e2>    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. \n",
      "Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in <e1>S-warfarin</e1> half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in <e2>R-warfarin</e2> half-life and AUC were also detected. \n",
      "Cyclosporine: Preliminary data from a XENICAL and <e1>cyclosporine</e1> drug interaction study indicate a reduction in cyclosporine plasma levels when <e2>XENICAL</e2> was coadministered with cyclosporine. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e1>Sinequan</e1>, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, <e1>primidone</e1>), phenylbutazone, and <e2>tricyclic drugs</e2> (imipramine, clomipramine, desipramine). \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e1>triamterene</e1>, flecainide, and <e2>quinidine</e2>. \n",
      "In the hot plate test in mice, co-administration of 15     g/kg <e1>dexmedetomidine</e1> with 10   mg/kg <e2>ephedrine</e2> intraperitoneally not only enhanced, but also prolonged the duration of antinociception induced by dexmedetomidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Palonosetron</e1> did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, <e2>cytarabine</e2>, doxorubicin and mitomycin C) in murine tumor models.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Sulfonamides: Concurrent use of <e1>procaine hydrochloride</e1> and <e2>sulfonamides</e2> may result in a reduction of the antibacterial action of the sulfonamide. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., <e1>digoxin</e1>) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, <e2>levodopa</e2>, ethanol, cyclosporine). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or <e1>macrolide antibiotics</e1> (e.g., erythromycin and <e2>clarithromycin</e2>), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing <e1>Mexitil</e1>   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the <e2>Mexitil</e2>    dose is changed. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, <e1>butyrophenones</e1>, thioxanthenes) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, <e1>cytarabine</e1>, <e2>doxorubicin</e2> and mitomycin C) in murine tumor models.\n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as <e1>digoxin</e1>, bronchodilators, other antiviral agents, <e2>antibiotics</e2>, or anti-metabolites have not been conducted. \n",
      "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or <e1>ergot-type medications</e1> (like dihydroergotamine or methysergide) and <e2>sumatriptan</e2> within 24 hours of each other should be avoided. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that <e1>dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, butyrophenones, <e2>thioxanthenes</e2>) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "The effect of <e1>orlistat</e1> on the absorption of supplemental vitamin D, vitamin A, and nutritionally-derived <e2>vitamin K</e2> is not known at this time. \n",
      "<e1>Salicylates</e1> may enhance the hypoglycemic effect of oral <e2>antidiabetic drugs</e2> of the sulfonylurea class. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., <e2>phenelzine</e2>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Since there is no interaction with <e1>theophylline</e1>, interaction with other <e2>methylxanthines</e2> such as caffeine is unlikely. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>Anticoagulants</e1> (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after <e2>TNKase</e2> therapy. \n",
      "The objective of this study was to evaluate the effect of oral administration of <e1>ginseng stem-and-leaf saponins</e1> (GSLS) on the humoral immune responses of chickens to <e2>inactivated ND</e2> and AI vaccines. \n",
      "Calcium does not inhibit the absorption of 5 milligrams of <e1>nonheme</e1> or <e2>heme iron</e2> at doses less than 800 milligrams in nonpregnant women.\n",
      "When daily doses of <e1>sulfasalazine</e1> 2 g and weekly doses of <e2>methotrexate</e2> 7.5 mg were coadministered to 15 rheumatoid arthritis patients in a drug-drug interaction study, the pharmacokinetic disposition of the drugs was not altered. \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of <e1>digoxin</e1>, warfarin, <e2>diazepam</e2>, or fluoxetine. \n",
      "<e1>Thiabendazole</e1> may compete with other drugs, such as <e2>theophylline</e2>, for sites of metabolism in the liver, thus elevating the serum levels of such compounds to potentially toxic levels. \n",
      "<e1>TRENTAL</e1> has been used concurrently with antihypertensive drugs, beta blockers, digitalis, <e2>diuretics</e2>, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "<e1>Posicor</e1> inhibits some of the liver's ability to metabolize some other drugs - <e2>terfenadine</e2>, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), <e2>doxepin</e2> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "While co-administration of <e1>ZAVESCA</e1>    appeared to increase the clearance of <e2>Cerezyme</e2> by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of Cerezyme. \n",
      "Remifentanil clearance is not altered by concomitant administration of <e1>thiopental</e1>, <e2>isoflurane</e2>, propofol, or temazepam during anesthesia. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (<e2>Sinequan</e2>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "While the effects of chronic <e1>phenytoin</e1> or carbamazepine therapy on the action of <e2>MIVACRON</e2> are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher. \n",
      "Some <e1>anticonvulsants</e1> may interact with <e2>Mephenytoin</e2>. \n",
      "Triprolidine may enhance the sedative effects of <e1>central nervous system depressants</e1> including alcohol, barbiturates, hypnotics, <e2>narcotic analgesics</e2>, sedatives, and tranquillisers. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Due to its effects on gastric emptying, <e1>SYMLIN</e1> therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., <e2>anticholinergic agents</e2> such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors). \n",
      "e.g., other <e1>belladonna alkaloids</e1>, <e2>antihistamines</e2> (including meclizine), tricyclic antidepressants, and muscle relaxants. \n",
      "A 5.5-fold decrease in the mean <e1>warfarin</e1> dose from 6.13 mg/day to 1.13 mg/day (approximately 80-85% reduction of <e2>warfarin</e2> dose), was necessary to maintain a target INR of 1.5. \n",
      "Mean oxybutynin chloride plasma concentrations were approximately 2 fold higher when <e1>DITROPAN XL</e1> was administered with <e2>ketoconazole</e2>, a potent CYP3A4 inhibitor. \n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "<e1>Phenytoin</e1>, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and <e2>rifampicin</e2>), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (<e1>Dilantin</e1>) carbamazepine (Tegretol) Estrogens may decrease the effects of <e2>benzodiazepines</e2> (lorezepam oxezepam temezepam). \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other <e1>CNS depressants</e1> such as <e2>alcohol</e2>, sedatives, antihistaminics, or psychotropic drugs. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>TERAZOL</e1> 3 Vaginal Cream 0.8% The levels of <e2>estradiol</e2> (E2) and progesterone did not differ significantly when 0.8% terconazole vaginal cream was administered to healthy female volunteers established on a low dose oral contraceptive.    \n",
      "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or <e1>rifampin</e1>, are co-administered with <e2>montelukast</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e1>anesthetics</e1>, procainamide, and <e2>quinidine</e2>. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (<e1>NNRTI</e1>), a <e2>protease inhibitor</e2> (PI) or an integrase inhibitor (II) is recommended. \n",
      "<e1>Adrenal steroids</e1> or ACTH In patients with edema, concomitant administration with <e2>adrenal cortical steroids</e2> or ACTH may increase the edema. \n",
      "Careful monitoring of serum theophylline concentrations in patients receiving <e1>DIFLUCAN</e1> and <e2>theophylline</e2> is recommended. \n",
      "Interaction with Guanethidine: Although <e1>minoxidil</e1> does not itself cause orthostatic hypotension, its administration to patients already receiving <e2>guanethidine</e2> can result in profound orthostatic effects. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, <e1>phenothiazines</e1>, nalidixic acid, <e2>halogenated salicylanilides</e2> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Calcium is the only known component in the diet that may affect absorption of both <e1>nonheme</e1> and <e2>heme iron</e2>. \n",
      "Thus strong inhibitors of cytochrome P4501A2, such as <e1>fluvoxamine</e1>, given concomitantly during administration of <e2>Ropivacaine</e2>, can interact with Ropivacaine leading to increased ropivacaine plasma levels. \n",
      "<e1>Warfarin</e1> users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), <e2>fluoxetine</e2> (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "Mexitil    does not alter serum <e1>digoxin</e1> levels but <e2>magnesium-aluminum hydroxide</e2>, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels. \n",
      "<e1>Ticlopidine</e1> treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral <e2>ketamine</e2> by 2.4-fold, whereas itraconazole treatment did not increase the exposure to S-ketamine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Coadministration of methyldopa with <e1>ferrous sulfate</e1> or <e2>ferrous gluconate</e2> is not recommended. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, <e1>saquinavir</e1>, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving <e1>MAO-A inhibitors</e1> is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, <e2>sertraline</e2>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, <e1>hypnotics</e1>, narcotic analgesics, <e2>sedatives</e2>, and tranquillisers. \n",
      "Therefore, do not administer <e1>Myfortic</e1> with <e2>cholestyramine</e2> or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral activated charcoal, because of the potential to reduce the efficacy of Myfortic. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e1>benzodiazepines</e1>, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, <e1>triamterene</e1> and others), <e2>potassium</e2> supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and quinine) decreases the oral clearance of <e2>pramipexole</e2> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Use with <e1>Anticholinergics</e1>: Because of their mechanism of action, cholinesterase inhibitors have the potential to interfere with the activity of <e2>anticholinergic medications</e2>. \n",
      "<e1>TERAZOL</e1> 7 Vaginal Cream 0.4% and <e2>TERAZOL</e2> 3 Vaginal Suppositories 80 mg The therapeutic effect of these products is not affected by oral contraceptive usage. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and <e1>miconazole</e1>) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter <e2>oxybutynin</e2> mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with <e1>Permax</e1> (a <e2>dopamine agonist</e2>); \n",
      "Although a causal relationship has not been established, there have been reports of bleeding and/or prolonged prothrombin time in patients treated with <e1>TRENTAL</e1> with and without anticoagulants or <e2>platelet aggregation inhibitors</e2>. \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of <e1>XENICAL</e1> and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of <e2>alcohol</e2> pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving cyclosporine than in those receiving <e1>tacrolimus</e1>, indicating that, at the doses generally used in clinical practice, <e2>cyclosporine</e2> is the stronger of the two with respect to CYP3A inhibition. \n",
      "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that <e1>ketoconazole</e1>, itraconazole, <e2>erythromycin</e2>, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). \n",
      "These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data, and with post-mortem stereological counts of midbrain dopaminergic neurons, as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity, which were all significantly higher in <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated animals than in <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/vehicle-treated monkeys. \n",
      "May interact with <e1>cimetidine</e1>, digoxin, medicines to control heart rhythm, <e2>sevelamer</e2>, and theophylline.\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, itraconazole, <e2>miconazole</e2>) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "<e1>Mequitazine</e1> can interact with CNS depressant, <e2>antichlolinergic</e2>, TCA, MAOIs, and alcohol.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the <e2>neuroleptics</e2> (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, <e1>dasatinib</e1> + paclitaxel vs <e2>paclitaxel</e2>: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Although specific drug or food interactions with <e1>mifepristone</e1> have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, <e2>itraconazole</e2>, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e2>isocarboxazid</e2>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "and combinations of <e1>opioids</e1> and <e2>sedatives</e2> (eg, benzodiazepines, barbiturates, chloral hydrate, droperidol, etc.). \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, <e1>diuretics</e1>, <e2>antidiabetic agents</e2>, and antiarrhythmics, without observed problems. \n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with <e1>succinylcholine</e1>, similar neuromuscular blocking agents or <e2>cholinergic agonists</e2> such as bethanechol.\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e2>digoxin</e2>, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of <e1>rivastigmine</e1> is not significantly affected by concurrent administration of <e2>digoxin</e2>, warfarin, diazepam, or fluoxetine. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e2>TRANQUILIZERS</e2>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, <e1>phenylpropanolamine</e1> or <e2>dihydroergotamine</e2>) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, <e1>telithromycin</e1>, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e1>Anafranil</e1>), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "Although it was previously reported that <e1>lapatinib</e1> combined with Herceptin improved the progression-free survival rate compared with <e2>lapatinib</e2> alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, <e1>tranquilizers</e1>, general anesthetics, <e2>phenothiazines</e2>, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "In humans, carmustine, <e1>etoposide</e1>, and <e2>cisplatin</e2> do not affect the pharmacokinetics of ondansetron.  \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "<e1>Penicillin</e1> blood levels may be prolonged by concurrent administration of probenecid which blocks the renal tubular secretion of <e2>penicillins</e2>. \n",
      "Addition of <e1>mexiletine</e1> to propafenone did not lead to further electrocardiographic parameters changes of QRS, QTc, RR, and PR intervals than <e2>propafenone</e2> alone. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, <e2>polymyxins</e2>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when <e1>FELDENE</e1> is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including <e2>FELDENE</e2>, have been reported to increase steady state plasma lithium levels. \n",
      "<e1>Digoxin</e1>: <e2>Sparfloxacin</e2> has no effect on the pharmacokinetics of digoxin. \n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "Use with Other <e1>Central Nervous System Depressants</e1>: The depressant effects of <e2>morphine</e2> are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs. \n",
      "To observe the injury in rat primary cultured neurons induced by Abeta(1-40) and the protective effects of combination of <e1>ginseng</e1> and <e2>ginko</e2> extracts.\n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Acetazolamide</e1>: Concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half-life of <e2>procaine</e2>.\n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, <e1>hypoglycemics</e1>, <e2>theophyllines</e2>, phenytoins, thiazide diuretics, beta blockers, and calcium channel blockers.\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "The effect of a series of flavonoids, including <e1>flavonols</e1>, flavones, isoflavone, flavanone, <e2>flavanonols</e2> and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Anticholinesterases: Concurrent use of <e1>procaine hydrochloride</e1> and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of <e2>procaine hydrochloride</e2>. \n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e2>beta blockers</e2> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, <e2>modafinil</e2>, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, <e2>pancuronium</e2>, morphine, vancomycin, metformin and tenofovir). \n",
      "<e1>Triprolidine</e1> may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, <e2>hypnotics</e2>, narcotic analgesics, sedatives, and tranquillisers. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Coumarin-type anticoagulants: Prothrombin time may be increased in patients receiving concomitant <e1>DIFLUCAN</e1> and <e2>coumarin-type anticoagulants</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Cyclosporine</e1>: When studied in stable renal transplant patients, <e2>cyclosporine</e2>, USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of Myfortic. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e1>indinavir</e1>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower <e2>melatonin</e2> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Neuromuscular blocking agents</e1> (such as suxamethonium chloride): Concurrent use of procaine hydrochloride and <e2>neuromuscular blocking agents</e2> may result in prolongation or enhancement of the neuromuscular blockade. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (<e1>NRTI</e1>) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI) or an <e2>integrase inhibitor</e2> (II) is recommended. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Curariform Drugs</e1>: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of <e2>curariform drugs</e2> (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. \n",
      "Macrolides: Clinical drug interaction studies indicate that erythromycin and <e1>clarithromycin</e1> can exert an effect on <e2>terfenadine</e2> metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent. \n",
      "<e1>Cyclosporine</e1>: Preliminary data from a XENICAL and <e2>cyclosporine</e2> drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with cyclosporine. \n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, <e1>ketamine</e1>, nitrous oxide, <e2>secobarbital</e2> and droperidol. \n",
      "<e1>Corticosteroids</e1> or <e2>ACTH</e2>: May increase the risk of hypokalemia and increase salt and water retention. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e2>estrogens</e2> (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "<e1>Phenytoin</e1>, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of <e2>ondansetron</e2> was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, <e1>nelfinavir</e1>, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e1>Anafranil</e1>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "As there is in vitro evidence that aminosalicylate derivatives (e.g., <e1>olsalazine</e1>, mesalazine, or <e2>sulphasalazine</e2>) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e1>clindamycin</e1>, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Coadministration of <e1>TRITEC</e1> with clarithromycin resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased <e2>14- hydroxy- clarithromycin</e2> plasma concentrations (31%). \n",
      "<e1>Anticholinergic drugs</e1> in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as <e2>corticosteroids</e2>. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (<e1>SSRIs</e1>) (e.g., fluoxetine, fluvoxamine, <e2>paroxetine</e2>, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Fluconazole tablets coadministered with <e1>ethinyl estradiol</e1>- and levonorgestrel-containing oral contraceptives produced an overall mean increase in <e2>ethinyl estradiol</e2> and levonorgestrel levels; \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Having moderate to severe pain (ARRR=1.54, 95% CI=1.08-2.20) and the prescribing of an <e1>anxiolytic</e1> or <e2>hypnotic</e2> (ARRR=1.33, 95% CI=1.02-1.74) increased the risk of potential inappropriate antidepressant use. \n",
      "Coadministration of TRITEC with <e1>clarithromycin</e1> resulted in increased plasma <e2>ranitidine</e2> concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e1>MAO inhibitors</e1>, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e2>Terfenadine</e2>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Concurrent use of <e1>DEMSER</e1> with alcohol or other <e2>CNS depressants</e2> can increase their sedative effects.\n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, <e1>Cholestyramine</e1>, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>amiloride</e1>, <e2>triamterene</e2> and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e1>PHENOTHIAZINES</e1>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e2>BARBITURATES</e2>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e2>Cisapride</e2>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and <e1>SKELID</e1> are administered at the same time, and 60% by some aluminum- or magnesium-containing <e2>antacids</e2>, when administered 1 hour before SKELID. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and <e2>rifampin</e2>. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (<e1>MAOI</e1>) such as isocarboxazid (<e2>Marplan</e2>), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e1>cimetidine</e1>, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, <e1>flavanone</e1>, flavanonols and catechins, on the elimination of luteolin and <e2>apigenin</e2> was studied. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, <e1>Sanctura</e1> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, <e2>metformin</e2> and tenofovir). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, <e1>paracetamol</e1>, and <e2>prednisone</e2>.\n",
      "Mexitil    does not alter serum digoxin levels but <e1>magnesium-aluminum hydroxide</e1>, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum <e2>digoxin</e2> levels. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., <e2>aminoglycosides</e2>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "The oral bioavailability of sparfloxacin is not reduced when the <e1>aluminum</e1>-<e2>magnesium</e2> suspension is administered 4 hours following sparfloxacin administration. \n",
      "<e1>Methyldopa</e1> does not interfere with measurement of VMA (<e2>vanillylmandelic acid</e2>), a test for pheochromocytoma, by those methods which convert VMA to vanillin. \n",
      "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of <e1>oxybutynin</e1> or <e2>desethyloxybutynin</e2>.    \n",
      "Concomitant administration of low-dose <e1>aspirin</e1> with MOBIC may result in an increased rate of GI ulceration or other complications, compared to use of <e2>MOBIC</e2> alone. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Agents that might be coadministered with <e1>trimetrexate</e1> in AIDS patients for other indications that could elicit this activity include <e2>erythromycin</e2>, rifampin, rifabutin, ketoconazole, and fluconazole. \n",
      "<e1>Pindolol</e1> has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and <e2>guanethidine</e2> without unexpected adverse interactions. \n",
      "<e1>Methenamine</e1>: Efficacy may be decreased due to urinary alkalizing effect of <e2>metolazone</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - <e2>neostigmine</e2> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "Due to the chemical similarity of other <e1>azole-type antifungal agents</e1> (including <e2>fluconazole</e2>, metronidazole, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "NSCLC cell lines with EGFR T790M mutation and K-ras mutation were exposed to either <e1>sunitinib</e1> or <e2>docetaxel</e2> or both based on various sequential administrations. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, <e1>furosemide</e1> and <e2>theophylline</e2> Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "When atropine and <e1>pralidoxime</e1> are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when <e2>atropine</e2> is used alone. \n",
      "A greater potentiation of the neuromuscular blocking effects of <e1>MIVACRON</e1> may be expected with higher concentrations of <e2>enflurane</e2> or isoflurane. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e1>melatonin</e1> with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Such occurrences have been reported when <e1>propoxyphene</e1> was administered to patients on antidepressants, <e2>anticonvulsants</e2>, or warfarin-like drugs. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e2>diazepam</e2> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, phenothiazines, <e2>nalidixic acid</e2>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Additive sedative effects can occur when <e1>metoclopramide</e1> is given with alcohol, <e2>sedatives</e2>, hypnotics, narcotics, or tranquilizers. \n",
      "Use of potassium-sparing diuretics (spironolactone, triamterene, amiloride) or <e1>potassium</e1> supplements concomitantly with <e2>ACE inhibitors</e2> can increase the risk of hyperkalemia. \n",
      "and/or <e1>antibiotic drug</e1> <e2>doxycycline</e2> (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP) (4 x 20 mg/kg, i. p.) \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Clinical studies of interactions of <e1>VIRAZOLE</e1> with other drugs commonly used to treat infants with RSV infections, such as digoxin, bronchodilators, other <e2>antiviral agents</e2>, antibiotics, or anti-metabolites have not been conducted. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e1>MAO inhibitors</e1>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "<e1>Calcium</e1> does not inhibit the absorption of 5 milligrams of <e2>nonheme</e2> or heme iron at doses less than 800 milligrams in nonpregnant women.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain <e1>macrolides</e1> interact with terfenadine and <e2>astemizole</e2> leading to increased serum concentrations of the latter. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing <e1>Mexitil</e1>   . If <e2>Mexitil</e2> and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . <e1>Selective serotonin reuptake inhibitors</e1> (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and <e1>ELDEPRYL</e1> and selective serotonin reuptake inhibitors and <e2>ELDEPRYL</e2>. \n",
      "In female rats, neonatal <e1>quinpirole</e1> treatment enhanced amphetamine locomotor sensitization compared with <e2>quinpirole</e2>-free controls sensitized to amphetamine. \n",
      "In clinical studies of <e1>TOBI</e1>, patients taking TOBI concomitantly with <e2>dornase alfa</e2> (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, <e1>ketamine</e1>, <e2>nitrous oxide</e2>, secobarbital and droperidol. \n",
      "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as <e1>tricyclic antidepressants</e1>,    -blockers, selective serotonin reuptake inhibitors (<e2>SSRIs</e2>), and monoamine oxidase inhibitors (MAO-Is) Type B, if they have a narrow therapeutic window. \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, analgesics, <e1>antiemetics</e1>/<e2>antinauseants</e2>, antispasmodics and anticholinergic agents. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., <e1>digoxin</e1>) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, <e2>cyclosporine</e2>). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Cimetidine</e1>: Cimetidine, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in <e2>pramipexole</e2> AUC and a 40% increase in half-life (N= 12). \n",
      "Amantadine: Population pharmacokinetic analysis suggests that <e1>amantadine</e1> is unlikely to alter the oral clearance of <e2>pramipexole</e2> (N= 54). \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (<e1>Marplan</e1>), tranylcypromine (Parnate), or phenelzine (<e2>Nardil</e2>) in the last 14 days. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e1>warfarin</e1>, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "There have been postmarketing reports of increased INR and prothrombin time in patients receiving <e1>proton pump inhibitors</e1>, including <e2>pantoprazole</e2>, and warfarin concomitantly. \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, <e1>carbamazepine</e1>, and rifampicin), the clearance of ondansetron was significantly increased and <e2>ondansetron</e2> blood concentrations were decreased. \n",
      "- did not cause any clinically significant change in plasma profiles of <e1>prednisone</e1> or prednisolone following administration of either oral <e2>prednisone</e2> or intravenous prednisolone.  \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, <e1>ritonavir</e1>, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of <e1>ethinyl estradiol</e1> or <e2>levonorgestrel</e2> metabolism. \n",
      "<e1>Anticoagulants</e1> Anabolic steroids may increase sensitivity to oral <e2>anticoagulants</e2>. \n",
      "<e1>Adrenal steroids</e1> or ACTH In patients with edema, concomitant administration with adrenal cortical steroids or <e2>ACTH</e2> may increase the edema. \n",
      "This study examined drug-drug interactions of oral S-ketamine with the cytochrome P450 (CYP) 2B6 inhibitor <e1>ticlopidine</e1> and the CYP3A inhibitor <e2>itraconazole</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e1>kaolin</e1>-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Concomitant administration of low-dose aspirin with <e1>MOBIC</e1> may result in an increased rate of GI ulceration or other complications, compared to use of <e2>MOBIC</e2> alone. \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Nifedipine</e1> (extended-release tablets): In 17 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not alter the bioavailability of <e2>nifedipine</e2> (extended-release tablets). \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when <e1>calcium</e1> and SKELID are administered at the same time, and 60% by some <e2>aluminum</e2>- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "We elucidated the expression of HB-EGF in T-ALL cell lines, and evaluated the effect of <e1>CRM197</e1> on these cells alone or in combination with <e2>anticancer agent</e2>. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . <e1>Theophylline</e1> plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the <e2>Mexitil</e2>    dose is changed. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, <e1>Choline</e1> and <e2>magnesium salicylate</e2>s, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Isoflurane and <e1>enflurane</e1> (administered with nitrous oxide/<e2>oxygen</e2> to achieve 1.25 M.C. \n",
      "Because <e1>ondansetron</e1> is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes (CYP3A4, CYP2D6, CYP1A2), inducers or inhibitors of these enzymes may change the clearance and, hence, the half-life of <e2>ondansetron</e2>. \n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when <e1>cholinesterase inhibitors</e1> are given concurrently with succinylcholine, similar neuromuscular blocking agents or <e2>cholinergic agonists</e2> such as bethanechol.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, <e2>caffeine</e2>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, <e1>sympathomimetic drugs</e1>, tricyclic antidepressant drugs (e.g., amitriptyline HCl, <e2>imipramine HCl</e2>) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Patients receiving sirolimus or <e1>nifedipine</e1> in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and <e2>sirolimus</e2> or nifedipine dosage should be reduced if necessary. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "- did not cause any clinically significant change in plasma profiles of <e1>prednisone</e1> or prednisolone following administration of either oral prednisone or intravenous <e2>prednisolone</e2>.  \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, <e2>linezolid</e2>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e1>Cisapride</e1>, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "<e1>Sulfamethizole</e1> may increase the effects of <e2>barbiturates</e2>, tolbutamide, and uricosurics. \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e2>carbamazepine</e2> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e1>phenytoin</e1> (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e1>metoprolol</e1>, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., <e2>Elavil</e2>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>Mephenytoin</e1> may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and <e2>theophylline</e2> Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, <e1>triiodothyronine</e1>, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "Finally, co-administration of <e1>eugenol</e1> in <e2>colchicine</e2> nanoemulsion to enhance the colchicine bioavailability was investigated by an oral administration method. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of <e1>norethindrone</e1> and ethinyl estradiol following administration of a single dose containing 1.0 mg of <e2>norethindrone acetate</e2> and 75    g of ethinyl estradiol were studied. \n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, <e2>carbamazepine</e2>, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and <e1>magnesium salicylate</e1>s, <e2>Colestipol</e2>, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, sulfonamides, phenothiazines, <e1>sulfonylurea</e1> hypoglycemia agents, thiazide diuretics, and <e2>griseofulvin</e2>) could increase the photosensitivity reaction. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e1>Pamelor</e1>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "The effect of a series of flavonoids, including flavonols, <e1>flavones</e1>, isoflavone, flavanone, flavanonols and catechins, on the elimination of <e2>luteolin</e2> and apigenin was studied. \n",
      "Penicillin blood levels may be prolonged by concurrent administration of <e1>probenecid</e1> which blocks the renal tubular secretion of <e2>penicillins</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e1>phenobarbital</e1>, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "In addition to bleeding associated with <e1>heparin</e1> and <e2>vitamin K antagonists</e2>, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "Administration of paclitaxel in combination with <e1>HERCEPTIN</e1> resulted in a two-fold decrease in <e2>HERCEPTIN</e2> clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e1>ritonavir</e1>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, <e2>atazanavir</e2>, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Oral <e1>Anticoagulants</e1>: Interaction studies with warfarin failed to identify any clinically important effect on the serum concentrations of the <e2>anticoagulant</e2> or on its anticoagulant effect. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain <e1>monoamine oxidase inhibitors</e1>) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing <e2>neuromuscular blocking agents</e2> has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "The effects of <e1>anticholinergic drugs</e1>, such as atropine and <e2>tricyclic antidepressants</e2> may be enhanced by the concomitant administration of triprolidine. \n",
      "and combinations of <e1>opioids</e1> and sedatives (eg, benzodiazepines, barbiturates, chloral hydrate, <e2>droperidol</e2>, etc.). \n",
      "<e1>Ethanol</e1> decreases the elimination of <e2>abacavir</e2> causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e1>desglymidodrine</e1> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "An inhibitor of CYP2C8 (such as <e1>gemfibrozil</e1>) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of <e2>rosiglitazone</e2>. \n",
      "Interactions for <e1>Dronabinol</e1>:  In studies involving patients with AIDS and/or cancer, MARINOL (<e2>Dronabinol</e2>) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, sedatives, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (Dilantin) <e2>carbamazepine</e2> (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with <e1>live organism vaccines</e1> are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous <e2>melphalan</e2> has caused deaths in children due to haemorrhagic enterocolitis.  \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e2>medroxyprogesterone acetate</e2>, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and <e1>tramadol</e1> has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by <e2>ondansetron</e2>. \n",
      "Concomitant administration of TRENTAL and <e1>theophylline</e1>-containing drugs leads to increased theophylline levels and <e2>theophylline</e2> toxicity in some individuals. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), <e1>phenylbutazone</e1>, and tricyclic drugs (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e1>ANESTHETICS</e1>, <e2>PHENOTHIAZINES</e2>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "In vitro, <e1>raloxifene</e1> did not affect the binding of warfarin, <e2>phenytoin</e2>, or tamoxifen. \n",
      "In vitro, raloxifene did not affect the binding of <e1>warfarin</e1>, <e2>phenytoin</e2>, or tamoxifen. \n",
      "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as <e1>tricyclic antidepressants</e1>,    -blockers, selective serotonin reuptake inhibitors (SSRIs), and <e2>monoamine oxidase inhibitors (MAO-Is) Type B</e2>, if they have a narrow therapeutic window. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e1>methotrexate</e1>, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and <e1>levonorgestrel</e1>, there is no evidence that fluconazole is a net inducer of <e2>ethinyl estradiol</e2> or levonorgestrel metabolism. \n",
      "These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, <e1>benzodiazepines</e1>, and <e2>decongestants</e2>. \n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, <e1>protease inhibitors</e1>, calcium channel antagonists, and <e2>macrolide antibiotics</e2>). \n",
      "In humans, <e1>carmustine</e1>, <e2>etoposide</e2>, and cisplatin do not affect the pharmacokinetics of ondansetron.  \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (phenobarbital, <e2>diphenylhydantoin</e2>, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "If a <e1>diuretic</e1> is also used, the risk of <e2>lithium</e2> toxicity may be increased. \n",
      "Oral contraceptives containing <e1>estrogen</e1>: <e2>tetracyclines</e2> may decrease the contraceptive effect and increase the chance of unwanted pregnancy.\n",
      "Furafylline and sulfaphenazole had no effect, while <e1>quinidine</e1> appeared to augment <e2>precocene I</e2> toxicity. \n",
      "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, <e1>magnesium hydroxide</e1>, and simethicone) did not significantly affect the exposure of <e2>oxybutynin</e2> or desethyloxybutynin.    \n",
      "Such occurrences have been reported when propoxyphene was administered to patients on <e1>antidepressants</e1>, anticonvulsants, or <e2>warfarin</e2>-like drugs. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), <e2>salicylate analgesics</e2> (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, <e1>prednisolone</e1>, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), <e2>terfenadine</e2>, digoxin, and warfarin. \n",
      "Digoxin: <e1>Meloxicam</e1> 15 mg once daily for 7 days did not alter the plasma concentration profile of <e2>digoxin</e2> after b-acetyldigoxin administration for 7 days at clinical doses. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma <e1>digoxin</e1> concentrations when coadministered with <e2>ACEON</e2>    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e1>midazolam</e1>, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Concomitant use of <e1>omeprazole</e1> and clopidogrel was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity, as a result of inhibition by <e2>omeprazole</e2> of CYP2C19, a cytochrome P450 (CYP) enzyme. \n",
      "Less potent inhibitors include <e1>saquinavir</e1>, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, <e2>zileuton</e2>, and clotrimazole. \n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, <e2>rifampin</e2>, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and <e2>quinine</e2>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), <e2>antihypertensives</e2> (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, <e1>sirolimus</e1>, nifedipine, <e2>fluconazole</e2>, ritonavir, and rifampin. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - <e2>edrophonium</e2> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, <e1>meperidine</e1> and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and <e2>droperidol</e2>. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., <e1>tetracyclines</e1>, sulfonamides, phenothiazines, sulfonylurea hypoglycemia agents, <e2>thiazide diuretics</e2>, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, <e2>indinavir</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Less potent inhibitors include saquinavir, <e1>nefazodone</e1>, fluconazole, grapefruit juice, fluoxetine, <e2>fluvoxamine</e2>, zileuton, and clotrimazole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of <e1>morphine</e1> are potentiated by the presence of other CNS depressants such as alcohol, sedatives, <e2>antihistaminics</e2>, or psychotropic drugs. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e1>methotrexate</e1>, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), <e1>phenylbutazone</e1>, and tricyclic drugs (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "MAO Inhibitors: The pressor effect of <e1>sympathomimetic pressor amines</e1> is markedly potentiated in patients receiving <e2>monoamine oxidase inhibitors</e2> (MAOI). \n",
      "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of <e1>citalopram</e1> (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), <e2>amitriptyline</e2> (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "<e1>Amantadine</e1>: Population pharmacokinetic analysis suggests that amantadine is unlikely to alter the oral clearance of <e2>pramipexole</e2> (N= 54). \n",
      "In a study conducted in healthy subjects, mean pre-dose <e1>lithium</e1> concentration and AUC were increased by 21% in subjects receiving <e2>lithium</e2> doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving lithium alone. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when <e1>FELDENE</e1> is administered in conjunction with <e2>aspirin</e2> (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Because <e1>antacids</e1> may interfere with the absorption of <e2>anticholinergic agents</e2>, simultaneous use of these drugs should be avoided. \n",
      "Phenytoin, Carbamazepine, and <e1>Rifampicin</e1>: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, <e2>carbamazepine</e2>, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, <e2>polymyxins</e2>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Concurrent ingestion of antacid (20 mL of <e1>antacid</e1> containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of <e2>oxybutynin</e2> or desethyloxybutynin.    \n",
      "<e1>Anticoagulants</e1> (such as heparin and <e2>vitamin K antagonists</e2>) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e1>absorbent-type anti-diarrhea medicines</e1> (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "In these 2 single-dose studies, these healthy volunteers administered a single oral dose of 105-mg fenofibric acid met the US Food and Drug Administration regulatory criteria for assuming bioequivalence to a single oral dose of 145-mg <e1>fenofibrate</e1> tablets with respect to the rate and extent of <e2>fenofibric acid</e2> absorption in both fed and fasted states. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, <e1>phenothiazines</e1>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e2>sulfonamides</e2>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Limited published data indicate that <e1>GH</e1> treatment increases cytochrome P450 (CP450) mediated <e2>antipyrine</e2> clearance in man. \n",
      "In the present study, we tested whether the highly specific metabotropic glutamate receptor 5 antagonist, <e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1>, reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>. \n",
      "<e1>Rifampin</e1>: Rifampin enhances the metabolism of concurrently administered <e2>DIFLUCAN</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e1>sodium colistimethate</e1>), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, <e1>modafinil</e1>, penicillins, <e2>rifampin</e2>, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Macrolides: Clinical drug interaction studies indicate that <e1>erythromycin</e1> and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of <e2>ketoconazole</e2>, but to a lesser extent. \n",
      "Furthermore, we present a case report in which a second <e1>Herceptin</e1> treatment following <e2>lapatinib</e2> resulted in the marked shrinkage of multiple metastatic tumors in HER2-positive breast cancer. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI) or an <e1>integrase inhibitor</e1> (<e2>II</e2>) is recommended. \n",
      "We have demonstrated appropriateness of inhospital administration of fixed <e1>amlodipine</e1>/valsartan combination as an approach allowing to achieve target BP in shorter time, with the use of fewer <e2>antihypertensive drugs</e2>, and diminishing concealed inefficacy of treatment.\n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Concurrent use of antibacterial drugs with oral <e1>contraceptives</e1> may render oral <e2>contraceptives</e2> less effective.  \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving <e1>MAO-A inhibitors</e1> is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, <e2>fluvoxamine</e2>, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Mixing <e1>SYMLIN</e1> and Insulin The pharmacokinetic parameters of SYMLIN were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant <e2>human insulin</e2> immediately prior to injection. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Concomitant administrations not recommended:  - <e1>Terfenadine</e1> and astemizole: Certain <e2>macrolides</e2> interact with terfenadine and astemizole leading to increased serum concentrations of the latter. \n",
      "Moxifloxacin and Lomefloxacin reacts faster with sucralfate and <e1>gelusil</e1> in acidic media whereas with <e2>erythromycin</e2> in basic media and multi-minerals in neutral media. \n",
      "<e1>Lithium</e1>: In clinical trials, NSAIDs have produced an elevation of plasma <e2>lithium</e2> levels and a reduction in renal lithium clearance. \n",
      "Additive sedative effects can occur when metoclopramide is given with <e1>alcohol</e1>, sedatives, hypnotics, <e2>narcotics</e2>, or tranquilizers. \n",
      "Cyclosporine: The total <e1>ezetimibe</e1> level increased 12-fold in one renal transplant patient receiving multiple medications, including <e2>cyclosporine</e2>. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, <e1>pseudoephedrine</e1>, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when <e2>ProAmatine</e2>    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Finally, co-administration of <e1>eugenol</e1> in colchicine nanoemulsion to enhance the <e2>colchicine</e2> bioavailability was investigated by an oral administration method. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) <e1>carbamazepine</e1> (Tegretol) Estrogens may decrease the effects of <e2>benzodiazepines</e2> (lorezepam oxezepam temezepam). \n",
      "In Trial 1, the proportions of patients in the placebo and <e1>Synagis</e1>    groups who received routine childhood vaccines, <e2>influenza vaccine</e2>, bronchodilators or corticosteroids were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e1>indinavir</e1>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "The concurrent administration of potent inhalational agents (eg, isoflurane, <e1>enflurane</e1>, and halothane) during maintenance with <e2>DIPRIVAN</e2> Injectable Emulsion has not been extensively evaluated. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, <e2>conjugated estrogens</e2>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general <e1>anesthetics</e1>, <e2>phenothiazines</e2>, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "<e1>Azathioprine</e1>/Mycophenolate Mofetil: Given that <e2>azathioprine</e2> and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, <e2>phenytoin</e2>, and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "The bioavailability of <e1>SKELID</e1> is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing <e2>antacids</e2>, when administered 1 hour before SKELID. \n",
      "ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO <e1>DISALCID</e1> AND MAY INCREASE PLASMA CONCENTRATIONS OF <e2>SALICYLIC ACID</e2> TO TOXIC LEVELS. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, taxol, <e1>rifampicin</e1>, and <e2>human immunodeficiency virus protease inhibitors</e2> such as ritonavir and saquinavir. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e1>meperidine</e1>), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "In clinical studies of <e1>TOBI</e1>, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral <e2>aminoglycosides</e2> demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Use of a <e1>diuretic</e1> may further increase the risk of <e2>lithium</e2> toxicity. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "In a study of 11 HIV-infected patients receiving methadone-maintenance therapy (40 mg and 90 mg daily) with 600 mg of <e1>ZIAGEN</e1> twice daily (twice the currently recommended dose), oral <e2>methadone</e2> clearance increased 22% (90% CI 6% to 42%). \n",
      "A controlled study found that concomitant fluconazole 200 mg once daily and <e1>cisapride</e1> 20 mg four times a day yielded a significant increase in <e2>cisapride</e2> plasma levels and prolongation of QTc interval.\n",
      "Adrenal steroids or <e1>ACTH</e1> In patients with edema, concomitant administration with <e2>adrenal cortical steroids</e2> or ACTH may increase the edema. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and <e2>doxazosin</e2>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Although this has not occurred in in vitro studies with <e1>coumarin-type anticoagulants</e1>, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering <e2>FELDENE</e2> to patients on coumarin-type anticoagulants and other highly protein-bound drugs. \n",
      "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., <e1>corticosteroids</e1>, sex steroids, <e2>anticonvulsants</e2>, cyclosporin). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e2>sulfonamides</e2>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "The effects of extracts of <e1>ginseng</e1> and <e2>ginko</e2> (EGGB) on cellular proliferative activity, apoptotic rate, ultrastructure and caspase-3 expression were detected. \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of <e1>digoxin</e1>, warfarin, diazepam, or <e2>fluoxetine</e2>. \n",
      "Mequitazine can interact with CNS depressant, <e1>antichlolinergic</e1>, TCA, <e2>MAOIs</e2>, and alcohol.\n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e1>nelfinavir</e1>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "This study was aimed to investigate the efficacy of single use of <e1>sunitinib</e1> and that of concurrent or sequential administration of sunitinib and <e2>docetaxel</e2> in NSCLC cell lines that are resistant to EGFR TKIs.\n",
      "Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral ketamine by 2.4-fold, whereas <e1>itraconazole</e1> treatment did not increase the exposure to <e2>S-ketamine</e2>. \n",
      "Anticoagulants (such as <e1>heparin</e1> and <e2>vitamin K antagonists</e2>) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "A controlled study found that concomitant <e1>fluconazole</e1> 200 mg once daily and cisapride 20 mg four times a day yielded a significant increase in <e2>cisapride</e2> plasma levels and prolongation of QTc interval.\n",
      "Use with Other <e1>Central Nervous System Depressants</e1>: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or <e2>psychotropic drugs</e2>. \n",
      "Administration of <e1>valproic acid</e1> decreases oral clearance of <e2>temozolomide</e2> by about 5%. \n",
      "<e1>heparin</e1>, warfarin, <e2>diazepam</e2>, insulin; \n",
      "<e1>Mexitil</e1>    does not alter serum <e2>digoxin</e2> levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels. \n",
      "Pharmacokinetic properties of abacavir were not altered by the addition of either lamivudine or <e1>zidovudine</e1> or the combination of <e2>lamivudine</e2> and zidovudine. \n",
      "Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of <e1>ZOLINZA</e1> and other HDAC inhibitors (e.g., <e2>valproic acid</e2>). \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e2>clarithromycin</e2>, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg <e1>S-ketamine</e1> after pretreatments with oral <e2>ticlopidine</e2> (250 mg twice daily), itraconazole (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks. \n",
      "The effect of a series of flavonoids, including <e1>flavonols</e1>, flavones, isoflavone, flavanone, flavanonols and catechins, on the elimination of luteolin and <e2>apigenin</e2> was studied. \n",
      "Standard antibiotic such as <e1>Gentamicin</e1> (10 microg), Cephalothin (30 microg), Ceftriaxone (10 microg), <e2>Nystatin</e2> (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "However, interactions may be expected and <e1>FLOMAX</e1> capsules should NOT be used in combination with other <e2>alpha-adrenergic blocking agents</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - neostigmine - <e2>polymyxin B</e2> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by <e1>metoclopramide</e1>, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, <e2>cyclosporine</e2>). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e1>hypoglycemics</e1>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e1>indinavir</e1>, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, <e1>sympathomimetic drugs</e1>, <e2>tricyclic antidepressant</e2> drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Interactions for Vitamin B1 (Thiamine):  <e1>Loop Diuretics</e1>, Oral Contraceptives, <e2>Stavudine</e2>, Tricyclic Antidepressants\n",
      "morphine, theophylline, <e1>aminophylline</e1>, succinylcholine, reserpine, and <e2>phenothiazine-type tranquilizers</e2> should be avoided in patients with organophosphate poisoning.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, <e1>naproxen</e1>, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "Anticoagulants (such as <e1>heparin</e1> and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after <e2>TNKase</e2> therapy. \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of <e1>alcohol</e1> (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, <e2>orlistat</e2> pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "Concomitant administration of terfenadine with <e1>clarithromycin</e1>, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other <e2>macrolide antibiotics</e2>, including azithromycin, is not recommended. \n",
      "Pyrimethamine may be used with sulfonamides, <e1>quinine</e1> and other antimalarials, and with other <e2>antibiotics</e2>. \n",
      "<e1>TERAZOL</e1> 7 Vaginal Cream 0.4% and TERAZOL 3 Vaginal Suppositories 80 mg The therapeutic effect of these products is not affected by oral <e2>contraceptive</e2> usage. \n",
      "Such occurrences have been reported when propoxyphene was administered to patients on <e1>antidepressants</e1>, <e2>anticonvulsants</e2>, or warfarin-like drugs. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as <e1>isocarboxazid</e1> (Marplan), tranylcypromine (<e2>Parnate</e2>), or phenelzine (Nardil) in the last 14 days. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Therefore, do not administer Myfortic with <e1>cholestyramine</e1> or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral <e2>activated charcoal</e2>, because of the potential to reduce the efficacy of Myfortic. \n",
      "After 21 weeks of <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1> treatment, all <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected. \n",
      "Cholestyramine: <e1>Cholestyramine</e1> causes a 60% reduction in the absorption and enterohepatic cycling of <e2>raloxifene</e2> and should not be coadministered with EVISTA. \n",
      "Drugs such as erythromycin, diltiazem, verapamil, <e1>ketoconazole</e1>, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered <e2>midazolam</e2>. \n",
      "If concomitant treatment with <e1>sumatriptan</e1> and an <e2>SSRI</e2> is clinically warranted, appropriate observation of the patient is advised.\n",
      "Drugs such as <e1>erythromycin</e1>, diltiazem, verapamil, ketoconazole, fluconazole and <e2>itraconazole</e2> were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, <e1>calcium channel antagonists</e1>, and <e2>macrolide antibiotics</e2>). \n",
      "Therefore, do not administer <e1>Myfortic</e1> with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral activated charcoal, because of the potential to reduce the efficacy of <e2>Myfortic</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e1>PHENOTHIAZINES</e1>, OTHER TRANQUILIZERS, <e2>SEDATIVE-HYPNOTICS</e2> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "<e1>Misoprostol</e1> has not been shown to interfere with the beneficial effects of <e2>aspirin</e2> on signs and symptoms of rheumatoid arthritis. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Therefore, as <e1>vitamin K</e1> absorption may be decreased with XENICAL, patients on chronic stable doses of <e2>warfarin</e2> who are prescribed XENICAL should be monitored closely for changes in coagulation parameters.\n",
      "We found antagonism between celecoxib and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between <e1>celecoxib</e1> and <e2>doxorubicin</e2> in all cell lines except for two combinations in HCT116 cells. \n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as digoxin, bronchodilators, other <e1>antiviral agents</e1>, <e2>antibiotics</e2>, or anti-metabolites have not been conducted. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e1>lithium</e1>, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Having moderate to severe pain (ARRR=1.54, 95% CI=1.08-2.20) and the prescribing of an anxiolytic or <e1>hypnotic</e1> (ARRR=1.33, 95% CI=1.02-1.74) increased the risk of potential inappropriate <e2>antidepressant</e2> use. \n",
      "In vitro studies with human liver microsomes showed that <e1>terbinafine</e1> does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and <e2>cyclosporine</e2>. \n",
      "Since Celontin (methsuximide) may interact with concurrently administered <e1>antiepileptic drugs</e1>, periodic serum level determinations of these drugs may be necessary (eg <e2>methsuximide</e2> may increase the plasma concentrations of phenytoin and phenobarbital).\n",
      "<e1>Cimetidine</e1>: The effects of chronic <e2>cimetidine</e2> use on the metabolism of rimantadine are not known. \n",
      "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain <e1>ergot alkaloid drugs</e1> (e.g. <e2>dihydroergotamine</e2> and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e1>warfarin</e1>, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, <e1>dipyridamole</e1>, and <e2>abciximab</e2>) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "<e1>Moxifloxacin</e1> and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with <e2>erythromycin</e2> in basic media and multi-minerals in neutral media. \n",
      "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of <e1>tolbutamide</e1>, ethinylestradiol, ethoxycoumarin, and <e2>cyclosporine</e2>. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (<e1>Dilantin</e1>) <e2>carbamazepine</e2> (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Treatment of HEY xenograft-bearing mice with dasatinib plus <e1>paclitaxel</e1> inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs <e2>paclitaxel</e2>: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e1>Tofranil</e1>, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "Impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose intravenous <e1>melphalan</e1> and who subsequently received <e2>cyclosporin</e2> to prevent graft-versus-host disease\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Furosemide</e1>: single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of <e2>meloxicam</e2>. \n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as <e1>digoxin</e1>, <e2>bronchodilators</e2>, other antiviral agents, antibiotics, or anti-metabolites have not been conducted. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e1>imipramine</e1> (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, <e1>Sanctura</e1> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, <e2>procainamide</e2>, pancuronium, morphine, vancomycin, metformin and tenofovir). \n",
      "<e1>SKELAXIN</e1> may enhance the effects of alcohol, barbiturates and other <e2>CNS depressants</e2>.\n",
      "<e1>Pantoprazole</e1> has a much weaker effect on <e2>clopidogrel</e2>'s pharmacokinetics and on platelet reactivity during concomitant use. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Therefore, physicians should closely monitor patients for a change in anticoagulant dosage requirements when administering <e1>Mitotane</e1> to patients on <e2>coumarin-type anticoagulants</e2>. \n",
      "<e1>Carbidopa</e1>/Levodopa: Carbidopa/<e2>Levodopa</e2> does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). \n",
      "Phenytoin: In 12 normal-weight subjects receiving <e1>XENICAL</e1> 120 mg three times a day for 7 days, XENICAL did not alter the pharmacokinetics of a single 300-mg dose of <e2>phenytoin</e2>. \n",
      "The predicted % liver blood flow was 82.3% and 85.4% for <e1>luteolin</e1> and <e2>apigenin</e2>, respectively. \n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), <e2>terfenadine</e2>, digoxin, and warfarin. \n",
      "chlorthalidone, <e1>furosemide</e1>, <e2>hydrochlorothiazide</e2>, spironolactone; \n",
      "Dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a <e2>dopamine agonist</e2>); \n",
      "Treatment of HEY xenograft-bearing mice with <e1>dasatinib</e1> plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + <e2>paclitaxel</e2> vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Drugs which may potentiate the myeloproliferative effects of <e1>Leukine</e1>, such as lithium and <e2>corticosteroids</e2>, should be used with caution.\n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . <e1>Selective serotonin reuptake inhibitors</e1> (SSRIs) (e.g., fluoxetine, fluvoxamine, <e2>paroxetine</e2>, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Compared with the elimination of pure luteolin and apigenin, the elimination of luteolin and <e1>apigenin</e1> was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of <e2>luteolin</e2> and apigenin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e2>atazanavir</e2>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "CYP 3A4 Inhibitors (e.g. <e1>Macrolide Antibiotics</e1> and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. <e2>dihydroergotamine</e2> and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e1>pectin</e1>), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (<e1>Marplan</e1>), tranylcypromine (<e2>Parnate</e2>), or phenelzine (Nardil) in the last 14 days. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and <e2>ketoconazole</e2> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Rats treated with neonatal quinpirole enhanced time spent in the <e1>amphetamine</e1>-paired context compared with quinpirole-free controls conditioned with amphetamine, but only female controls conditioned with <e2>amphetamine</e2> spent more time in the drug-paired context compared with saline-treated controls. \n",
      "TERAZOL 7 Vaginal Cream 0.4% and <e1>TERAZOL</e1> 3 Vaginal Suppositories 80 mg The therapeutic effect of these products is not affected by oral <e2>contraceptive</e2> usage. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of <e2>benzodiazepines</e2> (lorezepam oxezepam temezepam). \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and <e2>rifampin</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e1>benzodiazepines</e1>, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, analgesics, antiemetics/antinauseants, <e1>antispasmodics</e1> and <e2>anticholinergic agents</e2>. \n",
      "<e1>Mitotane</e1> has been reported to accelerate the metabolism of <e2>warfarin</e2> by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Other eye drops or medications such as acetylcholine chloride (<e1>Miochol</e1>) and <e2>carbachol</e2> (Carboptic, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.\n",
      "Coumarin-Derivative Anticoagulants: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving <e1>ZOLINZA</e1> concomitantly with <e2>coumarin-derivative anticoagulants</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, indinavir, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, <e2>diazepam</e2> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Co-administration of oral ketoconazole 200 mg twice daily increased <e1>retapamulin</e1> geometric mean AUC(0-24) and Cmax by 81% after topical application of <e2>retapamulin</e2> ointment, 1% on the abraded skin of healthy adult males. \n",
      "Fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in <e1>ethinyl estradiol</e1> and <e2>levonorgestrel</e2> levels; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e2>doxazosin</e2>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Therefore, caution should be exercised when administering <e1>TOLECTIN</e1> to patients on <e2>anticoagulants</e2>. \n",
      "The effect of a series of flavonoids, including flavonols, <e1>flavones</e1>, <e2>isoflavone</e2>, flavanone, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Aspirin: Concomitant administration of <e1>aspirin</e1> (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of <e2>meloxicam</e2>. \n",
      "Drug interactions should be kept in mind when METROGEL (<e1>metronidazole</e1> gel), 1% is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical <e2>metronidazole</e2> administration because of low absorption.    \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or <e1>magnesium</e1>-containing <e2>antacids</e2>, when administered 1 hour before SKELID. \n",
      "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or <e1>ergot-type medications</e1> (like dihydroergotamine or <e2>methysergide</e2>) and sumatriptan within 24 hours of each other should be avoided. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - <e1>Live virus vaccines</e1>: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - <e2>Mitomycin-C</e2>: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "<e1>Curariform Drugs</e1>: <e2>Diuretic</e2>-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. \n",
      "<e1>Thalidomide</e1> has been reported to enhance the sedative activity of <e2>barbiturates</e2>, alcohol, chlorpromazine, and reserpine. \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, <e2>hypnotics</e2>, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with <e1>azathioprine</e1> or <e2>mycophenolate mofetil</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e1>Pertofrane</e1>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "We sought to determine (1) the frequency of <e1>colchicine</e1> toxicity among hospitalized patients taking <e2>colchicine</e2> who died during an admission, (2) the likelihood that colchicine contributed to death, (3) whether patients were taking interacting medications that could have contributed to toxicity, and (4) whether colchicine dosing among these patients adhered to established guidelines. \n",
      "A new orally administered agent, <e1>fenofibric acid</e1>, was developed as an alternative to <e2>fenofibrate</e2>.\n",
      "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as <e1>phenobarbital</e1> or rifampin, are co-administered with <e2>montelukast</e2>.\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e2>SEDATIVE-HYPNOTICS</e2> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "While the effects of chronic phenytoin or <e1>carbamazepine</e1> therapy on the action of <e2>MIVACRON</e2> are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher. \n",
      "- <e1>Cisapride</e1>, pimozide: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some <e2>macrolide antibacterials</e2>. \n",
      "and combinations of opioids and <e1>sedatives</e1> (eg, benzodiazepines, <e2>barbiturates</e2>, chloral hydrate, droperidol, etc.). \n",
      "<e1>Potassium</e1> Supplements and Potassium-Sparing Diuretics: <e2>UNIVASC</e2>    can increase serum potassium because it decreases aldosterone secretion. \n",
      "<e1>Fluconazole</e1> tablets coadministered with <e2>ethinyl estradiol</e2>- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels; \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine or <e1>dihydroergotamine</e1>) may enhance or potentiate the pressor effects of <e2>ProAmatine</e2>   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (<e1>Tegretol</e1>) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "Additive sedative effects can occur when metoclopramide is given with alcohol, <e1>sedatives</e1>, hypnotics, narcotics, or <e2>tranquilizers</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e1>narcotic analgesics</e1> (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and <e1>miconazole</e1>) to ketoconazole, and itraconazole, concomitant use of these products with <e2>terfenadine</e2> is not recommended pending full examination of potential interactions. \n",
      "<e1>Phenytoin</e1>: <e2>DIFLUCAN</e2> increases the plasma concentrations of phenytoin. \n",
      "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as <e1>rifampin</e1>, carbamazepine, and phenytoin, induce metabolism and caused a markedly decreased C max and AUC of oral <e2>midazolam</e2> in adult studies. \n",
      "Coadministration with a high dose of <e1>antacid</e1> (170 mEq) results in a 28% decrease in plasma concentrations of <e2>ranitidine</e2> and may decrease plasma concentrations of bismuth from TRITEC. \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Drugs such as erythromycin, diltiazem, verapamil, <e1>ketoconazole</e1>, <e2>fluconazole</e2> and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, <e2>anticonvulsants</e2> (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, <e1>procainamide</e1>, pancuronium, morphine, <e2>vancomycin</e2>, metformin and tenofovir). \n",
      "<e1>Sulfoxone</e1> may increase the effects of barbiturates, tolbutamide, and <e2>uricosurics</e2>. \n",
      "Hypokalemia may develop during concomitant use of <e1>steroids</e1> or <e2>ACTH</e2>. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly <e1>narcotics</e1> (eg, morphine, meperidine and fentanyl), propofol, ketamine, <e2>nitrous oxide</e2>, secobarbital and droperidol. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, <e2>indinavir</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "When <e1>atropine</e1> and <e2>pralidoxime</e2> are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when atropine is used alone. \n",
      "Cimetidine: The effects of chronic <e1>cimetidine</e1> use on the metabolism of <e2>rimantadine</e2> are not known. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>Vasopressors</e1>, particularly metaraminol, may cause serious cardiac arrhythmias during <e2>halothane</e2> anesthesia and therefore should be used only with great caution or not at all. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (<e1>fluoxetine</e1> 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (<e2>curcumin</e2> 100 mg/kg plus imipramine 15 mg/kg). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with <e1>coumarin-type anticoagulants</e1> have been reported with <e2>FELDENE</e2> since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e1>metformin</e1>, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "When <e1>phenytoin</e1> or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered <e2>Mexitil</e2>    plasma levels have been reported. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Alcohol</e1>: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of <e2>alcohol</e2> pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e2>fluvoxamine</e2> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Cimetidine: <e1>Cimetidine</e1>, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in <e2>pramipexole</e2> AUC and a 40% increase in half-life (N= 12). \n",
      "However, the co   administration of SPIRIVA with other <e1>anticholinergic</e1>   containing drugs (e.g., <e2>ipratropium</e2>) has not been studied and is therefore not recommended.\n",
      "Anticoagulants (such as heparin and <e1>vitamin K antagonists</e1>) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after <e2>TNKase</e2> therapy. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (<e1>PULMOZYME</e1>   , Genentech), (beta)-agonists, inhaled corticosteroids, other <e2>anti-pseudomonal antibiotics</e2>, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e1>desglymidodrine</e1> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, <e2>Coumarin-type anticoagulants</e2>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e1>naproxen</e1>, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "<e1>MAO Inhibitors</e1>: The pressor effect of <e2>sympathomimetic pressor amines</e2> is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI). \n",
      "Interactions for Vitamin B2 (<e1>Riboflavin</e1>):  Alcohol - impairs the intestinal absorption of <e2>riboflavin</e2>\n",
      "<e1>SKELAXIN</e1> may enhance the effects of alcohol, <e2>barbiturates</e2> and other CNS depressants.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Additive sedative effects and confusional states may emerge if <e1>levomepromazine</e1> is given with <e2>benzodiazepines</e2> or barbiturates. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/<e1>ethinyl estradiol</e1> 35 mcg), terfenadine, digoxin, and <e2>warfarin</e2>. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (<e1>curcumin</e1> 50 mg/kg), group 3 (<e2>curcumin</e2> 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving <e1>cyclosporine</e1> than in those receiving tacrolimus, indicating that, at the doses generally used in clinical practice, <e2>cyclosporine</e2> is the stronger of the two with respect to CYP3A inhibition. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e1>triamterene</e1>, <e2>flecainide</e2>, and quinidine. \n",
      "Thalidomide has been reported to enhance the sedative activity of barbiturates, <e1>alcohol</e1>, <e2>chlorpromazine</e2>, and reserpine. \n",
      "Use with <e1>Anticholinergics</e1>: Because of their mechanism of action, <e2>cholinesterase inhibitors</e2> have the potential to interfere with the activity of anticholinergic medications. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The neuromuscular blocking effect of <e1>MIVACRON</e1> may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain <e2>monoamine oxidase inhibitors</e2>) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, <e1>rifabutin</e1>, <e2>rifapentin</e2>, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e1>Rifabutin</e1>, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e1>itraconazole</e1>, miconazole) or macrolide antibiotics (eg, <e2>erythromycin</e2>, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., <e1>fluoxetine</e1>, fluvoxamine, paroxetine, <e2>sertraline</e2>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "The bioavailability of SKELID is increased 2-4 fold by <e1>indomethacin</e1> but is not significantly altered by coadministration of <e2>diclofenac</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (<e2>Elavil</e2>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (<e1>curcumin</e1> 100 mg/kg), group 4 (<e2>fluoxetine</e2> 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Phenytoin, <e1>Carbamazepine</e1>, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., <e2>phenytoin</e2>, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, <e1>glucocorticoids</e1>, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or <e2>carbamazepine</e2>. \n",
      "These medications included thyroid hormones, sedative hypnotics, <e1>non-steroidal anti-inflammatory agents</e1>, <e2>benzodiazepines</e2>, and decongestants. \n",
      "Concurrent use of tetracyclines with oral <e1>contraceptives</e1> may render oral <e2>contraceptives</e2> less effective.\n",
      "Caffeine and/or stimulantes of the <e1>ephedrine</e1>/<e2>amphetamine</e2> type may counteract the specific actions of levomepromazine. \n",
      "Caffeine and/or stimulantes of the <e1>ephedrine</e1>/amphetamine type may counteract the specific actions of <e2>levomepromazine</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "morphine, <e1>theophylline</e1>, aminophylline, succinylcholine, <e2>reserpine</e2>, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "There were no significant differences between the pharmacokinetics parameters of <e1>amiodarone</e1> administered intravenously or intragastrically and the control (without <e2>neferine</e2>) group (with ratios of 0.7-1.4 in all experimental groups), suggesting that neferine had no effect on amiodarone plasma pharmacokinetics. \n",
      "Absorption of <e1>tetracyclines</e1> is impaired by antacids containing aluminum, calcium or magnesium, and <e2>iron</e2>-containing preparations. \n",
      "ECG intervals (PR, QRS, and QT) were not affected by concurrent Mexitil    and <e1>digoxin</e1>, diuretics, or <e2>propranolol</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Fenofibrate: In a pharmacokinetic study, concomitant <e1>fenofibrate</e1> administration increased total <e2>ezetimibe</e2> concentrations approximately 1.5-fold. \n",
      "In the hot plate test in mice, co-administration of 15     g/kg dexmedetomidine with 10   mg/kg <e1>ephedrine</e1> intraperitoneally not only enhanced, but also prolonged the duration of antinociception induced by <e2>dexmedetomidine</e2>. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled <e1>corticosteroids</e1>, other <e2>anti-pseudomonal antibiotics</e2>, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "<e1>Trimethoprim</e1>, given at a common clinical dosage, increased the <e2>phenytoin</e2> half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%. \n",
      "A fatal poisoning case involving <e1>etizolam</e1>, <e2>phenobarbital</e2>, promethazine and chlorpromazine is presented. \n",
      "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, <e1>dipyridamole</e1>, and abciximab) may increase the risk of bleeding if administered prior to or after <e2>Retavase</e2>    therapy.\n",
      "<e1>Triprolidine</e1> may enhance the sedative effects of central nervous system depressants including <e2>alcohol</e2>, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. \n",
      "<e1>Caffeine</e1> and/or stimulantes of the ephedrine/<e2>amphetamine</e2> type may counteract the specific actions of levomepromazine. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e1>thioxanthenes</e1>) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "<e1>Triprolidine</e1> may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and <e2>tranquillisers</e2>. \n",
      "Prior administration of <e1>succinylcholine</e1> can potentiate the neuromuscular blocking effects of <e2>nondepolarizing agents</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e1>diphenhydramine</e1>), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Concurrent use of alcohol and other <e1>CNS depression-producing drugs</e1> may increase the CNS depressant effects of <e2>methyprylon</e2> or these other medications.\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e1>digoxin</e1>, procainamide, pancuronium, morphine, vancomycin, <e2>metformin</e2> and tenofovir). \n",
      "Absorption of <e1>tetracyclines</e1> is impaired by antacids containing aluminum, calcium or <e2>magnesium</e2>, and iron-containing preparations. \n",
      "<e1>Pyrimethamine</e1> may be used with sulfonamides, quinine and other <e2>antimalarials</e2>, and with other antibiotics. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, sulfonamides, <e1>phenothiazines</e1>, sulfonylurea hypoglycemia agents, thiazide diuretics, and <e2>griseofulvin</e2>) could increase the photosensitivity reaction. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (<e2>phenobarbital</e2>, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, analgesics, antiemetics/<e1>antinauseants</e1>, <e2>antispasmodics</e2> and anticholinergic agents. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, <e1>phenytoins</e1>, thiazide diuretics, <e2>beta blockers</e2>, and calcium channel blockers.\n",
      "<e1>Warfarin</e1>: The coadministration of EVISTA and <e2>warfarin</e2> has not been assessed under chronic conditions. \n",
      "Both <e1>acyclovir</e1>/<e2>ganciclovir</e2> and MPAG concentrations are increased in the presence of renal impairment, their coexistence may compete for tubular secretion and further increase in the concentrations of the two. \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, <e1>rifampin</e1>, rifabutin, ketoconazole, and <e2>fluconazole</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Studies to evaluate potential interactions of <e1>terfenadine</e1> with <e2>azithromycin</e2> are in progress.\n",
      "In these subjects, <e1>meloxicam</e1> did not alter <e2>warfarin</e2> pharmacokinetics and the average anticoagulant effect of warfarin as determined by prothrombin time. \n",
      "Concurrent ingestion of <e1>antacid</e1> (20 mL of <e2>antacid</e2> containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e1>midazolam</e1>, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - <e2>edrophonium</e2> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, <e1>cisplatin</e1>, <e2>doxorubicin</e2> and etoposide   celecoxib following different incubation schedules were analyzed.\n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, <e1>digoxin</e1>, and <e2>warfarin</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e1>magnesium</e1> salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Sunitinib</e1> as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to <e2>sunitinib</e2> followed by docetaxel and concurrent administration.\n",
      "The bioavailability of <e1>SKELID</e1> is increased 2-4 fold by <e2>indomethacin</e2> but is not significantly altered by coadministration of diclofenac. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Therefore, do not administer <e1>Myfortic</e1> with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral <e2>activated charcoal</e2>, because of the potential to reduce the efficacy of Myfortic. \n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving MAO-A inhibitors is contraindicated . <e2>Selective serotonin reuptake inhibitors</e2> (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e1>Astemizole</e1>, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e1>digoxin</e1>, <e2>procainamide</e2>, pancuronium, morphine, vancomycin, metformin and tenofovir). \n",
      "After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2>-treated monkeys were significantly affected. \n",
      "In female rats, neonatal <e1>quinpirole</e1> treatment enhanced <e2>amphetamine</e2> locomotor sensitization compared with quinpirole-free controls sensitized to amphetamine. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e2>ritonavir</e2>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "<e1>Cholestyramine</e1> and Drugs that Bind Bile Acids: These drugs interrupt enterohepatic recirculation and reduce <e2>MPA</e2> exposure when coadministered with mycophenolate mofetil. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e1>metformin</e1>, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, <e2>sertraline</e2>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Tacrolimus: There have been reports of nephrotoxicity in patients to whom <e1>fluconazole</e1> and <e2>tacrolimus</e2> were coadministered. \n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, hypnotics, <e2>tranquilizers</e2>, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, itraconazole, miconazole) or macrolide antibiotics (eg, <e2>erythromycin</e2>, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e1>chlorpropamide</e1>) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "After oral administration of <e1>colchicine</e1> (8 mg/kg) in the form of either the nanoemulsion or in free <e2>colchicine</e2> solution, the relative bioavailability of nanoemulsion and eugenol-nanoemulsion were enhanced by about 1.6- and 2.1-fold, respectively, compared with free colchicine solution. \n",
      "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and <e1>mycophenolate mofetil</e1> inhibit purine metabolism, it is recommended that <e2>Myfortic</e2> not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e2>methotrexate</e2>, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e2>melatonin</e2> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Uncontrolled hy-per-parathyroidism causes bone marrow fibrosis, leading to <e1>erythropoietin</e1> (<e2>EPO</e2>) resistance. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "The aim of the present study was to investigate whether HB-EGF is a therapeutic target for T-ALL, and to further elucidate the antitumor effects of a specific inhibitor of HB-EGF, <e1>cross-reacting material 197</e1> (<e2>CRM197</e2>). \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, <e1>prednisolone</e1>, sirolimus, nifedipine, fluconazole, ritonavir, and <e2>rifampin</e2>. \n",
      "however, as with other NSAIDs, concomitant administration of <e1>meloxicam</e1> and <e2>aspirin</e2> is not generally recommended because of the potential for increased adverse effects. \n",
      "MAO Inhibitors: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving <e1>monoamine oxidase inhibitors</e1> (<e2>MAOI</e2>). \n",
      "Concomitant glucocorticoid therapy may inhibit the response to <e1>Geref</e1>   . There was no evidence in the controlled studies of <e2>Geref</e2>   's interaction with drugs commonly used in the treatment of routine pediatric problems/illnesses. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Sunitinib</e1> as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by <e2>sunitinib</e2> is superior to sunitinib followed by docetaxel and concurrent administration.\n",
      "<e1>Itraconazole</e1>: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and <e2>itraconazole</e2> in clinical trials of itraconazole and from foreign post-marketing sources. \n",
      "Diuretics: Patients on <e1>diuretics</e1>, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of <e2>ACEON</e2>    Tablets therapy. \n",
      "The colchicine nanoemulsion was prepared with isopropyl myristate, eugenol, Tween80, <e1>ethanol</e1> and water, and <e2>eugenol</e2> was used as an oil phase in the formulation; \n",
      "<e1>Calcium</e1> doses   1000 mg diminished <e2>nonheme iron</e2> absorption by an average of 49.6%.\n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "The effect of a series of flavonoids, including flavonols, <e1>flavones</e1>, isoflavone, flavanone, flavanonols and catechins, on the elimination of luteolin and <e2>apigenin</e2> was studied. \n",
      "<e1>HMG-CoA reductase inhibitors</e1>: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, <e2>simvastatin</e2>, pravastatin, lovastatin, or fluvastatin. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, <e1>echothiophate</e1>, neostigmine, <e2>physostigmine</e2>, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "The bioavailability of SKELID is decreased 80% by <e1>calcium</e1>, when calcium and <e2>SKELID</e2> are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and <e1>rifampin</e1> may increase the clearance of corticosteroids and may require increases in <e2>corticosteroid</e2> dose to achieve the desired response. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), <e1>antihypertensives</e1> (n=72), calcium channel blockers (n=75), antidiabetics (n=21), <e2>nonsteroidal anti-inflammatory drugs</e2> (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e1>Surmontil</e1>) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "<e1>Warfarin</e1>: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with <e2>warfarin</e2>, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drug Interactions: Women on oral <e1>contraceptives</e1> have shown a significant increase in plasma <e2>vitamin A</e2> levels.\n",
      "<e1>TOBI</e1> should not be administered concomitantly with ethacrynic acid, furosemide, urea, or <e2>mannitol</e2>.\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - <e1>Phenytoin</e1>: can increase seizure activity - <e2>Live virus vaccines</e2>: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . <e1>Theophylline</e1> plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, <e2>theophylline</e2> blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., <e2>fluoxetine</e2>, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "The use of AGGRASTAT, in combination with <e1>heparin</e1> and aspirin, has been associated with an increase in bleeding compared to heparin and <e2>aspirin</e2> alone (see\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease <e2>melatonin</e2> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of HIV-protease inhibitors, <e2>griseofulvin</e2>, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - <e1>Phenytoin</e1>: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - <e2>Mitomycin-C</e2>: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e1>indomethacin</e1>, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "This effect on <e1>midazolam</e1> appears to be more pronounced following oral administration of fluconazole than with <e2>fluconazole</e2> administered intravenously. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, echothiophate, neostigmine, <e1>physostigmine</e1>, and midazolam revealed no inhibition of <e2>remifentanil</e2> hydrolysis in whole human blood by these drugs.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e1>itraconazole</e1>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "The induction dose requirements of <e1>DIPRIVAN</e1> Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, morphine, meperidine, and <e2>fentanyl</e2>, etc.) \n",
      "Since <e1>trimetrexate</e1> is metabolized by a P450 enzyme system, drugs that induce or inhibit this drug metabolizing enzyme system may elicit important drug-drug interactions that may alter <e2>trimetrexate</e2> plasma concentrations. \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, <e1>diuretics</e1>, antidiabetic agents, and <e2>antiarrhythmics</e2>, without observed problems. \n",
      "Isoflurane and enflurane (administered with <e1>nitrous oxide</e1>/<e2>oxygen</e2> to achieve 1.25 M.C. \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include <e1>erythromycin</e1>, rifampin, rifabutin, ketoconazole, and <e2>fluconazole</e2>. \n",
      "When a single 100 mg dose of <e1>rimantadine HCl</e1> was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total <e2>rimantadine</e2> clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "<e1>Trimethoprim</e1> may inhibit the hepatic metabolism of <e2>phenytoin</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, <e2>quinidine</e2>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Lithium</e1>: Serum <e2>lithium</e2> levels may increase. \n",
      "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as <e1>aspirin</e1>, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after <e2>Retavase</e2>    therapy.\n",
      "<e1>Cimetidine</e1>: Cimetidine does not affect the pharmacokinetics of <e2>sparfloxacin</e2>. \n",
      "Oral <e1>metronidazole</e1> has been reported to potentiate the anticoagulant effect of coumarin and <e2>warfarin</e2>, resulting in a prolongation of prothrombin time. \n",
      "Laboratory Tests There have been reports of false-positive urine screening tests for <e1>tetrahydrocannabinol</e1> (THC) in patients receiving most <e2>proton pump inhibitors</e2>, including pantoprazole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to <e1>5-FU</e1>, cisplatin, doxorubicin and etoposide   <e2>celecoxib</e2> following different incubation schedules were analyzed.\n",
      "Rate of achievement of target BP with fixed combination <e1>amlodipine</e1>/<e2>valsartan</e2> (93%) was comparable with that on traditional therapy (90%). \n",
      "Probenecid: <e1>Probenecid</e1> does not alter the pharmacokinetics of <e2>sparfloxacin</e2>.\n",
      "Administration of paclitaxel in combination with HERCEPTIN resulted in a two-fold decrease in <e1>HERCEPTIN</e1> clearance in a non-human primate study and in a 1.5-fold increase in <e2>HERCEPTIN</e2> serum levels in clinical studies.\n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as <e1>digoxin</e1>, bronchodilators, other <e2>antiviral agents</e2>, antibiotics, or anti-metabolites have not been conducted. \n",
      "An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of <e1>rosiglitazone</e1> and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of <e2>rosiglitazone</e2>. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - <e1>Phenytoin</e1>: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the <e2>vaccine</e2>\n",
      "<e1>Acetazolamide</e1>: Concurrent use of <e2>acetazolamide</e2> and procaine hydrochloride may extend the plasma half-life of procaine.\n",
      "The pressor response of <e1>adrenergic agents</e1> may also be potentiated by <e2>tricyclic antidepressants</e2>.\n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., <e1>phenylephrine</e1>, pseudoephedrine, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when <e2>ProAmatine</e2>    is administered concomitantly with agents that cause vasoconstriction. \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, diazepam, <e1>hydroxyzine</e1>, and other muscle relaxants) or local <e2>anesthetics</e2> have been observed.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "TERAZOL 3 Vaginal Cream 0.8% The levels of <e1>estradiol</e1> (E2) and <e2>progesterone</e2> did not differ significantly when 0.8% terconazole vaginal cream was administered to healthy female volunteers established on a low dose oral contraceptive.    \n",
      "Warfarin users who initiated <e1>citalopram</e1>, fluoxetine, <e2>paroxetine</e2>, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e1>potassium chloride</e1> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, <e2>cisapride</e2>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "If <e1>EVISTA</e1> is given concurrently with <e2>warfarin</e2>, prothrombin time should be monitored. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (<e1>PI</e1>) or an <e2>integrase inhibitor</e2> (II) is recommended. \n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower <e2>melatonin</e2> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "In most cases, the application of two <e1>nucleoside or nucleotide reverse transcriptase inhibitors</e1> (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI) or an integrase inhibitor (<e2>II</e2>) is recommended. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "There is usually complete cross-resistance between <e1>PURINETHOL</e1> (mercaptopurine) and <e2>TABLOID</e2> brand Thioguanine. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, <e1>warfarin</e1>, certain heart medicines, birth control pills, anti-infective medicines, <e2>furosemide</e2> and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e1>quinine</e1>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include <e1>methanol</e1>, ethylene glycol, <e2>diethylene glycol</e2>, propylene glycol, or isopropanol. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e1>absorbent-type anti-diarrhea medicines</e1> (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e2>sulfonamides</e2>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Although not studied, the potent cytochrome P450 3A4 inhibitors <e1>ritonavir</e1> and nelfinavir may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of <e2>midazolam</e2>. \n",
      "Coadministration with <e1>aspirin</e1> results in a slight decrease in the rate of <e2>salicylate</e2> absorption that is clinically unimportant. \n",
      "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of <e1>tolbutamide</e1>, sodium salicylate and <e2>sulfamethizole</e2> displaced protein-bound teniposide in fresh human serum to a small but significant extent. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like <e1>dihydroergotamine</e1> or <e2>methysergide</e2>) and sumatriptan within 24 hours of each other should be avoided. \n",
      "Absorption of tetracyclines is impaired by antacids containing <e1>aluminum</e1>, <e2>calcium</e2> or magnesium, and iron-containing preparations. \n",
      "<e1>Barbiturates</e1> may decrease the effectiveness of oral contraceptives, certain antibiotics, <e2>quinidine</e2>, theophylline, corticosteroids, anticoagulants, and beta blockers.\n",
      "Accordingly, patients should be advised to avoid <e1>diazepam</e1> and other similar drugs while taking <e2>REMERON SolTab</e2>.\n",
      "The bioavailability of SKELID is decreased 80% by <e1>calcium</e1>, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or <e2>magnesium</e2>-containing antacids, when administered 1 hour before SKELID. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, <e2>ritonavir</e2>, and rifampin. \n",
      "Warfarin users who initiated <e1>citalopram</e1>, fluoxetine, paroxetine, amitriptyline, or <e2>mirtazapine</e2> had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, <e1>nefazodone</e1>, nelfinavir, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "<e1>Barbiturates</e1> may decrease the effectiveness of oral contraceptives, certain <e2>antibiotics</e2>, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.\n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e2>Tricyclic antidepressants</e2> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain macrolides interact with <e1>terfenadine</e1> and <e2>astemizole</e2> leading to increased serum concentrations of the latter. \n",
      "The <e1>3-Deazaneplanocin A</e1> (<e2>DZNep</e2>), one of S-adenosylhomocysteine (AdoHcy) hydrolase inhibitors, has shown antitumor activities in a broad range of solid tumors and acute myeloid leukemia. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e1>indomethacin</e1>, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "<e1>Itraconazole</e1>: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of <e2>itraconazole</e2> and from foreign post-marketing sources. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, Cisapride, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, <e1>clarithromycin</e1>) or cyclosporine or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Absorption of tetracyclines is impaired by <e1>antacids</e1> containing aluminum, <e2>calcium</e2> or magnesium, and iron-containing preparations. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with <e1>atorvastatin</e1>, <e2>simvastatin</e2>, pravastatin, lovastatin, or fluvastatin. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, <e1>prednisolone</e1>, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, <e2>digoxin</e2>, and warfarin. \n",
      "Although such a reaction has not been demonstrated with roxithromycin, concomitant administration of roxithromycin with <e1>terfenadine</e1> or <e2>astemizole</e2> is not recommended. \n",
      "These medications included <e1>thyroid hormones</e1>, sedative hypnotics, non-steroidal anti-inflammatory agents, <e2>benzodiazepines</e2>, and decongestants. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e1>indinavir</e1>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (<e2>Asendin</e2>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e2>metformin</e2>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), <e1>propofol</e1>, ketamine, nitrous oxide, secobarbital and <e2>droperidol</e2>. \n",
      "Exert particular caution in combining <e1>levomepromazine</e1> with other anticholinergic drugs (tricyclic antidepressants and <e2>antiparkinsonian-agents</e2>): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, <e1>bacitracin</e1>, <e2>polymyxin B</e2>, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, <e1>anti-infective medicines</e1>, <e2>furosemide</e2> and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e2>NARCOTIC ANALGESICS</e2>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Acromegalic patients with diabetes mellitus being treated with <e1>insulin</e1> and/or oral hypoglycemic agents may require dose reductions of these therapeutic agents after the initiation of therapy with <e2>SOMAVERT</e2>. \n",
      "<e1>Gemfibrozil</e1>: In a pharmacokinetic study, concomitant <e2>gemfibrozil</e2> administration increased total ezetimibe concentrations approximately 1.7-fold. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "<e1>TRENTAL</e1> has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and <e2>antiarrhythmics</e2>, without observed problems. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e1>levothyroxine sodium</e1>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "Therefore, as vitamin K absorption may be decreased with XENICAL, patients on chronic stable doses of <e1>warfarin</e1> who are prescribed <e2>XENICAL</e2> should be monitored closely for changes in coagulation parameters.\n",
      "There are reports of enhanced as well as diminished effects of <e1>anticoagulant</e1> when given concurrently with <e2>corticosteroids</e2>. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving <e1>MAO-A inhibitors</e1> is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, <e2>paroxetine</e2>, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  <e1>Tramadol</e1>: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that <e2>ondansetron</e2> may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, <e2>antipsychotic agents</e2> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "The FDA has approved ticagrelor (<e1>Brilinta</e1>-AstraZeneca), an oral <e2>antiplatelet drug</e2>, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include methanol, ethylene glycol, diethylene glycol, <e1>propylene glycol</e1>, or <e2>isopropanol</e2>. \n",
      "Drugs such as <e1>troleandomycin</e1> and <e2>ketoconazole</e2> may inhibit the metabolism of corticosteroids and thus decrease their clearance. \n",
      "Drugs such as erythromycin, <e1>diltiazem</e1>, verapamil, ketoconazole, <e2>fluconazole</e2> and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Given the primary CNS effects of paliperidone, <e1>INVEGA</e1>    should be used with caution in combination with other centrally acting drugs and <e2>alcohol</e2>. \n",
      "A fatal poisoning case involving <e1>etizolam</e1>, phenobarbital, <e2>promethazine</e2> and chlorpromazine is presented. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e1>indinavir</e1>, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as digoxin, bronchodilators, other antiviral agents, <e1>antibiotics</e1>, or <e2>anti-metabolites</e2> have not been conducted. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e1>protriptyline</e1> (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or <e1>metoclopramide</e1>, ordinarily should not be administered concurrently with Permax (a <e2>dopamine agonist</e2>); \n",
      "<e1>Anticholinesterases</e1>: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of <e2>procaine hydrochloride</e2>. \n",
      "The use of <e1>AGGRASTAT</e1>, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to <e2>heparin</e2> and aspirin alone (see\n",
      "Warfarin users who initiated citalopram, fluoxetine, <e1>paroxetine</e1>, <e2>amitriptyline</e2>, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Concomitant administration of <e1>terfenadine</e1> with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including <e2>azithromycin</e2>, is not recommended. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving <e1>MAO-A inhibitors</e1> is contraindicated . <e2>Selective serotonin reuptake inhibitors</e2> (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as <e1>isocarboxazid</e1> (Marplan), tranylcypromine (Parnate), or phenelzine (<e2>Nardil</e2>) in the last 14 days. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some <e1>steroid medications</e1>, warfarin, certain heart medicines, birth control pills, anti-infective medicines, <e2>furosemide</e2> and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Concomitant administration of terfenadine with clarithromycin, <e1>erythromycin</e1>, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including <e2>azithromycin</e2>, is not recommended. \n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with <e1>ACEON</e1>    Tablets, but an effect of digoxin on the plasma concentration of <e2>perindopril</e2>/perindoprilat has not been excluded. \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (<e2>phenothiazines</e2>, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e1>progestin</e1> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), <e2>doxepin</e2> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Group 2 consisted of 10% <e1>carbamide peroxide</e1>-based bleaching gel and 0.01% <e2>manganese gluconate</e2>. \n",
      "Clinical studies of interactions of <e1>VIRAZOLE</e1> with other drugs commonly used to treat infants with RSV infections, such as digoxin, <e2>bronchodilators</e2>, other antiviral agents, antibiotics, or anti-metabolites have not been conducted. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The effect of a series of <e1>flavonoids</e1>, including flavonols, flavones, isoflavone, flavanone, flavanonols and <e2>catechins</e2>, on the elimination of luteolin and apigenin was studied. \n",
      "There were no significant differences between the pharmacokinetics parameters of amiodarone administered intravenously or intragastrically and the control (without neferine) group (with ratios of 0.7-1.4 in all experimental groups), suggesting that <e1>neferine</e1> had no effect on <e2>amiodarone</e2> plasma pharmacokinetics. \n",
      "This increase was observed at the first test point which was the second day after starting <e1>Mexitil</e1>   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing <e2>Mexitil</e2>   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the <e1>neuroleptics</e1> (<e2>phenothiazines</e2>, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e1>nelfinavir</e1>, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Sympathomimetics may reduce the antihypertensive effects of <e1>methyldopa</e1>, mecamylamine, <e2>reserpine</e2> and veratrum alkaloids.\n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or <e2>macrolide antibiotics</e2> (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, <e1>barbiturates</e1>, hypnotics, narcotic analgesics, <e2>sedatives</e2>, and tranquillisers. \n",
      "Cyclosporine: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in <e1>cyclosporine</e1> plasma levels when <e2>XENICAL</e2> was coadministered with cyclosporine. \n",
      "<e1>Mequitazine</e1> can interact with CNS depressant, antichlolinergic, <e2>TCA</e2>, MAOIs, and alcohol.\n",
      "In vivo, the plasma clearance of <e1>ropivacaine</e1> was reduced by 70% during coadministration of <e2>fluvoxamine</e2> (25 mg bid for 2 days), a selective and potent CYP1A2 inhibitor. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, <e1>nitrous oxide</e1>, <e2>secobarbital</e2> and droperidol. \n",
      "We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of <e1>dexmedetomidine</e1> as an <e2>analgesic</e2> in humans.\n",
      "The bioavailability of <e1>SKELID</e1> is increased 2-4 fold by indomethacin but is not significantly altered by coadministration of <e2>diclofenac</e2>. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), <e1>terfenadine</e1>, digoxin, and <e2>warfarin</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "The siRNA knockdown of p27(Kip1) decreased <e1>dasatinib</e1>- and <e2>paclitaxel</e2>-induced apoptosis compared with a negative control siRNA (sub-G1 fraction, control siRNA vs. p27(Kip1) siRNA: 42.5% vs. 20.1%, difference = 22.4%, 95% CI = 20.1% to 24.7%, P = .017). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e1>bacitracin</e1> - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., <e1>tetracyclines</e1>, sulfonamides, phenothiazines, <e2>sulfonylurea</e2> hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, indinavir, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, <e1>Cholestyramine</e1>, Choline and magnesium salicylates, <e2>Colestipol</e2>, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e1>Rifabutin</e1>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, <e1>aminoglycosides</e1>, bacitracin, polymyxin B, <e2>colistin</e2>, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "We also found that Bcl-2 was overexpressed in <e1>DZNep</e1> insensitive cells, and cotreatment with DZNep and <e2>ABT-737</e2>, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells. \n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (<e2>indomethacin</e2>, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e2>prednisone</e2>, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, <e1>fluoxetine</e1>, fluvoxamine, zileuton, and <e2>clotrimazole</e2>. \n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, <e2>paroxetine</e2>, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, <e1>ketoconazole</e1>, <e2>ampicillin</e2> esters, and iron salts). \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other <e2>anticholinergics</e2> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with <e1>coumarin-type anticoagulants</e1> have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on <e2>coumarin-type anticoagulants</e2> and other highly protein-bound drugs. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/<e1>ethinyl estradiol</e1> 35 mcg), terfenadine, <e2>digoxin</e2>, and warfarin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, <e2>isocarboxazid</e2>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Azathioprine/<e1>Mycophenolate Mofetil</e1>: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with <e2>azathioprine</e2> or mycophenolate mofetil. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, <e1>halogenated salicylanilides</e1> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, <e1>paroxetine</e1>, <e2>sertraline</e2>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "In the present study piperine (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of <e1>ibuprofen</e1> evaluated by both <e2>acetic acid</e2> writhing and formalin test, when it was administered with ibuprofen. \n",
      "In humans, carmustine, <e1>etoposide</e1>, and cisplatin do not affect the pharmacokinetics of <e2>ondansetron</e2>.  \n",
      "Patients studied in clinical trials of <e1>TNKase</e1> were routinely treated with heparin and <e2>aspirin</e2>. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e2>beta blockers</e2> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Isoflurane and <e1>enflurane</e1> (administered with <e2>nitrous oxide</e2>/oxygen to achieve 1.25 M.C. \n",
      "Additive sedative effects can occur when <e1>metoclopramide</e1> is given with <e2>alcohol</e2>, sedatives, hypnotics, narcotics, or tranquilizers. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, <e2>hydroxychloroquine sulfate</e2>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e1>polymyxin B</e1> or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Warfarin: The coadministration of <e1>EVISTA</e1> and <e2>warfarin</e2> has not been assessed under chronic conditions. \n",
      "Interactions with cylcopholsphamide, <e1>fludarabine</e1> and <e2>vidarabine</e2>\n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as <e1>alcohol</e1>, sedatives, antihistaminics, or <e2>psychotropic drugs</e2>. \n",
      "Synergism was also noted when <e1>methylglyoxal</e1> was combined with <e2>carbenicillin</e2> and amikacin.\n",
      "Other eye drops or medications such as acetylcholine chloride (Miochol) and carbachol (<e1>Carboptic</e1>, Isopto Carbachol) may decrease the effects of <e2>suprofen</e2> ophthalmic.\n",
      "Oral <e1>Contraceptives</e1>: Given the different metabolism of Myfortic and oral <e2>contraceptives</e2>, no drug interaction between these two classes of drug is expected. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "The sedative effect of <e1>VERSED Syrup</e1> is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and <e2>droperidol</e2>. \n",
      "Absorption of <e1>tetracyclines</e1> is impaired by antacids containing aluminum, <e2>calcium</e2> or magnesium, and iron-containing preparations. \n",
      "When <e1>ZETIA</e1> is administered with an <e2>HMG-CoA reductase inhibitor</e2> in a woman of childbearing potential, refer to the pregnancy category and package labeling for the HMG-CoA reductase inhibitor. \n",
      "The effect of orlistat on the absorption of supplemental vitamin D, <e1>vitamin A</e1>, and nutritionally-derived <e2>vitamin K</e2> is not known at this time. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e1>hypoglycemics</e1>: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>triamterene</e1>, amiloride) or potassium supplements concomitantly with <e2>ACE inhibitors</e2> can increase the risk of hyperkalemia. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e1>quinine</e1>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Methyldopa does not interfere with measurement of VMA (<e1>vanillylmandelic acid</e1>), a test for pheochromocytoma, by those methods which convert <e2>VMA</e2> to vanillin. \n",
      "The colchicine nanoemulsion was prepared with isopropyl myristate, <e1>eugenol</e1>, Tween80, <e2>ethanol</e2> and water, and eugenol was used as an oil phase in the formulation; \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of <e1>alcohol</e1> pharmacokinetics, <e2>orlistat</e2> pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "Other <e1>Antihypertensives</e1>: When MYKROX Tablets are used with other <e2>antihypertensive drugs</e2>, care must be taken, especially during initial therapy. \n",
      "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, <e1>ethoxycoumarin</e1>, and <e2>cyclosporine</e2>. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, <e1>corticosteroids</e1>, <e2>anticoagulants</e2>, and beta blockers.\n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, diazepam, <e1>hydroxyzine</e1>, and other <e2>muscle relaxants</e2>) or local anesthetics have been observed.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "If at all possible <e1>guanethidine</e1> should be discontinued well before <e2>minoxidil</e2> is begun. \n",
      "Patients with mild to moderate renal insufficiency should avoid taking <e1>NSAIDs</e1> with short elimination half-lives for a period of 2 days before, the day of, and 2 days following administration of <e2>ALIMTA</e2>. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, <e1>Sanctura</e1> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, <e2>pancuronium</e2>, morphine, vancomycin, metformin and tenofovir). \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, <e1>vancomycin</e1>, <e2>metformin</e2> and tenofovir). \n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>amiloride</e1>, triamterene and others), <e2>potassium</e2> supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "<e1>Barbiturates</e1> may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, <e2>theophylline</e2>, corticosteroids, anticoagulants, and beta blockers.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e1>estrogens</e1> (n=70), <e2>salicylate analgesics</e2> (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "<e1>Calcium</e1> does not inhibit the absorption of 5 milligrams of nonheme or <e2>heme iron</e2> at doses less than 800 milligrams in nonpregnant women.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e2>nortriptyline</e2> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Because there is a theoretical basis that these effects may be additive, use of <e1>ergotamine</e1>-containing or ergot-type medications (like dihydroergotamine or methysergide) and <e2>sumatriptan</e2> within 24 hours of each other should be avoided. \n",
      "In conclusion, we demonstrated an isolated effect of <e1>calcium</e1> (as chloride) on absorption of 5 mg of iron provided as <e2>nonheme</e2> (as sulfate) and heme (as CRBC) iron. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (<e1>MAOI</e1>) such as <e2>isocarboxazid</e2> (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, <e1>ephedrine</e1>, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of <e2>ProAmatine</e2>   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "In clinical trials, the concomitant use of <e1>sulfonylureas</e1> or biguanides did not alter the adverse event profile of <e2>SYMLIN</e2>. \n",
      "When <e1>DIFLUCAN</e1> is used concomitantly with these or other sulfonylurea oral hypoglycemic agents, blood glucose concentrations should be carefully monitored and the dose of the <e2>sulfonylurea</e2> should be adjusted as necessary. \n",
      "Addition of <e1>mexiletine</e1> to <e2>propafenone</e2> did not lead to further electrocardiographic parameters changes of QRS, QTc, RR, and PR intervals than propafenone alone. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e1>benzodiazepines</e1>, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "In vitro studies with atracurium, <e1>mivacurium</e1>, esmolol, echothiophate, <e2>neostigmine</e2>, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "<e1>Thalidomide</e1> has been reported to enhance the sedative activity of barbiturates, alcohol, <e2>chlorpromazine</e2>, and reserpine. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-<e1>Mexitil</e1>    values within 48 hours after discontinuing <e2>Mexitil</e2>   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "An additional clinical drug-drug interaction study showed no effect of rifaximin on the presystemic metabolism of an oral <e1>contraceptive</e1> containing <e2>ethinyl estradiol</e2> and norgestimate. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), <e1>terfenadine</e1>, <e2>digoxin</e2>, and warfarin. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e1>antacids</e1>, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e2>pramipexole</e2> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Calcium was administered as <e1>calcium chloride</e1> in all studies and <e2>minerals</e2> were ingested on an empty stomach. \n",
      "morphine, theophylline, <e1>aminophylline</e1>, <e2>succinylcholine</e2>, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "TRENTAL has been used concurrently with <e1>antihypertensive drugs</e1>, <e2>beta blockers</e2>, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e1>ritonavir</e1>, indinavir, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar <e1>neuromuscular blocking agents</e1> or <e2>cholinergic agonists</e2> such as bethanechol.\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Cyclosporine: When studied in stable renal transplant patients, <e1>cyclosporine</e1>, USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of <e2>Myfortic</e2>. \n",
      "These medications included thyroid hormones, <e1>sedative hypnotics</e1>, <e2>non-steroidal anti-inflammatory agents</e2>, benzodiazepines, and decongestants. \n",
      "morphine, theophylline, aminophylline, <e1>succinylcholine</e1>, reserpine, and <e2>phenothiazine-type tranquilizers</e2> should be avoided in patients with organophosphate poisoning.\n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, <e1>anti-infective medicines</e1>, furosemide and theophylline Please note that <e2>Mephenytoin</e2> may interact with other drugs that are not listed here.\n",
      "<e1>Live Vaccines</e1>: During treatment with Myfortic, the use of <e2>live attenuated vaccines</e2> should be avoided and patients should be advised that vaccinations may be less effective. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e1>ritonavir</e1>, <e2>indinavir</e2>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, <e2>quinidine</e2>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e1>sympathomimetic agents</e1>, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, <e2>griseofulvin</e2>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "In conclusion, we demonstrated an isolated effect of calcium (as chloride) on absorption of 5 mg of iron provided as <e1>nonheme</e1> (as sulfate) and <e2>heme</e2> (as CRBC) iron. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e1>PHENOTHIAZINES</e1>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, <e2>Theophylline</e2>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), <e2>nortriptyline</e2> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "<e1>o-Cymen-5-ol</e1>/<e2>zinc chloride</e2> in toothpaste showed greater effects than placebo (120s log10 kill=7.35  0.40 and 4.02  0.40, respectively). \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, <e1>anticoagulants</e1>, and <e2>beta blockers</e2>.\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, <e2>voriconizole</e2>) may increases sunitinib concentrations. \n",
      "Administration of <e1>paclitaxel</e1> in combination with <e2>HERCEPTIN</e2> resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.\n",
      "Contradictory results regarding the effect of <e1>proton pump inhibitors</e1> on platelet reactivity and on clinical outcome in <e2>clopidogrel</e2>-treated patients have been reported in literature. \n",
      "Careful monitoring of cyclosporine concentrations and serum creatinine is recommended in patients receiving <e1>DIFLUCAN</e1> and <e2>cyclosporine</e2>. \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include <e1>methanol</e1>, ethylene glycol, diethylene glycol, propylene glycol, or <e2>isopropanol</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Patients receiving sirolimus or <e1>nifedipine</e1> in combination with <e2>MYCAMINE</e2> should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. \n",
      "There is usually complete cross-resistance between PURINETHOL (<e1>mercaptopurine</e1>) and <e2>TABLOID</e2> brand Thioguanine. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e1>TRICYCLIC ANTIDEPRESSANTS</e1> AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "Dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with <e2>Permax</e2> (a dopamine agonist); \n",
      "In a formal, single-dose interaction study (n = 6 males) the clearance of <e1>mexiletine</e1> was decreased by 38% following the coadministration of <e2>fluvoxamine</e2>, an inhibitor of CYP1A2. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Furosemide</e1>: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of <e2>furosemide</e2> and thiazide diuretics in some patients. \n",
      "<e1>Paliperidone</e1> may antagonize the effect of levodopa and other <e2>dopamine agonists</e2>. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e1>BARBITURATES</e1>), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e1>colistin</e1>, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Plasma levels of <e1>piroxicam</e1> are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma <e2>lithium</e2> levels. \n",
      "Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other <e1>HDAC inhibitors</e1> (e.g., <e2>valproic acid</e2>). \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other <e1>opioids</e1>, <e2>tricyclic antidepressants</e2>, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Cimetidine: Concomitant administration of 200 mg <e1>cimetidine</e1> QID did not alter the single-dose pharmacokinetics of 30 mg <e2>meloxicam</e2>. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., <e1>dexamethasone</e1>, phenytoin, carbamazepine, rifampin, <e2>rifabutin</e2>, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Standard <e1>antibiotic</e1> such as Gentamicin (10 microg), Cephalothin (30 microg), <e2>Ceftriaxone</e2> (10 microg), Nystatin (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, <e1>flavanone</e1>, flavanonols and <e2>catechins</e2>, on the elimination of luteolin and apigenin was studied. \n",
      "In vitro studies with atracurium, <e1>mivacurium</e1>, esmolol, echothiophate, neostigmine, physostigmine, and midazolam revealed no inhibition of <e2>remifentanil</e2> hydrolysis in whole human blood by these drugs.\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e1>methotrexate</e1> (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, prednisolone, and <e2>fluconazole</e2> pharmacokinetics. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Fluconazole tablets coadministered with <e1>ethinyl estradiol</e1>- and levonorgestrel-containing oral <e2>contraceptives</e2> produced an overall mean increase in ethinyl estradiol and levonorgestrel levels; \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e1>Sinequan</e1>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Concurrent ingestion of antacid (20 mL of <e1>antacid</e1> containing <e2>aluminum hydroxide</e2>, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, <e1>sex steroids</e1>, <e2>anticonvulsants</e2>, cyclosporin). \n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, <e1>cisapride</e1>, cyclosporine, and <e2>tricyclic antidepressants</e2>. \n",
      "Patients on <e1>lithium</e1> treatment should be closely monitored when <e2>MOBIC</e2> is introduced or withdrawn. \n",
      "Careful monitoring of prothrombin time in patients receiving <e1>DIFLUCAN</e1> and <e2>coumarin-type anticoagulants</e2> is recommended. \n",
      "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with <e1>sucralfate</e1>, gelusil, erythromycin and <e2>multi minerals</e2>. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, prednisolone, <e2>sirolimus</e2>, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, <e1>ibuprofen</e1>, diazepam, and <e2>diazoxide</e2>. \n",
      "As there is in vitro evidence that aminosalicylate derivatives (e.g., <e1>olsalazine</e1>, <e2>mesalazine</e2>, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    \n",
      "Therefore, physicians should closely monitor patients for a change in <e1>anticoagulant</e1> dosage requirements when administering Mitotane to patients on <e2>coumarin-type anticoagulants</e2>. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, butyrophenones, thioxanthenes) or <e2>metoclopramide</e2>, may diminish the effectiveness of MIRAPEX. \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), <e2>fluvoxamine</e2> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, <e1>pravastatin</e1>, lovastatin, or <e2>fluvastatin</e2>. \n",
      "Terbinafine clearance is increased 100% by <e1>rifampin</e1>, a CyP450 enzyme inducer, and decreased 33% by <e2>cimetidine</e2>, a CyP450 enzyme inhibitor. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e2>benzodiazepines</e2>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Weekly intramuscular <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1> injections (0.2-0.5 mg/kg body weight), in combination with daily administration of <e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2> or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle). \n",
      "In humans, carmustine, etoposide, and <e1>cisplatin</e1> do not affect the pharmacokinetics of <e2>ondansetron</e2>.  \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as prazosin, terazosin, and <e2>doxazosin</e2>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (<e1>Marplan</e1>), tranylcypromine (Parnate), or <e2>phenelzine</e2> (Nardil) in the last 14 days. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, <e2>lincomycin</e2>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as rifampin, carbamazepine, and <e1>phenytoin</e1>, induce metabolism and caused a markedly decreased C max and AUC of oral <e2>midazolam</e2> in adult studies. \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, <e1>carbamazepine</e1>, and rifampicin), the clearance of <e2>ondansetron</e2> was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "Acetazolamide: Concurrent use of <e1>acetazolamide</e1> and procaine hydrochloride may extend the plasma half-life of <e2>procaine</e2>.\n",
      "Concomitant administration of terfenadine with clarithromycin, erythromycin, or <e1>troleandomycin</e1> is contraindicated: Pending full characterization of potential interactions, concomitant administration of <e2>terfenadine</e2> with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "In controlled clinical trials, <e1>ALOXI</e1> injection has been safely administered with <e2>corticosteroids</e2>, analgesics, antiemetics/antinauseants, antispasmodics and anticholinergic agents. \n",
      "<e1>Ticagrelor</e1> (Brilinta)--better than clopidogrel (<e2>Plavix</e2>)\n",
      "Ketoconazole: Spontaneous adverse reaction reports of patients taking concomitant <e1>ketoconazole</e1> with recommended doses of <e2>terfenadine</e2> demonstrate QT interval prolongation and rare serious cardiac events, e.g. \n",
      "Other eye drops or medications such as <e1>acetylcholine chloride</e1> (Miochol) and carbachol (Carboptic, Isopto Carbachol) may decrease the effects of <e2>suprofen</e2> ophthalmic.\n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as <e1>antimycotic agents</e1> (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter <e2>oxybutynin</e2> mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "MAO Inhibitors: The pressor effect of <e1>sympathomimetic pressor amines</e1> is markedly potentiated in patients receiving monoamine oxidase inhibitors (<e2>MAOI</e2>). \n",
      "<e1>Acyclovir</e1>/Ganciclovir: may be taken with <e2>Myfortic</e2>; \n",
      "This study examined drug-drug interactions of oral <e1>S-ketamine</e1> with the cytochrome P450 (CYP) 2B6 inhibitor <e2>ticlopidine</e2> and the CYP3A inhibitor itraconazole. \n",
      "Clinical studies of interactions of <e1>VIRAZOLE</e1> with other drugs commonly used to treat infants with RSV infections, such as <e2>digoxin</e2>, bronchodilators, other antiviral agents, antibiotics, or anti-metabolites have not been conducted. \n",
      "<e1>Trilostane</e1> may interact with aminoglutethimide or <e2>mitotane</e2> (causing too great a decrease in adrenal function).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, indinavir, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Dopamine antagonists</e1>, such as the <e2>neuroleptics</e2> (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, <e2>morphine</e2>, vancomycin, metformin and tenofovir). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, <e2>levothyroxine sodium</e2>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-<e1>Mexitil</e1>    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, <e2>theophylline</e2> blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "The effect of orlistat on the absorption of supplemental <e1>vitamin D</e1>, vitamin A, and nutritionally-derived <e2>vitamin K</e2> is not known at this time. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e1>penicillins</e1>, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "The latter displayed <e1>midazolam</e1> clearances similar to those in two larger cohorts of nonmatched <e2>tacrolimus</e2>-treated patients (n = 58 and n = 80) and to those receiving a calcineurin inhibitor-free regimen (n = 6). \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Cyclosporine: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in <e1>cyclosporine</e1> plasma levels when XENICAL was coadministered with <e2>cyclosporine</e2>. \n",
      "<e1>TRENTAL</e1> has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, <e2>antidiabetic agents</e2>, and antiarrhythmics, without observed problems. \n",
      "According to the calculated level of risk, guidelines recommend patients with atrial fibrillation receive <e1>antithrombotic</e1> therapy either as a <e2>vitamin K antagonist</e2> or aspirin. \n",
      "Concomitant administration of terfenadine with <e1>clarithromycin</e1>, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of <e2>terfenadine</e2> with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, <e2>ketoconazole</e2>, fluconazole, calcium channel blockers and cimetidine.\n",
      "There was no effect of a single dose or multiple doses of <e1>MYCAMINE</e1> on <e2>mycophenolate mofetil</e2>, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, <e1>halogenated salicylanilides</e1> (bacteriostatic soaps), <e2>sulfonamides</e2>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), HIV protease or reverse transcriptase inhibitors (e.g., <e2>ritonavir</e2>, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "John   s Wort, and certain <e1>anticonvulsants</e1> (phenytoin, phenobarbital, carbamazepine) may induce <e2>mifepristone</e2> metabolism (lowering serum levels of mifepristone). \n",
      "Interactions for <e1>Vitamin B1</e1> (Thiamine):  Loop Diuretics, Oral Contraceptives, Stavudine, <e2>Tricyclic Antidepressants</e2>\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, <e2>clarithromycin</e2>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "The effect of <e1>eugenol</e1> on <e2>colchicine</e2> transport across an isolated rat intestinal membrane was studied using an in vitro diffusion chamber system. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., <e1>itraconazole</e1> and <e2>miconazole</e2>) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) <e1>carbamazepine</e1> (Tegretol) <e2>Estrogens</e2> may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., <e1>corticosteroids</e1>, sex steroids, anticonvulsants, <e2>cyclosporin</e2>). \n",
      "Questioning revealed the child was taking <e1>Infacol</e1> drops before feeds while on <e2>levothyroxine</e2>. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, <e1>phenobarbital</e1>, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The effect of a series of <e1>flavonoids</e1>, including flavonols, flavones, <e2>isoflavone</e2>, flavanone, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Caution should be exercised when <e1>Methergine</e1>    (<e2>methylergonovine maleate</e2>) is used concurrently with other vasoconstrictors or ergot alkaloids.\n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "Concurrent use of <e1>antibacterial drugs</e1> with oral <e2>contraceptives</e2> may render oral contraceptives less effective.  \n",
      "In addition to bleeding associated with <e1>heparin</e1> and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after <e2>Retavase</e2>    therapy.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), <e2>doxepin</e2> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e1>estrogens</e1> (n=70), salicylate analgesics (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "Such occurrences have been reported when <e1>propoxyphene</e1> was administered to patients on antidepressants, anticonvulsants, or <e2>warfarin</e2>-like drugs. \n",
      "<e1>Fibrates</e1>: The safety and effectiveness of <e2>ezetimibe</e2> administered with fibrates have not been established. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), <e2>nortriptyline</e2> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Severe hypertension has been reported when <e1>oxytocin</e1> was given three to four hours following prophylactic administration of a <e2>vasoconstrictor</e2> in conjunction with caudal block anesthesia. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "No pharmacokinetic interaction was observed between <e1>rivastigmine</e1> and digoxin, warfarin, <e2>diazepam</e2>, or fluoxetine in studies in healthy volunteers. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e2>linezolid</e2>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - neostigmine - polymyxin B or <e2>bacitracin</e2> - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, <e2>ranitidine</e2>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Glyburide: In 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, <e1>orlistat</e1> did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of <e2>glyburide</e2>. \n",
      "A variety of <e1>antiarrhythmics</e1> such as <e2>quinidine</e2> or propranolol were also added, sometimes with improved control of ventricular ectopy. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, <e1>delavirdine</e1>) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of <e1>Ropivacaine</e1>, can interact with <e2>Ropivacaine</e2> leading to increased ropivacaine plasma levels. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e1>levothyroxine sodium</e1>, medroxyprogesterone acetate, methotrexate, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "In vitro testing found no protein binding drug interaction between <e1>digoxin</e1> and <e2>meloxicam</e2>. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, <e1>sulfonamides</e1>, phenothiazines, <e2>sulfonylurea</e2> hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "In vitro studies indicate that <e1>moxifloxacin</e1> does not inhibit CYP3A4, CYP2D6, CYP2C9, CYP2C19, or CYP1A2 indicating that <e2>moxifloxacin</e2> is unlikely to alter the pharmacokinetics of drugs metabolized by these cytochrome P450 isozymes.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e1>antacids</e1>, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Multiple dose studies of ezetimibe given in combination with <e1>HMG-CoA reductase inhibitors</e1> (<e2>statins</e2>) in rats and rabbits during organogenesis result in higher ezetimibe and statin exposures. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e1>sulfonamides</e1>, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e1>ritonavir</e1>, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "<e1>Triprolidine</e1> may enhance the sedative effects of <e2>central nervous system depressants</e2> including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. \n",
      "CYP 3A4 Inhibitors (e.g. <e1>Macrolide Antibiotics</e1> and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain <e2>ergot alkaloid drugs</e2> (e.g. dihydroergotamine and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "<e1>Caffeine</e1> and/or stimulantes of the ephedrine/amphetamine type may counteract the specific actions of <e2>levomepromazine</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "While there is evidence that fluconazole can inhibit the metabolism of <e1>ethinyl estradiol</e1> and levonorgestrel, there is no evidence that <e2>fluconazole</e2> is a net inducer of ethinyl estradiol or levonorgestrel metabolism. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, <e1>penicillins</e1>, rifampin, <e2>rifabutin</e2>, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Coadministration of TRITEC with <e1>clarithromycin</e1> resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased <e2>14- hydroxy- clarithromycin</e2> plasma concentrations (31%). \n",
      "However, the co   administration of <e1>SPIRIVA</e1> with other anticholinergic   containing drugs (e.g., <e2>ipratropium</e2>) has not been studied and is therefore not recommended.\n",
      "Given the primary CNS effects of paliperidone, <e1>INVEGA</e1>    should be used with caution in combination with other <e2>centrally acting drugs</e2> and alcohol. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, <e2>bacitracin</e2>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Phenytoin, <e1>Carbamazepine</e1>, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of <e2>ondansetron</e2> was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Laboratory Tests There have been reports of false-positive urine screening tests for tetrahydrocannabinol (<e1>THC</e1>) in patients receiving most <e2>proton pump inhibitors</e2>, including pantoprazole. \n",
      "Cyclosporine: Preliminary data from a <e1>XENICAL</e1> and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with <e2>cyclosporine</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e2>polymyxins</e2>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Dopamine antagonists</e1>, such as the neuroleptics (<e2>phenothiazines</e2>, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e1>azole antifungals</e1> (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of <e1>antacids</e1> has no effect on piroxicam plasma levels . <e2>Nonsteroidal anti-inflammatory agents</e2>, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "Itraconazole: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of <e1>terfenadine</e1> and <e2>itraconazole</e2> in clinical trials of itraconazole and from foreign post-marketing sources. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e1>medroxyprogesterone acetate</e1>, <e2>methotrexate</e2>, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e1>bacitracin</e1> - local anesthetics such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (<e1>curcumin</e1> 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (<e2>curcumin</e2> 100 mg/kg plus imipramine 15 mg/kg). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, <e1>rifapentin</e1>, phenobarbital, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "Therefore, as vitamin K absorption may be decreased with <e1>XENICAL</e1>, patients on chronic stable doses of <e2>warfarin</e2> who are prescribed XENICAL should be monitored closely for changes in coagulation parameters.\n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and miconazole) to <e1>ketoconazole</e1>, and <e2>itraconazole</e2>, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "<e1>o-Cymen-5-ol</e1> and <e2>zinc gluconate</e2> minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined against Streptococcus mutans, Actinomyces viscosus, Porphyromonas gingivalis, Fusobacterium nucleatum and Candida albicans. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus <e1>fluoxetine</e1> 20 mg/kg) and group 7 (<e2>curcumin</e2> 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Cisapride: There have been reports of cardiac events, including torsade de pointes in patients to whom <e1>fluconazole</e1> and <e2>cisapride</e2> were coadministered. \n",
      "Adrenal steroids or ACTH In patients with edema, concomitant administration with <e1>adrenal cortical steroids</e1> or <e2>ACTH</e2> may increase the edema. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e2>indinavir</e2>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain <e1>monoamine oxidase inhibitors</e1>) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or <e2>carbamazepine</e2>. \n",
      "There was no effect of a single dose or multiple doses of <e1>MYCAMINE</e1> on mycophenolate mofetil, cyclosporine, tacrolimus, <e2>prednisolone</e2>, and fluconazole pharmacokinetics. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e1>phenytoin</e1>, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "This interaction should be given consideration in patients taking <e1>NSAIDs</e1> concomitantly with <e2>ACE inhibitors</e2>. \n",
      "To observe the injury in rat primary cultured neurons induced by <e1>Abeta(1-40)</e1> and the protective effects of combination of ginseng and <e2>ginko</e2> extracts.\n",
      "<e1>Theophylline</e1>: Theophylline clearance may decrease when hyperthyroid patients on a stable <e2>theophylline</e2> regimen become euthyroid; \n",
      "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with <e1>sucralfate</e1>, <e2>gelusil</e2>, erythromycin and multi minerals. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, <e1>rifampin</e1>, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e1>methotrexate</e1>), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "While there is evidence that <e1>fluconazole</e1> can inhibit the metabolism of ethinyl estradiol and <e2>levonorgestrel</e2>, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism. \n",
      "We sought to determine (1) the frequency of <e1>colchicine</e1> toxicity among hospitalized patients taking colchicine who died during an admission, (2) the likelihood that <e2>colchicine</e2> contributed to death, (3) whether patients were taking interacting medications that could have contributed to toxicity, and (4) whether colchicine dosing among these patients adhered to established guidelines. \n",
      "No clinically significant changes to <e1>lamivudine</e1> or <e2>zidovudine</e2> pharmacokinetics were observed following concomitant administration of abacavir. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., <e1>phenylephrine</e1>, pseudoephedrine, <e2>ephedrine</e2>, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "In vitro studies show that <e1>tiludronate</e1> does not displace <e2>warfarin</e2> from its binding site on protein.\n",
      "Another study at a 400-mg and 800-mg daily dose of fluconazole demonstrated that <e1>DIFLUCAN</e1> taken in doses of 400 mg per day or greater significantly increases plasma levels of <e2>terfenadine</e2> when taken concomitantly. \n",
      "Although this has not occurred in in vitro studies with <e1>coumarin-type anticoagulants</e1>, interactions with <e2>coumarin-type anticoagulants</e2> have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. \n",
      "The latter displayed midazolam clearances similar to those in two larger cohorts of nonmatched <e1>tacrolimus</e1>-treated patients (n = 58 and n = 80) and to those receiving a <e2>calcineurin inhibitor</e2>-free regimen (n = 6). \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of <e1>antacids</e1> has no effect on <e2>piroxicam</e2> plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "<e1>Glyburide</e1>: In 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, <e2>orlistat</e2> did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, <e1>theophyllines</e1>, phenytoins, <e2>thiazide diuretics</e2>, beta blockers, and calcium channel blockers.\n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with <e1>aspirin</e1> (3900 mg/day), but concomitant administration of <e2>antacids</e2> has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including <e2>atazanavir</e2>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>AAV2</e1> containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, <e2>heparinase III</e2>, or chondroitin ABC lyase. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., <e1>pentazocine</e1>, nalbuphine, <e2>butorphanol</e2>, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Methylxanthines: <e1>Sparfloxacin</e1> does not increase plasma <e2>theophylline</e2> concentrations. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, <e1>rifabutin</e1>, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "The effect of <e1>meloxicam</e1> on the anticoagulant effect of <e2>warfarin</e2> was studied in a group of healthy subjects receiving daily doses of warfarin that produced an INR (International Normalized Ratio) between 1.2 and 1.8. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, flavanone, <e1>flavanonols</e1> and <e2>catechins</e2>, on the elimination of luteolin and apigenin was studied. \n",
      "<e1>HMG-CoA reductase inhibitors</e1>: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or <e2>fluvastatin</e2>. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (Dilantin) carbamazepine (<e2>Tegretol</e2>) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include <e1>erythromycin</e1>, <e2>rifampin</e2>, rifabutin, ketoconazole, and fluconazole. \n",
      "The permeation of <e1>colchicine</e1> in the nanoemulsion across the intestinal membrane was significantly different from that of the control group (0.2 mM <e2>colchicine</e2>). \n",
      "Another study at a 400-mg and 800-mg daily dose of <e1>fluconazole</e1> demonstrated that <e2>DIFLUCAN</e2> taken in doses of 400 mg per day or greater significantly increases plasma levels of terfenadine when taken concomitantly. \n",
      "In vitro studies with <e1>atracurium</e1>, mivacurium, esmolol, echothiophate, neostigmine, physostigmine, and midazolam revealed no inhibition of <e2>remifentanil</e2> hydrolysis in whole human blood by these drugs.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "After oral administration of <e1>colchicine</e1> (8 mg/kg) in the form of either the nanoemulsion or in free colchicine solution, the relative bioavailability of nanoemulsion and <e2>eugenol</e2>-nanoemulsion were enhanced by about 1.6- and 2.1-fold, respectively, compared with free colchicine solution. \n",
      "However, it is possible that concomitant use of other <e1>photosensitizing agents</e1> (e.g., <e2>tetracyclines</e2>, sulfonamides, phenothiazines, sulfonylurea hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e1>benzodiazepenes</e1> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, polymyxin B, <e1>colistin</e1>, <e2>viomycin</e2>, or cisplatin, when indicated, requires careful monitoring.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, <e1>naproxen</e1>, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, <e1>narcotic analgesics</e1>, sedatives, and <e2>tranquillisers</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Agents that might be coadministered with <e1>trimetrexate</e1> in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, <e2>rifabutin</e2>, ketoconazole, and fluconazole. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - <e2>edrophonium</e2> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Furafylline and <e1>sulfaphenazole</e1> had no effect, while <e2>quinidine</e2> appeared to augment precocene I toxicity. \n",
      "Remifentanil clearance is not altered by concomitant administration of <e1>thiopental</e1>, isoflurane, propofol, or <e2>temazepam</e2> during anesthesia. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or <e2>reverse transcriptase inhibitors</e2> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Acromegalic patients with diabetes mellitus being treated with <e1>insulin</e1> and/or oral <e2>hypoglycemic</e2> agents may require dose reductions of these therapeutic agents after the initiation of therapy with SOMAVERT. \n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, cisplatin, <e1>doxorubicin</e1> and etoposide   <e2>celecoxib</e2> following different incubation schedules were analyzed.\n",
      "<e1>Monoamine oxidase inhibitors</e1> or tricyclic antidepressants may potentiate the action of <e2>sympathomimetic amines</e2>. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, itraconazole, miconazole) or <e2>macrolide antibiotics</e2> (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with <e1>dornase alfa</e1> (PULMOZYME   , Genentech), (beta)-agonists, inhaled <e2>corticosteroids</e2>, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The synergistic antinociception activity of <e1>ibuprofen</e1> when administered with <e2>piperine</e2> can be attributed to increased plasma concentration of ibuprofen. \n",
      "Rifampin: <e1>Rifampin</e1> enhances the metabolism of concurrently administered <e2>DIFLUCAN</e2>. \n",
      "Accordingly, patients should be advised to avoid <e1>alcohol</e1> while taking <e2>REMERON SolTab</e2>. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. \n",
      "In an in vitro assay, <e1>lapatinib</e1> induced HER2 expression at the cell surface of HER2-positive breast cancer cell lines, leading to the enhancement of <e2>Herceptin</e2>-mediated ADCC. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, <e1>warfarin</e1>, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that <e2>Mephenytoin</e2> may interact with other drugs that are not listed here.\n",
      "Due to the chemical similarity of other azole-type antifungal agents (including <e1>fluconazole</e1>, metronidazole, and miconazole) to ketoconazole, and <e2>itraconazole</e2>, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Lithium: Increased serum <e1>lithium</e1> and symptoms of lithium toxicity have been reported in patients receiving concomitant <e2>lithium</e2> and ACE inhibitor therapy. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, echothiophate, <e1>neostigmine</e1>, <e2>physostigmine</e2>, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e1>clindamycin</e1>, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Telbivudine</e1> is excreted mainly by passive diffusion so the potential for interactions between <e2>telbivudine</e2> and other drugs eliminated by renal excretion is low. \n",
      "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, <e1>sex steroids</e1>, anticonvulsants, <e2>cyclosporin</e2>). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "In Trial 1, the proportions of patients in the placebo and Synagis    groups who received routine childhood <e1>vaccines</e1>, <e2>influenza vaccine</e2>, bronchodilators or corticosteroids were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "In 1984, Drs Rimmer and Richens at the University of Wales reported that administering <e1>vigabatrin</e1> with <e2>phenytoin</e2> lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy. \n",
      "After 21 weeks of <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1> treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2>-treated monkeys were significantly affected. \n",
      "Anticholinesterases: Concurrent use of <e1>procaine hydrochloride</e1> and anticholinesterase agents may result in increased systemic toxicity since <e2>anticholinesterases</e2> inhibit the breakdown of procaine hydrochloride. \n",
      "ECG intervals (PR, QRS, and QT) were not affected by concurrent Mexitil    and digoxin, <e1>diuretics</e1>, or <e2>propranolol</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Therefore, the coadministration of <e1>probenecid</e1> with <e2>meropenem</e2> is not recommended. \n",
      "Fluconazole tablets coadministered with ethinyl estradiol- and <e1>levonorgestrel</e1>-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and <e2>levonorgestrel</e2> levels; \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Oral <e1>Contraceptives</e1>: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of <e2>norethindrone acetate</e2> and 75    g of ethinyl estradiol were studied. \n",
      "heparin, <e1>warfarin</e1>, <e2>diazepam</e2>, insulin; \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and <e1>magnesium salicylate</e1>s, Colestipol, Iron-containing drugs, Laxatives, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "Alcohol, <e1>Barbiturates</e1>, and Narcotics: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with <e2>metolazone</e2> therapy. \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of <e2>coumarin anticoagulants</e2>, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "<e1>Mequitazine</e1> can interact with CNS depressant, antichlolinergic, TCA, MAOIs, and <e2>alcohol</e2>.\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e1>phenobarbital</e1>, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Warfarin users who initiated citalopram, <e1>fluoxetine</e1>, paroxetine, amitriptyline, or <e2>mirtazapine</e2> had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Mixing SYMLIN and Insulin The pharmacokinetic parameters of <e1>SYMLIN</e1> were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant <e2>human insulin</e2> immediately prior to injection. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, <e1>miconazole</e1>) or macrolide antibiotics (eg, erythromycin, <e2>clarithromycin</e2>) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "The colchicine nanoemulsion was prepared with isopropyl myristate, <e1>eugenol</e1>, <e2>Tween80</e2>, ethanol and water, and eugenol was used as an oil phase in the formulation; \n",
      "In a study conducted in healthy subjects, mean pre-dose <e1>lithium</e1> concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with <e2>meloxicam</e2> 15 mg QD as compared to subjects receiving lithium alone. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e1>TRANQUILIZERS</e1>, SEDATIVE-HYPNOTICS (INCLUDING <e2>BARBITURATES</e2>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "The induction dose requirements of <e1>DIPRIVAN</e1> Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, <e2>morphine</e2>, meperidine, and fentanyl, etc.) \n",
      "Although a causal relationship has not been established, there have been reports of bleeding and/or prolonged prothrombin time in patients treated with TRENTAL with and without <e1>anticoagulants</e1> or <e2>platelet aggregation inhibitors</e2>. \n",
      "Concurrent use with vasoconstrictor agents including ergot alkaloids, <e1>sumatriptan</e1>, and <e2>nicotine</e2> (e.g. smoking) may result in enhanced vasoconstriction.\n",
      "However, the extent of biotransformation of <e1>perindopril</e1> to the active metabolite, <e2>perindoprilat</e2>, is reduced approximately 43%, resulting in a reduction in the plasma ACE inhibition curve of approximately 20%, probably clinically insignificant. \n",
      "<e1>Terfenadine</e1>: Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving azole antifungals in conjunction with <e2>terfenadine</e2>, interaction studies have been performed. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e2>clarithromycin</e2>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with <e1>tamoxifen</e1> for breast cancer, especially <e2>SSRI antidepressants</e2> such as paroxetine and fluoxetine. \n",
      "Fluconazole tablets coadministered with <e1>ethinyl estradiol</e1>- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and <e2>levonorgestrel</e2> levels; \n",
      "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that <e1>fluconazole</e1> is a net inducer of <e2>ethinyl estradiol</e2> or levonorgestrel metabolism. \n",
      "<e1>Cyclosporine</e1>: The total ezetimibe level increased 12-fold in one renal transplant patient receiving multiple medications, including <e2>cyclosporine</e2>. \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e2>antibiotics</e2> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "<e1>Digitalis Glycosides</e1>: <e2>Diuretic</e2>-induced hypokalemia can increase the sensitivity of the myocardium to digitalis. \n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (<e1>cisplatin</e1>, cyclophosphamide, <e2>cytarabine</e2>, doxorubicin and mitomycin C) in murine tumor models.\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, <e1>ethanol</e1>, <e2>cyclosporine</e2>). \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e2>tetracyclines</e2>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Treatment of HEY xenograft-bearing mice with <e1>dasatinib</e1> plus <e2>paclitaxel</e2> inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e2>lincomycin</e2>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Use of Anticoagulants and Antiplatelet Agents -- Streptase, Streptokinase, alone or in combination with <e1>antiplatelet agents</e1> and <e2>anticoagulants</e2>, may cause bleeding complications. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, <e1>nalbuphine</e1>, <e2>butorphanol</e2>, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e1>nelfinavir</e1>, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Concurrent use with vasoconstrictor agents including <e1>ergot alkaloids</e1>, sumatriptan, and <e2>nicotine</e2> (e.g. smoking) may result in enhanced vasoconstriction.\n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including <e1>alcohol</e1>, barbiturates, hypnotics, narcotic analgesics, sedatives, and <e2>tranquillisers</e2>. \n",
      "Concomitant administration of TRENTAL and <e1>theophylline</e1>-containing drugs leads to increased <e2>theophylline</e2> levels and theophylline toxicity in some individuals. \n",
      "Warfarin: A multidose study of <e1>oxandrolone</e1>, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with <e2>warfarin</e2>, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. \n",
      "<e1>Sulfamethizole</e1> may increase the effects of barbiturates, tolbutamide, and <e2>uricosurics</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e1>phenobarbital</e1>, <e2>diphenylhydantoin</e2>, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, <e1>diazepam</e1>, hydroxyzine, and other <e2>muscle relaxants</e2>) or local anesthetics have been observed.\n",
      "Results revealed that the strains were resistant to many drugs at high levels, only piperacillin, <e1>carbenicillin</e1>, amikacin and <e2>ciprofloxacin</e2> showed resistances at comparatively lower levels. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), <e2>benzodiazepines</e2>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e1>desglymidodrine</e1> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e1>imipramine</e1> (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . <e1>Theophylline</e1> plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing <e2>Mexitil</e2>   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "in 10 of the 12 patients, this occurred when <e1>LUCENTIS</e1> was administered 7 days (   2 days) after <e2>verteporfin</e2> PDT.\n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain <e1>monoamine oxidase inhibitors</e1>) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered <e2>phenytoin</e2> or carbamazepine. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e1>levothyroxine sodium</e1>, medroxyprogesterone acetate, <e2>methotrexate</e2>, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Less potent inhibitors include <e1>saquinavir</e1>, nefazodone, <e2>fluconazole</e2>, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole. \n",
      "The FDA has approved ticagrelor (Brilinta-AstraZeneca), an oral <e1>antiplatelet drug</e1>, for use with low-dose <e2>aspirin</e2> to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). \n",
      "Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of <e1>diazepam</e1> (15 mg) had a minimal effect on plasma levels of <e2>mirtazapine</e2> (15 mg) in 12 healthy subjects. \n",
      "Due to the chemical similarity of other <e1>azole-type antifungal agents</e1> (including fluconazole, metronidazole, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with <e2>terfenadine</e2> is not recommended pending full examination of potential interactions. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, <e1>phenylpropanolamine</e1> or dihydroergotamine) may enhance or potentiate the pressor effects of <e2>ProAmatine</e2>   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e1>penicillins</e1>, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, hypnotics, <e2>tranquilizers</e2>, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e1>Potassium chloride</e1> (e.g., <e2>Kay Ciel</e2>)\n",
      "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and <e1>simethicone</e1>) did not significantly affect the exposure of <e2>oxybutynin</e2> or desethyloxybutynin.    \n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e2>TRANQUILIZERS</e2>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "To minimize CNS depression and possible potentiation, barbiturates, antihistamines, narcotics, <e1>hypotensive agents</e1> or <e2>phenothiazines</e2> should be used with caution. \n",
      "<e1>Lapatinib</e1> may have the potential to convert <e2>Herceptin</e2>-refractory to Herceptin-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e1>clomipramine</e1> (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Because <e1>Matulane</e1> exhibits some monoamine oxidase inhibitory activity, <e2>sympathomimetic drugs</e2>, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e1>medroxyprogesterone acetate</e1>, methotrexate, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, <e1>Colestipol</e1>, Iron-containing drugs, Laxatives, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "e.g., other belladonna alkaloids, antihistamines (including <e1>meclizine</e1>), tricyclic antidepressants, and <e2>muscle relaxants</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e1>imipramine</e1> (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "A pharmacokinetic study demonstrated that coadministration of <e1>megestrol acetate</e1> and <e2>indinavir</e2> results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of indinavir. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, <e1>rifampin</e1>, rifabutin, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, <e2>Phenytoin</e2>, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Pindolol has been used with a variety of <e1>antihypertensive agents</e1>, including hydrochlorothiazide, hydralazine, and <e2>guanethidine</e2> without unexpected adverse interactions. \n",
      "Dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, butyrophenones, <e2>thioxanthines</e2> ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e1>quinine</e1>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), <e1>antihypertensives</e1> (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e2>estrogens</e2> (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e1>Aventyl</e1>, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "In vitro perfusion of isolated rat liver has shown that cimetidine caused a significant reduction in <e1>trimetrexate</e1> metabolism and that <e2>acetaminophen</e2> altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites. \n",
      "The effect of a series of flavonoids, including <e1>flavonols</e1>, flavones, isoflavone, <e2>flavanone</e2>, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Preliminary evidence suggests that <e1>cimetidine</e1> inhibits <e2>mebendazole</e2> metabolism and may result in an increase in plasma concentrations of mebendazole.\n",
      "Based on an in vitro rat liver model, nitrogen substituted <e1>imidazole drugs</e1> (clotrimazole, ketoconazole, miconazole) were potent, non-competitive inhibitors of <e2>trimetrexate</e2> metabolism. \n",
      "<e1>Carbidopa</e1>/Levodopa: <e2>Carbidopa</e2>/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). \n",
      "There is usually complete cross-resistance between PURINETHOL (mercaptopurine) and <e1>TABLOID</e1> brand <e2>Thioguanine</e2>. \n",
      "You cannot take mazindol if you have taken a <e1>monoamine oxidase inhibitor</e1> (MAOI) such as isocarboxazid (Marplan), <e2>tranylcypromine</e2> (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Since Celontin (<e1>methsuximide</e1>) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and <e2>phenobarbital</e2>).\n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, <e1>MARINOL</e1> (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, sedatives, or <e2>opioid analgesics</e2>) without resulting in any clinically significant drug/drug interactions. \n",
      "<e1>Misoprostol</e1> has no clinically significant effect on the kinetics of diclofenac or <e2>ibuprofen</e2>.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Treatment of HEY xenograft-bearing mice with <e1>dasatinib</e1> plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, <e2>dasatinib</e2> + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e2>ketoconazole</e2> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, <e2>paracetamol</e2>, and prednisone.\n",
      "In this paper we discuss peculiarities of drug interaction between cyclooxygenase inhibitors and <e1>acetylsalicylic acid</e1>, and principles of selection of adequate <e2>NSAI</e2>.\n",
      "<e1>Digoxin</e1>: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of <e2>digoxin</e2> on the plasma concentration of perindopril/perindoprilat has not been excluded. \n",
      "The neuromuscular blocking effect of <e1>MIVACRON</e1> may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral <e2>contraceptives</e2>, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e1>nifedipine</e1>, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Although undercarboxylated osteocalcin, a marker of vitamin K nutritional status, was unaltered with <e1>XENICAL</e1> administration, vitamin K levels tended to decline in subjects taking <e2>XENICAL</e2>. \n",
      "<e1>Cholestyramine</e1>: Pretreatment for four days with <e2>cholestyramine</e2> significantly increased the clearance of meloxicam by 50%. \n",
      "<e1>LUCENTIS</e1> intravitreal injection has been used adjunctively with <e2>verteporfin</e2> photodynamic therapy (PDT). \n",
      "The effect of <e1>DTIC</e1> and <e2>imexon</e2>, alone and in combination, was evaluated for growth inhibition (MTT), radiolabeled drug uptake, cellular thiol content (HPLC), and DNA strand breaks (Comet assay). \n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including <e1>collagenase</e1>, <e2>hyaluronan lyase</e2>, heparinase III, or chondroitin ABC lyase. \n",
      "<e1>ASPIRIN</e1> AND OTHER <e2>SALICYLATE DRUGS</e2> WILL BE ADDITIVE TO DISALCID AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. \n",
      "<e1>Luteolin</e1> and <e2>apigenin</e2> experienced extensive first-pass metabolism. \n",
      "In a study of 11 HIV-infected patients receiving <e1>methadone</e1>-maintenance therapy (40 mg and 90 mg daily) with 600 mg of ZIAGEN twice daily (twice the currently recommended dose), oral <e2>methadone</e2> clearance increased 22% (90% CI 6% to 42%). \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, thyroxine, <e2>triiodothyronine</e2>, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, <e1>triamterene</e1> and others), potassium supplements or other drugs capable of increasing serum potassium (<e2>indomethacin</e2>, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Sulfamethizole may increase the effects of <e1>barbiturates</e1>, <e2>tolbutamide</e2>, and uricosurics. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, <e1>prednisolone</e1>, sirolimus, <e2>nifedipine</e2>, fluconazole, ritonavir, and rifampin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "<e1>Pilocarpine</e1> should be administered with caution to patients taking <e2>beta adrenergic antagonists</e2> because of the possibility of conduction disturbances. \n",
      "Use with Anticholinergics: Because of their mechanism of action, <e1>cholinesterase inhibitors</e1> have the potential to interfere with the activity of <e2>anticholinergic medications</e2>. \n",
      "Thus strong inhibitors of cytochrome P4501A2, such as <e1>fluvoxamine</e1>, given concomitantly during administration of Ropivacaine, can interact with Ropivacaine leading to increased <e2>ropivacaine</e2> plasma levels. \n",
      "When methyldopa and <e1>lithium</e1> are given concomitantly the patient should be carefully monitored for symptoms of <e2>lithium</e2> toxicity. \n",
      "DIPRIVAN Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used neuromuscular blocking agents (eg, <e1>succinylcholine</e1> and <e2>nondepolarizing muscle relaxants</e2>). \n",
      "The neuromuscular blocking effect of <e1>MIVACRON</e1> may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered <e2>phenytoin</e2> or carbamazepine. \n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e1>Anafranil</e1>), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Fluconazole tablets coadministered with ethinyl estradiol- and <e1>levonorgestrel</e1>-containing oral contraceptives produced an overall mean increase in <e2>ethinyl estradiol</e2> and levonorgestrel levels; \n",
      "Oral Anticoagulants: Interaction studies with <e1>warfarin</e1> failed to identify any clinically important effect on the serum concentrations of the <e2>anticoagulant</e2> or on its anticoagulant effect. \n",
      "Considering the safety of <e1>GSLS</e1>, because no adverse effect was found throughout the experiments, <e2>GSLS</e2> may be a promising oral adjuvant to improve immunization in poultry.\n",
      "Patients studied in clinical trials of <e1>TNKase</e1> were routinely treated with <e2>heparin</e2> and aspirin. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, <e1>clarithromycin</e1>), <e2>HIV protease</e2> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "<e1>Astemizole</e1>: The use of fluconazole in patients concurrently taking <e2>astemizole</e2> or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs. \n",
      "<e1>Digoxin</e1>: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, <e2>XENICAL</e2> did not alter the pharmacokinetics of a single dose of digoxin. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with <e1>succinylcholine</e1>, similar neuromuscular blocking agents or cholinergic agonists such as <e2>bethanechol</e2>.\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "Phenothiazines are capable of potentiating CNS depressants (e.g., barbiturates, anesthetics, <e1>opiates</e1>, <e2>alcohol</e2>, etc.) \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, <e1>levothyroxine sodium</e1>, <e2>medroxyprogesterone acetate</e2>, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e2>lithium</e2>, local anesthetics, procainamide, and quinidine. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "We evaluated how <e1>lapatinib</e1> interacts with <e2>Herceptin</e2> in HER2-positive breast cancer, with a particular focus on Herceptin-mediated antibody-dependent cellular cytotoxicity (ADCC). \n",
      "Compounds that quench active oxygen species or scavenge radicals, such as dimethyl sufloxide, <e1>b-carotene</e1>, <e2>ethanol</e2>, formate and mannitol would be expected to decrease PDT activity. \n",
      "Careful monitoring of <e1>phenytoin</e1> concentrations in patients receiving DIFLUCAN and <e2>phenytoin</e2> is recommended. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>Digitalis Glycosides</e1>: Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to <e2>digitalis</e2>. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including <e1>FELDENE</e1>, have been reported to increase steady state plasma <e2>lithium</e2> levels. \n",
      "A fatal poisoning case involving etizolam, <e1>phenobarbital</e1>, <e2>promethazine</e2> and chlorpromazine is presented. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, <e1>diphenylhydantoin</e1>, primidone), <e2>phenylbutazone</e2>, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, <e1>ketamine</e1>, nitrous oxide, secobarbital and <e2>droperidol</e2>. \n",
      "Drug Interactions: The use of ZEMURON    (<e1>rocuronium bromide</e1>) Injection before <e2>succinylcholine</e2>, for the purpose of attenuating some of the side effects of succinylcholine, has not been studied. \n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e2>sulfonylurea agents</e2> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Dosages of concomitantly administered opioids should be reduced by approximately half, because <e1>levomepromazine</e1> amplifies the therapeutic actions and side-effects of <e2>opioids</e2>. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, <e1>meperidine</e1> and <e2>fentanyl</e2>), propofol, ketamine, nitrous oxide, secobarbital and droperidol. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with <e1>narcotics</e1> (eg, morphine, meperidine, and <e2>fentanyl</e2>, etc.) \n",
      "<e1>Probenecid</e1>: <e2>Probenecid</e2>, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence pramipexole pharmacokinetics (N= 12). \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, <e1>theophyllines</e1>, phenytoins, thiazide diuretics, <e2>beta blockers</e2>, and calcium channel blockers.\n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: <e1>Agonist/antagonist analgesics</e1> (i.e., pentazocine, nalbuphine, <e2>butorphanol</e2>, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "The data presently available indicate that the decreases in some individual <e1>ethinyl estradiol</e1> and <e2>levonorgestrel</e2> AUC values with fluconazole treatment are likely the result of random variation. \n",
      "<e1>Dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a <e2>dopamine agonist</e2>); \n",
      "<e1>Gemfibrozil</e1>: In a pharmacokinetic study, concomitant gemfibrozil administration increased total <e2>ezetimibe</e2> concentrations approximately 1.7-fold. \n",
      "<e1>Dopamine antagonists</e1>, such as the neuroleptics (phenothiazines, butyrophenones, <e2>thioxanthines</e2> ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "A fatal poisoning case involving etizolam, <e1>phenobarbital</e1>, promethazine and <e2>chlorpromazine</e2> is presented. \n",
      "<e1>Salicylates</e1> given concomitantly with <e2>anticoagulant drugs</e2> may predispose to systemic bleeding. \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "To research the influence of <e1>glycyrrhiza extract</e1> on the pharmacokinetics characteristic parameters of <e2>daphnetin</e2>, which was aimed to explore the rationality of concert application of drugs.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of <e1>citalopram</e1> (OR   =   1.73 [95% CI, 1.25-2.38]), <e2>fluoxetine</e2> (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving methadone, treatment with <e1>PEG-Intron</e1> once weekly for 4 weeks was associated with a mean increase of 16% in <e2>methadone</e2> AUC; \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, prednisone, prednisolone, oral <e2>contraceptives</e2> (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e1>procainamide</e1>, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "Combination therapy with <e1>Cerezyme</e1>    (<e2>imiglucerase</e2>) and ZAVESCA    is not indicated.\n",
      "The effect of a series of flavonoids, including flavonols, flavones, isoflavone, flavanone, <e1>flavanonols</e1> and catechins, on the elimination of <e2>luteolin</e2> and apigenin was studied. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e1>methotrexate</e1> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "e.g., other belladonna alkaloids, <e1>antihistamines</e1> (including meclizine), <e2>tricyclic antidepressants</e2>, and muscle relaxants. \n",
      "Treatment of HEY xenograft-bearing mice with dasatinib plus <e1>paclitaxel</e1> inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, <e2>dasatinib</e2> + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Pharmacokinetic properties of abacavir were not altered by the addition of either <e1>lamivudine</e1> or zidovudine or the combination of lamivudine and <e2>zidovudine</e2>. \n",
      "<e1>Calcium</e1> is the only known component in the diet that may affect absorption of both <e2>nonheme</e2> and heme iron. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, <e1>echothiophate</e1>, neostigmine, physostigmine, and <e2>midazolam</e2> revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "and combinations of opioids and <e1>sedatives</e1> (eg, <e2>benzodiazepines</e2>, barbiturates, chloral hydrate, droperidol, etc.). \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing <e1>Mexitil</e1>   . If Mexitil and theophylline are to be used concurrently, <e2>theophylline</e2> blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "The colchicine nanoemulsion was prepared with <e1>isopropyl myristate</e1>, eugenol, Tween80, ethanol and water, and <e2>eugenol</e2> was used as an oil phase in the formulation; \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, <e1>metronidazole</e1>, and <e2>miconazole</e2>) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, <e1>thiazide diuretics</e1>, <e2>beta blockers</e2>, and calcium channel blockers.\n",
      "Use with Cholinomimetics and Other <e1>Cholinesterase Inhibitors</e1>: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with <e2>succinylcholine</e2>, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., <e1>acetaminophen</e1>, tetracycline, levodopa, ethanol, <e2>cyclosporine</e2>). \n",
      "<e1>Sirolimus</e1> AUC was increased by 21% with no effect on Cmax in the presence of steady-state MYCAMINE compared with <e2>sirolimus</e2> alone. \n",
      "Both acyclovir/<e1>ganciclovir</e1> and <e2>MPAG</e2> concentrations are increased in the presence of renal impairment, their coexistence may compete for tubular secretion and further increase in the concentrations of the two. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or <e1>bacitracin</e1> - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "The concurrent administration of potent inhalational agents (eg, <e1>isoflurane</e1>, enflurane, and <e2>halothane</e2>) during maintenance with DIPRIVAN Injectable Emulsion has not been extensively evaluated. \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e2>indinavir</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "<e1>Hyaluronidase</e1>: Hyaluronidase may increase the diffusion rate of <e2>procaine hydrochloride</e2>, resulting in a decreased time of onset, but an increase in systemic toxicity. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), <e1>calcium channel blockers</e1> (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), <e2>salicylate analgesics</e2> (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e1>TRANQUILIZERS</e1>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e1>indinavir</e1>, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, <e1>digitalis</e1>, diuretics, antidiabetic agents, and <e2>antiarrhythmics</e2>, without observed problems. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . <e1>Nonsteroidal anti-inflammatory agents</e1>, including FELDENE, have been reported to increase steady state plasma <e2>lithium</e2> levels. \n",
      "<e1>Imexon</e1> and <e2>dacarbazine</e2> show additive effects in vitro but not in vivo in human A375 melanoma cells.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e1>thyroxine</e1>, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, <e2>warfarin</e2>, methotrexate, and possibly corticosteroids. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., <e1>acetaminophen</e1>, tetracycline, <e2>levodopa</e2>, ethanol, cyclosporine). \n",
      "Drugs such as erythromycin, <e1>diltiazem</e1>, verapamil, <e2>ketoconazole</e2>, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, ketoconazole, fluconazole, <e2>calcium channel blockers</e2> and cimetidine.\n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), <e2>sulfonylurea agents</e2> (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with <e1>dornase alfa</e1> (<e2>PULMOZYME</e2>   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e1>absorbent-type anti-diarrhea medicines</e1> (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by <e1>sunitinib</e1> is superior to <e2>sunitinib</e2> followed by docetaxel and concurrent administration.\n",
      "Although ibuprofen (400 mg qid) can be administered with <e1>ALIMTA</e1> in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with <e2>ALIMTA</e2> to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Some examples of such drugs are erythromycin, itraconazole, ketoconazole, <e1>fluconazole</e1>, <e2>calcium channel blockers</e2> and cimetidine.\n",
      "Absorption of tetracyclines is impaired by antacids containing <e1>aluminum</e1>, calcium or <e2>magnesium</e2>, and iron-containing preparations. \n",
      "Interactions for <e1>Vitamin B2</e1> (<e2>Riboflavin</e2>):  Alcohol - impairs the intestinal absorption of riboflavin\n",
      "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering <e1>FELDENE</e1> to patients on <e2>coumarin-type anticoagulants</e2> and other highly protein-bound drugs. \n",
      "This increase was observed at the first test point which was the second day after starting <e1>Mexitil</e1>   . Theophylline plasma levels returned to pre-<e2>Mexitil</e2>    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Weekly intramuscular <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1> injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (<e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle). \n",
      "<e1>Aspirin</e1> may decrease bioavailability of SKELID by up to 50% when taken 2 hours after <e2>SKELID</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, <e2>phenothiazines</e2>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, <e1>lithium</e1>, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "<e1>Phenobarbital</e1>, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of <e2>montelukast</e2>. \n",
      "Do not exceed a 5 mg daily dose of <e1>VESIcare</e1> when administered with therapeutic doses of <e2>ketoconazole</e2> or other potent CYP3A4 inhibitors. \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of <e1>XENICAL</e1> and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, <e2>orlistat</e2> pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and <e2>tricyclic drugs</e2> (imipramine, clomipramine, desipramine). \n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, <e2>tricyclic antidepressants</e2>, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Although it was previously reported that <e1>lapatinib</e1> combined with <e2>Herceptin</e2> improved the progression-free survival rate compared with lapatinib alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, <e1>ritonavir</e1>, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Patients may require reduced doses of <e1>anesthetics</e1> when on <e2>methyldopa</e2>. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . <e1>Theophylline</e1> plasma levels returned to pre-<e2>Mexitil</e2>    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Drugs such as erythromycin, <e1>diltiazem</e1>, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered <e2>midazolam</e2>. \n",
      "<e1>Potassium</e1> Supplements and Potassium-Sparing Diuretics: <e2>ACEON</e2>    Tablets may increase serum potassium because of its potential to decrease aldosterone production. \n",
      "Anticholinesterases: Concurrent use of <e1>procaine hydrochloride</e1> and <e2>anticholinesterase agents</e2> may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. \n",
      "Some <e1>diuretics</e1> can enhance <e2>aminoglycoside</e2> toxicity by altering antibiotic concentrations in serum and tissue. \n",
      "CYP interactions: Inhibitors of cytochrome P450 enzymes would not be expected to affect <e1>pramipexole</e1> elimination because <e2>pramipexole</e2> is not appreciably metabolized by these enzymes in vivo or in vitro. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If <e1>Mexitil</e1> and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the <e2>Mexitil</e2>    dose is changed. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, <e1>fluconazole</e1>, ritonavir, and <e2>rifampin</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (<e2>tricyclic</e2> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Moxifloxacin and Lomefloxacin reacts faster with <e1>sucralfate</e1> and gelusil in acidic media whereas with <e2>erythromycin</e2> in basic media and multi-minerals in neutral media. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (<e1>NRTI</e1>) together with a <e2>non-nucleoside reverse transcriptase inhibitor</e2> (NNRTI), a protease inhibitor (PI) or an integrase inhibitor (II) is recommended. \n",
      "Considering the variability in exposure following enzyme inhibition and the fact that chronic dosing of <e1>panobinostat</e1> was not studied with CYP3A inhibitors, close monitoring of <e2>panobinostat</e2>-related adverse events is necessary.\n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, <e2>clarithromycin</e2>) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "In a large compassionate use program Mexitil    has been used concurrently with commonly employed antianginal, <e1>antihypertensive</e1>, and <e2>anticoagulant drugs</e2> without observed interactions. \n",
      "While there is evidence that fluconazole can inhibit the metabolism of <e1>ethinyl estradiol</e1> and <e2>levonorgestrel</e2>, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism. \n",
      "Concomitant administration of <e1>TRENTAL</e1> and theophylline-containing drugs leads to increased theophylline levels and <e2>theophylline</e2> toxicity in some individuals. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e1>Rifabutin</e1>, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e1>corticosteroids</e1> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to <e1>sunitinib</e1> followed by <e2>docetaxel</e2> and concurrent administration.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, thyroxine, triiodothyronine, <e2>phenytoin</e2>, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "<e1>Cyclosporine</e1>: Preliminary data from a <e2>XENICAL</e2> and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with cyclosporine. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, <e1>Choline</e1> and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing <e1>antacids</e1> (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when <e2>Myfortic</e2> was administered alone under fasting conditions. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e1>pramipexole</e1> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Concurrent administration of bacteriostatic antibiotics (e.g., erythromycin, <e1>tetracycline</e1>) may diminish the bactericidal effects of <e2>penicillins</e2> by slowing the rate of bacterial growth. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, <e1>naproxen</e1>, ibuprofen, diazepam, and <e2>diazoxide</e2>. \n",
      "The objective of this study was to evaluate the effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the humoral immune responses of chickens to <e1>inactivated</e1><e2>inactivated ND</e2> and AI vaccines. \n",
      "Mapping of residues important to <e1>alcohol</e1> modulation of ionotropic receptors for glycine,   -aminobutyric acid, and acetylcholine onto GLIC revealed their proximity to transmembrane cavities that may accommodate one or more <e2>alcohol</e2> molecules. \n",
      "In vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by <e1>doxorubicin</e1> and <e2>ribavirin</e2>. \n",
      "The roles of p27(Kip1), Bcl-2, and Cdk1 in apoptosis induced by <e1>dasatinib</e1> and <e2>paclitaxel</e2> were assessed using a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, siRNA knockdown of gene expression, transfection with Bcl-2 and Cdk1 expression vectors, and flow cytometry. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral <e1>contraceptives</e1>, hormone replacement therapies, hypoglycemics, theophyllines, <e2>phenytoins</e2>, thiazide diuretics, beta blockers, and calcium channel blockers.\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "<e1>Tacrolimus</e1>: There have been reports of nephrotoxicity in patients to whom fluconazole and <e2>tacrolimus</e2> were coadministered. \n",
      "<e1>UNIVASC</e1>    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, <e2>H2 blockers</e2>, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "Other eye drops or medications such as <e1>acetylcholine chloride</e1> (Miochol) and carbachol (Carboptic, <e2>Isopto Carbachol</e2>) may decrease the effects of suprofen ophthalmic.\n",
      "In most cases, the application of two <e1>nucleoside or nucleotide reverse transcriptase inhibitors</e1> (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (<e2>PI</e2>) or an integrase inhibitor (II) is recommended. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, <e1>hypoglycemics</e1>, theophyllines, phenytoins, thiazide diuretics, <e2>beta blockers</e2>, and calcium channel blockers.\n",
      "<e1>Sympathomimetics</e1> may reduce the antihypertensive effects of methyldopa, mecamylamine, <e2>reserpine</e2> and veratrum alkaloids.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e1>chlorpromazine</e1>, <e2>promethazine</e2>).\n",
      "<e1>Warfarin</e1>: The coadministration of <e2>EVISTA</e2> and warfarin has not been assessed under chronic conditions. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, indinavir, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "The effects of extracts of <e1>ginseng</e1> and ginko (<e2>EGGB</e2>) on cellular proliferative activity, apoptotic rate, ultrastructure and caspase-3 expression were detected. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> <e2>barbiturates</e2> phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, triamterene, amiloride) or potassium supplements concomitantly with <e2>ACE inhibitors</e2> can increase the risk of hyperkalemia. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, <e1>primidone</e1>), phenylbutazone, and tricyclic drugs (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, phenothiazines, <e2>nalidixic acid</e2>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, triamterene, <e2>amiloride</e2>) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e1>ranitidine</e1>, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-<e1>aluminum</e1> containing <e2>antacids</e2> (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Carbidopa/<e1>Levodopa</e1>: Carbidopa/Levodopa does not influence the pharmacokinetics of <e2>pramipexole</e2> in healthy volunteers (N= 10). \n",
      "<e1>Neuromuscular blocking agents</e1> (such as suxamethonium chloride): Concurrent use of <e2>procaine hydrochloride</e2> and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, <e1>rifapentin</e1>, <e2>phenobarbital</e2>, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e1>nefazodone</e1>, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e1>atazanavir</e1>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, <e1>warfarin</e1>, certain heart medicines, birth control pills, anti-infective medicines, furosemide and <e2>theophylline</e2> Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e2>ketoconazole</e2> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>Selegiline</e1>: In healthy volunteers (N= 11), selegiline did not influence the pharmacokinetics of <e2>pramipexole</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e2>desmethyldiazepam</e2>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, <e1>theophylline</e1>, corticosteroids, <e2>anticoagulants</e2>, and beta blockers.\n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, <e2>Iron</e2>-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "An expert panel reviewed each case and classified the likelihood of colchicine toxicity, the likelihood of a causal role of <e1>colchicine</e1> in the death using the WHO classification system, and the appropriateness of <e2>colchicine</e2> dosing. \n",
      "Drug interactions should be kept in mind when <e1>METROGEL</e1> (metronidazole gel), 1% is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical <e2>metronidazole</e2> administration because of low absorption.    \n",
      "Less potent inhibitors include <e1>saquinavir</e1>, <e2>nefazodone</e2>, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "and combinations of opioids and sedatives (eg, <e1>benzodiazepines</e1>, barbiturates, <e2>chloral hydrate</e2>, droperidol, etc.). \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, <e1>imipramine HCl</e1>) and other drugs and foods with known high <e2>tyramine</e2> content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "- Decreased absorption of colestipol, <e1>cholestyramine</e1>, mineral oil, and <e2>sucralfate</e2>.\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, <e1>analgesics</e1>, antiemetics/<e2>antinauseants</e2>, antispasmodics and anticholinergic agents. \n",
      "You cannot take <e1>mazindol</e1> if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (<e2>Nardil</e2>) in the last 14 days. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e1>colistin</e1>, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, <e2>ritonavir</e2>, and rifampin. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e1>progestin</e1> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "In post-marketing experience, as with other <e1>azole antifungals</e1>, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving fluconazole concurrently with <e2>warfarin</e2>. \n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, <e2>sulfinpyrazone</e2>, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-<e1>Mexitil</e1>    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the <e2>Mexitil</e2>    dose is changed. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - <e2>Central nervous system (CNS) depressants</e2> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Pharmacological effects of other <e1>cannabinoids</e1> or medication on the pharmacokinetics of <e2>THC</e2> have not yet been studied in detail. \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include methanol, <e1>ethylene glycol</e1>, diethylene glycol, <e2>propylene glycol</e2>, or isopropanol. \n",
      "Beside this, the medication oriented supplementation of vitamin D can also ameliorate the pharmacologic action of many drugs, such as bisphosphonates, <e1>statins</e1> and <e2>cytostatic drugs</e2>.\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, levothyroxine sodium, <e2>medroxyprogesterone acetate</e2>, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "The use of <e1>MIVACRON</e1> before <e2>succinylcholine</e2> to attenuate some of the side effects of succinylcholine has not been studied. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e1>anesthetics</e1> such as procaine - general <e2>anesthetics</e2> - succinylcholine or other muscle relaxants\n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of <e1>digoxin</e1> on the plasma concentration of perindopril/<e2>perindoprilat</e2> has not been excluded. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (<e1>curcumin</e1> 100 mg/kg plus <e2>imipramine</e2> 15 mg/kg). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Use of Anticoagulants and Antiplatelet Agents -- Streptase, <e1>Streptokinase</e1>, alone or in combination with antiplatelet agents and <e2>anticoagulants</e2>, may cause bleeding complications. \n",
      "<e1>Varenicline</e1> reduces <e2>nicotine</e2> withdrawal symptoms, cigarette craving and nicotine satisfaction. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), <e2>antidiabetics</e2> (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Coadministration of <e1>TRITEC</e1> with <e2>clarithromycin</e2> resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%). \n",
      "Patients receiving <e1>tacrolimus</e1> and <e2>fluconazole</e2> concomitantly should be carefully monitored. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and <e1>rifampin</e1> may increase the clearance of methylprednisolone and may require increased in <e2>methylprednisolone</e2> dose to achieve the desired response. \n",
      "The effect of a series of <e1>flavonoids</e1>, including <e2>flavonols</e2>, flavones, isoflavone, flavanone, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>Terbinafine</e1> clearance is increased 100% by <e2>rifampin</e2>, a CyP450 enzyme inducer, and decreased 33% by cimetidine, a CyP450 enzyme inhibitor. \n",
      "and combinations of <e1>opioids</e1> and sedatives (eg, benzodiazepines, barbiturates, <e2>chloral hydrate</e2>, droperidol, etc.). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, <e1>nefazodone</e1>, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "Not compatible with <e1>CNS depressants</e1> or <e2>trycyclic antidepressants</e2>\n",
      "Moxifloxacin and <e1>Lomefloxacin</e1> reacts faster with sucralfate and <e2>gelusil</e2> in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. \n",
      "Concomitant administration of <e1>terfenadine</e1> with clarithromycin, erythromycin, or <e2>troleandomycin</e2> is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "Digoxin: <e1>Sparfloxacin</e1> has no effect on the pharmacokinetics of <e2>digoxin</e2>. \n",
      "Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of <e1>ZOLINZA</e1> and other <e2>HDAC inhibitors</e2> (e.g., valproic acid). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e1>itraconazole</e1>, <e2>voriconazole</e2>). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "The effect of <e1>curcumin</e1> (100 mg/kg) was similar to that of fluoxetine and <e2>imipramine</e2> (p > 0.05) but its addition to fluoxetine and imipramine did not improve their antidepressant activity (p > 0.05). \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and <e1>SKELID</e1> are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before <e2>SKELID</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e1>indinavir</e1>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (<e1>curcumin</e1> 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (<e2>curcumin</e2> 100 mg/kg plus imipramine 15 mg/kg). \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as <e1>alcohol</e1>, sedatives, <e2>antihistaminics</e2>, or psychotropic drugs. \n",
      "<e1>ARAMINE</e1> should be used with caution in digitalized patients, since the combination of digitalis and <e2>sympathomimetic amines</e2> may cause ectopic arrhythmias. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "The effect of a series of flavonoids, including flavonols, flavones, <e1>isoflavone</e1>, <e2>flavanone</e2>, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "<e1>Barbiturates</e1> may decrease the effectiveness of oral <e2>contraceptives</e2>, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.\n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral <e1>contraceptives</e1>, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, <e2>thiazide diuretics</e2>, beta blockers, and calcium channel blockers.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e1>progestin</e1> (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), <e2>phenytoin</e2> (decreased hepatic clearance of phenytoin).\n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and <e1>tramadol</e1> has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of <e2>tramadol</e2>.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, <e1>ritonavir</e1>, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "The findings suggest that the dosage of <e1>S-ketamine</e1> should be reduced in patients receiving <e2>ticlopidine</e2>.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e1>procainamide</e1>, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, MARINOL (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, <e1>anti-infective</e1> agents, <e2>sedatives</e2>, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Therefore, use of <e1>zidovudine</e1> in combination with <e2>ZERIT</e2> should be avoided. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, <e1>Cholestyramine</e1>, Choline and <e2>magnesium salicylate</e2>s, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Because of profound and long lasting inhibition of gastric acid secretion, <e1>pantoprazole</e1> may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, <e2>ketoconazole</e2>, ampicillin esters, and iron salts). \n",
      "and combinations of <e1>opioids</e1> and sedatives (eg, <e2>benzodiazepines</e2>, barbiturates, chloral hydrate, droperidol, etc.). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, <e1>griseofulvin</e1>, phenothiazines, nalidixic acid, <e2>halogenated salicylanilides</e2> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "<e1>DIFLUCAN</e1> reduces the metabolism of tolbutamide, <e2>glyburide</e2>, and glipizide and increases the plasma concentration of these agents. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, <e1>naproxen</e1>, ibuprofen, <e2>diazepam</e2>, and diazoxide. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e1>indinavir</e1>, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Sulfamethizole may increase the effects of barbiturates, <e1>tolbutamide</e1>, and <e2>uricosurics</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e2>desmethyldiazepam</e2>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, <e1>erythromycin</e1>, clarithromycin) or cyclosporine or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "<e1>Aspirin</e1>: Concomitant administration of aspirin (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of <e2>meloxicam</e2>. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or <e1>buprenorphine</e1>) should NOT be administered to patients who have received or are receiving a course of therapy with a proof <e2>opioid agonist analgesic</e2>. \n",
      "However, on the basis of available data, no dosage adjustment for <e1>ondansetron</e1> is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of <e2>tramadol</e2>.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e2>quinine</e2>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>Phenytoin</e1>, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, <e2>carbamazepine</e2>, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Drug-Drug Interactions Although in vitro studies demonstrated the potential of <e1>rifaximin</e1> to interact with cytochrome P450 3A4 (CYP3A4), a clinical drug-drug interaction study demonstrated that rifaximin did not significantly affect the pharmacokinetics of <e2>midazolam</e2> either presystemically or systemically. \n",
      "The effect of a series of <e1>flavonoids</e1>, including flavonols, flavones, isoflavone, <e2>flavanone</e2>, flavanonols and catechins, on the elimination of luteolin and apigenin was studied. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, <e2>triamterene</e2>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of <e1>XENICAL</e1> and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to <e2>orlistat</e2>. \n",
      "This increase was observed at the first test point which was the second day after starting <e1>Mexitil</e1>   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the <e2>Mexitil</e2>    dose is changed. \n",
      "This study evaluated the effect of a potent CYP3A inhibitor, <e1>ketoconazole</e1>, on the pharmacokinetics and safety of <e2>panobinostat</e2>.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, Cisapride, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Pharmacokinetic properties of abacavir were not altered by the addition of either lamivudine or <e1>zidovudine</e1> or the combination of lamivudine and <e2>zidovudine</e2>. \n",
      "Oral hypoglycemic agents <e1>Oxandrolone</e1> may inhibit the metabolism of oral <e2>hypoglycemic agents</e2>. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as <e1>amphotericin B</e1>, aminoglycosides, bacitracin, polymyxin B, <e2>colistin</e2>, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and <e1>levonorgestrel</e1>, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or <e2>levonorgestrel</e2> metabolism. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e1>DIFLUCAN</e1> with oral <e2>hypoglycemic agents</e2>; \n",
      "A system combining <e1>o-cymen-5-ol</e1> and <e2>zinc</e2> shows properties desirable for incorporation in toothpastes.\n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when <e1>ezetimibe</e1> was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or <e2>fluvastatin</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (<e2>Sinequan</e2>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, <e1>cyclosporine</e1>, <e2>tacrolimus</e2>, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as <e1>amphotericin B</e1>, <e2>aminoglycosides</e2>, bacitracin, polymyxin B, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "The objective of this study was to evaluate the effect of oral administration of ginseng stem-and-leaf saponins (<e1>GSLS</e1>) on the humoral immune responses of chickens to <e2>inactivated</e2> ND and AI vaccines. \n",
      "Drugs such as <e1>erythromycin</e1>, diltiazem, <e2>verapamil</e2>, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "There was no effect of a single dose or multiple doses of <e1>MYCAMINE</e1> on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and <e2>fluconazole</e2> pharmacokinetics. \n",
      "John   s Wort, and certain anticonvulsants (phenytoin, <e1>phenobarbital</e1>, <e2>carbamazepine</e2>) may induce mifepristone metabolism (lowering serum levels of mifepristone). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., <e2>phenothiazines</e2>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., <e1>phenytoin</e1>, <e2>carbamazepine</e2>, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and <e2>tricyclic drugs</e2> (imipramine, clomipramine, desipramine). \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Due to the chemical similarity of other azole-type antifungal agents (including <e1>fluconazole</e1>, metronidazole, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with <e2>terfenadine</e2> is not recommended pending full examination of potential interactions. \n",
      "<e1>Methotrexate</e1>: A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of <e2>meloxicam</e2> on the pharmacokinetics of methotrexate taken once weekly. \n",
      "Moxifloxacin and Lomefloxacin reacts faster with sucralfate and <e1>gelusil</e1> in acidic media whereas with erythromycin in basic media and <e2>multi-minerals</e2> in neutral media. \n",
      "and/or <e1>antibiotic drug</e1> doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin <e2>1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine</e2> (MPTP) (4 x 20 mg/kg, i. p.) \n",
      "This could lead to decreased <e1>salicylate</e1> serum levels or increase the risk of salicylate toxicity when <e2>methylprednisolone</e2> is withdrawn. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "In 1984, Drs Rimmer and Richens at the University of Wales reported that administering <e1>vigabatrin</e1> with phenytoin lowered the serum <e2>phenytoin</e2> concentration in patients with treatment-resistant epilepsy. \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), <e1>potassium</e1> supplements or other drugs capable of increasing serum potassium (<e2>indomethacin</e2>, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Mild hepatotoxicity has been reported in some patients when <e1>lorazepam</e1> and <e2>pyrimethamine</e2> were administered concomitantly.\n",
      "Compared with the elimination of pure luteolin and apigenin, the elimination of luteolin and <e1>apigenin</e1> was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and <e2>apigenin</e2>. \n",
      "Oral <e1>hypoglycemic agents</e1> Oxandrolone may inhibit the metabolism of oral <e2>hypoglycemic agents</e2>. \n",
      "Concurrent ingestion of antacid (20 mL of antacid containing <e1>aluminum hydroxide</e1>, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or <e2>desethyloxybutynin</e2>.    \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "Reduced absorption of <e1>folic acid</e1> and digoxin have been reported when those agents were administered concomitantly with <e2>sulfasalazine</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, <e1>Phenytoin</e1>, <e2>Cyclosporine</e2>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "ASPIRIN AND OTHER <e1>SALICYLATE DRUGS</e1> WILL BE ADDITIVE TO <e2>DISALCID</e2> AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), <e2>MAO inhibitors</e2> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with <e1>erythromycin</e1> in basic media and <e2>multi-minerals</e2> in neutral media. \n",
      "The interaction of <e1>Streptase</e1>, <e2>Streptokinase</e2>, with other drugs has not been well studied. \n",
      "The neuromuscular blocking effect of <e1>MIVACRON</e1> may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing <e2>neuromuscular blocking agents</e2> has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e2>beta blockers</e2> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e1>progestin</e1> (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, <e1>astemizole</e1>, <e2>cisapride</e2>, cyclosporine, and tricyclic antidepressants. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (<e1>MAOI</e1>) such as isocarboxazid (Marplan), <e2>tranylcypromine</e2> (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with <e1>ropivacaine</e1> infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of <e2>ropivacaine</e2>.\n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e2>selegiline</e2>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e2>ANESTHETICS</e2>, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "<e1>morphine</e1>, theophylline, aminophylline, succinylcholine, <e2>reserpine</e2>, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "Interactions for <e1>Dronabinol</e1>:  In studies involving patients with AIDS and/or cancer, MARINOL (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, sedatives, or <e2>opioid analgesics</e2>) without resulting in any clinically significant drug/drug interactions. \n",
      "CNS depressant medications: Concurrent use of <e1>procaine hydrochloride</e1> and <e2>CNS depressant medications</e2> may result in additive depressant effects. \n",
      "Based on an in vitro rat liver model, nitrogen substituted <e1>imidazole drugs</e1> (clotrimazole, <e2>ketoconazole</e2>, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, <e1>tranquilizers</e1>, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, <e2>itraconazole</e2>, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "The safety of using <e1>methylphenidate</e1> in combination with <e2>clonidine</e2> or other centrally acting alpha-2 agonists has not been systemically evaluated.    \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and <e1>fentanyl</e1>), propofol, ketamine, nitrous oxide, <e2>secobarbital</e2> and droperidol. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e1>Cisapride</e1>, Astemizole, Rifabutin, <e2>Tacrolimus</e2>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e2>ibuprofen</e2>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as <e1>digoxin</e1>, bronchodilators, other antiviral agents, antibiotics, or <e2>anti-metabolites</e2> have not been conducted. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, <e2>linezolid</e2>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with <e1>meloxicam</e1> 15 mg QD as compared to subjects receiving <e2>lithium</e2> alone. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, <e1>penicillins</e1>, rifampin, rifabutin, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "The concurrent use of <e1>tetracycline</e1> and <e2>methoxyflurane</e2> has been reported to result in fatal renal toxicity. \n",
      "Use of <e1>potassium-sparing diuretics</e1> (<e2>spironolactone</e2>, triamterene, amiloride) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "The effects of <e1>anticholinergic drugs</e1>, such as <e2>atropine</e2> and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine. \n",
      "<e1>Palonosetron</e1> did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, <e2>cyclophosphamide</e2>, cytarabine, doxorubicin and mitomycin C) in murine tumor models.\n",
      "The influence of the other <e1>proton pump inhibitors</e1> when used simultaneously with <e2>clopidogrel</e2> has not yet been investigated in adequately randomized studies. \n",
      "The effect of <e1>curcumin</e1> (100 mg/kg) was similar to that of <e2>fluoxetine</e2> and imipramine (p > 0.05) but its addition to fluoxetine and imipramine did not improve their antidepressant activity (p > 0.05). \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of <e1>alcohol</e1> (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to <e2>orlistat</e2>. \n",
      "Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving <e1>tetracycline class drugs</e1> in conjunction with <e2>penicillin</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, polymyxins, lincomycin, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "This medicine is generally safe with other medications, but patient should consult doctor or pharmacist if patient is taking a blood thinner (anticoagulant), <e1>cyclosporin</e1>, phenytoin, or <e2>methotrexate</e2>.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, <e2>carbamazepine</e2>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Oral <e1>metronidazole</e1> has been reported to potentiate the anticoagulant effect of <e2>coumarin</e2> and warfarin, resulting in a prolongation of prothrombin time. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e1>Anafranil</e1>, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>Scopolamine</e1> should be used with care in patients taking other drugs that are capable of causing CNS effects such as <e2>sedatives</e2>, tranquilizers, or alcohol. \n",
      "<e1>Cyclosporine</e1>: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with <e2>cyclosporine</e2>. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral <e1>contraceptives</e1>, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, <e2>beta blockers</e2>, and calcium channel blockers.\n",
      "Absorption of drugs from the stomach may be diminished (e.g., <e1>digoxin</e1>) by <e2>metoclopramide</e2>, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as <e1>antiepileptic drugs</e1>, <e2>taxol</e2>, rifampicin, and human immunodeficiency virus protease inhibitors such as ritonavir and saquinavir. \n",
      "It will compete with clopidogrel (Plavix) and <e1>prasugrel</e1> (<e2>Effient</e2>) for such use. \n",
      "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of <e1>docetaxel</e1> followed by sunitinib is superior to <e2>sunitinib</e2> followed by docetaxel and concurrent administration.\n",
      "With respect to toxicity, the order of CYP inhibitor effectiveness was <e1>ABT</e1>>diethyldithiocarbamate~tranylcypromine><e2>ketoconazole</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, <e2>prednisolone</e2>, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "It has been reported that <e1>sulfamethoxazole</e1> may prolong the prothrombin time in patients who are receiving the <e2>anticoagulant</e2> warfarin. \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, <e2>prednisolone</e2>, and fluconazole pharmacokinetics. \n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., <e2>dexamethasone</e2>, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as <e2>antacids</e2> (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "The concomitant use of other CNS depressants including <e1>sedatives</e1>, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e1>nefazodone</e1>, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e2>cisplatin</e2> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "There was no effect of a single dose or multiple doses of <e1>MYCAMINE</e1> on mycophenolate mofetil, cyclosporine, <e2>tacrolimus</e2>, prednisolone, and fluconazole pharmacokinetics. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since <e2>paricalcitol</e2> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Drug-Drug Interactions Effect of Exelon    (<e1>rivastigmine tartrate</e1>) on the Metabolism of Other Drugs: <e2>Rivastigmine</e2> is primarily metabolized through hydrolysis by esterases. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, taxol, rifampicin, and human immunodeficiency virus protease inhibitors such as <e1>ritonavir</e1> and <e2>saquinavir</e2>. \n",
      "Use of Anticoagulants and Antiplatelet Agents -- <e1>Streptase</e1>, <e2>Streptokinase</e2>, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications. \n",
      "Some <e1>diuretics</e1> can enhance aminoglycoside toxicity by altering <e2>antibiotic</e2> concentrations in serum and tissue. \n",
      "Moxifloxacin and <e1>Lomefloxacin</e1> reacts faster with sucralfate and gelusil in acidic media whereas with <e2>erythromycin</e2> in basic media and multi-minerals in neutral media. \n",
      "Sulfoxone may increase the effects of <e1>barbiturates</e1>, <e2>tolbutamide</e2>, and uricosurics. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and <e1>magnesium salicylate</e1>s, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e1>nelfinavir</e1>, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "In Trial 1, the proportions of patients in the placebo and <e1>Synagis</e1>    groups who received routine childhood vaccines, influenza vaccine, bronchodilators or <e2>corticosteroids</e2> were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "Anticoagulants (such as heparin and <e1>vitamin K antagonists</e1>) and drugs that alter platelet function (such as acetylsalicylic acid, <e2>dipyridamole</e2>, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "We present an interesting case of an HIV-positive woman on <e1>antiretroviral</e1> therapy having tubal pregnancies on two separate occasions with <e2>Implanon</e2> in place.\n",
      "Mean <e1>oxybutynin chloride</e1> plasma concentrations were approximately 2 fold higher when <e2>DITROPAN XL</e2> was administered with ketoconazole, a potent CYP3A4 inhibitor. \n",
      "The CNS-depressant effect of <e1>propoxyphene</e1> is additive with that of other <e2>CNS depressants</e2>, including alcohol. \n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, <e1>cytarabine</e1>, doxorubicin and <e2>mitomycin C</e2>) in murine tumor models.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "<e1>Mephenytoin</e1> may also affect the effects of other drugs, which include some <e2>steroid medications</e2>, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  <e1>Tramadol</e1>: Although no pharmacokinetic drug interaction between <e2>ondansetron</e2> and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of <e1>morphine</e1> are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or <e2>psychotropic drugs</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e1>melatonin</e1> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e2>Asendin</e2>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, <e1>butyrophenones</e1>, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with <e2>Permax</e2> (a dopamine agonist); \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e1>neostigmine</e1> - polymyxin B or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, <e1>pancuronium</e1>, morphine, vancomycin, metformin and <e2>tenofovir</e2>). \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., <e1>erythromycin</e1> and clarithromycin), may alter <e2>oxybutynin</e2> mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: <e2>amantadine</e2>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., <e1>itraconazole</e1> and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter <e2>oxybutynin</e2> mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (<e2>phenothiazines</e2>, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Absorption of tetracyclines is impaired by <e1>antacids</e1> containing <e2>aluminum</e2>, calcium or magnesium, and iron-containing preparations. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain <e1>antibiotics</e1> given by injection - <e2>cisplatin</e2> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Other Agents: No clinically important pharmacokinetic interactions occurred when UNIVASC    was administered concomitantly with hydrochlorothiazide, <e1>digoxin</e1>, or <e2>cimetidine</e2>. \n",
      "Based on this experience, we suggest that low-dose ketamine added to <e1>propofol</e1> may be associated with prevention of EA in children with a history of EA with <e2>propofol</e2> TIVA.\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and <e2>quinine</e2>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "<e1>Sirolimus</e1> AUC was increased by 21% with no effect on Cmax in the presence of steady-state <e2>MYCAMINE</e2> compared with sirolimus alone. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, <e1>sulfonamides</e1>, phenothiazines, sulfonylurea hypoglycemia agents, thiazide diuretics, and <e2>griseofulvin</e2>) could increase the photosensitivity reaction. \n",
      "saline + saline, <e1>ephedrine</e1> (10   mg/kg) + saline, saline + dexmedetomidine (15     g/kg) and ephedrine (10   mg/kg) + <e2>dexmedetomidine</e2> (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e2>colistin</e2>, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e1>progestin</e1> (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "No significant adverse interactions with common premedications (such as <e1>atropine</e1>, scopolamine, glycopyrrolate, <e2>diazepam</e2>, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, <e1>cyclosporine</e1>, tacrolimus, prednisolone, sirolimus, <e2>nifedipine</e2>, fluconazole, ritonavir, and rifampin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Interaction with <e1>Mixed Agonist/Antagonist Opioid Analgesics</e1>: Agonist/antagonist analgesics (i.e., pentazocine, <e2>nalbuphine</e2>, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), <e2>HIV protease</e2> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Drug interactions should be kept in mind when <e1>METROGEL</e1> (<e2>metronidazole</e2> gel), 1% is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical metronidazole administration because of low absorption.    \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, <e2>triamterene</e2>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, amiloride, <e2>triamterene</e2> and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "In clinical studies of TOBI, patients taking <e1>TOBI</e1> concomitantly with dornase alfa (PULMOZYME   , Genentech), <e2>(beta)-agonists</e2>, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, <e1>griseofulvin</e1>, modafinil, penicillins, rifampin, <e2>rifabutin</e2>, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e2>protriptyline</e2> (Vivactil), or desipramine (Norpramin). \n",
      "Our results characterize and identify a novel opiate addiction switching mechanism directly in the BLA that can control the processing of <e1>opiate</e1> reward information as a direct function of <e2>opiate</e2> exposure state via D1 or D2 receptor signaling substrates.\n",
      "Digoxin: There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of <e1>digoxin</e1> with the co-administration of 100 mg <e2>sitagliptin</e2> for 10 days. \n",
      "Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of <e1>solifenacin</e1> 30 mg did not appear as large as that of the positive control <e2>moxifloxacin</e2> at its therapeutic dose. \n",
      "Pyrimethamine may be used with <e1>sulfonamides</e1>, quinine and other antimalarials, and with other <e2>antibiotics</e2>. \n",
      "<e1>Paliperidone</e1> may antagonize the effect of <e2>levodopa</e2> and other dopamine agonists. \n",
      "Concomitant administration of <e1>vancomycin</e1> and <e2>anesthetic agents</e2> has been associated with erythema and histamine-like flushing and anaphylactoid reactions. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Concomitant administration of <e1>terfenadine</e1> with clarithromycin, <e2>erythromycin</e2>, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended. \n",
      "Sulfoxone may increase the effects of <e1>barbiturates</e1>, tolbutamide, and <e2>uricosurics</e2>. \n",
      "<e1>Phenytoin</e1>, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., <e2>phenytoin</e2>, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Other <e1>short-acting beta adrenergic aerosol bronchodilators</e1> should not be used concomitantly with <e2>MAXAIR AUTOHALER</e2> because they may have additive effects.\n",
      "<e1>Monoamine oxidase inhibitors</e1> or <e2>tricyclic antidepressants</e2> may potentiate the action of sympathomimetic amines. \n",
      "Mutual inhibition of metabolism occurs with concurrent use of <e1>cyclosporin</e1> and <e2>methylprednisolone</e2>; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), <e1>antihypertensives</e1> (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "Use with Cholinomimetics and Other <e1>Cholinesterase Inhibitors</e1>: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or <e2>cholinergic agonists</e2> such as bethanechol.\n",
      "Patients receiving sirolimus or nifedipine in combination with <e1>MYCAMINE</e1> should be monitored for sirolimus or nifedipine toxicity and sirolimus or <e2>nifedipine</e2> dosage should be reduced if necessary. \n",
      "<e1>Digoxin</e1>: In 12 normal-weight subjects receiving <e2>XENICAL</e2> 120 mg three times a day for 6 days, XENICAL did not alter the pharmacokinetics of a single dose of digoxin. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e1>ketoconazole</e1>, <e2>itraconazole</e2>, voriconazole). \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., tetracyclines, <e1>sulfonamides</e1>, phenothiazines, sulfonylurea hypoglycemia agents, <e2>thiazide diuretics</e2>, and griseofulvin) could increase the photosensitivity reaction. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, <e2>hydroxychloroquine sulfate</e2>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when <e1>midazolam</e1> is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, <e2>calcium channel antagonists</e2>, and macrolide antibiotics). \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) <e1>carbamazepine</e1> (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include methanol, ethylene glycol, <e1>diethylene glycol</e1>, <e2>propylene glycol</e2>, or isopropanol. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with <e1>aspirin</e1> (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including <e2>FELDENE</e2>, have been reported to increase steady state plasma lithium levels. \n",
      "In controlled clinical trials, <e1>ALOXI</e1> injection has been safely administered with corticosteroids, analgesics, <e2>antiemetics</e2>/antinauseants, antispasmodics and anticholinergic agents. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Drugs such as troleandomycin and <e1>ketoconazole</e1> may inhibit the metabolism of <e2>methylprednisolone</e2> and thus decrease its clearance. \n",
      "These medications included thyroid hormones, <e1>sedative hypnotics</e1>, non-steroidal anti-inflammatory agents, <e2>benzodiazepines</e2>, and decongestants. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as <e1>amphotericin B</e1>, aminoglycosides, bacitracin, <e2>polymyxin B</e2>, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "The FDA has approved <e1>ticagrelor</e1> (Brilinta-AstraZeneca), an oral antiplatelet drug, for use with low-dose <e2>aspirin</e2> to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e1>ANESTHETICS</e1>, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e2>SEDATIVE-HYPNOTICS</e2> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, <e1>cisplatin</e1>, doxorubicin and <e2>etoposide</e2>   celecoxib following different incubation schedules were analyzed.\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease <e2>melatonin</e2> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral terbinafine and <e1>warfarin</e1>, however, a causal relationship between <e2>LAMISIL</e2>    Tablets and these changes has not been established. \n",
      "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of <e1>tolbutamide</e1>, <e2>sodium salicylate</e2> and sulfamethizole displaced protein-bound teniposide in fresh human serum to a small but significant extent. \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, <e1>digitalis</e1>, <e2>diuretics</e2>, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, <e1>morphine</e1>, vancomycin, metformin and <e2>tenofovir</e2>). \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a <e1>protease inhibitor</e1> (PI) or an integrase inhibitor (<e2>II</e2>) is recommended. \n",
      "ARAMINE should be used with caution in digitalized patients, since the combination of <e1>digitalis</e1> and <e2>sympathomimetic amines</e2> may cause ectopic arrhythmias. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, <e2>ibuprofen</e2>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "e.g., other belladonna alkaloids, antihistamines (including meclizine), <e1>tricyclic antidepressants</e1>, and <e2>muscle relaxants</e2>. \n",
      "The concomitant use of other CNS depressants including sedatives, <e1>hypnotics</e1>, <e2>tranquilizers</e2>, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain <e1>antibiotics</e1> (e.g., aminoglycosides, tetracyclines, <e2>bacitracin</e2>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), <e2>calcium channel blockers</e2> (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, <e2>Laxatives</e2>, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "DIPRIVAN Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used <e1>neuromuscular blocking agents</e1> (eg, <e2>succinylcholine</e2> and nondepolarizing muscle relaxants). \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when <e1>ezetimibe</e1> was co-administered with atorvastatin, <e2>simvastatin</e2>, pravastatin, lovastatin, or fluvastatin. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, <e2>terazosin</e2>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or <e1>tricyclic antidepressants</e1>, since the action of <e2>beta adrenergic agonists</e2> on the vascular system may be potentiated.\n",
      "Drug Interactions: The use of ZEMURON    (rocuronium bromide) Injection before <e1>succinylcholine</e1>, for the purpose of attenuating some of the side effects of <e2>succinylcholine</e2>, has not been studied. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other <e1>anti-pseudomonal antibiotics</e1>, or parenteral <e2>aminoglycosides</e2> demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "<e1>HMG-CoA reductase inhibitors</e1>: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, <e2>lovastatin</e2>, or fluvastatin. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e1>HIV-protease inhibitors</e1>, griseofulvin, modafinil, penicillins, rifampin, <e2>rifabutin</e2>, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "heparin, <e1>warfarin</e1>, diazepam, <e2>insulin</e2>; \n",
      "Digoxin: In 12 normal-weight subjects receiving <e1>XENICAL</e1> 120 mg three times a day for 6 days, <e2>XENICAL</e2> did not alter the pharmacokinetics of a single dose of digoxin. \n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e2>methotrexate</e2> (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e2>BARBITURATES</e2>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Anticoagulants (such as <e1>heparin</e1> and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, <e2>dipyridamole</e2>, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "In clinical studies of <e1>TOBI</e1>, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other <e2>anti-pseudomonal antibiotics</e2>, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Beta adrenergic agonists should be administered with caution to patients being treated with <e1>monoamine oxidase inhibitors</e1> or <e2>tricyclic antidepressants</e2>, since the action of beta adrenergic agonists on the vascular system may be potentiated.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of <e2>benzodiazepines</e2> (lorezepam oxezepam temezepam). \n",
      "Ethanol decreases the elimination of <e1>abacavir</e1> causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of <e2>abacavir</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and <e1>ketoconazole</e1> le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "Beside this, the medication oriented supplementation of vitamin D can also ameliorate the pharmacologic action of many drugs, such as <e1>bisphosphonates</e1>, statins and <e2>cytostatic drugs</e2>.\n",
      "The effect of a series of flavonoids, including <e1>flavonols</e1>, flavones, isoflavone, flavanone, flavanonols and catechins, on the elimination of <e2>luteolin</e2> and apigenin was studied. \n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Aspirin</e1>: Concomitant administration of <e2>aspirin</e2> (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of meloxicam. \n",
      "Cyclosporine: Preliminary data from a <e1>XENICAL</e1> and cyclosporine drug interaction study indicate a reduction in <e2>cyclosporine</e2> plasma levels when XENICAL was coadministered with cyclosporine. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "When <e1>methyldopa</e1> is used with other <e2>antihypertensive drugs</e2>, potentiation of antihypertensive effect may occur. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "As there is in vitro evidence that <e1>aminosalicylate derivatives</e1> (e.g., olsalazine, <e2>mesalazine</e2>, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., <e1>phenytoin</e1>, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and <e2>ondansetron</e2> blood concentrations were decreased. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Short-acting Benzodiazepines</e1>: Following oral administration of midazolam, fluconazole resulted in substantial increases in <e2>midazolam</e2> concentrations and psychomotor effects. \n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, <e2>rifapentin</e2>, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as tricyclic antidepressants,    -blockers, <e1>selective serotonin reuptake inhibitors</e1> (<e2>SSRIs</e2>), and monoamine oxidase inhibitors (MAO-Is) Type B, if they have a narrow therapeutic window. \n",
      "The purpose of this study was to assess the potential of <e1>neferine</e1>, an effective anti-pulmonary fibrosis drug isolated from the embryo of Nelumbo nucifera Gaertner's seeds, to alter the pharmacokinetic profile of <e2>amiodarone</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e2>TRICYCLIC ANTIDEPRESSANTS</e2> AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), antihypertensives (n=72), calcium channel blockers (n=75), <e2>antidiabetics</e2> (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, <e1>indinavir</e1>, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Mixing SYMLIN and <e1>Insulin</e1> The pharmacokinetic parameters of SYMLIN were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant <e2>human insulin</e2> immediately prior to injection. \n",
      "Adrenal steroids or <e1>ACTH</e1> In patients with edema, concomitant administration with adrenal cortical steroids or <e2>ACTH</e2> may increase the edema. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e1>imipramine</e1> (Tofranil), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as <e1>isocarboxazid</e1> (Marplan), tranylcypromine (Parnate), or <e2>phenelzine</e2> (Nardil) in the last 14 days. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), <e2>fluvoxamine</e2> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "In a study conducted in healthy subjects, mean pre-dose <e1>lithium</e1> concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving <e2>lithium</e2> alone. \n",
      "Other eye drops or medications such as acetylcholine chloride (Miochol) and <e1>carbachol</e1> (Carboptic, <e2>Isopto Carbachol</e2>) may decrease the effects of suprofen ophthalmic.\n",
      "Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, <e1>hypnotics</e1>, <e2>narcotics</e2>, or tranquilizers. \n",
      "Although specific drug or food interactions with <e1>mifepristone</e1> have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, <e2>erythromycin</e2>, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, <e2>procainamide</e2>, pancuronium, morphine, vancomycin, metformin and tenofovir). \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e1>phenobarbital</e1>, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Drug-Drug Interactions Although in vitro studies demonstrated the potential of <e1>rifaximin</e1> to interact with cytochrome P450 3A4 (CYP3A4), a clinical drug-drug interaction study demonstrated that <e2>rifaximin</e2> did not significantly affect the pharmacokinetics of midazolam either presystemically or systemically. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, <e2>griseofulvin</e2>, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "If in certain cases, an antidepressant is considered necessary, it may be advisable to replace <e1>tamoxifen</e1> with <e2>anastrozole</e2>.\n",
      "In study 1 (fasted), during each study period, volunteers received a single 105-mg dose of <e1>fenofibric acid</e1> or single 145-mg dose of <e2>fenofibrate</e2> (depending on their randomization scheme) after an overnight fast (a minimum fast of 10 hours). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e1>phenytoin</e1>, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or <e2>reverse transcriptase inhibitors</e2> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e1>nitrites</e1>, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e1>Sinequan</e1>, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Use with Cholinomimetics and Other <e1>Cholinesterase Inhibitors</e1>: A synergistic effect may be expected when <e2>cholinesterase inhibitors</e2> are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., <e2>diphenhydramine</e2>), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, <e1>lovastatin</e1>, or <e2>fluvastatin</e2>. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral <e1>ketamine</e1> by 2.4-fold, whereas itraconazole treatment did not increase the exposure to <e2>S-ketamine</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "We sought to determine (1) the frequency of colchicine toxicity among hospitalized patients taking colchicine who died during an admission, (2) the likelihood that <e1>colchicine</e1> contributed to death, (3) whether patients were taking interacting medications that could have contributed to toxicity, and (4) whether <e2>colchicine</e2> dosing among these patients adhered to established guidelines. \n",
      "May interact with <e1>cimetidine</e1>, digoxin, medicines to control heart rhythm, sevelamer, and <e2>theophylline</e2>.\n",
      "Thalidomide has been reported to enhance the sedative activity of <e1>barbiturates</e1>, <e2>alcohol</e2>, chlorpromazine, and reserpine. \n",
      "<e1>Phenytoin</e1>: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 7 days, <e2>XENICAL</e2> did not alter the pharmacokinetics of a single 300-mg dose of phenytoin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Nifedipine</e1> AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state MYCAMINE compared with <e2>nifedipine</e2> alone. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e1>itraconazole</e1>, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or <e2>vinblastine</e2>, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, <e2>vancomycin</e2>, metformin and tenofovir). \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, <e1>analgesics</e1>, antiemetics/antinauseants, antispasmodics and <e2>anticholinergic agents</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "All patients had indications for antihypertensive therapy and were randomized either to fixed combination <e1>amlodipine</e1>/<e2>valsartan</e2> (n=43) or to therapy which corresponded to the hospital formulary (n=43). \n",
      "Azathioprine/Mycophenolate Mofetil: Given that <e1>azathioprine</e1> and mycophenolate mofetil inhibit purine metabolism, it is recommended that <e2>Myfortic</e2> not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "A fatal poisoning case involving etizolam, phenobarbital, <e1>promethazine</e1> and <e2>chlorpromazine</e2> is presented. \n",
      "Coadministration of TRITEC with clarithromycin resulted in increased plasma <e1>ranitidine</e1> concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased <e2>14- hydroxy- clarithromycin</e2> plasma concentrations (31%). \n",
      "Probenecid: <e1>Probenecid</e1>, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence <e2>pramipexole</e2> pharmacokinetics (N= 12). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when <e1>ezetimibe</e1> was co-administered with <e2>atorvastatin</e2>, simvastatin, pravastatin, lovastatin, or fluvastatin. \n",
      "Caution should be exercised when <e1>Methergine</e1>    (methylergonovine maleate) is used concurrently with other vasoconstrictors or <e2>ergot alkaloids</e2>.\n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, <e1>sedatives</e1>, <e2>antihistaminics</e2>, or psychotropic drugs. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "CYP3A4 Inhibitors: <e1>Ketoconazole</e1>, an inhibitor of the drug metabolizing enzyme CYP3A4, significantly increased plasma concentrations of <e2>tolterodine</e2> when coadministered to subjects who were poor metabolizers (see CLINICAL PHARMACOLOGY, Variability in Metabolism and Drug-Drug Interactions). \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include methanol, <e1>ethylene glycol</e1>, <e2>diethylene glycol</e2>, propylene glycol, or isopropanol. \n",
      "In most cases, the application of two <e1>nucleoside or nucleotide reverse transcriptase inhibitors</e1> (<e2>NRTI</e2>) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI) or an integrase inhibitor (II) is recommended. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam <e1>oxezepam</e1> <e2>temezepam</e2>). \n",
      "Warfarin: <e1>Sparfloxacin</e1> does not increase the anti-coagulant effect of <e2>warfarin</e2>. \n",
      "<e1>Lapatinib</e1> may have the potential to convert Herceptin-refractory to <e2>Herceptin</e2>-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2.\n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), <e1>propofol</e1>, <e2>ketamine</e2>, nitrous oxide, secobarbital and droperidol. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Remifentanil</e1> clearance is not altered by concomitant administration of thiopental, <e2>isoflurane</e2>, propofol, or temazepam during anesthesia. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain <e1>antibiotics</e1>, quinidine, theophylline, corticosteroids, <e2>anticoagulants</e2>, and beta blockers.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e2>piroxicam</e2>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - <e1>Phenytoin</e1>: can increase seizure activity - Live virus vaccines: may potentiate the replication of the <e2>vaccine</e2> virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - Central nervous system (CNS) depressants - Other <e2>anticholinergics</e2> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, <e1>primidone</e1>), <e2>phenylbutazone</e2>, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "In clinical trials, the concomitant use of <e1>sulfonylureas</e1> or <e2>biguanides</e2> did not alter the adverse event profile of SYMLIN. \n",
      "DIPRIVAN Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used <e1>neuromuscular blocking agents</e1> (eg, succinylcholine and <e2>nondepolarizing muscle relaxants</e2>). \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e2>anticholinergics</e2>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>TOBI</e1> should not be administered concomitantly with ethacrynic acid, furosemide, <e2>urea</e2>, or mannitol.\n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (<e2>phenobarbital</e2>, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and <e1>rifampin</e1> may increase the clearance of <e2>corticosteroids</e2> and may require increases in corticosteroid dose to achieve the desired response. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of <e1>rosiglitazone</e1> and an inducer of CYP2C8 (such as <e2>rifampin</e2>) may decrease the AUC of rosiglitazone. \n",
      "<e1>norepinephrine</e1> and <e2>dobutamine</e2> are incompatible with sodium bicarbonate solution. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Drugs such as erythromycin, diltiazem, <e1>verapamil</e1>, ketoconazole, fluconazole and <e2>itraconazole</e2> were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, <e1>diphenylhydantoin</e1>, primidone), phenylbutazone, and tricyclic drugs (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., ritonavir, indinavir, nelfinavir, <e2>delavirdine</e2>) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "<e1>Rifabutin</e1>: There have been reports of uveitis in patients to whom fluconazole and <e2>rifabutin</e2> were coadministered. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as <e1>amitriptyline</e1> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e2>imipramine</e2> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), <e1>fluoxetine</e1> (OR   =   1.63 [95% CI, 1.11-2.38]), <e2>paroxetine</e2> (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "<e1>Beta adrenergic agonists</e1> should be administered with caution to patients being treated with monoamine oxidase inhibitors or <e2>tricyclic antidepressants</e2>, since the action of beta adrenergic agonists on the vascular system may be potentiated.\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, <e1>warfarin</e1>, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "The objective was to analyze the effects of neonatal <e1>quinpirole</e1> treatment on effects of <e2>amphetamine</e2> in adolescent rats using locomotor sensitization and conditioned place preference procedures. \n",
      "In vitro studies with atracurium, mivacurium, <e1>esmolol</e1>, echothiophate, <e2>neostigmine</e2>, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, butyrophenones, thioxanthines ) or <e2>metoclopramide</e2>, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, <e2>hydroxychloroquine sulfate</e2>, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "<e1>Triprolidine</e1> may enhance the sedative effects of central nervous system depressants including alcohol, <e2>barbiturates</e2>, hypnotics, narcotic analgesics, sedatives, and tranquillisers. \n",
      "<e1>Ropivacaine</e1> should be used with caution in patients receiving other local <e2>anesthetics</e2> or agents structurally related to amide-type local anesthetics, since the toxic effects of these drugs are additive. \n",
      "<e1>Warfarin</e1>: <e2>Sparfloxacin</e2> does not increase the anti-coagulant effect of warfarin. \n",
      "Hyaluronidase: <e1>Hyaluronidase</e1> may increase the diffusion rate of <e2>procaine hydrochloride</e2>, resulting in a decreased time of onset, but an increase in systemic toxicity. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Pindolol</e1> has been used with a variety of antihypertensive agents, including hydrochlorothiazide, <e2>hydralazine</e2>, and guanethidine without unexpected adverse interactions. \n",
      "Ticagrelor (<e1>Brilinta</e1>)--better than clopidogrel (<e2>Plavix</e2>)\n",
      "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with <e1>FELDENE</e1> since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering <e2>FELDENE</e2> to patients on coumarin-type anticoagulants and other highly protein-bound drugs. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e2>melatonin</e2> and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Scopolamine</e1> should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, <e2>tranquilizers</e2>, or alcohol. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), <e2>nonsteroidal anti-inflammatory drugs</e2> (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Phenytoin: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 7 days, <e1>XENICAL</e1> did not alter the pharmacokinetics of a single 300-mg dose of <e2>phenytoin</e2>. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral <e1>contraceptives</e1>, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing <e2>neuromuscular blocking agents</e2> has been demonstrated in patients chronically administered phenytoin or carbamazepine. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, <e1>triiodothyronine</e1>, <e2>phenytoin</e2>, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "Alcohol, Barbiturates, and <e1>Narcotics</e1>: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with <e2>metolazone</e2> therapy. \n",
      "In clinical studies of <e1>TOBI</e1>, patients taking TOBI concomitantly with dornase alfa (<e2>PULMOZYME</e2>   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "<e1>Probenecid</e1> - concurrent use decreases gastrointestinal absorption of <e2>riboflavin</e2>; \n",
      "Remifentanil clearance is not altered by concomitant administration of thiopental, isoflurane, <e1>propofol</e1>, or <e2>temazepam</e2> during anesthesia. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e2>indinavir</e2>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "<e1>Methotrexate</e1>: A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of meloxicam on the pharmacokinetics of <e2>methotrexate</e2> taken once weekly. \n",
      "In most cases, the application of two <e1>nucleoside or nucleotide reverse transcriptase inhibitors</e1> (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (<e2>NNRTI</e2>), a protease inhibitor (PI) or an integrase inhibitor (II) is recommended. \n",
      "Interactions for Vitamin B2 (Riboflavin):  <e1>Alcohol</e1> - impairs the intestinal absorption of <e2>riboflavin</e2>\n",
      "Mequitazine can interact with <e1>CNS depressant</e1>, antichlolinergic, TCA, <e2>MAOIs</e2>, and alcohol.\n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Concurrent administration of <e1>cimetidine</e1> and Mexitil    has been reported to increase, decrease, or leave unchanged <e2>Mexitil</e2>    plasma levels; \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, <e1>phenytoin</e1> and rifampin may increase the clearance of corticosteroids and may require increases in <e2>corticosteroid</e2> dose to achieve the desired response. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e1>HIV-protease inhibitors</e1>, griseofulvin, modafinil, <e2>penicillins</e2>, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Compounds that quench active oxygen species or scavenge radicals, such as dimethyl sufloxide, b-carotene, <e1>ethanol</e1>, <e2>formate</e2> and mannitol would be expected to decrease PDT activity. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "You cannot take <e1>mazindol</e1> if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or <e2>phenelzine</e2> (Nardil) in the last 14 days. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (<e1>imipramine</e1> 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (<e2>curcumin</e2> 100 mg/kg plus imipramine 15 mg/kg). \n",
      "<e1>Itraconazole</e1>: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of <e2>terfenadine</e2> and itraconazole in clinical trials of itraconazole and from foreign post-marketing sources. \n",
      "Drug-Drug Interactions: The pharmacokinetic and pharmacodynamic interactions between <e1>FLOMAX</e1> capsules and other <e2>alpha-adrenergic blocking agents</e2> have not been determined. \n",
      "<e1>Carbidopa</e1>/<e2>Levodopa</e2>: Carbidopa/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). \n",
      "Gemfibrozil: In a pharmacokinetic study, concomitant <e1>gemfibrozil</e1> administration increased total <e2>ezetimibe</e2> concentrations approximately 1.7-fold. \n",
      "<e1>Cimetidine</e1>: The effects of chronic cimetidine use on the metabolism of <e2>rimantadine</e2> are not known. \n",
      "Drug-Drug Interactions Although in vitro studies demonstrated the potential of rifaximin to interact with cytochrome P450 3A4 (CYP3A4), a clinical drug-drug interaction study demonstrated that <e1>rifaximin</e1> did not significantly affect the pharmacokinetics of <e2>midazolam</e2> either presystemically or systemically. \n",
      "Probenecid competes with <e1>meropenem</e1> for active tubular secretion and thus inhibits the renal excretion of <e2>meropenem</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, <e1>Tacrolimus</e1>, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Sympathomimetics may reduce the antihypertensive effects of <e1>methyldopa</e1>, mecamylamine, reserpine and <e2>veratrum alkaloids</e2>.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e1>indinavir</e1>, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "Other beta adrenergic aerosol bronchodilators should not be used concomitantly with <e1>Alupent</e1>    (<e2>metaproterenol sulfate</e2> USP) because they may have additive effects. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e1>Short-acting benzodiazepines</e1>,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Cyclosporine: Preliminary data from a <e1>XENICAL</e1> and <e2>cyclosporine</e2> drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with cyclosporine. \n",
      "ECG intervals (PR, QRS, and QT) were not affected by concurrent <e1>Mexitil</e1>    and <e2>digoxin</e2>, diuretics, or propranolol. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of <e2>pramipexole</e2> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, <e1>warfarin</e1>, <e2>diazepam</e2>, or fluoxetine. \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, <e2>Aventyl</e2>, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "TOBI should not be administered concomitantly with ethacrynic acid, <e1>furosemide</e1>, <e2>urea</e2>, or mannitol.\n",
      "<e1>Phenytoin</e1>, Carbamazepine, and <e2>Rifampicin</e2>: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "The ratio of norketamine AUC(0-   ) to <e1>ketamine</e1> AUC(0-   ) was significantly decreased in the ticlopidine (P &lt; 0.001) and <e2>itraconazole</e2> phases (P = 0.006) as compared to placebo. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, indinavir, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Use of potassium-sparing diuretics (spironolactone, triamterene, <e1>amiloride</e1>) or potassium supplements concomitantly with <e2>ACE inhibitors</e2> can increase the risk of hyperkalemia. \n",
      "- did not change the plasma concentration profile of terfenadine (a substrate of cytochrome P450 3A4) or <e1>fexofenadine</e1>, its carboxylated metabolite, and did not prolong the QTc interval following co-administration with <e2>terfenadine</e2> 60 mg twice daily. \n",
      "<e1>Sunitinib</e1> exhibited dose-dependent growth inhibition in NSCLC cell lines and arrested cell cycle at G1 phase, whereas <e2>docetaxel</e2> arrested at S phase. \n",
      "Systemic and apparent oral <e1>midazolam</e1> clearance were 24% (269    73 vs. 354    102  ml/min, P = 0.022) and 31% (479    190 vs. 688    265  ml/min, P = 0.013), respectively, lower in <e2>cyclosporine</e2>-treated patients (n = 20) than in matched tacrolimus-treated patients (n = 20). \n",
      "The concurrent administration of potent inhalational agents (eg, <e1>isoflurane</e1>, <e2>enflurane</e2>, and halothane) during maintenance with DIPRIVAN Injectable Emulsion has not been extensively evaluated. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e1>CNS DEPRESSANTS</e1> (INCLUDING <e2>ALCOHOL</e2>). \n",
      "<e1>Mequitazine</e1> can interact with <e2>CNS depressant</e2>, antichlolinergic, TCA, MAOIs, and alcohol.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) <e1>Estrogens</e1> may decrease the effects of <e2>benzodiazepines</e2> (lorezepam oxezepam temezepam). \n",
      "Sympathomimetics may reduce the antihypertensive effects of methyldopa, <e1>mecamylamine</e1>, <e2>reserpine</e2> and veratrum alkaloids.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e1>metformin</e1>, cimetidine, ranitidine, procainamide, triamterene, <e2>flecainide</e2>, and quinidine. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e1>methotrexate</e1>), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "<e1>Antacids</e1>: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking <e2>magnesium</e2>-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and <e1>theophylline</e1> Please note that <e2>Mephenytoin</e2> may interact with other drugs that are not listed here.\n",
      "Drugs such as <e1>erythromycin</e1>, diltiazem, verapamil, ketoconazole, <e2>fluconazole</e2> and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "Pharmacokinetic data indicate that <e1>ketoconazole</e1> markedly inhibits the metabolism of terfenadine, resulting in elevated plasma <e2>terfenadine</e2> levels. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e2>ketoconazole</e2> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>Anticholinesterases</e1>: Concurrent use of procaine hydrochloride and <e2>anticholinesterase agents</e2> may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. \n",
      "Glyburide: In 12 normal-weight subjects receiving <e1>orlistat</e1> 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of <e2>glyburide</e2>. \n",
      "However, because telbivudine is eliminated primarily by renal excretion, co   administration of <e1>telbivudine</e1> with drugs that alter renal function may alter plasma concentrations of <e2>telbivudine</e2>.\n",
      "However, on the basis of available data, no dosage adjustment for <e1>ondansetron</e1> is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that <e2>ondansetron</e2> may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Warfarin</e1>: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in <e2>R-warfarin</e2> half-life and AUC were also detected. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - <e1>Ketoconazole</e1> - <e2>Central nervous system (CNS) depressants</e2> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - <e1>Tricyclic antidepressants</e1> (e.g., Elavil, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "It may also interact with thiazides (increased thrombocytopenia), <e1>cyclosporine</e1> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, <e2>triamterene</e2>, amiloride) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "Plasma levels of <e1>piroxicam</e1> are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of <e2>antacids</e2> has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e1>multivitamins</e1>, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "Anticoagulants <e1>Anabolic steroids</e1> may increase sensitivity to oral <e2>anticoagulants</e2>. \n",
      "<e1>CRM197</e1> induced apoptosis, and furthermore, the combination of <e2>CRM197</e2> plus doxorubicin enhanced cytotoxicity in a T-ALL cell line. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (<e1>Vivactil</e1>), or <e2>desipramine</e2> (Norpramin). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e1>methotrexate</e1>, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, <e1>nalbuphine</e1>, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof <e2>opioid agonist analgesic</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>MAO inhibitors</e1> and beta adrenergic blockers increase the effects of <e2>pseudoephedrine</e2>. \n",
      "<e1>Pyrimethamine</e1> may be used with sulfonamides, quinine and other antimalarials, and with other <e2>antibiotics</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general <e1>anesthetics</e1> - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "In controlled clinical trials, ALOXI injection has been safely administered with corticosteroids, <e1>analgesics</e1>, antiemetics/antinauseants, <e2>antispasmodics</e2> and anticholinergic agents. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and <e1>doxazosin</e1>, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of <e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1> or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/vehicle). \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., <e1>dexamethasone</e1>, phenytoin, carbamazepine, <e2>rifampin</e2>, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Use with <e1>Cholinomimetics</e1> and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with <e2>succinylcholine</e2>, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.\n",
      "Some examples of such drugs are <e1>erythromycin</e1>, <e2>itraconazole</e2>, ketoconazole, fluconazole, calcium channel blockers and cimetidine.\n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, amiloride, <e2>triamterene</e2> and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, <e1>phenylpropanolamine</e1> or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when <e2>ProAmatine</e2>    is administered concomitantly with agents that cause vasoconstriction. \n",
      "<e1>Acetaminophen</e1>: <e2>Rimantadine HCl</e2>, 100 mg, was given twice daily for 13 days to 12 healthy volunteers. \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of <e1>morphine</e1> are potentiated by the presence of other CNS depressants such as <e2>alcohol</e2>, sedatives, antihistaminics, or psychotropic drugs. \n",
      "In addition to bleeding associated with heparin and <e1>vitamin K antagonists</e1>, drugs that alter platelet function (such as aspirin, dipyridamole, and <e2>abciximab</e2>) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "EA signs were observed in all 7 patients in association with <e1>propofol</e1> TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose <e2>ketamine</e2> was added to propofol. \n",
      "<e1>Zinc</e1>/iron salts: Absorption of <e2>quinolones</e2> is reduced significantly by these preparations. \n",
      "Concurrent use of <e1>tetracyclines</e1> with oral contraceptives may render oral <e2>contraceptives</e2> less effective.\n",
      "<e1>Adrenal steroids</e1> or <e2>ACTH</e2> In patients with edema, concomitant administration with adrenal cortical steroids or ACTH may increase the edema. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that <e1>terbinafine</e1> does not affect the clearance of <e2>antipyrine</e2> or digoxin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e1>clarithromycin</e1>, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of Ropivacaine, can interact with <e1>Ropivacaine</e1> leading to increased <e2>ropivacaine</e2> plasma levels. \n",
      "<e1>TOLECTIN</e1> and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of <e2>methotrexate</e2> in an animal model, possibly enhancing the toxicity of methotrexate. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, <e1>rifampin</e1>, rifabutin, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "Such occurrences have been reported when <e1>propoxyphene</e1> was administered to patients on <e2>antidepressants</e2>, anticonvulsants, or warfarin-like drugs. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, <e1>nefazodone</e1>, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2>, voriconizole) may increases sunitinib concentrations. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "<e1>Pindolol</e1> has been used with a variety of <e2>antihypertensive agents</e2>, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/<e2>ethinyl estradiol</e2> 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e1>HIV-protease inhibitors</e1>, griseofulvin, <e2>modafinil</e2>, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "The bioavailability of <e1>SKELID</e1> is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or <e2>magnesium</e2>-containing antacids, when administered 1 hour before SKELID. \n",
      "Interaction with <e1>Guanethidine</e1>: Although <e2>minoxidil</e2> does not itself cause orthostatic hypotension, its administration to patients already receiving guanethidine can result in profound orthostatic effects. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Cimetidine</e1>: <e2>Cimetidine</e2> does not affect the pharmacokinetics of sparfloxacin. \n",
      "Compounds that quench active oxygen species or scavenge radicals, such as dimethyl sufloxide, b-carotene, ethanol, <e1>formate</e1> and <e2>mannitol</e2> would be expected to decrease PDT activity. \n",
      "Inhibition of Src family and Abl kinases with either siRNAs or <e1>dasatinib</e1> enhances <e2>paclitaxel</e2> sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.\n",
      "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, <e1>gelusil</e1>, <e2>erythromycin</e2> and multi minerals. \n",
      "Because of profound and long lasting inhibition of gastric acid secretion, <e1>pantoprazole</e1> may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, ampicillin esters, and <e2>iron</e2> salts). \n",
      "Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering <e1>ibuprofen</e1> concurrently with <e2>ALIMTA</e2> to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). \n",
      "Nifedipine (extended-release tablets): In 17 normal-weight subjects receiving <e1>XENICAL</e1> 120 mg three times a day for 6 days, <e2>XENICAL</e2> did not alter the bioavailability of nifedipine (extended-release tablets). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e1>metronidazole</e1>, or <e2>amoxicillin</e2>. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, <e1>methotrexate</e1>, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "This medicine is generally safe with other medications, but patient should consult doctor or pharmacist if patient is taking a blood thinner (anticoagulant), cyclosporin, <e1>phenytoin</e1>, or <e2>methotrexate</e2>.\n",
      "- Cisapride, <e1>pimozide</e1>: Other drugs such as <e2>cisapride</e2> or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. \n",
      "The effects of metoclopramide on gastrointestinal motility are antagonized by <e1>anticholinergic drugs</e1> and <e2>narcotic analgesics</e2>. \n",
      "Thalidomide has been reported to enhance the sedative activity of barbiturates, <e1>alcohol</e1>, chlorpromazine, and <e2>reserpine</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The concomitant use of other <e1>CNS depressants</e1> including <e2>sedatives</e2>, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with <e1>atorvastatin</e1>, simvastatin, pravastatin, <e2>lovastatin</e2>, or fluvastatin. \n",
      "John   s Wort, and certain anticonvulsants (<e1>phenytoin</e1>, phenobarbital, <e2>carbamazepine</e2>) may induce mifepristone metabolism (lowering serum levels of mifepristone). \n",
      "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, <e1>gelusil</e1>, erythromycin and <e2>multi minerals</e2>. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e2>Theophylline</e2>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, <e2>rifabutin</e2>, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, <e2>antipyrine</e2>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "According to the calculated level of risk, guidelines recommend patients with atrial fibrillation receive <e1>antithrombotic</e1> therapy either as a vitamin K antagonist or <e2>aspirin</e2>. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), <e1>(beta)-agonists</e1>, inhaled <e2>corticosteroids</e2>, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e1>saquinavir</e1>, telithromycin or <e2>voriconazole</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as <e2>amitriptyline</e2> (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, <e2>digoxin</e2>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interactions for Vitamin B1 (<e1>Thiamine</e1>):  Loop Diuretics, Oral Contraceptives, <e2>Stavudine</e2>, Tricyclic Antidepressants\n",
      "At the same time, the locomotor inhibitory effect of <e1>dexmedetomidine</e1> was counteracted by <e2>ephedrine</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e1>caffeine</e1>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Other eye drops or medications such as acetylcholine chloride (<e1>Miochol</e1>) and carbachol (Carboptic, Isopto Carbachol) may decrease the effects of <e2>suprofen</e2> ophthalmic.\n",
      "Neuromuscular blocking agents (such as <e1>suxamethonium chloride</e1>): Concurrent use of <e2>procaine hydrochloride</e2> and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on <e1>piroxicam</e1> plasma levels . <e2>Nonsteroidal anti-inflammatory agents</e2>, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "In addition, CNS toxicity has been reported (confusion, disorientation, respiratory depression, apnea, seizures) following coadministration of <e1>cimetidine</e1> with <e2>opioid analgesics</e2>; \n",
      "Concomitant administrations not recommended:  - Terfenadine and <e1>astemizole</e1>: Certain macrolides interact with terfenadine and <e2>astemizole</e2> leading to increased serum concentrations of the latter. \n",
      "<e1>Warfarin</e1> users who initiated <e2>citalopram</e2>, fluoxetine, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "When <e1>phenytoin</e1> or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with <e2>Mexitil</e2>   , lowered Mexitil    plasma levels have been reported. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, thyroxine, triiodothyronine, phenytoin, <e2>sulfinpyrazone</e2>, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "<e1>TOBI</e1> should not be administered concomitantly with ethacrynic acid, <e2>furosemide</e2>, urea, or mannitol.\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as <e1>isocarboxazid</e1> (Marplan), <e2>tranylcypromine</e2> (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (<e2>Dilantin</e2>) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Rats treated with neonatal quinpirole enhanced time spent in the <e1>amphetamine</e1>-paired context compared with <e2>quinpirole</e2>-free controls conditioned with amphetamine, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls. \n",
      "Some examples of such drugs are erythromycin, itraconazole, <e1>ketoconazole</e1>, <e2>fluconazole</e2>, calcium channel blockers and cimetidine.\n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e2>phenothiazines</e2>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "If <e1>ZEMURON</e1>    is administered following administration of <e2>succinylcholine</e2>, it should not be given until recovery from succinylcholine has been observed. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), <e2>sulfonamides</e2>, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., <e1>ritonavir</e1>, indinavir, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, <e1>prednisolone</e1>, oral contraceptives (norethindrone 1 mg/<e2>ethinyl estradiol</e2> 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Two separate studies were conducted to evaluate the bioequivalence of fenofibric acid relative to <e1>fenofibrate</e1> under fasted and fed (standard breakfast) conditions, characterize the pharmacokinetic profile, and assess the safety and tolerability of <e2>fenofibric acid</e2>. \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including <e1>fluconazole</e1>, metronidazole, and <e2>miconazole</e2>) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "The aim of this study was to assess the influence of <e1>manganese gluconate</e1>, a chemical activator of bleaching agents, at a concentration of 0.01% on the efficiency of a 10% <e2>carbamide peroxide</e2>-based bleaching agent. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The effects of anticholinergic drugs, such as <e1>atropine</e1> and <e2>tricyclic antidepressants</e2> may be enhanced by the concomitant administration of triprolidine. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, <e2>quinidine</e2>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e1>methylene blue</e1>, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e2>anticholinergics</e2> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "There is evidence that <e1>meropenem</e1> may reduce serum levels of <e2>valproic acid</e2> to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total valproate).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Phenytoin: <e1>DIFLUCAN</e1> increases the plasma concentrations of <e2>phenytoin</e2>. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, <e1>Choline</e1> and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, <e2>Magnesium salicylate</e2>: these drugs may decrease the potency of tetracyclines. \n",
      "The 90% CIs about the ratio of the <e1>fenofibric acid</e1> geometric mean to the <e2>fenofibrate</e2> geometric mean were within the 80% and 125% limits for the pharmacokinetic parameters C(max), AUC(0-t), and AUC(0-   ) of the ln-transformed data in both study 1 (fasted) and study 2. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Therefore, physicians should closely monitor patients for a change in <e1>anticoagulant</e1> dosage requirements when administering <e2>Mitotane</e2> to patients on coumarin-type anticoagulants. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e1>progestin</e1> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e1>desglymidodrine</e1> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with DZNep and <e1>ABT-737</e1>, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of <e2>DZNep</e2> insensitive MM cells. \n",
      "Methyldopa does not interfere with measurement of VMA (<e1>vanillylmandelic acid</e1>), a test for pheochromocytoma, by those methods which convert VMA to <e2>vanillin</e2>. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, <e2>troleandomycin</e2>, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Accordingly, patients should be advised to avoid <e1>alcohol</e1> while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of <e2>mirtazapine</e2> (15 mg) in 12 healthy subjects. \n",
      "In Trial 1, the proportions of patients in the placebo and Synagis    groups who received routine childhood vaccines, <e1>influenza vaccine</e1>, bronchodilators or <e2>corticosteroids</e2> were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, <e1>nitrous oxide</e1>, secobarbital and <e2>droperidol</e2>. \n",
      "<e1>Posicor</e1> inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and <e2>tricyclic antidepressants</e2>. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, <e1>sertraline</e1>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "Lithium: In clinical trials, NSAIDs have produced an elevation of plasma <e1>lithium</e1> levels and a reduction in renal <e2>lithium</e2> clearance. \n",
      "In Trial 1, the proportions of patients in the placebo and Synagis    groups who received routine childhood vaccines, <e1>influenza vaccine</e1>, <e2>bronchodilators</e2> or corticosteroids were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "- Decreased absorption of colestipol, <e1>cholestyramine</e1>, <e2>mineral oil</e2>, and sucralfate.\n",
      "While co-administration of <e1>ZAVESCA</e1>    appeared to increase the clearance of Cerezyme by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of <e2>Cerezyme</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e2>paricalcitol</e2> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Additive sedative effects can occur when <e1>metoclopramide</e1> is given with alcohol, sedatives, hypnotics, <e2>narcotics</e2>, or tranquilizers. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, <e1>rifabutin</e1>, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "No significant adverse interactions with common premedications (such as atropine, <e1>scopolamine</e1>, <e2>glycopyrrolate</e2>, diazepam, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.\n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "The FDA has approved ticagrelor (<e1>Brilinta</e1>-AstraZeneca), an oral antiplatelet drug, for use with low-dose <e2>aspirin</e2> to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). \n",
      "Catecholamine-depleting drugs (e.g., <e1>reserpine</e1>) may have an additive effect when given with <e2>beta-blocking agents</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, <e1>phenothiazines</e1>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, <e2>Iron</e2>-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., <e2>quinidine</e2>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Limited evidence suggests that <e1>ascorbic acid</e1> may influence the intensity and duration of action of <e2>bishydroxycoumarin</e2>.\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, <e2>clarithromycin</e2>), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "and/or antibiotic drug doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin <e1>1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine</e1> (<e2>MPTP</e2>) (4 x 20 mg/kg, i. p.) \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The objective of this study was to evaluate the effect of oral administration of <e1>ginseng stem-and-leaf saponins</e1> (GSLS) on the humoral immune responses of chickens to <e2>inactivated</e2> ND and AI vaccines. \n",
      "<e1>Curcumin</e1> can be a useful <e2>antidepressant</e2> especially in cases which respond to drugs having mixed effects on serotonin and catecholamines levels in the brain.\n",
      "In vitro studies with human liver microsomes showed that <e1>terbinafine</e1> does not inhibit the metabolism of tolbutamide, ethinylestradiol, <e2>ethoxycoumarin</e2>, and cyclosporine. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - <e1>Live virus vaccines</e1>: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the <e2>vaccine</e2>\n",
      "The colchicine nanoemulsion was prepared with isopropyl myristate, eugenol, <e1>Tween80</e1>, <e2>ethanol</e2> and water, and eugenol was used as an oil phase in the formulation; \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), <e2>antihistamines</e2>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases <e2>sunitinib</e2> concentrations. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), <e2>HIV protease</e2> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Regulatory agencies state that the combination of <e1>clopidogrel</e1> and the CYP2C19 inhibitors <e2>omeprazole</e2> and esomeprazole should be avoided. \n",
      "These data suggest that <e1>GH</e1> administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, <e2>sex steroids</e2>, anticonvulsants, cyclosporin). \n",
      "The incubations were performed in the absence and presence of the non-specific CYP inhibitor, <e1>1-aminobenzotriazole</e1> (<e2>ABT</e2>) and isoform-specific inhibitors. \n",
      "Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with <e1>solifenacin</e1> 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control <e2>moxifloxacin</e2> at its therapeutic dose. \n",
      "No pharmacokinetic interaction was observed between rivastigmine and digoxin, <e1>warfarin</e1>, <e2>diazepam</e2>, or fluoxetine in studies in healthy volunteers. \n",
      "Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, <e1>dasatinib</e1> + <e2>paclitaxel</e2> vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); \n",
      "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (<e1>indomethacin</e1>, <e2>heparin</e2>, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "In addition to bleeding associated with <e1>heparin</e1> and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and <e2>abciximab</e2>) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "saline + saline, <e1>ephedrine</e1> (10   mg/kg) + saline, saline + dexmedetomidine (15     g/kg) and <e2>ephedrine</e2> (10   mg/kg) + dexmedetomidine (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests. \n",
      "We also evaluated the effects of <e1>calcium</e1> doses between 200 and 800 mg on absorption of 5 mg <e2>heme iron</e2> [as concentrated RBC (CRBC)]. \n",
      "When concomitant administration of either of these two drugs with <e1>mexiletine</e1> is initiated, the dose of <e2>mexiletine</e2> should be slowly titrated to desired effect. \n",
      "The effects of <e1>indinavir</e1>, <e2>zidovudine</e2> or rifabutin on the pharmacokinetics of megestrol acetate were not studied.\n",
      "In the absence of data regarding potential interaction between ALIMTA and <e1>NSAIDs</e1> with longer half-lives, all patients taking these <e2>NSAIDs</e2> should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e2>BARBITURATES</e2>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, <e1>thiopental</e1>, <e2>thyroxine</e2>, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "<e1>Digitalis glycosides</e1>: Serum digitalis levels may be increased when hyperthyroid patients on a stable <e2>digitalis glycoside</e2> regimen become euthyroid; \n",
      "Several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with <e1>ferrous sulfate</e1> or <e2>ferrous gluconate</e2>. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with <e1>aspirin</e1> (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . <e2>Nonsteroidal anti-inflammatory agents</e2>, including FELDENE, have been reported to increase steady state plasma lithium levels. \n",
      "A rapid, sensitive and reliable high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was developed and validated for the determination of <e1>propiverine hydrochloride</e1> (CAS 54556-98-8) in human plasma using <e2>cetirizine di-hydrochloride</e2> as internal standard (IS, CAS 8388-51-0). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Other <e1>HDAC Inhibitors</e1> Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of <e2>ZOLINZA</e2> and other HDAC inhibitors (e.g., valproic acid). \n",
      "In the absence of data regarding potential interaction between <e1>ALIMTA</e1> and NSAIDs with longer half-lives, all patients taking these <e2>NSAIDs</e2> should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. \n",
      "DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with <e1>live organism vaccines</e1> are not recommended in immunocompromised individuals  <e2>Nalidixic acid</e2> together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.  \n",
      "After oral administration of colchicine (8 mg/kg) in the form of either the nanoemulsion or in free <e1>colchicine</e1> solution, the relative bioavailability of nanoemulsion and <e2>eugenol</e2>-nanoemulsion were enhanced by about 1.6- and 2.1-fold, respectively, compared with free colchicine solution. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, <e1>griseofulvin</e1>, modafinil, penicillins, rifampin, rifabutin, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e2>phenothiazines</e2>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "as well as <e1>atropine</e1> and <e2>phosphorous insecticides</e2>.\n",
      "Other eye drops or medications such as acetylcholine chloride (Miochol) and carbachol (Carboptic, <e1>Isopto Carbachol</e1>) may decrease the effects of <e2>suprofen</e2> ophthalmic.\n",
      "These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data, and with post-mortem stereological counts of midbrain dopaminergic neurons, as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity, which were all significantly higher in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/<e1>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e1>-treated animals than in <e2>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e2>/vehicle-treated monkeys. \n",
      "Interactions for <e1>Dronabinol</e1>:  In studies involving patients with AIDS and/or cancer, <e2>MARINOL</e2> (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, sedatives, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "Less potent inhibitors include saquinavir, <e1>nefazodone</e1>, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and <e2>clotrimazole</e2>. \n",
      "In vitro, <e1>raloxifene</e1> did not affect the binding of <e2>warfarin</e2>, phenytoin, or tamoxifen. \n",
      "However, the evidence for a <e1>calcium</e1> effect on <e2>iron</e2> absorption mainly comes from studies that did not isolate the effect of calcium from that of other dietary components, because it was detected in single-meal studies. \n",
      "There are no clinical data on the use of <e1>MIVACRON</e1> with other <e2>nondepolarizing neuromuscular blocking agents</e2>. \n",
      "There was no effect of a single dose or multiple doses of MYCAMINE on <e1>mycophenolate mofetil</e1>, cyclosporine, <e2>tacrolimus</e2>, prednisolone, and fluconazole pharmacokinetics. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or <e2>cyclosporine</e2> or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e1>neostigmine</e1> - polymyxin B or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and <e1>miconazole</e1>) to <e2>ketoconazole</e2>, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when <e1>FELDENE</e1> is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma <e2>lithium</e2> levels. \n",
      "<e1>Warfarin</e1>: In 12 normal-weight subjects, administration of XENICAL 120 mg three times a day for 16 days did not result in any change in either <e2>warfarin</e2> pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII). \n",
      "The concomitant use of other CNS depressants including sedatives, <e1>hypnotics</e1>, tranquilizers, general anesthetics, phenothiazines, other <e2>opioids</e2>, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, polymyxin B, <e1>colistin</e1>, viomycin, or <e2>cisplatin</e2>, when indicated, requires careful monitoring.\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, <e1>tranquilizers</e1>, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "Because <e1>Matulane</e1> exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, <e2>imipramine HCl</e2>) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, <e1>medroxyprogesterone acetate</e1>, methotrexate, multivitamins, <e2>naproxen</e2>, omeprazole, paracetamol, and prednisone.\n",
      "Additive sedative effects can occur when metoclopramide is given with <e1>alcohol</e1>, sedatives, hypnotics, narcotics, or <e2>tranquilizers</e2>. \n",
      "<e1>Azathioprine</e1>/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that <e2>Myfortic</e2> not be administered concomitantly with azathioprine or mycophenolate mofetil. \n",
      "Phenytoin, Carbamazepine, and <e1>Rifampicin</e1>: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of <e2>ondansetron</e2> was significantly increased and ondansetron blood concentrations were decreased. \n",
      "In vitro perfusion of isolated rat liver has shown that <e1>cimetidine</e1> caused a significant reduction in <e2>trimetrexate</e2> metabolism and that acetaminophen altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include methanol, <e1>ethylene glycol</e1>, diethylene glycol, propylene glycol, or <e2>isopropanol</e2>. \n",
      "<e1>Digoxin</e1>: Meloxicam 15 mg once daily for 7 days did not alter the plasma concentration profile of <e2>digoxin</e2> after b-acetyldigoxin administration for 7 days at clinical doses. \n",
      "Although <e1>ibuprofen</e1> (400 mg qid) can be administered with <e2>ALIMTA</e2> in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., <e2>erythromycin</e2>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates <e1>phenytoin</e1> (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam <e2>temezepam</e2>). \n",
      "Rats treated with neonatal quinpirole enhanced time spent in the amphetamine-paired context compared with <e1>quinpirole</e1>-free controls conditioned with amphetamine, but only female controls conditioned with <e2>amphetamine</e2> spent more time in the drug-paired context compared with saline-treated controls. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), <e1>TRICYCLIC ANTIDEPRESSANTS</e1> AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (<e1>curcumin</e1> 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus <e2>imipramine</e2> 15 mg/kg). \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., <e2>quinidine</e2>), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e2>desmethyldiazepam</e2>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Less potent inhibitors include saquinavir, nefazodone, <e1>fluconazole</e1>, grapefruit juice, fluoxetine, fluvoxamine, <e2>zileuton</e2>, and clotrimazole. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, <e1>Sanctura</e1> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and <e2>tenofovir</e2>). \n",
      "<e1>Ropivacaine</e1> should be used with caution in patients receiving other local anesthetics or agents structurally related to <e2>amide-type local anesthetics</e2>, since the toxic effects of these drugs are additive. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, <e1>butorphanol</e1>, or <e2>buprenorphine</e2>) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or <e1>nifedipine</e1> toxicity and <e2>sirolimus</e2> or nifedipine dosage should be reduced if necessary. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, <e1>quinidine</e1>, theophylline, <e2>corticosteroids</e2>, anticoagulants, and beta blockers.\n",
      "In controlled clinical trials, ALOXI injection has been safely administered with <e1>corticosteroids</e1>, analgesics, <e2>antiemetics</e2>/antinauseants, antispasmodics and anticholinergic agents. \n",
      "Barbiturates may decrease the effectiveness of oral <e1>contraceptives</e1>, certain antibiotics, <e2>quinidine</e2>, theophylline, corticosteroids, anticoagulants, and beta blockers.\n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as <e1>antimycotic agents</e1> (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., <e2>erythromycin</e2> and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "According to the calculated level of risk, guidelines recommend patients with atrial fibrillation receive antithrombotic therapy either as a <e1>vitamin K antagonist</e1> or <e2>aspirin</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e1>Tofranil</e1>), <e2>clomipramine</e2> (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Sympathomimetics may reduce the antihypertensive effects of methyldopa, <e1>mecamylamine</e1>, reserpine and <e2>veratrum alkaloids</e2>.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., <e1>phenylephrine</e1>, <e2>pseudoephedrine</e2>, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "<e1>Paroxetine</e1> and <e2>fluoxetine</e2> reduce the plasma concentration of endoxifen by about 50%. \n",
      "It will compete with <e1>clopidogrel</e1> (Plavix) and <e2>prasugrel</e2> (Effient) for such use. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e1>Astemizole</e1>, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, <e1>nelfinavir</e1>, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, <e1>clindamycin</e1>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and <e2>quinidine</e2>. \n",
      "In humans, <e1>carmustine</e1>, etoposide, and <e2>cisplatin</e2> do not affect the pharmacokinetics of ondansetron.  \n",
      "Because the action of <e1>metoclopramide</e1> will influence the delivery of food to the intestines and thus the rate of absorption, <e2>insulin</e2> dosage or timing of dosage may require adjustment.\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - <e2>cisplatin</e2> - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Other <e1>beta adrenergic aerosol bronchodilators</e1> should not be used concomitantly with <e2>Alupent</e2>    (metaproterenol sulfate USP) because they may have additive effects. \n",
      "Drug Interactions: The use of <e1>ZEMURON</e1>    (rocuronium bromide) Injection before <e2>succinylcholine</e2>, for the purpose of attenuating some of the side effects of succinylcholine, has not been studied. \n",
      "<e1>Warfarin</e1>: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing MOBIC therapy in patients receiving <e2>warfarin</e2> or similar agents, since these patients are at an increased risk of bleeding. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e2>anticholinergics</e2> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Acute administration of <e1>hemantane</e1> or <e2>doxycycline</e2> failed to influence locomotion in mice, while their combination normalized motor activity. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), <e1>estrogens</e1> (n=70), salicylate analgesics (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e1>PHENOTHIAZINES</e1>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "TOBI should not be administered concomitantly with <e1>ethacrynic acid</e1>, furosemide, urea, or <e2>mannitol</e2>.\n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "In Trial 1, the proportions of patients in the placebo and <e1>Synagis</e1>    groups who received routine childhood vaccines, influenza vaccine, <e2>bronchodilators</e2> or corticosteroids were similar and no incremental increase in adverse reactions was observed among patients receiving these agents.    \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e1>progestin</e1> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), <e1>doxepin</e1> (Sinequan), nortriptyline (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Interaction with <e1>Mixed Agonist/Antagonist Opioid Analgesics</e1>: <e2>Agonist/antagonist analgesics</e2> (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "<e1>Lithium</e1> renal clearance is reduced by <e2>thiazides</e2>, increasing the risk of lithium toxicity. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "<e1>Probenecid</e1>: <e2>Probenecid</e2> does not alter the pharmacokinetics of sparfloxacin.\n",
      "In clinical studies of TOBI, patients taking <e1>TOBI</e1> concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral <e2>aminoglycosides</e2> demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, <e1>indomethacin</e1>, <e2>naproxen</e2>, ibuprofen, diazepam, and diazoxide. \n",
      "<e1>Phenobarbital</e1>, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of <e2>montelukast</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (<e1>clotrimazole</e1>, ketoconazole, <e2>miconazole</e2>) were potent, non-competitive inhibitors of trimetrexate metabolism. \n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of <e1>digoxin</e1> on the plasma concentration of <e2>perindopril</e2>/perindoprilat has not been excluded. \n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, cisplatin, doxorubicin and <e1>etoposide</e1>   <e2>celecoxib</e2> following different incubation schedules were analyzed.\n",
      "Before taking this medication, tell your doctor if you are taking a <e1>tricyclic antidepressant</e1> such as amitriptyline (Elavil), amoxapine (Asendin), <e2>doxepin</e2> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), <e2>doxepin</e2> (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "In controlled clinical trials, ALOXI injection has been safely administered with <e1>corticosteroids</e1>, analgesics, antiemetics/<e2>antinauseants</e2>, antispasmodics and anticholinergic agents. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Concurrent ingestion of <e1>antacid</e1> (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or <e2>desethyloxybutynin</e2>.    \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, MARINOL (<e1>Dronabinol</e1>) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, <e2>sedatives</e2>, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, <e2>clarithromycin</e2>, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, <e1>aminoglycosides</e1>, <e2>bacitracin</e2>, polymyxin B, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "We evaluated the effects of <e1>calcium</e1> doses between 200 and 1500 mg on absorption of 5 mg nonheme iron (as <e2>ferrous sulfate</e2>). \n",
      "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other <e1>CNS depressants</e1> such as alcohol, <e2>sedatives</e2>, antihistaminics, or psychotropic drugs. \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, <e1>metronidazole</e1>, and miconazole) to ketoconazole, and <e2>itraconazole</e2>, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., <e1>amitriptyline HCl</e1>, imipramine HCl) and other drugs and foods with known high <e2>tyramine</e2> content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, <e1>miconazole</e1>) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "Less potent inhibitors include saquinavir, <e1>nefazodone</e1>, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, <e2>zileuton</e2>, and clotrimazole. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, <e1>modafinil</e1>, penicillins, rifampin, rifabutin, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: <e2>theophylline</e2>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "<e1>Rifampin</e1>: <e2>Rifampin</e2> enhances the metabolism of concurrently administered DIFLUCAN. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of <e1>azole antimycotics</e1>, protease inhibitors, calcium channel antagonists, and <e2>macrolide antibiotics</e2>). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e2>metformin</e2>, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and quinine) decreases the oral clearance of <e2>pramipexole</e2> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with <e2>Permax</e2> (a dopamine agonist); \n",
      "<e1>AAV2</e1> containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including <e2>collagenase</e2>, hyaluronan lyase, heparinase III, or chondroitin ABC lyase. \n",
      "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of <e1>XENICAL</e1> and 40 grams of <e2>alcohol</e2> (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, <e1>calcium</e1>, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "Oral metronidazole has been reported to potentiate the anticoagulant effect of <e1>coumarin</e1> and <e2>warfarin</e2>, resulting in a prolongation of prothrombin time. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (<e2>Anafranil</e2>), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, <e1>Laxatives</e1>, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "Both <e1>acyclovir</e1>/ganciclovir and <e2>MPAG</e2> concentrations are increased in the presence of renal impairment, their coexistence may compete for tubular secretion and further increase in the concentrations of the two. \n",
      "The biochemical and cellular alterations that occur after <e1>1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine</e1> (<e2>MPTP</e2>) treatment are remarkably similar to that observed in idiopathic PD. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as <e1>clofibrate</e1>, indomethacin, naproxen, ibuprofen, diazepam, and <e2>diazoxide</e2>. \n",
      "Aminoglutethimide administered concomitantly with <e1>depo-subQ provera 104</e1> may significantly decrease the serum concentrations of <e2>MPA</e2>. \n",
      "Drugs that may decrease the effects of this medicine include: <e1>Rifampin</e1> barbiturates <e2>phenytoin</e2> (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (<e1>Elavil</e1>), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e2>Tofranil</e2>), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "<e1>Furafylline</e1> and <e2>sulfaphenazole</e2> had no effect, while quinidine appeared to augment precocene I toxicity. \n",
      "The addition of <e1>heparinase III</e1> or <e2>chondroitin ABC lyase</e2> greatly enhanced transduction of the retinal ganglion cell layer and increased the depth of transduction into the outer retina. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, <e1>verapamil</e1>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1>MIVACRON</e1> include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e2>bacitracin</e2>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as <e1>amphotericin B</e1>, aminoglycosides, bacitracin, polymyxin B, colistin, viomycin, or <e2>cisplatin</e2>, when indicated, requires careful monitoring.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e1>itraconazole</e1>, <e2>miconazole</e2>) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "During maintenance of anesthesia or sedation, the rate of <e1>DIPRIVAN</e1> Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents (eg, <e2>nitrous oxide</e2> or opioids). \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, <e1>bacitracin</e1>, polymyxin B, colistin, <e2>viomycin</e2>, or cisplatin, when indicated, requires careful monitoring.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, <e1>butyrophenones</e1>, <e2>thioxanthenes</e2>) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Possible interactions with drugs known to be metabolized by CYP1A2 via competitive inhibition such as <e1>theophylline</e1> and <e2>imipramine</e2> may also occur. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e1>benzodiazepenes</e1> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the <e2>corticosteroids</e2>).\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e1>benzodiazepines</e1>, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, <e1>rifampin</e1>, rifabutin, <e2>rifapentin</e2>, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e2>polymyxin B</e2> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, <e2>Terfenadine</e2>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and <e1>ethinyl estradiol</e1> following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of <e2>ethinyl estradiol</e2> were studied. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, <e1>fluvoxamine</e1>, paroxetine, <e2>sertraline</e2>) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Paroxetine and <e1>fluoxetine</e1> reduce the plasma concentration of <e2>endoxifen</e2> by about 50%. \n",
      "Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after <e1>ketoconazole</e1>) caused a 15% reduction in in-vivo plasma clearance of <e2>ropivacaine</e2>.\n",
      "<e1>lidocaine</e1>, <e2>quinidine</e2>; \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, MARINOL (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, <e1>anti-infective</e1> agents, sedatives, or <e2>opioid analgesics</e2>) without resulting in any clinically significant drug/drug interactions. \n",
      "<e1>MAO Inhibitors</e1> - The pressor effect of <e2>sympathomimetic pressor amines</e2> is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e1>antacids</e1>, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e1>ANESTHETICS</e1>, PHENOTHIAZINES, OTHER <e2>TRANQUILIZERS</e2>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "There have been postmarketing reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including <e1>pantoprazole</e1>, and <e2>warfarin</e2> concomitantly. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, <e2>verapamil</e2>, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Quantitative toxicological analysis showed that the concentrations of etizolam, <e1>phenobarbital</e1>, <e2>promethazine</e2> and chlorpromazine in the femoral blood were 86 ng/ml, 5082 microg/ml, 0.107 microg/ml and 0.144 microg/ml, respectively, and large amounts of drugs were also detected in the stomach contents. \n",
      "You cannot take mazindol if you have taken a <e1>monoamine oxidase inhibitor</e1> (<e2>MAOI</e2>) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "<e1>Short-acting Benzodiazepines</e1>: Following oral administration of midazolam, <e2>fluconazole</e2> resulted in substantial increases in midazolam concentrations and psychomotor effects. \n",
      "Attention is paid to <e1>calcium channel blockers</e1>, diuretics and <e2>digoxin</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e1>penicillins</e1>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "Interactions for Vitamin B1 (<e1>Thiamine</e1>):  Loop Diuretics, Oral Contraceptives, Stavudine, <e2>Tricyclic Antidepressants</e2>\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as <e1>rifampin</e1>) may decrease the AUC of <e2>rosiglitazone</e2>. \n",
      "Synergism was also noted when methylglyoxal was combined with <e1>carbenicillin</e1> and <e2>amikacin</e2>.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e1>tetracyclines</e1>, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "However, the evidence for a <e1>calcium</e1> effect on iron absorption mainly comes from studies that did not isolate the effect of <e2>calcium</e2> from that of other dietary components, because it was detected in single-meal studies. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, <e2>cyclosporine</e2>, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e1>nifedipine</e1>, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and <e1>tricyclic drugs</e1> (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e1>polymyxin B</e1> or bacitracin - local anesthetics such as <e2>procaine</e2> - general anesthetics - succinylcholine or other muscle relaxants\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), <e1>methotrexate</e1> (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e1>neostigmine</e1> - <e2>polymyxin B</e2> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "Pharmacokinetic properties of abacavir were not altered by the addition of either <e1>lamivudine</e1> or <e2>zidovudine</e2> or the combination of lamivudine and zidovudine. \n",
      "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain <e1>ergot alkaloid drugs</e1> (e.g. dihydroergotamine and <e2>ergotamine</e2>) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a <e1>non-nucleoside reverse transcriptase inhibitor</e1> (NNRTI), a protease inhibitor (PI) or an integrase inhibitor (<e2>II</e2>) is recommended. \n",
      "Quantitative toxicological analysis showed that the concentrations of etizolam, phenobarbital, <e1>promethazine</e1> and <e2>chlorpromazine</e2> in the femoral blood were 86 ng/ml, 5082 microg/ml, 0.107 microg/ml and 0.144 microg/ml, respectively, and large amounts of drugs were also detected in the stomach contents. \n",
      "No formal interaction studies have been performed to assess the effect of <e1>SYMLIN</e1> on the kinetics of oral <e2>antidiabetic agents</e2>. \n",
      "- did not change the pharmacokinetic profile of <e1>warfarin</e1> (a substrate of cytochromes P450 2A6 and 2C9) or influence the effect of a single 30-mg oral dose of <e2>warfarin</e2> on prothrombin time or the INR (International Normalized Ratio). \n",
      "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, <e1>tricyclic antidepressant</e1> drugs (e.g., <e2>amitriptyline HCl</e2>, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "When <e1>DIFLUCAN</e1> is used concomitantly with these or other <e2>sulfonylurea oral hypoglycemic agents</e2>, blood glucose concentrations should be carefully monitored and the dose of the sulfonylurea should be adjusted as necessary. \n",
      "In the light of contradictory data on efficacy and safety of <e1>NSAID</e1> in cardiovascular patients selection of most appropriate <e2>NSAID</e2> (basing on profile of efficacy and safety) in patients receiving continuous therapy with low dose aspirin appears to be a problem. \n",
      "Post-exposure prophylaxis of H1N1 with <e1>oseltamivir</e1> was safe, effective and well tolerated to prevent H1N1 influenza A virus infection in newly transplanted renal allograft recipient receiving triple immunosuppression without any interaction with <e2>tacrolimus</e2> level. \n",
      "It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the <e1>anticoagulant</e1> <e2>warfarin</e2>. \n",
      "The effects of anticholinergic drugs, such as <e1>atropine</e1> and tricyclic antidepressants may be enhanced by the concomitant administration of <e2>triprolidine</e2>. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, <e1>glucocorticoids</e1>, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered <e2>phenytoin</e2> or carbamazepine. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, <e2>quinidine</e2>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the <e1>neuroleptics</e1> (phenothiazines, <e2>butyrophenones</e2>, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "For patients receiving <e1>ketoconazole</e1> or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or <e2>cyclosporine</e2> or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "<e1>AGGRASTAT</e1> has been studied on a background of <e2>aspirin</e2> and heparin. \n",
      "TOLECTIN and other <e1>nonsteroidal anti-inflammatory drugs</e1> have been reported to reduce the tubular secretion of <e2>methotrexate</e2> in an animal model, possibly enhancing the toxicity of methotrexate. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, <e1>tetracyclines</e1>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e1>antacids</e1>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Pindolol has been used with a variety of antihypertensive agents, including <e1>hydrochlorothiazide</e1>, hydralazine, and <e2>guanethidine</e2> without unexpected adverse interactions. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), <e1>antihypertensives</e1> (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), <e2>salicylate analgesics</e2> (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "With respect to toxicity, the order of CYP inhibitor effectiveness was ABT>diethyldithiocarbamate~<e1>tranylcypromine</e1>><e2>ketoconazole</e2>. \n",
      "<e1>Ticlopidine</e1> treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral ketamine by 2.4-fold, whereas itraconazole treatment did not increase the exposure to <e2>S-ketamine</e2>. \n",
      "The induction dose requirements of <e1>DIPRIVAN</e1> Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, morphine, <e2>meperidine</e2>, and fentanyl, etc.) \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include <e1>erythromycin</e1>, rifampin, rifabutin, <e2>ketoconazole</e2>, and fluconazole. \n",
      "In controlled clinical trials, ALOXI injection has been safely administered with <e1>corticosteroids</e1>, analgesics, antiemetics/antinauseants, <e2>antispasmodics</e2> and anticholinergic agents. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, <e2>hydrochlorothiazide</e2>, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "We evaluated mechanisms of interaction between the alkyating agent <e1>dacarbazine</e1> (DTIC) and the pro-oxidant, <e2>imexon</e2>, in the human A375 melanoma cell line.\n",
      "In vitro studies with atracurium, mivacurium, <e1>esmolol</e1>, echothiophate, neostigmine, <e2>physostigmine</e2>, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e1>warfarin</e1> (increased anticoagulant effect), methotrexate (decreased renal excretion of <e2>methotrexate</e2>), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "e.g., other belladonna alkaloids, <e1>antihistamines</e1> (including <e2>meclizine</e2>), tricyclic antidepressants, and muscle relaxants. \n",
      "Cyclosporine: Preliminary data from a XENICAL and <e1>cyclosporine</e1> drug interaction study indicate a reduction in <e2>cyclosporine</e2> plasma levels when XENICAL was coadministered with cyclosporine. \n",
      "<e1>Trimethoprim</e1>, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the <e2>phenytoin</e2> metabolic clearance rate by 30%. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving <e1>methadone</e1>, treatment with PEG-Intron once weekly for 4 weeks was associated with a mean increase of 16% in <e2>methadone</e2> AUC; \n",
      "Concomitant administrations not recommended:  - <e1>Terfenadine</e1> and <e2>astemizole</e2>: Certain macrolides interact with terfenadine and astemizole leading to increased serum concentrations of the latter. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "Some examples of such drugs are erythromycin, <e1>itraconazole</e1>, ketoconazole, fluconazole, <e2>calcium channel blockers</e2> and cimetidine.    \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., <e1>pentazocine</e1>, <e2>nalbuphine</e2>, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "<e1>Aspirin</e1> may decrease bioavailability of <e2>SKELID</e2> by up to 50% when taken 2 hours after SKELID. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Although single or concurrent use of <e1>sunitinib</e1> and <e2>docetaxel</e2> has some anti-proliferative effects, the sequential administrations of both drugs remarkably enhanced anti-tumor activity. \n",
      "TRENTAL has been used concurrently with <e1>antihypertensive drugs</e1>, beta blockers, digitalis, diuretics, antidiabetic agents, and <e2>antiarrhythmics</e2>, without observed problems. \n",
      "Theophylline: <e1>Theophylline</e1> clearance may decrease when hyperthyroid patients on a stable <e2>theophylline</e2> regimen become euthyroid; \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e1>itraconazole</e1>, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e1>nefazodone</e1>, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "<e1>Montelukast</e1> at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing norethindrone 1 mg/ethinyl <e2>estradiol</e2> 35 mcg. \n",
      "Ticagrelor (<e1>Brilinta</e1>)--better than <e2>clopidogrel</e2> (Plavix)\n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The use of <e1>MIVACRON</e1> before succinylcholine to attenuate some of the side effects of <e2>succinylcholine</e2> has not been studied. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . <e1>Selective serotonin reuptake inhibitors</e1> (<e2>SSRIs</e2>) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "The effect of a series of flavonoids, including flavonols, flavones, <e1>isoflavone</e1>, flavanone, flavanonols and catechins, on the elimination of luteolin and <e2>apigenin</e2> was studied. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, <e1>furazolidone</e1>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Less potent inhibitors include saquinavir, <e1>nefazodone</e1>, fluconazole, grapefruit juice, <e2>fluoxetine</e2>, fluvoxamine, zileuton, and clotrimazole. \n",
      "Trimethoprim, given at a common clinical dosage, increased the <e1>phenytoin</e1> half-life by 51% and decreased the <e2>phenytoin</e2> metabolic clearance rate by 30%. \n",
      "Melatonin may interact with the following drugs: aspirin and other <e1>NSAIDs</e1> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when <e1>cholinesterase inhibitors</e1> are given concurrently with <e2>succinylcholine</e2>, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, <e1>clarithromycin</e1>) or <e2>cyclosporine</e2> or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral <e2>contraceptives</e2> (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Interactions  Interaction may occur with Antacids, <e1>Calcium</e1> supplements, Cholestyramine, Choline and magnesium salicylates, <e2>Colestipol</e2>, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e1>indinavir</e1>, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "<e1>Fibrates</e1>: The safety and effectiveness of ezetimibe administered with <e2>fibrates</e2> have not been established. \n",
      "In the present study <e1>piperine</e1> (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of ibuprofen evaluated by both <e2>acetic acid</e2> writhing and formalin test, when it was administered with ibuprofen. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, levothyroxine sodium, medroxyprogesterone acetate, <e2>methotrexate</e2>, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "Mazindol may reduce the effects of <e1>guanethidine</e1> (<e2>Ismelin</e2>). \n",
      "<e1>Mexitil</e1>    does not alter serum digoxin levels but <e2>magnesium-aluminum hydroxide</e2>, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "<e1>Nifedipine</e1> AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state <e2>MYCAMINE</e2> compared with nifedipine alone. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, <e2>amantadine</e2>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "It has been reported that <e1>sulfamethoxazole</e1> may prolong the prothrombin time in patients who are receiving the anticoagulant <e2>warfarin</e2>. \n",
      "<e1>Sympathomimetics</e1>: <e2>Metolazone</e2> may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. \n",
      "Those anticonvulsants include divalproex sodium, <e1>valproic acid</e1>, and <e2>phenobarbital</e2>. \n",
      "TRENTAL has been used concurrently with <e1>antihypertensive drugs</e1>, beta blockers, digitalis, <e2>diuretics</e2>, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e1>NARCOTIC ANALGESICS</e1>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, <e1>beta blockers</e1>, digitalis, diuretics, antidiabetic agents, and <e2>antiarrhythmics</e2>, without observed problems. \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e2>antihistamines</e2>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "It has been reported that the incidence of bradycardia was increased when <e1>oxymorphone</e1> was combined with <e2>propofol</e2> for induction of anesthesia. \n",
      "It will compete with clopidogrel (<e1>Plavix</e1>) and <e2>prasugrel</e2> (Effient) for such use. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, <e1>griseofulvin</e1>, modafinil, penicillins, rifampin, rifabutin, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing <e1>neuromuscular blocking agents</e1> has been demonstrated in patients chronically administered phenytoin or <e2>carbamazepine</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, <e2>Theophylline</e2>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, triamterene, amiloride) or potassium supplements concomitantly with <e2>ACE inhibitors</e2> can increase the risk of hyperkalemia. \n",
      "Concomitant administrations not recommended:  - <e1>Terfenadine</e1> and astemizole: Certain macrolides interact with <e2>terfenadine</e2> and astemizole leading to increased serum concentrations of the latter. \n",
      "Concomitant administration of terfenadine with clarithromycin, <e1>erythromycin</e1>, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other <e2>macrolide antibiotics</e2>, including azithromycin, is not recommended. \n",
      "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as <e1>aspirin</e1>, <e2>dipyridamole</e2>, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, <e1>aminoglycosides</e1>, bacitracin, <e2>polymyxin B</e2>, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.\n",
      "Patients receiving <e1>sirolimus</e1> or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or <e2>nifedipine</e2> dosage should be reduced if necessary. \n",
      "Exert particular caution in combining levomepromazine with other <e1>anticholinergic drugs</e1> (<e2>tricyclic antidepressants</e2> and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), <e1>antihypertensives</e1> (n=72), <e2>calcium channel blockers</e2> (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, <e2>clindamycin</e2>, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "In vitro studies with atracurium, mivacurium, <e1>esmolol</e1>, echothiophate, neostigmine, physostigmine, and <e2>midazolam</e2> revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "The use of AGGRASTAT, in combination with <e1>heparin</e1> and aspirin, has been associated with an increase in bleeding compared to <e2>heparin</e2> and aspirin alone (see\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e1>naproxen</e1>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with <e1>Mexitil</e1>   , lowered <e2>Mexitil</e2>    plasma levels have been reported. \n",
      "Less potent inhibitors include <e1>saquinavir</e1>, nefazodone, fluconazole, grapefruit juice, <e2>fluoxetine</e2>, fluvoxamine, zileuton, and clotrimazole. \n",
      "May increase the effect of oral <e1>blood thinners</e1>, for example <e2>warfarin</e2> (Coumadin). \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), antihypertensives (n=72), <e2>calcium channel blockers</e2> (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e1>metoprolol</e1>, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Cyclosporine: Preliminary data from a XENICAL and <e1>cyclosporine</e1> drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with <e2>cyclosporine</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "Depending on clinical circumstances, consideration should be given to increasing the dose of <e1>DIFLUCAN</e1> when it is administered with <e2>rifampin</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, <e1>ranitidine</e1>, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, <e1>Sinequan</e1>, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, <e2>Sanctura</e2> has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "<e1>Calcium</e1> was administered as <e2>calcium chloride</e2> in all studies and minerals were ingested on an empty stomach. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including <e2>atazanavir</e2>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>Fluconazole</e1> tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in <e2>ethinyl estradiol</e2> and levonorgestrel levels; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, <e2>ethanol</e2>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "and combinations of opioids and sedatives (eg, benzodiazepines, <e1>barbiturates</e1>, <e2>chloral hydrate</e2>, droperidol, etc.). \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (NRTI) together with a <e1>non-nucleoside reverse transcriptase inhibitor</e1> (NNRTI), a <e2>protease inhibitor</e2> (PI) or an integrase inhibitor (II) is recommended. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, <e2>rifabutin</e2>, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Moxifloxacin and Lomefloxacin reacts faster with <e1>sucralfate</e1> and gelusil in acidic media whereas with erythromycin in basic media and <e2>multi-minerals</e2> in neutral media. \n",
      "<e1>Tetracycline</e1>, a bacteriostatic antibiotic, may antagonize the bactericidal effect of <e2>penicillin</e2> and concurrent use of these drugs should be avoided.\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, <e1>fluconazole</e1>, <e2>ritonavir</e2>, and rifampin. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e1>quinine</e1>) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e2>cephalosporins</e2>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (<e1>fluoxetine</e1> 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (<e2>curcumin</e2> 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg). \n",
      "<e1>Sunitinib</e1> as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to sunitinib followed by <e2>docetaxel</e2> and concurrent administration.\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, <e1>procainamide</e1>, pancuronium, morphine, vancomycin, metformin and <e2>tenofovir</e2>). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and <e1>SKELID</e1> are administered at the same time, and 60% by some aluminum- or <e2>magnesium</e2>-containing antacids, when administered 1 hour before SKELID. \n",
      "<e1>Calcium</e1> is the only known component in the diet that may affect absorption of both nonheme and <e2>heme iron</e2>. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, <e1>phenytoin</e1>, carbamazepine, rifampin, rifabutin, <e2>rifapentin</e2>, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (<e1>Dilantin</e1>) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (<e2>lorezepam</e2> oxezepam temezepam). \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), <e1>antihypertensives</e1> (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, <e1>phenytoin</e1> and rifampin may increase the clearance of <e2>corticosteroids</e2> and may require increases in corticosteroid dose to achieve the desired response. \n",
      "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or <e1>macrolide antibiotics</e1> (e.g., <e2>erythromycin</e2> and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, <e1>phenytoin</e1>, carbamazepine, <e2>rifampin</e2>, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, <e1>itraconazole</e1>, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "The addition of <e1>aspirin</e1> to <e2>Streptokinase</e2> causes a minimal increase in the risk of minor bleeding (3.9% vs. 3.1%), but does not appear to increase the incidence of major bleeding (see\n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or <e2>attapulgite</e2> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, <e2>phenytoin</e2>, carbamazepine, or certain herbal supplements such as St. \n",
      "Compared with the elimination of pure <e1>luteolin</e1> and apigenin, the elimination of luteolin and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of <e2>luteolin</e2> and apigenin. \n",
      "The effect of <e1>methylprednisolone</e1> on oral <e2>anticoagulants</e2> is variable. \n",
      "Anticoagulants: Metolazone, as well as other <e1>thiazide-like diuretics</e1>, may affect the hypoprothrombinemic response to <e2>anticoagulants</e2>; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with <e1>ketoconazole</e1> and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, <e1>ketoconazole</e1>, miconazole) were potent, non-competitive inhibitors of <e2>trimetrexate</e2> metabolism. \n",
      "In adult diabetic patients under treatment with either <e1>sulfonylureas</e1> or insulin there is no change in the clinical effects of either <e2>TOLECTIN</e2> or the hypoglycemic agents. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, <e1>pancuronium</e1>, morphine, vancomycin, <e2>metformin</e2> and tenofovir). \n",
      "Based on an in vitro rat liver model, nitrogen substituted <e1>imidazole drugs</e1> (clotrimazole, ketoconazole, <e2>miconazole</e2>) were potent, non-competitive inhibitors of trimetrexate metabolism. \n",
      "Coadministration of <e1>TRITEC</e1> with clarithromycin resulted in increased plasma <e2>ranitidine</e2> concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%). \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other <e2>anticholinergics</e2> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (<e1>clotrimazole</e1>, ketoconazole, miconazole) were potent, non-competitive inhibitors of <e2>trimetrexate</e2> metabolism. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Co-administration of oral <e1>ketoconazole</e1> 200 mg twice daily increased retapamulin geometric mean AUC(0-24) and Cmax by 81% after topical application of <e2>retapamulin</e2> ointment, 1% on the abraded skin of healthy adult males. \n",
      "<e1>Cisapride</e1>: There have been reports of cardiac events, including torsade de pointes in patients to whom <e2>fluconazole</e2> and cisapride were coadministered. \n",
      "There was no change in the plasma kinetics of <e1>teniposide</e1> when coadministered with <e2>methotrexate</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, <e2>Rifabutin</e2>, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with <e1>narcotics</e1> (eg, morphine, <e2>meperidine</e2>, and fentanyl, etc.) \n",
      "This study aimed to evaluate the in vitro activity of minocycline combined with <e1>fosfomycin</e1> against isolates of <e2>methicillin</e2>-resistant Staphylococcus aureus (MRSA). \n",
      "In rabbits treated with <e1>ezetimibe</e1>, an increased incidence of extra thoracic ribs was observed at 1000 mg/kg/day (150 times the human exposure at 10 mg daily based on AUC0-24hr for total <e2>ezetimibe</e2>). \n",
      "ProAmatine. <e1>Alpha-adrenergic blocking agents</e1>, such as <e2>prazosin</e2>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, <e1>carbamazepine</e1>, diazepam (and its active metabolite, desmethyldiazepam), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "We evaluated mechanisms of interaction between the alkyating agent <e1>dacarbazine</e1> (<e2>DTIC</e2>) and the pro-oxidant, imexon, in the human A375 melanoma cell line.\n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e2>SEDATIVE-HYPNOTICS</e2> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, <e1>erythromycin</e1>, and grapefruit juice may inhibit its metabolism (increasing serum levels of <e2>mifepristone</e2>). \n",
      "The purpose of this study was to investigate both the effect and mechanisms of IGF1R inhibition by tyrphostin AG1024 in the presence or absence of <e1>doxorubicin</e1> in a panel of six osteosarcoma cell lines and a self-established <e2>doxorubicin</e2>-resistant cell line. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e1>ethinyl estradiol</e1>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e2>Terfenadine</e2>, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  <e1>Tramadol</e1>: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of <e2>tramadol</e2>.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. \n",
      "- did not change the plasma concentration profile of <e1>terfenadine</e1> (a substrate of cytochrome P450 3A4) or fexofenadine, its carboxylated metabolite, and did not prolong the QTc interval following co-administration with <e2>terfenadine</e2> 60 mg twice daily. \n",
      "However, it is possible that concomitant use of other photosensitizing agents (e.g., <e1>tetracyclines</e1>, sulfonamides, phenothiazines, sulfonylurea hypoglycemia agents, thiazide diuretics, and <e2>griseofulvin</e2>) could increase the photosensitivity reaction. \n",
      "<e1>Salicylate</e1> competes with a number of drugs for protein binding sites, notably <e2>penicillin</e2>, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "<e1>Melatonin</e1> may interact with the following drugs: aspirin and other <e2>NSAIDs</e2> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, <e1>nalidixic acid</e1>, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "<e1>morphine</e1>, theophylline, <e2>aminophylline</e2>, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "Therefore, caution should be used in administering <e1>VUMON</e1> (<e2>teniposide</e2> injection) to patients receiving these other agents. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "<e1>Warfarin</e1> users who initiated citalopram, fluoxetine, <e2>paroxetine</e2>, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Clinical studies of interactions of <e1>VIRAZOLE</e1> with other drugs commonly used to treat infants with RSV infections, such as digoxin, bronchodilators, other antiviral agents, antibiotics, or <e2>anti-metabolites</e2> have not been conducted. \n",
      "There is evidence that <e1>meropenem</e1> may reduce serum levels of valproic acid to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total <e2>valproate</e2>).\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, <e1>metformin</e1> and <e2>tenofovir</e2>). \n",
      "An inhibitor of CYP2C8 (such as <e1>gemfibrozil</e1>) may increase the AUC of <e2>rosiglitazone</e2> and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, <e1>diltiazem</e1>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and <e2>chlorpropamide</e2>) are likely to have little effect on the oral clearance of pramipexole. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, <e2>multivitamins</e2>, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), benzodiazepines, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, prednisolone, sirolimus, <e2>nifedipine</e2>, fluconazole, ritonavir, and rifampin. \n",
      "In most cases, the application of two <e1>nucleoside or nucleotide reverse transcriptase inhibitors</e1> (NRTI) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI) or an <e2>integrase inhibitor</e2> (II) is recommended. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, <e1>troleandomycin</e1>, clarithromycin), HIV protease or <e2>reverse transcriptase inhibitors</e2> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "There are reports of enhanced as well as diminished effects of <e1>anticoagulants</e1> when given concurrently with <e2>corticosteroids</e2>. \n",
      "Standard antibiotic such as <e1>Gentamicin</e1> (10 microg), <e2>Cephalothin</e2> (30 microg), Ceftriaxone (10 microg), Nystatin (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "Therefore, as vitamin K absorption may be decreased with <e1>XENICAL</e1>, patients on chronic stable doses of warfarin who are prescribed <e2>XENICAL</e2> should be monitored closely for changes in coagulation parameters.\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e1>Tofranil</e1>, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e1>phenothiazines</e1> (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, <e1>Terfenadine</e1>, Cisapride, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Interactions for Vitamin B1 (<e1>Thiamine</e1>):  <e2>Loop Diuretics</e2>, Oral Contraceptives, Stavudine, Tricyclic Antidepressants\n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e2>SEDATIVE-HYPNOTICS</e2> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, <e1>griseofulvin</e1>, modafinil, <e2>penicillins</e2>, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral <e1>contraceptives</e1> (<e2>norethindrone</e2> 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (<e1>Tofranil</e1>), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, <e2>indomethacin</e2>, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "There was a >75% reduction in cellular glutathione and cysteine with <e1>imexon</e1> but not <e2>DTIC</e2>. \n",
      "Lithium: Increased serum lithium and symptoms of <e1>lithium</e1> toxicity have been reported in patients receiving concomitant <e2>lithium</e2> and ACE inhibitor therapy. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (<e1>Dilantin</e1>) carbamazepine (<e2>Tegretol</e2>) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Methyldopa does not interfere with measurement of <e1>VMA</e1> (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert VMA to <e2>vanillin</e2>. \n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, <e1>rifabutin</e1>, <e2>ketoconazole</e2>, and fluconazole. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e1>antihistamines</e1> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e1>Tofranil</e1>, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>amiloride</e1>, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, <e2>heparin</e2>, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with <e1>Hormonal Contraceptives</e1>: Concomitant use of <e2>HIV-protease inhibitors</e2>, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "<e1>Isoflurane</e1> and enflurane (administered with nitrous oxide/<e2>oxygen</e2> to achieve 1.25 M.C. \n",
      "<e1>Antacids</e1>: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-<e2>aluminum</e2> containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions. \n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, <e1>tricyclic antidepressants</e1>, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, <e1>antiarrhythmic agents of class I</e1> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local <e2>anesthetics</e2>, procainamide, and quinidine. \n",
      "There were no significant differences between the pharmacokinetics parameters of <e1>amiodarone</e1> administered intravenously or intragastrically and the control (without neferine) group (with ratios of 0.7-1.4 in all experimental groups), suggesting that <e2>neferine</e2> had no effect on amiodarone plasma pharmacokinetics. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, echothiophate, neostigmine, <e1>physostigmine</e1>, and <e2>midazolam</e2> revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, phenytoin and rifampin may increase the clearance of <e2>corticosteroids</e2> and may require increases in corticosteroid dose to achieve the desired response. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Other eye drops or medications such as <e1>acetylcholine chloride</e1> (<e2>Miochol</e2>) and carbachol (Carboptic, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., <e1>phenothiazines</e1>), benzodiazepines, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, <e2>metformin</e2> and tenofovir). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, <e1>indinavir</e1>, nelfinavir, delavirdine) or <e2>azole antifungals</e2> (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: <e1>acetylsalicylic acid</e1>, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, <e2>omeprazole</e2>, paracetamol, and prednisone.\n",
      "Some examples of such drugs are erythromycin, itraconazole, ketoconazole, fluconazole, <e1>calcium channel blockers</e1> and <e2>cimetidine</e2>.\n",
      "<e1>Paroxetine</e1> and fluoxetine reduce the plasma concentration of <e2>endoxifen</e2> by about 50%. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e1>absorbent-type anti-diarrhea medicines</e1> (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., <e1>dexamethasone</e1>, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease <e2>sunitinib</e2> concentrations. \n",
      "This study investigates the ability of <e1>cyclooxygenase-2 inhibitors</e1> to sensitize cells from different origins to several <e2>chemotherapeutic agents</e2>. \n",
      "There is usually complete cross-resistance between <e1>PURINETHOL</e1> (mercaptopurine) and TABLOID brand <e2>Thioguanine</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "The effects of <e1>indinavir</e1>, zidovudine or rifabutin on the pharmacokinetics of <e2>megestrol acetate</e2> were not studied.\n",
      "However, the impairment of cognitive and motor skills produced by <e1>REMERON</e1>    were shown to be additive with those produced by <e2>alcohol</e2>. \n",
      "Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with <e1>solifenacin</e1> 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of <e2>solifenacin</e2> 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e2>Anafranil</e2>, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (<e1>clotrimazole</e1>, <e2>ketoconazole</e2>, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism. \n",
      "The use of MIVACRON before <e1>succinylcholine</e1> to attenuate some of the side effects of <e2>succinylcholine</e2> has not been studied. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e2>nitrates</e2> and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "If ZEMURON    is administered following administration of <e1>succinylcholine</e1>, it should not be given until recovery from <e2>succinylcholine</e2> has been observed. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, ketoconazole, fluconazole, calcium channel blockers and <e2>cimetidine</e2>.\n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, <e1>rifampin</e1>, rifabutin, rifapentin, <e2>phenobarbital</e2>, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "Concurrent administration of <e1>bacteriostatic antibiotics</e1> (e.g., <e2>erythromycin</e2>, tetracycline) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth. \n",
      "<e1>Cisapride</e1>: There have been reports of cardiac events, including torsade de pointes in patients to whom fluconazole and <e2>cisapride</e2> were coadministered. \n",
      "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with <e1>tamoxifen</e1> for breast cancer, especially SSRI antidepressants such as <e2>paroxetine</e2> and fluoxetine. \n",
      "We found antagonism between <e1>celecoxib</e1> and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between <e2>celecoxib</e2> and doxorubicin in all cell lines except for two combinations in HCT116 cells. \n",
      "Mitotane has been reported to accelerate the metabolism of <e1>warfarin</e1> by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for <e2>warfarin</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e1>fluoxetine</e1> (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "In clinical studies, patients on <e1>opioids</e1> often needed higher serum pegvisomant concentrations to achieve appropriate IGF-I suppression compared with patients not receiving <e2>opioids</e2>. \n",
      "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. <e1>dihydroergotamine</e1> and <e2>ergotamine</e2>) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, <e1>hypnotics</e1>, narcotic analgesics, sedatives, and <e2>tranquillisers</e2>. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, <e1>Colestipol</e1>, <e2>Iron</e2>-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as tricyclic antidepressants,    -blockers, <e1>selective serotonin reuptake inhibitors</e1> (SSRIs), and <e2>monoamine oxidase inhibitors (MAO-Is) Type B</e2>, if they have a narrow therapeutic window. \n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and <e1>magnesium salicylate</e1>s, Colestipol, <e2>Iron</e2>-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Pharmacokinetic properties of <e1>abacavir</e1> were not altered by the addition of either lamivudine or <e2>zidovudine</e2> or the combination of lamivudine and zidovudine. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-<e1>Mexitil</e1>    values within 48 hours after discontinuing Mexitil   . If <e2>Mexitil</e2> and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as <e1>procaine</e1> - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "<e1>HMG-CoA reductase inhibitors</e1>: No clinically significant pharmacokinetic interactions were seen when <e2>ezetimibe</e2> was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, <e1>digoxin</e1>, ethanol, glyburide, an oral contraceptive (levonorgestrel/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Oral <e1>Contraceptives</e1>: In 10 healthy women, the pharmacokinetic profiles of <e2>norethindrone</e2> and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. \n",
      "The effect of <e1>corticosteroids</e1> on oral <e2>anticoagulants</e2> is variable. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, <e1>secobarbital</e1> and <e2>droperidol</e2>. \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (Dilantin) carbamazepine (Tegretol) <e2>Estrogens</e2> may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "However, it is possible that concomitant use of other <e1>photosensitizing agents</e1> (e.g., tetracyclines, <e2>sulfonamides</e2>, phenothiazines, sulfonylurea hypoglycemia agents, thiazide diuretics, and griseofulvin) could increase the photosensitivity reaction. \n",
      "All mRPCs of 20 passages or less were transplanted into the subretinal space of B6 mice together with chondroitinase ABC, and into Rho(-/-) mice combined with chondroitinase ABC, N-[N-(3, 5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (<e1>DAPT</e1>), and insulin growth factor <e2>(IGF)-1</e2>. \n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as antiepileptic drugs, <e1>taxol</e1>, rifampicin, and <e2>human immunodeficiency virus protease inhibitors</e2> such as ritonavir and saquinavir. \n",
      "Although such a risk is not verified for <e1>roxithromycin</e1>, combination of <e2>roxithromycin</e2> with such drugs is not recommended.\n",
      "In the light of contradictory data on efficacy and safety of NSAID in cardiovascular patients selection of most appropriate <e1>NSAID</e1> (basing on profile of efficacy and safety) in patients receiving continuous therapy with low dose <e2>aspirin</e2> appears to be a problem. \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - <e2>Ketoconazole</e2> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Also <e1>mirtazapine</e1>, which is not believed to interact with <e2>warfarin</e2>, increased the risk of GI bleeding (OR   =   1.75 [95% CI, 1.30-2.35]). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Drugs which may potentiate the myeloproliferative effects of <e1>Leukine</e1>, such as <e2>lithium</e2> and corticosteroids, should be used with caution.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e1>potassium chloride</e1> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, <e1>nefazodone</e1>, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "<e1>chlorthalidone</e1>, furosemide, hydrochlorothiazide, <e2>spironolactone</e2>; \n",
      "<e1>Cyclosporine</e1>: The total <e2>ezetimibe</e2> level increased 12-fold in one renal transplant patient receiving multiple medications, including cyclosporine. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or <e1>cyclosporine</e1> or vinblastine, the recommended dose of <e2>DETROL LA</e2> is 2 mg daily. \n",
      "UNIVASC    has been used in clinical trials concomitantly with <e1>calcium-channel-blocking agents</e1>, diuretics, H2 blockers, <e2>digoxin</e2>, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (<e2>Asendin</e2>), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, <e2>prednisone</e2>, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: <e1>Agonist/antagonist analgesics</e1> (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof <e2>opioid agonist analgesic</e2>. \n",
      "The addition of <e1>sodium bicarbonate</e1> to parenteral solutions containing <e2>calcium</e2> should be avoided, except where compatibility has been previously established. \n",
      "The use of AGGRASTAT, in combination with <e1>heparin</e1> and <e2>aspirin</e2>, has been associated with an increase in bleeding compared to heparin and aspirin alone (see\n",
      "Those <e1>anticonvulsants</e1> include divalproex sodium, <e2>valproic acid</e2>, and phenobarbital. \n",
      "- did not cause any clinically significant change in plasma profiles of <e1>prednisone</e1> or <e2>prednisolone</e2> following administration of either oral prednisone or intravenous prednisolone.  \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "In drug-interaction studies, the recommended clinical dose of <e1>montelukast</e1> did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and <e2>warfarin</e2>. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., <e1>Elavil</e1>, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "The bioavailability of SKELID is decreased 80% by <e1>calcium</e1>, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing <e2>antacids</e2>, when administered 1 hour before SKELID. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (<e2>Pamelor</e2>), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e2>atazanavir</e2>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., <e1>digoxin</e1>) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, <e2>ethanol</e2>, cyclosporine). \n",
      "<e1>Pindolol</e1> has been shown to increase serum <e2>thioridazine</e2> levels when both drugs are co-administered. \n",
      "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as <e1>aspirin</e1>, dipyridamole, and <e2>abciximab</e2>) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of <e1>ProAmatine</e1>   . Therefore, caution should be used when <e2>ProAmatine</e2>    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Montelukast at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral <e1>contraceptive</e1> containing norethindrone 1 mg/ethinyl <e2>estradiol</e2> 35 mcg. \n",
      "DIFLUCAN reduces the metabolism of <e1>tolbutamide</e1>, <e2>glyburide</e2>, and glipizide and increases the plasma concentration of these agents. \n",
      "Patients receiving <e1>sirolimus</e1> or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and <e2>sirolimus</e2> or nifedipine dosage should be reduced if necessary. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, <e2>indinavir</e2>, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and <e1>theophylline</e1> are to be used concurrently, <e2>theophylline</e2> blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Moxifloxacin and <e1>Lomefloxacin</e1> reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and <e2>multi-minerals</e2> in neutral media. \n",
      "<e1>Anticoagulants</e1> (such as <e2>heparin</e2> and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, <e1>phenytoin</e1>, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly <e2>corticosteroids</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of <e1>rivastigmine</e1> were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), <e2>salicylate analgesics</e2> (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Therefore, as <e1>vitamin K</e1> absorption may be decreased with <e2>XENICAL</e2>, patients on chronic stable doses of warfarin who are prescribed XENICAL should be monitored closely for changes in coagulation parameters.\n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral <e1>contraceptives</e1>, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, beta blockers, and <e2>calcium channel blockers</e2>.\n",
      "Palonosetron did not inhibit the antitumor activity of the five <e1>chemotherapeutic agents</e1> tested (cisplatin, <e2>cyclophosphamide</e2>, cytarabine, doxorubicin and mitomycin C) in murine tumor models.\n",
      "<e1>Pravastatin</e1>: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not affect the pharmacokinetics of <e2>pravastatin</e2>. \n",
      "<e1>morphine</e1>, theophylline, aminophylline, <e2>succinylcholine</e2>, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "Vasopressors, particularly <e1>metaraminol</e1>, may cause serious cardiac arrhythmias during <e2>halothane</e2> anesthesia and therefore should be used only with great caution or not at all. \n",
      "<e1>Sympathomimetics</e1> may reduce the antihypertensive effects of <e2>methyldopa</e2>, mecamylamine, reserpine and veratrum alkaloids.\n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, <e1>cisapride</e1>, <e2>cyclosporine</e2>, and tricyclic antidepressants. \n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . <e1>Theophylline</e1> plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If <e2>Mexitil</e2> and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e1>thyroxine</e1>, <e2>triiodothyronine</e2>, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), <e2>cyclosporine</e2> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or <e1>carbamazepine</e1> - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - <e2>polymyxin B</e2> or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "While in vitro studies have shown that <e1>mirtazapine</e1> is not a potent inhibitor of any of these enzymes, an indication that <e2>mirtazapine</e2> is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of REMERON SolTab with most other drugs metabolized by these enzymes has not been formally studied. \n",
      "Those anticonvulsants include <e1>divalproex sodium</e1>, <e2>valproic acid</e2>, and phenobarbital. \n",
      "No significant adverse interactions with common premedications (such as <e1>atropine</e1>, <e2>scopolamine</e2>, glycopyrrolate, diazepam, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.\n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, <e1>fluvoxamine</e1>, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with <e2>sumatriptan</e2>. \n",
      "Interference of <e1>MPAG</e1> hydrolysis may lead to less <e2>MPA</e2> available for absorption.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), <e1>antihistamines</e1>, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, <e2>sympathomimetic agents</e2>, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Antacids: Absorption of a single dose of <e1>Myfortic</e1> was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when <e2>Myfortic</e2> was administered alone under fasting conditions. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e1>digoxin</e1>, procainamide, <e2>pancuronium</e2>, morphine, vancomycin, metformin and tenofovir). \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, <e2>triamterene</e2>, flecainide, and quinidine. \n",
      "During maintenance of anesthesia or sedation, the rate of DIPRIVAN Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents (eg, <e1>nitrous oxide</e1> or <e2>opioids</e2>). \n",
      "In experiment 2, the same regimen of <e1>GSLS</e1> was administered to chickens inoculated with <e2>inactivated AI vaccines</e2>, and an enhanced serum antibody response to AI vaccination was also observed. \n",
      "The effect of curcumin (100 mg/kg) was similar to that of fluoxetine and <e1>imipramine</e1> (p > 0.05) but its addition to <e2>fluoxetine</e2> and imipramine did not improve their antidepressant activity (p > 0.05). \n",
      "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, <e1>anti-infective medicines</e1>, furosemide and <e2>theophylline</e2> Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, <e1>magnesium hydroxide</e1>, and simethicone) did not significantly affect the exposure of oxybutynin or <e2>desethyloxybutynin</e2>.    \n",
      "Patients treated with <e1>proton pump inhibitors</e1> and <e2>warfarin</e2> concomitantly should be monitored for increases in INR and prothrombin time. \n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, hypnotics, tranquilizers, general anesthetics, <e2>phenothiazines</e2>, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e1>prednisone</e1>, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), <e2>terfenadine</e2>, digoxin, and warfarin. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including <e1>alcohol</e1>, <e2>barbiturates</e2>, hypnotics, narcotic analgesics, sedatives, and tranquillisers. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, <e1>corticosteroids</e1>, anticoagulants, and <e2>beta blockers</e2>.\n",
      "Although a causal relationship has not been established, there have been reports of bleeding and/or prolonged prothrombin time in patients treated with <e1>TRENTAL</e1> with and without <e2>anticoagulants</e2> or platelet aggregation inhibitors. \n",
      "The effects of <e1>anti-parkinsonian drug</e1> <e2>hemantane</e2> [(2-adamantyl)hexamethylenimine] (10 mg/kg, p. o.) \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, <e2>heparin</e2>, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., <e1>cephalosporins</e1>, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of <e1>norethindrone acetate</e1> and 75    g of <e2>ethinyl estradiol</e2> were studied. \n",
      "Interactions for Vitamin B1 (Thiamine):  <e1>Loop Diuretics</e1>, Oral Contraceptives, Stavudine, <e2>Tricyclic Antidepressants</e2>\n",
      "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of <e1>azole antimycotics</e1>, protease inhibitors, <e2>calcium channel antagonists</e2>, and macrolide antibiotics). \n",
      "No significant adverse interactions with common premedications (such as atropine, <e1>scopolamine</e1>, glycopyrrolate, diazepam, <e2>hydroxyzine</e2>, and other muscle relaxants) or local anesthetics have been observed.\n",
      "MAO Inhibitors - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving <e1>monoamine oxidase inhibitors</e1> (<e2>MAOI</e2>). \n",
      "2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of <e1>pralidoxime</e1>: since <e2>barbiturates</e2> are potentiated by the anticholinesterases, they should be used cautiously in the treatment of convulsions; \n",
      "Lithium: Increased serum <e1>lithium</e1> levels and symptoms of <e2>lithium</e2> toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as <e2>prazosin</e2>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, <e1>ibuprofen</e1>, <e2>diazepam</e2>, and diazoxide. \n",
      "The neuromuscular blocking effect of <e1>MIVACRON</e1> may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or <e2>carbamazepine</e2>. \n",
      "Warfarin users who initiated citalopram, fluoxetine, <e1>paroxetine</e1>, amitriptyline, or <e2>mirtazapine</e2> had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Rats treated with neonatal <e1>quinpirole</e1> enhanced time spent in the <e2>amphetamine</e2>-paired context compared with quinpirole-free controls conditioned with amphetamine, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls. \n",
      "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of <e1>Cimetidine</e1> (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total <e2>rimantadine</e2> clearance in the same subjects in the absence of cimetidine). \n",
      "Use of Anticoagulants and Antiplatelet Agents -- <e1>Streptase</e1>, Streptokinase, alone or in combination with antiplatelet agents and <e2>anticoagulants</e2>, may cause bleeding complications. \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., <e1>fluoxetine</e1>, fluvoxamine, <e2>paroxetine</e2>, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), <e1>nitrates</e1> and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "A variety of antiarrhythmics such as <e1>quinidine</e1> or <e2>propranolol</e2> were also added, sometimes with improved control of ventricular ectopy. \n",
      "<e1>Cyclosporine</e1>: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in <e2>cyclosporine</e2> plasma levels when XENICAL was coadministered with cyclosporine. \n",
      "The following agents may increase certain actions or side effects of <e1>anticholinergic drugs</e1>: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., <e2>meperidine</e2>), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Drugs that impair intestinal absorption of <e1>fat-soluble vitamins</e1>, such as cholestyramine, may interfere with the absorption of <e2>Zemplar</e2> Capsules.\n",
      "The pharmacokinetic interaction between <e1>cimetidine</e1> and <e2>FLOMAX</e2> capsules was investigated. \n",
      "Patients receiving sirolimus or nifedipine in combination with <e1>MYCAMINE</e1> should be monitored for sirolimus or nifedipine toxicity and <e2>sirolimus</e2> or nifedipine dosage should be reduced if necessary. \n",
      "Diuretics: Furosemide and probably other <e1>loop diuretics</e1> given concomitantly with <e2>metolazone</e2> can cause unusually large or prolonged losses of fluid and electrolytes. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER <e1>TRANQUILIZERS</e1>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), <e1>clomipramine</e1> (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of <e1>Ropivacaine</e1>, can interact with Ropivacaine leading to increased <e2>ropivacaine</e2> plasma levels. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., <e1>quinidine</e1>), antihistamines, antipsychotic agents (e.g., <e2>phenothiazines</e2>), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "<e1>Dopamine antagonists</e1>: Since pramipexole is a dopamine agonist, it is possible that <e2>dopamine antagonists</e2>, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total <e1>rimantadine</e1> clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total <e2>rimantadine</e2> clearance in the same subjects in the absence of cimetidine). \n",
      "<e1>Moxifloxacin</e1> and lomefloxacin are <e2>fluoroquinolone antibiotics</e2> used in treating urinary and respiratory tract infections. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, <e1>phenytoin</e1>, <e2>sulfinpyrazone</e2>, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "If short-acting benzodiazepines, which are metabolized by the cytochrome P450 system, are concomitantly administered with <e1>fluconazole</e1>, consideration should be given to decreasing the <e2>benzodiazepine</e2> dosage, and the patients should be appropriately monitored. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably <e1>penicillin</e1>, thiopental, thyroxine, <e2>triiodothyronine</e2>, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "The in vitro binding of <e1>warfarin</e1> to human plasma proteins is unaffected by <e2>tolmetin</e2>, and tolmetin does not alter the prothrombin time of normal volunteers. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e1>thiazides</e1>, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "To minimize CNS depression and possible potentiation, barbiturates, <e1>antihistamines</e1>, narcotics, hypotensive agents or <e2>phenothiazines</e2> should be used with caution. \n",
      "The latter displayed <e1>midazolam</e1> clearances similar to those in two larger cohorts of nonmatched tacrolimus-treated patients (n = 58 and n = 80) and to those receiving a <e2>calcineurin inhibitor</e2>-free regimen (n = 6). \n",
      "This study aimed to evaluate the in vitro activity of <e1>minocycline</e1> combined with fosfomycin against isolates of <e2>methicillin</e2>-resistant Staphylococcus aureus (MRSA). \n",
      "In these subjects, <e1>meloxicam</e1> did not alter warfarin pharmacokinetics and the average anticoagulant effect of <e2>warfarin</e2> as determined by prothrombin time. \n",
      "<e1>Digoxin</e1>: There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of <e2>digoxin</e2> with the co-administration of 100 mg sitagliptin for 10 days. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e1>metoprolol</e1>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "The concomitant use of <e1>oxybutynin</e1> with other <e2>anticholinergic drugs</e2> or with other agents which produce dry mouth, constipation, somnolence (drowsiness), and/or other anticholinergic-like effects may increase the frequency and/or severity of such effects. \n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, <e2>saquinavir</e2>, telithromycin or voriconazole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), <e1>salicylate analgesics</e1> (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, <e2>Theophylline</e2>, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Use of <e1>potassium-sparing diuretics</e1> (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, <e2>cyclosporine</e2> and others) can increase the risk of hyperkalemia. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e1>phenelzine</e1>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Mequitazine can interact with CNS depressant, antichlolinergic, <e1>TCA</e1>, <e2>MAOIs</e2>, and alcohol.\n",
      "<e1>Selective serotonin reuptake inhibitors</e1> were the most commonly prescribed <e2>antidepressant</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e1>paricalcitol</e1> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, Choline and <e1>magnesium salicylate</e1>s, Colestipol, Iron-containing drugs, <e2>Laxatives</e2>, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "The pressor response of <e1>adrenergic agents</e1> may also be potentiated by <e2>tricyclic antidepressants</e2>.\n",
      "The elevation of prothrombin time induced by <e1>warfarin</e1> is not affected by administration of <e2>Exelon</e2>. \n",
      "In vitro studies with <e1>atracurium</e1>, mivacurium, <e2>esmolol</e2>, echothiophate, neostigmine, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "A multiple dose drug-drug interaction study demonstrated that <e1>ketoconazole</e1> approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including <e2>atazanavir</e2>, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Drugs such as erythromycin, <e1>diltiazem</e1>, verapamil, ketoconazole, fluconazole and <e2>itraconazole</e2> were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or <e1>phenelzine</e1> (<e2>Nardil</e2>) in the last 14 days. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of <e1>melatonin</e1> and <e2>corticosteroids</e2> may interfere with the efficacy of the corticosteroids).\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, <e2>nifedipine</e2>, fluconazole, ritonavir, and rifampin. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local <e2>anesthetics</e2> such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), benzodiazepines, <e2>MAO inhibitors</e2>, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, cyclosporine, <e2>tacrolimus</e2>, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral <e2>melatonin</e2> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Interactions  Interaction may occur with Antacids, Calcium supplements, Cholestyramine, <e1>Choline</e1> and magnesium salicylates, Colestipol, <e2>Iron</e2>-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when <e1>calcium</e1> and SKELID are administered at the same time, and 60% by some aluminum- or <e2>magnesium</e2>-containing antacids, when administered 1 hour before SKELID. \n",
      "But the use of fixed combination <e1>amlodipine</e1>/valsartan compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of <e2>antihypertensive drugs</e2> (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05). \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including <e1>alcohol</e1>, barbiturates, hypnotics, <e2>narcotic analgesics</e2>, sedatives, and tranquillisers. \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), <e1>tranylcypromine</e1> (Parnate), or <e2>phenelzine</e2> (Nardil) in the last 14 days. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, <e1>phenytoin</e1>, <e2>carbamazepine</e2>, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, <e1>carbamazepine</e1>, and <e2>rifampicin</e2>), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of <e1>coumarin anticoagulants</e1>, <e2>anticonvulsants</e2> (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "These include <e1>sympathomimetic bronchodilators</e1>, methylxanthines, and oral and inhaled <e2>steroids</e2>. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e2>nifedipine</e2>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), <e1>antidiabetics</e1> (n=21), <e2>nonsteroidal anti-inflammatory drugs</e2> (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, <e1>chlorpromazine</e1>, and <e2>reserpine</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, <e1>phenothiazines</e1>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, <e1>atazanavir</e1>, indinavir, nefazodone, <e2>nelfinavir</e2>, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, ketoconazole, fluconazole, <e2>calcium channel blockers</e2> and cimetidine.\n",
      "<e1>John's Wort</e1> with <e2>hormonal contraceptive agents</e2> may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies. \n",
      "<e1>Probenecid</e1>: Probenecid, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence <e2>pramipexole</e2> pharmacokinetics (N= 12). \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, <e2>phenothiazines</e2>, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or <e1>macrolide antibiotics</e1> (eg, <e2>erythromycin</e2>, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, <e1>Astemizole</e1>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral <e2>hypoglycemics</e2>: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "<e1>Penicillin</e1> blood levels may be prolonged by concurrent administration of <e2>probenecid</e2> which blocks the renal tubular secretion of penicillins. \n",
      "- Antacids - Diarrhea medicine containing kaolin or <e1>attapulgite</e1> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e2>Pertofrane</e2>, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "The purpose of this study was to investigate both the effect and mechanisms of IGF1R inhibition by <e1>tyrphostin AG1024</e1> in the presence or absence of <e2>doxorubicin</e2> in a panel of six osteosarcoma cell lines and a self-established doxorubicin-resistant cell line. \n",
      "In the present study <e1>piperine</e1> (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of <e2>ibuprofen</e2> evaluated by both acetic acid writhing and formalin test, when it was administered with ibuprofen. \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), <e2>MAO inhibitors</e2> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - <e1>cisplatin</e1> - edrophonium - <e2>neostigmine</e2> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "These effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication (e.g., <e1>atropine</e1>, inhaled <e2>ipratropium</e2>). \n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, <e2>Calcium</e2> supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Drugs that induce hepatic enzymes such as <e1>phenobarbital</e1>, phenytoin, and rifampin may increase the clearance of methylprednisolone and may require increased in <e2>methylprednisolone</e2> dose to achieve the desired response. \n",
      "Being moxifloxacin and lomefloxacin <e1>fluoroquinolones</e1> the interaction study of was carried out with sucralfate, <e2>gelusil</e2>, erythromycin and multi minerals. \n",
      "The concomitant use of other <e1>CNS depressants</e1> including sedatives, hypnotics, tranquilizers, general <e2>anesthetics</e2>, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. \n",
      "The susceptibility results for <e1>minocycline</e1> and <e2>fosfomycin</e2> were interpreted according to the most relevant criteria. \n",
      "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, <e1>bacitracin</e1>, polymyxin B, colistin, viomycin, or <e2>cisplatin</e2>, when indicated, requires careful monitoring.\n",
      "An additional clinical drug-drug interaction study showed no effect of rifaximin on the presystemic metabolism of an oral contraceptive containing <e1>ethinyl estradiol</e1> and <e2>norgestimate</e2>. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or <e2>voriconazole</e2>. \n",
      "Concurrent administration of bacteriostatic antibiotics (e.g., <e1>erythromycin</e1>, tetracycline) may diminish the bactericidal effects of <e2>penicillins</e2> by slowing the rate of bacterial growth. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, <e1>naproxen</e1>, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "Concomitant administrations not recommended:  - Terfenadine and <e1>astemizole</e1>: Certain <e2>macrolides</e2> interact with terfenadine and astemizole leading to increased serum concentrations of the latter. \n",
      "Decreased seizure threshold has been reported in patients receiving <e1>CYLERT</e1> concomitantly with <e2>antiepileptic medications</e2>.\n",
      "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that <e1>ketoconazole</e1>, <e2>itraconazole</e2>, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). \n",
      "Mexitil    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to <e1>Mexitil</e1>   , has been reported to lower serum <e2>digoxin</e2> levels. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral <e2>melatonin</e2> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of <e1>perindopril</e1>/<e2>perindoprilat</e2> has not been excluded. \n",
      "Interaction with Other <e1>Central Nervous System Depressants</e1>: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER <e2>NARCOTIC ANALGESICS</e2>, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "<e1>UNIVASC</e1>    has been used in clinical trials concomitantly with <e2>calcium-channel-blocking agents</e2>, diuretics, H2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and <e1>tricyclic drugs</e1> (<e2>imipramine</e2>, clomipramine, desipramine). \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as <e1>clofibrate</e1>, indomethacin, naproxen, ibuprofen, <e2>diazepam</e2>, and diazoxide. \n",
      "In vitro studies with <e1>atracurium</e1>, mivacurium, esmolol, echothiophate, neostigmine, physostigmine, and <e2>midazolam</e2> revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as <e1>antacids</e1> (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), <e2>antianginals</e2> (n=35), and antihistamines (n=15). \n",
      "Interactions for Vitamin B1 (Thiamine):  Loop Diuretics, Oral <e1>Contraceptives</e1>, <e2>Stavudine</e2>, Tricyclic Antidepressants\n",
      "The elimination percent of <e1>luteolin</e1> and <e2>apigenin</e2> was found to be 91.9% and 86.7% after 120 min of incubation. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, <e1>prednisolone</e1>, oral <e2>contraceptives</e2> (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, <e1>MARINOL</e1> (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, <e2>sedatives</e2>, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, <e1>prednisone</e1>, <e2>prednisolone</e2>, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral <e1>contraceptives</e1> produced an overall mean increase in <e2>ethinyl estradiol</e2> and levonorgestrel levels; \n",
      "Weekly intramuscular <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1> injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2> versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle). \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, <e1>anticonvulsants</e1> (phenobarbital, diphenylhydantoin, primidone), <e2>phenylbutazone</e2>, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e2>PHENOTHIAZINES</e2>, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Barbiturates may decrease the effectiveness of oral <e1>contraceptives</e1>, certain <e2>antibiotics</e2>, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e1>imipramine</e1> (Tofranil), clomipramine (Anafranil), protriptyline (<e2>Vivactil</e2>), or desipramine (Norpramin). \n",
      "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as <e1>isocarboxazid</e1> (<e2>Marplan</e2>), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days. \n",
      "Consult your doctor or pharmacist if you are taking any of the following: seizure medications <e1>antibiotics</e1> <e2>warfarin</e2> medications to help you sleep\n",
      "Pravastatin: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving <e1>XENICAL</e1> 120 mg three times a day for 6 days, XENICAL did not affect the pharmacokinetics of <e2>pravastatin</e2>. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e2>desglymidodrine</e2> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), <e1>sulfonylurea agents</e1> (increased hypoglycemic response), <e2>warfarin</e2> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by <e1>metoclopramide</e1>, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, <e2>tetracycline</e2>, levodopa, ethanol, cyclosporine). \n",
      "<e1>Pyrimethamine</e1> may be used with <e2>sulfonamides</e2>, quinine and other antimalarials, and with other antibiotics. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some <e1>aluminum</e1>- or magnesium-containing <e2>antacids</e2>, when administered 1 hour before SKELID. \n",
      "Caution should be observed in administering DEMSER to patients receiving <e1>phenothiazines</e1> or <e2>haloperidol</e2> because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis. \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, MARINOL (<e1>Dronabinol</e1>) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, anti-infective agents, sedatives, or <e2>opioid analgesics</e2>) without resulting in any clinically significant drug/drug interactions. \n",
      "One case of hypertensive crisis has been reported in a patient taking the recommended doses of <e1>selegiline</e1> and a <e2>sympathomimetic medication</e2> (ephedrine).\n",
      "No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of muscle relaxants, inhalational agents, <e1>analgesic agents</e1>, and local <e2>anesthetic agents</e2>) have been observed.\n",
      "Therefore, the use of <e1>sumatriptan succinate</e1> tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, <e2>fluvoxamine</e2>, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Although such a reaction has not been demonstrated with roxithromycin, concomitant administration of <e1>roxithromycin</e1> with <e2>terfenadine</e2> or astemizole is not recommended. \n",
      "The concomitant use of <e1>Sanctura</e1> with other <e2>anticholinergic agents</e2> that produce dry mouth, constipation, and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include <e1>macrolide antibiotics</e1> (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, <e2>nelfinavir</e2>, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). \n",
      "Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, <e1>hypnotics</e1>, narcotics, or <e2>tranquilizers</e2>. \n",
      "Although it was previously reported that lapatinib combined with <e1>Herceptin</e1> improved the progression-free survival rate compared with lapatinib alone for patients with <e2>Herceptin</e2>-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "<e1>Diuretics</e1>: <e2>Furosemide</e2> and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes. \n",
      "Acetazolamide: Concurrent use of acetazolamide and <e1>procaine hydrochloride</e1> may extend the plasma half-life of <e2>procaine</e2>.\n",
      "Since Celontin (<e1>methsuximide</e1>) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg <e2>methsuximide</e2> may increase the plasma concentrations of phenytoin and phenobarbital).\n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral <e1>contraceptives</e1>, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered <e2>phenytoin</e2> or carbamazepine. \n",
      "<e1>norepinephrine</e1> and dobutamine are incompatible with <e2>sodium bicarbonate</e2> solution. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, <e1>griseofulvin</e1>, <e2>modafinil</e2>, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e1>Pertofrane</e1>, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Montelukast at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing <e1>norethindrone</e1> 1 mg/ethinyl <e2>estradiol</e2> 35 mcg. \n",
      "Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with <e1>ropivacaine</e1> infusion administered 1 hour after <e2>ketoconazole</e2>) caused a 15% reduction in in-vivo plasma clearance of ropivacaine.\n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "TOLECTIN and other <e1>nonsteroidal anti-inflammatory drugs</e1> have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of <e2>methotrexate</e2>. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as <e1>prazosin</e1>, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and <e2>quinidine</e2>. \n",
      "Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and ELDEPRYL and <e1>selective serotonin reuptake inhibitors</e1> and <e2>ELDEPRYL</e2>. \n",
      "Melatonin may interact with the following drugs: <e1>aspirin</e1> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "The effects of <e1>anticholinergic drugs</e1>, such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of <e2>triprolidine</e2>. \n",
      "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, <e1>fluvoxamine</e1>, zileuton, and <e2>clotrimazole</e2>. \n",
      "To minimize CNS depression and possible potentiation, barbiturates, <e1>antihistamines</e1>, <e2>narcotics</e2>, hypotensive agents or phenothiazines should be used with caution. \n",
      "Lithium: In clinical trials, <e1>NSAIDs</e1> have produced an elevation of plasma <e2>lithium</e2> levels and a reduction in renal lithium clearance. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some <e1>aluminum</e1>- or <e2>magnesium</e2>-containing antacids, when administered 1 hour before SKELID. \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), <e1>propofol</e1>, ketamine, nitrous oxide, <e2>secobarbital</e2> and droperidol. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, <e1>prednisolone</e1>, sirolimus, nifedipine, fluconazole, <e2>ritonavir</e2>, and rifampin. \n",
      "The purpose of this study was to investigate both the effect and mechanisms of IGF1R inhibition by <e1>tyrphostin AG1024</e1> in the presence or absence of doxorubicin in a panel of six osteosarcoma cell lines and a self-established <e2>doxorubicin</e2>-resistant cell line. \n",
      "May interact with cimetidine, <e1>digoxin</e1>, medicines to control heart rhythm, sevelamer, and <e2>theophylline</e2>.\n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e1>ANESTHETICS</e1>, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING <e2>BARBITURATES</e2>), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or <e1>reverse transcriptase inhibitors</e1> (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, <e2>voriconazole</e2>). \n",
      "Pyrimethamine may be used with sulfonamides, quinine and other <e1>antimalarials</e1>, and with other <e2>antibiotics</e2>. \n",
      "Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as <e1>sedatives</e1>, <e2>tranquilizers</e2>, or alcohol. \n",
      "Interactions for Dronabinol:  In studies involving patients with AIDS and/or cancer, MARINOL (<e1>Dronabinol</e1>) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, <e2>anti-infective</e2> agents, sedatives, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e1>progestin</e1> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Being <e1>moxifloxacin</e1> and lomefloxacin <e2>fluoroquinolones</e2> the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., <e1>ketoconazole</e1>, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, <e1>terazosin</e1>, and doxazosin, can antagonize the effects of <e2>ProAmatine</e2>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, <e1>nifedipine</e1>, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "The in vitro binding of <e1>warfarin</e1> to human plasma proteins is unaffected by tolmetin, and <e2>tolmetin</e2> does not alter the prothrombin time of normal volunteers. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, <e1>tetracycline</e1>, levodopa, <e2>ethanol</e2>, cyclosporine). \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e1>itraconazole</e1>, miconazole) or <e2>macrolide antibiotics</e2> (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "DRUG INTERACTIONS  There are no known drug/drug interactions with oral <e1>ALKERAN</e1>  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  <e2>Nalidixic acid</e2> together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.  \n",
      "Methscopolamine may interact with antidepressants (<e1>tricyclic</e1> type), MAO inhibitors (e.g., phenelzine, linezolid, <e2>tranylcypromine</e2>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, <e1>sulfinpyrazone</e1>, naproxen, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), <e1>amoxapine</e1> (Asendin), doxepin (<e2>Sinequan</e2>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Coadministration of <e1>methyldopa</e1> with ferrous sulfate or <e2>ferrous gluconate</e2> is not recommended. \n",
      "<e1>Phenytoin</e1>, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and <e2>ondansetron</e2> blood concentrations were decreased. \n",
      "The CNS-depressant effect of propoxyphene is additive with that of other <e1>CNS depressants</e1>, including <e2>alcohol</e2>. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (<e1>imipramine</e1>, clomipramine, <e2>desipramine</e2>). \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - <e1>neostigmine</e1> - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that <e1>Myfortic</e1> not be administered concomitantly with azathioprine or <e2>mycophenolate mofetil</e2>. \n",
      "<e1>Furafylline</e1> and sulfaphenazole had no effect, while <e2>quinidine</e2> appeared to augment precocene I toxicity. \n",
      "The possibility of hypotensive effects with UNIVASC    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with <e1>UNIVASC</e1>   . If this is not possible, the starting dose of <e2>moexpril</e2> should be reduced.. \n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), <e2>cyclosporine</e2> (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, <e1>linezolid</e1>, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "Use of <e1>Anticoagulants</e1> and Antiplatelet Agents -- Streptase, Streptokinase, alone or in combination with antiplatelet agents and <e2>anticoagulants</e2>, may cause bleeding complications. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, <e1>Pertofrane</e1>, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "Caution should be exercised when Methergine    (<e1>methylergonovine maleate</e1>) is used concurrently with other vasoconstrictors or <e2>ergot alkaloids</e2>.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, <e1>ethanol</e1>, <e2>glyburide</e2>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of <e1>corticosteroids</e1> and may require increases in <e2>corticosteroid</e2> dose to achieve the desired response. \n",
      "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and <e1>sirolimus</e1> or <e2>nifedipine</e2> dosage should be reduced if necessary. \n",
      "- Decreased absorption of <e1>colestipol</e1>, <e2>cholestyramine</e2>, mineral oil, and sucralfate.\n",
      "In vitro studies have identified <e1>cyclosporine</e1> and <e2>tacrolimus</e2> as CYP3A inhibitors. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, <e1>carbamazepine</e1>, rifampin, rifabutin, rifapentin, <e2>phenobarbital</e2>, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (<e1>cisplatin</e1>, cyclophosphamide, cytarabine, doxorubicin and <e2>mitomycin C</e2>) in murine tumor models.\n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of <e2>phenytoin</e2>).\n",
      "<e1>Phenytoin</e1>: In 12 normal-weight subjects receiving <e2>XENICAL</e2> 120 mg three times a day for 7 days, XENICAL did not alter the pharmacokinetics of a single 300-mg dose of phenytoin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral <e2>contraceptive</e2> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, <e1>penicillins</e1>, <e2>rifampin</e2>, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Patients receiving <e1>rifabutin</e1> and <e2>fluconazole</e2> concomitantly should be carefully monitored. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other <e1>anticholinergics</e1> - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, <e2>Surmontil</e2>) - Potassium chloride (e.g., Kay Ciel)\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, Cholestyramine, Choline and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of <e2>tetracyclines</e2>. \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, <e1>pseudoephedrine</e1>, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of <e2>ProAmatine</e2>   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction. \n",
      "We also found that Bcl-2 was overexpressed in <e1>DZNep</e1> insensitive cells, and cotreatment with <e2>DZNep</e2> and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells. \n",
      "Since Celontin (<e1>methsuximide</e1>) may interact with concurrently administered <e2>antiepileptic drugs</e2>, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).\n",
      "<e1>Thalidomide</e1> has been reported to enhance the sedative activity of barbiturates, <e2>alcohol</e2>, chlorpromazine, and reserpine. \n",
      "<e1>Anticoagulants</e1>: Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to <e2>anticoagulants</e2>; \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: <e1>theophylline</e1>, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e2>levonorgestrel</e2>/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "<e1>Alcohol</e1>: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of <e2>alcohol</e2> (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, <e2>antacids</e2>, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "This is typical of the interaction of <e1>meperidine</e1> and <e2>MAOIs</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral <e1>melatonin</e1> is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "There have been postmarketing reports of increased INR and prothrombin time in patients receiving <e1>proton pump inhibitors</e1>, including pantoprazole, and <e2>warfarin</e2> concomitantly. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., <e1>dexamethasone</e1>, phenytoin, carbamazepine, rifampin, rifabutin, <e2>rifapentin</e2>, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "The data presently available indicate that the decreases in some individual ethinyl estradiol and <e1>levonorgestrel</e1> AUC values with <e2>fluconazole</e2> treatment are likely the result of random variation. \n",
      "Sulfoxone may increase the effects of barbiturates, <e1>tolbutamide</e1>, and <e2>uricosurics</e2>. \n",
      "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, <e1>clarithromycin</e1>, atazanavir, <e2>indinavir</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Caution should be used if <e1>TOLECTIN</e1> is administered concomitantly with <e2>methotrexate</e2>. \n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e2>bacitracin</e2>, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Anticholinergic drugs</e1> may antagonize the effects of drugs that alter gastrointestinal motility, such as <e2>metoclopramide</e2>. \n",
      "Interactions  Interaction may occur with <e1>Antacids</e1>, Calcium supplements, Cholestyramine, <e2>Choline</e2> and magnesium salicylates, Colestipol, Iron-containing drugs, Laxatives, Magnesium salicylate: these drugs may decrease the potency of tetracyclines. \n",
      "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or <e1>metoclopramide</e1>, may diminish the effectiveness of <e2>MIRAPEX</e2>. \n",
      "As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, <e1>mesalazine</e1>, or <e2>sulphasalazine</e2>) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (<e1>Tegretol</e1>) Estrogens may decrease the effects of <e2>benzodiazepines</e2> (lorezepam oxezepam temezepam). \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, <e1>Theophylline</e1>, Terfenadine, Cisapride, <e2>Astemizole</e2>, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when calcium and <e1>SKELID</e1> are administered at the same time, and 60% by some <e2>aluminum</e2>- or magnesium-containing antacids, when administered 1 hour before SKELID. \n",
      "There was no effect of a single dose or multiple doses of <e1>MYCAMINE</e1> on mycophenolate mofetil, <e2>cyclosporine</e2>, tacrolimus, prednisolone, and fluconazole pharmacokinetics. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of <e1>desglymidodrine</e1> (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, <e2>furazolidone</e2>), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e2>melatonin</e2> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, <e1>astemizole</e1>, cisapride, cyclosporine, and <e2>tricyclic antidepressants</e2>. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), <e2>beta blockers</e2> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Drug-Drug Interactions Effect of <e1>Exelon</e1>    (<e2>rivastigmine tartrate</e2>) on the Metabolism of Other Drugs: Rivastigmine is primarily metabolized through hydrolysis by esterases. \n",
      "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like <e1>dihydroergotamine</e1> or methysergide) and <e2>sumatriptan</e2> within 24 hours of each other should be avoided. \n",
      "Concurrent ingestion of <e1>antacid</e1> (20 mL of antacid containing <e2>aluminum hydroxide</e2>, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "When DIFLUCAN is used concomitantly with these or other <e1>sulfonylurea oral hypoglycemic agents</e1>, blood glucose concentrations should be carefully monitored and the dose of the <e2>sulfonylurea</e2> should be adjusted as necessary. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e1>potassium chloride</e1> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "While there is evidence that <e1>fluconazole</e1> can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that <e2>fluconazole</e2> is a net inducer of ethinyl estradiol or levonorgestrel metabolism. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, <e1>SEDATIVE-HYPNOTICS</e1> (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "<e1>Digoxin</e1>: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/<e2>perindoprilat</e2> has not been excluded. \n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - <e1>Mitomycin-C</e1>: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the <e2>vaccine</e2>\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Interaction with <e1>Mixed Agonist/Antagonist Opioid Analgesics</e1>: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or <e2>buprenorphine</e2>) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic. \n",
      "and combinations of opioids and sedatives (eg, <e1>benzodiazepines</e1>, <e2>barbiturates</e2>, chloral hydrate, droperidol, etc.). \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, <e1>griseofulvin</e1>, modafinil, penicillins, <e2>rifampin</e2>, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, <e1>tacrolimus</e1>, prednisolone, sirolimus, nifedipine, <e2>fluconazole</e2>, ritonavir, and rifampin. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - <e1>Central nervous system (CNS) depressants</e1> - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., <e2>Kay Ciel</e2>)\n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other <e1>azole antifungals</e1> (eg, <e2>itraconazole</e2>, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, <e1>procainamide</e1>, pancuronium, <e2>morphine</e2>, vancomycin, metformin and tenofovir). \n",
      "Because <e1>Matulane</e1> exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high <e2>tyramine</e2> content, such as wine, yogurt, ripe cheese and bananas, should be avoided. \n",
      "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: <e1>theophylline</e1>, prednisone, prednisolone, oral contraceptives (<e2>norethindrone</e2> 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin. \n",
      "Daily doses of <e1>sulfasalazine</e1> 2 g (maximum 3 g) and weekly doses of <e2>methotrexate</e2> 7.5 mg (maximum 15 mg) were administered alone or in combination to 310 rheumatoid arthritis patients in two controlled 52-week clinical studies. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Compared with the elimination of pure <e1>luteolin</e1> and apigenin, the elimination of luteolin and apigenin was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and <e2>apigenin</e2>. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and <e1>quinine</e1>) decreases the oral clearance of <e2>pramipexole</e2> by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "These are described in greater detail below:  Oral hypoglycemics, <e1>Coumarin-type anticoagulants</e1>, Phenytoin, Cyclosporine, <e2>Rifampin</e2>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "<e1>Warfarin</e1>: In 12 normal-weight subjects, administration of <e2>XENICAL</e2> 120 mg three times a day for 16 days did not result in any change in either warfarin pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII). \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL <e1>ANESTHETICS</e1>, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING <e2>ALCOHOL</e2>). \n",
      "In the present study <e1>piperine</e1> (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of ibuprofen evaluated by both acetic acid writhing and formalin test, when it was administered with <e2>ibuprofen</e2>. \n",
      "Because there is a theoretical basis that these effects may be additive, use of <e1>ergotamine</e1>-containing or ergot-type medications (like dihydroergotamine or <e2>methysergide</e2>) and sumatriptan within 24 hours of each other should be avoided. \n",
      "Regulatory agencies state that the combination of <e1>clopidogrel</e1> and the CYP2C19 inhibitors omeprazole and <e2>esomeprazole</e2> should be avoided. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e1>cisapride</e1>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, <e1>ritonavir</e1>, and <e2>rifampin</e2>. \n",
      "In the absence of data regarding potential interaction between ALIMTA and NSAIDs with longer half-lives, all patients taking these <e1>NSAIDs</e1> should interrupt dosing for at least 5 days before, the day of, and 2 days following <e2>ALIMTA</e2> administration. \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e1>thyroxine</e1>, triiodothyronine, phenytoin, <e2>sulfinpyrazone</e2>, naproxen, warfarin, methotrexate, and possibly corticosteroids. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, <e1>conjugated estrogens</e1>, hydroxychloroquine sulfate, <e2>ibuprofen</e2>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "Moxifloxacin and Lomefloxacin reacts faster with <e1>sucralfate</e1> and <e2>gelusil</e2> in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. \n",
      "<e1>Amantadine</e1>: Population pharmacokinetic analysis suggests that <e2>amantadine</e2> is unlikely to alter the oral clearance of pramipexole (N= 54). \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, <e1>piroxicam</e1>, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "But the use of fixed combination <e1>amlodipine</e1>/<e2>valsartan</e2> compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of antihypertensive drugs (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05). \n",
      "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, <e1>itraconazole</e1>, <e2>erythromycin</e2>, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). \n",
      "When a single 100 mg dose of <e1>rimantadine HCl</e1> was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total <e2>rimantadine</e2> clearance in the same subjects in the absence of cimetidine). \n",
      "Dopamine antagonists, such as the neuroleptics (<e1>phenothiazines</e1>, butyrophenones, thioxanthines ) or <e2>metoclopramide</e2>, ordinarily should not be administered concurrently with Permax (a dopamine agonist); \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e1>phenothiazines</e1> (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (<e1>Asendin</e1>), doxepin (Sinequan), <e2>nortriptyline</e2> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, <e2>tetracyclines</e2>, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Additive sedative effects can occur when metoclopramide is given with <e1>alcohol</e1>, <e2>sedatives</e2>, hypnotics, narcotics, or tranquilizers. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, <e1>bacitracin</e1>, <e2>polymyxins</e2>, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Human pharmacologic studies have shown that <e1>Ritalin</e1> may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, <e2>desipramine</e2>). \n",
      "<e1>Warfarin</e1> users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), <e2>paroxetine</e2> (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e1>fluvoxamine</e1> (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), <e2>fluoxetine</e2> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Since <e1>Celontin</e1> (<e2>methsuximide</e2>) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).\n",
      "No pharmacokinetic interaction was observed between rivastigmine and digoxin, warfarin, <e1>diazepam</e1>, or <e2>fluoxetine</e2> in studies in healthy volunteers. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or <e1>coal tar derivatives</e1>, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as <e2>methylene blue</e2>, toluidine blue, rose bengal and methyl orange.\n",
      "Phenothiazines are capable of potentiating <e1>CNS depressants</e1> (e.g., <e2>barbiturates</e2>, anesthetics, opiates, alcohol, etc.) \n",
      "DRUG INTERACTIONS  There are no known drug/drug interactions with oral <e1>ALKERAN</e1>  Vaccinations with <e2>live organism vaccines</e2> are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.  \n",
      "We have demonstrated appropriateness of inhospital administration of fixed amlodipine/<e1>valsartan</e1> combination as an approach allowing to achieve target BP in shorter time, with the use of fewer <e2>antihypertensive drugs</e2>, and diminishing concealed inefficacy of treatment.\n",
      "<e1>Montelukast</e1> at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing <e2>norethindrone</e2> 1 mg/ethinyl estradiol 35 mcg. \n",
      "The ratio of norketamine AUC(0-   ) to <e1>ketamine</e1> AUC(0-   ) was significantly decreased in the <e2>ticlopidine</e2> (P &lt; 0.001) and itraconazole phases (P = 0.006) as compared to placebo. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), <e1>phenylbutazone</e1>, and tricyclic drugs (imipramine, <e2>clomipramine</e2>, desipramine). \n",
      "DIFLUCAN reduces the metabolism of <e1>tolbutamide</e1>, glyburide, and <e2>glipizide</e2> and increases the plasma concentration of these agents. \n",
      "Use with Cholinomimetics and Other <e1>Cholinesterase Inhibitors</e1>: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar <e2>neuromuscular blocking agents</e2> or cholinergic agonists such as bethanechol.\n",
      "CYP 3A4 Inhibitors (e.g. <e1>Macrolide Antibiotics</e1> and <e2>Protease Inhibitors</e2>) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. dihydroergotamine and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. \n",
      "An expert panel reviewed each case and classified the likelihood of <e1>colchicine</e1> toxicity, the likelihood of a causal role of <e2>colchicine</e2> in the death using the WHO classification system, and the appropriateness of colchicine dosing. \n",
      "Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain <e1>macrolides</e1> interact with <e2>terfenadine</e2> and astemizole leading to increased serum concentrations of the latter. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, ketoconazole, fluconazole, calcium channel blockers and <e2>cimetidine</e2>.    \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, <e1>amantadine</e1>, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., <e2>chlorpromazine</e2>, promethazine).\n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, <e1>ibuprofen</e1>, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and <e2>prednisone</e2>.\n",
      "During maintenance of anesthesia or sedation, the rate of <e1>DIPRIVAN</e1> Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents (eg, nitrous oxide or <e2>opioids</e2>). \n",
      "norepinephrine and <e1>dobutamine</e1> are incompatible with <e2>sodium bicarbonate</e2> solution. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease <e1>melatonin</e1> levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with <e2>progestin</e2> can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Although no drug/drug interactions were discovered during the clinical trials of <e1>MARINOL</e1> Capsules, <e2>cannabinoids</e2> may interact with other medications through both metabolic and pharmacodynamic mechanisms. \n",
      "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma <e1>digoxin</e1> concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of <e2>perindopril</e2>/perindoprilat has not been excluded. \n",
      "Drugs such as erythromycin, <e1>diltiazem</e1>, <e2>verapamil</e2>, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. \n",
      "<e1>MAO Inhibitors</e1>: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving <e2>monoamine oxidase inhibitors</e2> (MAOI). \n",
      "In vitro studies with <e1>atracurium</e1>, <e2>mivacurium</e2>, esmolol, echothiophate, neostigmine, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "PXR-ligands include a wide variety of pharmaceutical agents, such as <e1>antiepileptic drugs</e1>, taxol, rifampicin, and <e2>human immunodeficiency virus protease inhibitors</e2> such as ritonavir and saquinavir. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e1>potassium chloride</e1> supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "No significant adverse interactions with common premedications (such as atropine, <e1>scopolamine</e1>, glycopyrrolate, <e2>diazepam</e2>, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, <e2>sirolimus</e2>, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with <e1>DZNep</e1> and <e2>ABT-737</e2>, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells. \n",
      "Phenytoin, Carbamazepine, and <e1>Rifampicin</e1>: In patients treated with potent inducers of CYP3A4 (i.e., <e2>phenytoin</e2>, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. \n",
      "Drugs that impair intestinal absorption of <e1>fat-soluble vitamins</e1>, such as <e2>cholestyramine</e2>, may interfere with the absorption of Zemplar Capsules.\n",
      "Other drugs which may enhance the neuromuscular blocking action of <e1>nondepolarizing agents</e1> such as MIVACRON include certain <e2>antibiotics</e2> (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), <e1>MAO inhibitors</e1> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., <e2>kaolin</e2>-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled <e1>paricalcitol</e1> AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing <e2>paricalcitol</e2> with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e1>midazolam</e1>, clarithromycin, metronidazole, or <e2>amoxicillin</e2>. \n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, <e1>hypnotics</e1>, <e2>narcotic analgesics</e2>, sedatives, and tranquillisers. \n",
      "<e1>Phenothiazines</e1> are capable of potentiating CNS depressants (e.g., barbiturates, anesthetics, opiates, <e2>alcohol</e2>, etc.) \n",
      "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, <e1>cyclosporine</e1>, and <e2>tricyclic antidepressants</e2>. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, Rifampin, Theophylline, Terfenadine, <e2>Cisapride</e2>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of <e1>phenytoin</e1> and <e2>phenobarbital</e2>).\n",
      "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including <e1>collagenase</e1>, hyaluronan lyase, heparinase III, or <e2>chondroitin ABC lyase</e2>. \n",
      "Co-administration of <e1>SUTENT</e1> with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, <e2>rifampin</e2>, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "<e1>Fat-soluble Vitamin Supplements</e1> and Analogues: A pharmacokinetic interaction study showed a 30% reduction in beta-carotene supplement absorption when concomitantly administered with <e2>XENICAL</e2>. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), <e1>protriptyline</e1> (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e1>potassium chloride</e1> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Use of potassium-sparing diuretics (<e1>spironolactone</e1>, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, <e2>heparin</e2>, cyclosporine and others) can increase the risk of hyperkalemia. \n",
      "Concomitant administration of terfenadine with clarithromycin, erythromycin, or <e1>troleandomycin</e1> is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other <e2>macrolide antibiotics</e2>, including azithromycin, is not recommended. \n",
      "The bioavailability of SKELID is decreased 80% by calcium, when <e1>calcium</e1> and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing <e2>antacids</e2>, when administered 1 hour before SKELID. \n",
      "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, <e1>simvastatin</e1>, pravastatin, lovastatin, or <e2>fluvastatin</e2>. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: <e1>amantadine</e1>, <e2>antiarrhythmic agents of class I</e2> (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of <e1>ProAmatine</e1>. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e2>cimetidine</e2>, ranitidine, procainamide, triamterene, flecainide, and quinidine. \n",
      "and combinations of opioids and sedatives (eg, <e1>benzodiazepines</e1>, barbiturates, chloral hydrate, <e2>droperidol</e2>, etc.). \n",
      "Conventional therapeutic drug monitoring based on measuring <e1>immunosupressive drug</e1> concentrations in blood is important in the clinical management of <e2>immunosuppressive</e2> therapy in transplantation medicine. \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), <e2>benzodiazepines</e2>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - <e1>edrophonium</e1> - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - <e2>succinylcholine</e2> or other muscle relaxants\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e2>progestin</e2> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Studies with forced expression and siRNA knockdown of Bcl-2 and Cdk1 suggest that <e1>dasatinib</e1>-mediated induction of p27(Kip1) enhanced <e2>paclitaxel</e2>-induced apoptosis by negatively regulating Bcl-2 and Cdk1 expression. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., <e1>aminoglycosides</e1>, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, <e2>procainamide</e2>, and quinidine. \n",
      "TERAZOL 3 Vaginal Cream 0.8% The levels of estradiol (E2) and <e1>progesterone</e1> did not differ significantly when 0.8% terconazole vaginal cream was administered to healthy female volunteers established on a low dose oral <e2>contraceptive</e2>.    \n",
      "The colchicine nanoemulsion was prepared with isopropyl myristate, <e1>eugenol</e1>, Tween80, ethanol and water, and <e2>eugenol</e2> was used as an oil phase in the formulation; \n",
      "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by <e1>sunitinib</e1> is superior to sunitinib followed by <e2>docetaxel</e2> and concurrent administration.\n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and <e1>mycophenolate mofetil</e1>, cyclosporine, tacrolimus, prednisolone, sirolimus, <e2>nifedipine</e2>, fluconazole, ritonavir, and rifampin. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), <e1>imipramine</e1> (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> <e2>phenytoin</e2> (Dilantin) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between <e1>MYCAMINE</e1> and mycophenolate mofetil, <e2>cyclosporine</e2>, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., <e2>phenelzine</e2>, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Mephenytoin may also affect the effects of other drugs, which include some <e1>steroid medications</e1>, <e2>warfarin</e2>, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (<e1>Sinequan</e1>), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (<e2>Norpramin</e2>). \n",
      "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine or <e1>dihydroergotamine</e1>) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when <e2>ProAmatine</e2>    is administered concomitantly with agents that cause vasoconstriction. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, <e2>caffeine</e2>, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interactions for <e1>Dronabinol</e1>:  In studies involving patients with AIDS and/or cancer, MARINOL (Dronabinol) Capsules has been co-administered with a variety of medications (e.g., cytotoxic agents, <e2>anti-infective</e2> agents, sedatives, or opioid analgesics) without resulting in any clinically significant drug/drug interactions. \n",
      "Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, <e1>narcotics</e1>, or <e2>tranquilizers</e2>. \n",
      "Furafylline and <e1>sulfaphenazole</e1> had no effect, while quinidine appeared to augment <e2>precocene I</e2> toxicity. \n",
      "Patients studied in clinical trials of TNKase were routinely treated with <e1>heparin</e1> and <e2>aspirin</e2>. \n",
      "Macrolides: Clinical drug interaction studies indicate that <e1>erythromycin</e1> and <e2>clarithromycin</e2> can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent. \n",
      "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral <e1>contraceptives</e1>, hormone replacement therapies, hypoglycemics, <e2>theophyllines</e2>, phenytoins, thiazide diuretics, beta blockers, and calcium channel blockers.\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e1>diclofenac</e1>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e2>warfarin</e2>, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Interactions for Vitamin B1 (Thiamine):  Loop Diuretics, Oral Contraceptives, <e1>Stavudine</e1>, <e2>Tricyclic Antidepressants</e2>\n",
      "Absorption of drugs from the stomach may be diminished (e.g., <e1>digoxin</e1>) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., <e2>acetaminophen</e2>, tetracycline, levodopa, ethanol, cyclosporine). \n",
      "Therefore, <e1>furosemide</e1> should not be administered in intravenous lines containing <e2>PRIMACOR</e2>.\n",
      "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, <e1>barbiturates</e1>, hypnotics, <e2>narcotic analgesics</e2>, sedatives, and tranquillisers. \n",
      "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., <e1>phenytoin</e1>, carbamazepine, and rifampicin), the clearance of <e2>ondansetron</e2> was significantly increased and ondansetron blood concentrations were decreased. \n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "<e1>Warfarin</e1> users who initiated citalopram, fluoxetine, paroxetine, amitriptyline, or <e2>mirtazapine</e2> had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of <e2>melatonin</e2> with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Caution should be exercised when Methergine    (<e1>methylergonovine maleate</e1>) is used concurrently with other <e2>vasoconstrictors</e2> or ergot alkaloids.\n",
      "No pharmacokinetic interaction was observed between <e1>rivastigmine</e1> and digoxin, warfarin, diazepam, or <e2>fluoxetine</e2> in studies in healthy volunteers. \n",
      "We have demonstrated appropriateness of inhospital administration of fixed <e1>amlodipine</e1>/<e2>valsartan</e2> combination as an approach allowing to achieve target BP in shorter time, with the use of fewer antihypertensive drugs, and diminishing concealed inefficacy of treatment.\n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, <e1>triamterene</e1>, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of <e2>pramipexole</e2>. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by <e1>metoclopramide</e1>, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, <e2>levodopa</e2>, ethanol, cyclosporine). \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, <e2>cisapride</e2>, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "Azathioprine/Mycophenolate Mofetil: Given that <e1>azathioprine</e1> and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with <e2>azathioprine</e2> or mycophenolate mofetil. \n",
      "Compounds that quench active oxygen species or scavenge radicals, such as <e1>dimethyl sufloxide</e1>, b-carotene, ethanol, formate and <e2>mannitol</e2> would be expected to decrease PDT activity. \n",
      "The effect of a series of flavonoids, including <e1>flavonols</e1>, flavones, isoflavone, flavanone, flavanonols and <e2>catechins</e2>, on the elimination of luteolin and apigenin was studied. \n",
      "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, <e1>itraconazole</e1>, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or <e2>cyclosporine</e2> or vinblastine, the recommended dose of DETROL LA is 2 mg daily. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e1>tetracyclines</e1>, thiazides, and certain organic staining dyes such as methylene blue, <e2>toluidine blue</e2>, rose bengal and methyl orange.\n",
      "Some drug interactions are:  - birth control pills - <e1>corticosteroids</e1> - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e2>phenytoin</e2> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, <e1>antipsychotic agents</e1> (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e2>narcotic analgesics</e2> (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, <e1>diphenylhydantoin</e1>, <e2>primidone</e2>), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, <e1>glycopyrrolate</e1>, diazepam, <e2>hydroxyzine</e2>, and other muscle relaxants) or local anesthetics have been observed.\n",
      "Interaction with Other Central Nervous System Depressants: <e1>MEPERIDINE</e1> SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER <e2>CNS DEPRESSANTS</e2> (INCLUDING ALCOHOL). \n",
      "Some examples of such drugs are erythromycin, itraconazole, <e1>ketoconazole</e1>, fluconazole, <e2>calcium channel blockers</e2> and cimetidine.    \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, <e1>diazepam</e1> (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of <e1>HIV-protease inhibitors</e1>, griseofulvin, modafinil, penicillins, <e2>rifampin</e2>, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. \n",
      "Some examples of such drugs are <e1>erythromycin</e1>, itraconazole, ketoconazole, <e2>fluconazole</e2>, calcium channel blockers and cimetidine.\n",
      "Clinical studies of interactions of VIRAZOLE with other drugs commonly used to treat infants with RSV infections, such as digoxin, <e1>bronchodilators</e1>, other antiviral agents, <e2>antibiotics</e2>, or anti-metabolites have not been conducted. \n",
      "An increase in serum osmolality and serum osmolal gap with or without high-anion-gap metabolic acidosis is an important clue to exposure to one of the toxic alcohols, which include methanol, ethylene glycol, <e1>diethylene glycol</e1>, propylene glycol, or <e2>isopropanol</e2>. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e2>antipyrine</e2>, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Some examples of such drugs are erythromycin, itraconazole, <e1>ketoconazole</e1>, fluconazole, calcium channel blockers and <e2>cimetidine</e2>.\n",
      "<e1>AAV2</e1> containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, <e2>hyaluronan lyase</e2>, heparinase III, or chondroitin ABC lyase. \n",
      "<e1>SKELAXIN</e1> may enhance the effects of <e2>alcohol</e2>, barbiturates and other CNS depressants.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (<e2>Dilantin</e2>) carbamazepine (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, <e1>glycopyrrolate</e1>, <e2>diazepam</e2>, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general <e1>anesthetics</e1>, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and <e2>alcohol</e2> may produce additive CNS depressant effects. \n",
      "TRENTAL has been used concurrently with antihypertensive drugs, <e1>beta blockers</e1>, <e2>digitalis</e2>, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, <e2>naproxen</e2>, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce <e1>mifepristone</e1> metabolism (lowering serum levels of <e2>mifepristone</e2>). \n",
      "Although such a reaction has not been demonstrated with roxithromycin, concomitant administration of <e1>roxithromycin</e1> with terfenadine or <e2>astemizole</e2> is not recommended. \n",
      "Absorption of drugs from the stomach may be diminished (e.g., <e1>digoxin</e1>) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, <e2>tetracycline</e2>, levodopa, ethanol, cyclosporine). \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with <e1>Sanctura</e1> have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and <e2>tenofovir</e2>). \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or attapulgite - <e2>Ketoconazole</e2> - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing <e1>Mexitil</e1>   . If Mexitil and <e2>theophylline</e2> are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. \n",
      "Important Non-<e1>Thalidomide</e1> Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, <e2>carbamazepine</e2>, or certain herbal supplements such as St. \n",
      "<e1>Palonosetron</e1> did not inhibit the antitumor activity of the five chemotherapeutic agents tested (<e2>cisplatin</e2>, cyclophosphamide, cytarabine, doxorubicin and mitomycin C) in murine tumor models.\n",
      "In vitro studies with atracurium, <e1>mivacurium</e1>, esmolol, <e2>echothiophate</e2>, neostigmine, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.\n",
      "Alcohol: Concomitant administration of <e1>alcohol</e1> (equivalent to 60 g) had a minimal effect on plasma levels of <e2>mirtazapine</e2> (15 mg) in 6 healthy male subjects. \n",
      "Combination with <e1>tramadol</e1> (<e2>Ultram</e2>) is associated with increased risk of seizures. \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., <e1>cimetidine</e1>, ranitidine, <e2>diltiazem</e2>, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as <e1>metformin</e1>, cimetidine, <e2>ranitidine</e2>, procainamide, triamterene, flecainide, and quinidine. \n",
      "Exert particular caution in combining levomepromazine with other <e1>anticholinergic drugs</e1> (tricyclic antidepressants and <e2>antiparkinsonian-agents</e2>): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., <e1>erythromycin</e1>, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, <e2>itraconazole</e2>, voriconazole). \n",
      "Agents that might be coadministered with <e1>trimetrexate</e1> in AIDS patients for other indications that could elicit this activity include erythromycin, <e2>rifampin</e2>, rifabutin, ketoconazole, and fluconazole. \n",
      "Compounds that quench active oxygen species or scavenge radicals, such as <e1>dimethyl sufloxide</e1>, b-carotene, <e2>ethanol</e2>, formate and mannitol would be expected to decrease PDT activity. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, <e1>desmethyldiazepam</e1>), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of <e1>tolbutamide</e1>, ethinylestradiol, <e2>ethoxycoumarin</e2>, and cyclosporine. \n",
      "Potassium Supplements and <e1>Potassium-Sparing Diuretics</e1>: <e2>ACEON</e2>    Tablets may increase serum potassium because of its potential to decrease aldosterone production. \n",
      "Due to the chemical similarity of other azole-type antifungal agents (including <e1>fluconazole</e1>, metronidazole, and miconazole) to <e2>ketoconazole</e2>, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions. \n",
      "No significant adverse interactions with common premedications (such as atropine, scopolamine, <e1>glycopyrrolate</e1>, diazepam, hydroxyzine, and other muscle relaxants) or local <e2>anesthetics</e2> have been observed.\n",
      "It may also interact with <e1>thiazides</e1> (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), <e2>warfarin</e2> (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).\n",
      "<e1>Barbiturates</e1> may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and <e2>beta blockers</e2>.\n",
      "When oxandrolone therapy is initiated in a patient already receiving treatment with <e1>warfarin</e1>, the INR or prothrombin time (PT) should be monitored closely and the dose of <e2>warfarin</e2> adjusted as necessary until a stable target INR or PT has been achieved. \n",
      "Compared with the elimination of pure luteolin and apigenin, the elimination of <e1>luteolin</e1> and <e2>apigenin</e2> was much lower in hydrolyzed Flos Chrysanthemi extract (FCE) containing comparable amounts of luteolin and apigenin. \n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, <e1>procainamide</e1>, <e2>pancuronium</e2>, morphine, vancomycin, metformin and tenofovir). \n",
      "The <e1>colchicine</e1> nanoemulsion was prepared with isopropyl myristate, eugenol, <e2>Tween80</e2>, ethanol and water, and eugenol was used as an oil phase in the formulation; \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since <e1>paricalcitol</e1> is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e2>ritonavir</e2>, saquinavir, telithromycin or voriconazole. \n",
      "When phenytoin or other hepatic enzyme inducers such as <e1>rifampin</e1> and phenobarbital have been taken concurrently with Mexitil   , lowered <e2>Mexitil</e2>    plasma levels have been reported. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower <e1>melatonin</e1> levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e2>benzodiazepenes</e2> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other <e1>opioids</e1>, tricyclic antidepressants, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "<e1>MAO-A inhibitors</e1> reduce <e2>sumatriptan</e2> clearance, significantly increasing systemic exposure. \n",
      "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as <e1>tricyclic antidepressants</e1>,    -blockers, <e2>selective serotonin reuptake inhibitors</e2> (SSRIs), and monoamine oxidase inhibitors (MAO-Is) Type B, if they have a narrow therapeutic window. \n",
      "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of <e1>antacids</e1> has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma <e2>lithium</e2> levels. \n",
      "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered <e1>phenytoin</e1> or <e2>carbamazepine</e2>. \n",
      "<e1>Sulfonamides</e1>: Concurrent use of procaine hydrochloride and sulfonamides may result in a reduction of the antibacterial action of the <e2>sulfonamide</e2>. \n",
      "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, <e1>hydroxychloroquine sulfate</e1>, ibuprofen, <e2>levothyroxine sodium</e2>, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.\n",
      "<e1>Lithium</e1>: In clinical trials, <e2>NSAIDs</e2> have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. \n",
      "Dopamine antagonists: Since pramipexole is a <e1>dopamine agonist</e1>, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, <e2>butyrophenones</e2>, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "No pharmacokinetic interaction was observed between <e1>rivastigmine</e1> and <e2>digoxin</e2>, warfarin, diazepam, or fluoxetine in studies in healthy volunteers. \n",
      "Based on studies evaluating possible interactions of <e1>pantoprazole</e1> with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), <e2>diclofenac</e2>, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), <e1>nonsteroidal anti-inflammatory drugs</e1> (n=79), <e2>estrogens</e2> (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "<e1>XENICAL</e1> inhibited absorption of a <e2>vitamin E acetate</e2> supplement by approximately 60%. \n",
      "Chemical Interactions There is an immediate chemical interaction which is evidenced by the formation of a precipitate when <e1>furosemide</e1> is injected into an intravenous line of an infusion of <e2>PRIMACOR</e2>. \n",
      "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, <e1>PHENOTHIAZINES</e1>, OTHER <e2>TRANQUILIZERS</e2>, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL). \n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, <e1>narcotic analgesics</e1> (e.g., meperidine), nitrates and <e2>nitrites</e2>, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. \n",
      "TERAZOL 3 Vaginal Cream 0.8% The levels of <e1>estradiol</e1> (E2) and progesterone did not differ significantly when 0.8% terconazole vaginal cream was administered to healthy female volunteers established on a low dose oral <e2>contraceptive</e2>.    \n",
      "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, <e1>quinidine</e1>, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, <e2>penicillins</e2>, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. \n",
      "Standard <e1>antibiotic</e1> such as <e2>Gentamicin</e2> (10 microg), Cephalothin (30 microg), Ceftriaxone (10 microg), Nystatin (10 U) discs were used for comparison with the antimicrobial activities of essential oils of these plants. \n",
      "Drug Interactions:  <e1>Pirenzepine</e1> may interact with the following drugs, which may affect the effect of <e2>Pirenzepine</e2> or whose effects may be affected. \n",
      "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e1>beta blockers</e1> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e2>corticosteroids</e2> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).\n",
      "Two separate studies were conducted to evaluate the bioequivalence of <e1>fenofibric acid</e1> relative to fenofibrate under fasted and fed (standard breakfast) conditions, characterize the pharmacokinetic profile, and assess the safety and tolerability of <e2>fenofibric acid</e2>. \n",
      "Dopamine antagonists: Since pramipexole is a <e1>dopamine agonist</e1>, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, <e2>thioxanthenes</e2>) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (<e1>PULMOZYME</e1>   , Genentech), (beta)-agonists, inhaled <e2>corticosteroids</e2>, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. \n",
      "Multiple dose studies of ezetimibe given in combination with <e1>HMG-CoA reductase inhibitors</e1> (statins) in rats and rabbits during organogenesis result in higher <e2>ezetimibe</e2> and statin exposures. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/<e2>ethinyl estradiol</e2>), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "The effect of curcumin (100 mg/kg) was similar to that of fluoxetine and imipramine (p > 0.05) but its addition to <e1>fluoxetine</e1> and <e2>imipramine</e2> did not improve their antidepressant activity (p > 0.05). \n",
      "a reduction of the <e1>doxorubicin</e1> dosage should be considered in patients receiving <e2>ZANOSAR</e2> concurrently. \n",
      "The response of <e1>moxifloxacin</e1> and <e2>lomefloxacin</e2> after interaction with co-administered drugs at different conditions and temperature were noted using a Shimadzu HPLC system with PDA detector. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral <e1>contraceptive</e1> (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, <e2>clarithromycin</e2>, metronidazole, or amoxicillin. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, <e1>tranylcypromine</e1>, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, <e2>antihistamines</e2> (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, <e1>phenytoin</e1>, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., <e1>dexamethasone</e1>, phenytoin, <e2>carbamazepine</e2>, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations. \n",
      "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, <e1>indomethacin</e1>, naproxen, ibuprofen, <e2>diazepam</e2>, and diazoxide. \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e2>isocarboxazid</e2>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (<e1>cisplatin</e1>, cyclophosphamide, cytarabine, <e2>doxorubicin</e2> and mitomycin C) in murine tumor models.\n",
      "Phenothiazines are capable of potentiating <e1>CNS depressants</e1> (e.g., barbiturates, <e2>anesthetics</e2>, opiates, alcohol, etc.) \n",
      "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, cisplatin, <e1>doxorubicin</e1> and <e2>etoposide</e2>   celecoxib following different incubation schedules were analyzed.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e1>Cisapride</e1>, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Use of Anticoagulants and <e1>Antiplatelet Agents</e1> -- <e2>Streptase</e2>, Streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, <e1>ritonavir</e1>, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "In elderly patients concurrently receiving certain <e1>diuretics</e1>, primarily <e2>thiazides</e2>, an increased incidence of thrombopenia with purpura has been reported. \n",
      "Studies with <e1>furosemide</e1> agents and <e2>meloxicam</e2> have not demonstrated a reduction in natriuretic effect. \n",
      "After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all <e1>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</e1>/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/<e2>3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine</e2>-treated monkeys were significantly affected. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, <e1>coal tar</e1> or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, <e2>halogenated salicylanilides</e2> (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Use of Anticoagulants and Antiplatelet Agents -- Streptase, <e1>Streptokinase</e1>, alone or in combination with <e2>antiplatelet agents</e2> and anticoagulants, may cause bleeding complications. \n",
      "In vitro data indicate that the phosphorylation of <e1>stavudine</e1> is also inhibited at relevant concentrations by <e2>doxorubicin</e2> and ribavirin. \n",
      "Mephenytoin may also affect the effects of other drugs, which include some <e1>steroid medications</e1>, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and <e2>theophylline</e2> Please note that Mephenytoin may interact with other drugs that are not listed here.\n",
      "While the effects of chronic <e1>phenytoin</e1> or <e2>carbamazepine</e2> therapy on the action of MIVACRON are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, <e2>absorbent-type anti-diarrhea medicines</e2> (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the <e1>vaccine</e1> virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - <e2>Killed virus vaccines</e2>: may decrease patient's response to the vaccine\n",
      "Warfarin users who initiated citalopram, fluoxetine, paroxetine, <e1>amitriptyline</e1>, or <e2>mirtazapine</e2> had an increased risk of hospitalization for gastrointestinal bleeding. \n",
      "<e1>Cyclosporine</e1>: DIFLUCAN may significantly increase <e2>cyclosporine</e2> levels in renal transplant patients with or without renal impairment. \n",
      "In vitro studies with atracurium, mivacurium, esmolol, echothiophate, neostigmine, physostigmine, and <e1>midazolam</e1> revealed no inhibition of <e2>remifentanil</e2> hydrolysis in whole human blood by these drugs.\n",
      "Use with Other Central Nervous System Depressants: The depressant effects of <e1>morphine</e1> are potentiated by the presence of other <e2>CNS depressants</e2> such as alcohol, sedatives, antihistaminics, or psychotropic drugs. \n",
      "As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, <e1>mesalazine</e1>, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent <e2>thioguanine</e2> therapy.    \n",
      "Laboratory Tests There have been reports of false-positive urine screening tests for <e1>tetrahydrocannabinol</e1> (THC) in patients receiving most proton pump inhibitors, including <e2>pantoprazole</e2>. \n",
      "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as <e1>phenytoin</e1> or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other <e2>muscle relaxants</e2>\n",
      "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include <e1>erythromycin</e1>, rifampin, <e2>rifabutin</e2>, ketoconazole, and fluconazole. \n",
      "Drug-Drug Interactions Effect of <e1>Exelon</e1>    (rivastigmine tartrate) on the Metabolism of Other Drugs: <e2>Rivastigmine</e2> is primarily metabolized through hydrolysis by esterases. \n",
      "While there is evidence that fluconazole can inhibit the metabolism of <e1>ethinyl estradiol</e1> and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or <e2>levonorgestrel</e2> metabolism. \n",
      "In most cases, the application of two nucleoside or nucleotide reverse transcriptase inhibitors (<e1>NRTI</e1>) together with a non-nucleoside reverse transcriptase inhibitor (NNRTI), a <e2>protease inhibitor</e2> (PI) or an integrase inhibitor (II) is recommended. \n",
      "Some examples of such drugs are erythromycin, itraconazole, <e1>ketoconazole</e1>, fluconazole, calcium channel blockers and <e2>cimetidine</e2>.    \n",
      "You cannot take mazindol if you have taken a <e1>monoamine oxidase inhibitor</e1> (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or <e2>phenelzine</e2> (Nardil) in the last 14 days. \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e1>indinavir</e1>, <e2>itraconazole</e2>, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e1>tetracyclines</e1>, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "Concurrent use of <e1>Mexitil</e1>    and theophylline may lead to increased plasma <e2>theophylline</e2> levels. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, <e1>Anafranil</e1>, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, <e1>indinavir</e1>, itraconazole, <e2>nefazodone</e2>, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. \n",
      "Concomitant administration of terfenadine with <e1>clarithromycin</e1>, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including <e2>azithromycin</e2>, is not recommended. \n",
      "In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving <e1>methadone</e1>, treatment with <e2>PEG-Intron</e2> once weekly for 4 weeks was associated with a mean increase of 16% in methadone AUC; \n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing <e2>kaolin</e2> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "In vitro studies with atracurium, mivacurium, esmolol, echothiophate, <e1>neostigmine</e1>, physostigmine, and midazolam revealed no inhibition of <e2>remifentanil</e2> hydrolysis in whole human blood by these drugs.\n",
      "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), <e1>benzodiazepines</e1>, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, <e2>tricyclic antidepressants</e2>, and other drugs having anticholinergic activity. \n",
      "Barbiturates may decrease the effectiveness of oral contraceptives, certain <e1>antibiotics</e1>, <e2>quinidine</e2>, theophylline, corticosteroids, anticoagulants, and beta blockers.\n",
      "To minimize CNS depression and possible potentiation, <e1>barbiturates</e1>, antihistamines, narcotics, hypotensive agents or <e2>phenothiazines</e2> should be used with caution. \n",
      "<e1>Methscopolamine</e1> may interact with antidepressants (tricyclic type), <e2>MAO inhibitors</e2> (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "<e1>Anticoagulants</e1> (oral): The activity of oral <e2>anticoagulants</e2> may be potentiated by anti-vitamin-K activity attributed to methimazole.    \n",
      "The combined use of <e1>fluconazole</e1> with <e2>cisapride</e2> is contraindicated. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, <e1>glyburide</e1>, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e2>metoprolol</e2>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Dopamine antagonists: Since <e1>pramipexole</e1> is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, <e2>butyrophenones</e2>, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other <e1>anticholinergics</e1>, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Compounds that quench active oxygen species or scavenge radicals, such as dimethyl sufloxide, b-carotene, <e1>ethanol</e1>, formate and <e2>mannitol</e2> would be expected to decrease PDT activity. \n",
      "The bioavailability of <e1>olmesartan</e1> was not significantly altered by the co-administration of <e2>antacids</e2> [Al(OH)3/Mg(OH)2]. \n",
      "ECG intervals (PR, QRS, and QT) were not affected by concurrent Mexitil    and <e1>digoxin</e1>, <e2>diuretics</e2>, or propranolol. \n",
      "Caution should be observed in administering <e1>DEMSER</e1> to patients receiving phenothiazines or <e2>haloperidol</e2> because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), <e1>quinidine</e1>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, <e2>potassium chloride</e2> supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "The concomitant use of other CNS depressants including sedatives, <e1>hypnotics</e1>, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, <e2>monoamine oxidase (MAO) inhibitors</e2>, and alcohol may produce additive CNS depressant effects. \n",
      "These are described in greater detail below:  Oral <e1>hypoglycemics</e1>, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e2>Rifampin</e2>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "No significant adverse interactions with common premedications (such as atropine, <e1>scopolamine</e1>, glycopyrrolate, diazepam, hydroxyzine, and other muscle relaxants) or local <e2>anesthetics</e2> have been observed.\n",
      "- <e1>Antacids</e1> - Diarrhea medicine containing kaolin or <e2>attapulgite</e2> - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "<e1>ProAmatine</e1>. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e1>pectin</e1>), phenothiazines (e.g., chlorpromazine, <e2>promethazine</e2>).\n",
      "Pyrimethamine may be used with <e1>sulfonamides</e1>, <e2>quinine</e2> and other antimalarials, and with other antibiotics. \n",
      "Coadministration of <e1>Sanctura</e1> with drugs that are eliminated by active renal tubular secretion may increase the serum concentration of <e2>Sanctura</e2> and/or the coadministered drug due to competition for this elimination pathway. \n",
      "These data suggest that <e1>GH</e1> administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., <e2>corticosteroids</e2>, sex steroids, anticonvulsants, cyclosporin). \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e1>lincomycin</e1>, clindamycin, colistin, and sodium colistimethate), <e2>magnesium</e2> salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "<e1>Phenothiazines</e1> are capable of potentiating CNS depressants (e.g., barbiturates, <e2>anesthetics</e2>, opiates, alcohol, etc.) \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, Anafranil, Pertofrane, Sinequan, Tofranil, Aventyl, Surmontil) - <e2>Potassium chloride</e2> (e.g., Kay Ciel)\n",
      "morphine, <e1>theophylline</e1>, aminophylline, <e2>succinylcholine</e2>, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e1>Short-acting benzodiazepines</e1>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of <e2>DIFLUCAN</e2> with oral hypoglycemic agents; \n",
      "Due to low systemic exposure to <e1>retapamulin</e1> following topical application in patients, dosage adjustments for <e2>retapamulin</e2> are unnecessary when co-administered with CYP3A4 inhibitors, such as ketoconazole. \n",
      "Concurrent use of <e1>Mexitil</e1>    and <e2>theophylline</e2> may lead to increased plasma theophylline levels. \n",
      "In addition to bleeding associated with heparin and <e1>vitamin K antagonists</e1>, drugs that alter platelet function (such as <e2>aspirin</e2>, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.\n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>amiloride</e1>, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, <e2>cyclosporine</e2> and others) can increase the risk of hyperkalemia. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, <e1>colistin</e1>, and <e2>sodium colistimethate</e2>), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "With respect to toxicity, the order of CYP inhibitor effectiveness was <e1>ABT</e1>><e2>diethyldithiocarbamate</e2>~tranylcypromine>ketoconazole. \n",
      "- Antacids - Diarrhea medicine containing kaolin or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, <e1>Asendin</e1>, Anafranil, Pertofrane, <e2>Sinequan</e2>, Tofranil, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n",
      "Concurrent use of <e1>antibacterial drugs</e1> with oral contraceptives may render oral <e2>contraceptives</e2> less effective.  \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, <e1>halogenated salicylanilides</e1> (bacteriostatic soaps), sulfonamides, tetracyclines, <e2>thiazides</e2>, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, <e1>Rifampin</e1>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, <e2>Short-acting benzodiazepines</e2>,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, <e1>thyroxine</e1>, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, <e2>methotrexate</e2>, and possibly corticosteroids. \n",
      "Prothrombin time or other suitable anticoagulation test should be monitored if <e1>tigecycline</e1> is administered with <e2>warfarin</e2>.   \n",
      "These data suggest that <e1>GH</e1> administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, sex steroids, anticonvulsants, <e2>cyclosporin</e2>). \n",
      "The <e1>colchicine</e1> nanoemulsion was prepared with isopropyl myristate, <e2>eugenol</e2>, Tween80, ethanol and water, and eugenol was used as an oil phase in the formulation; \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, <e1>selegiline</e1>, furazolidone), <e2>quinidine</e2>, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Multiple dose studies of <e1>ezetimibe</e1> given in combination with HMG-CoA reductase inhibitors (statins) in rats and rabbits during organogenesis result in higher <e2>ezetimibe</e2> and statin exposures. \n",
      "Vasopressors, particularly <e1>metaraminol</e1>, may cause serious cardiac arrhythmias during <e2>halothane</e2> anesthesia and therefore should be used only with great caution or not at all. \n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, <e1>Cyclosporine</e1>, <e2>Rifampin</e2>, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; \n",
      "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, <e1>morphine</e1>, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and <e2>droperidol</e2>. \n",
      "Physicians should carefully monitor PT and INR in patients concurrently administered <e1>ZOLINZA</e1> and <e2>coumarin derivatives</e2>. \n",
      "Administration of <e1>paclitaxel</e1> in combination with HERCEPTIN resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in <e2>HERCEPTIN</e2> serum levels in clinical studies.\n",
      "Other eye drops or medications such as acetylcholine chloride (Miochol) and carbachol (<e1>Carboptic</e1>, <e2>Isopto Carbachol</e2>) may decrease the effects of suprofen ophthalmic.\n",
      "In vitro, <e1>methotrexate</e1> did not displace <e2>meloxicam</e2> from its human serum binding sites. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, <e1>antipyrine</e1>, caffeine, <e2>carbamazepine</e2>, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), <e1>metoprolol</e1>, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, <e2>metronidazole</e2>, or amoxicillin. \n",
      "Co-administration of <e1>SUTENT</e1> with strong inhibitors of the CYP3A4 family (e.g., <e2>ketoconazole</e2>, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations. \n",
      "Oral <e1>contraceptives</e1> containing estrogen: <e2>tetracyclines</e2> may decrease the contraceptive effect and increase the chance of unwanted pregnancy.\n",
      "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. <e1>digoxin</e1>, procainamide, pancuronium, morphine, <e2>vancomycin</e2>, metformin and tenofovir). \n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>triamterene</e1>, <e2>amiloride</e2>) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, <e1>cimetidine</e1>, ranitidine, <e2>procainamide</e2>, triamterene, flecainide, and quinidine. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (<e1>levonorgestrel</e1>/ethinyl estradiol), metoprolol, nifedipine, <e2>phenytoin</e2>, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), <e1>calcium channel blockers</e1> (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and <e2>antihistamines</e2> (n=15). \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., <e1>fluoxetine</e1>, <e2>fluvoxamine</e2>, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Use of potassium-sparing diuretics (spironolactone, <e1>triamterene</e1>, amiloride) or <e2>potassium</e2> supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia. \n",
      "<e1>Acetazolamide</e1>: Concurrent use of acetazolamide and <e2>procaine hydrochloride</e2> may extend the plasma half-life of procaine.\n",
      "Concurrent ingestion of <e1>antacid</e1> (20 mL of antacid containing aluminum hydroxide, <e2>magnesium hydroxide</e2>, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    \n",
      "In a randomized controlled clinical trial, the abstinence rate at 1 year for patients using <e1>varencline</e1> was superior to that of patients in the group using <e2>bupropion SR</e2> (Zyban) and in the placebo group (11). \n",
      "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, <e1>clarithromycin</e1>, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, <e2>telithromycin</e2> or voriconazole. \n",
      "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, <e1>polymyxins</e1>, <e2>lincomycin</e2>, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. \n",
      "Caffeine and/or stimulantes of the ephedrine/<e1>amphetamine</e1> type may counteract the specific actions of <e2>levomepromazine</e2>. \n",
      "Concomitant Therapy  Special care should be exercised in treating patients who are receiving concomitant therapy (either topically or systemically) with known photosensitizing agents such as <e1>anthralin</e1>, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, <e2>tetracyclines</e2>, thiazides, and certain organic staining dyes such as methylene blue, toluidine blue, rose bengal and methyl orange.\n",
      "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, <e1>Cisapride</e1>, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral <e2>hypoglycemic agents</e2>; \n",
      "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, <e1>fluvoxamine</e1>, <e2>paroxetine</e2>, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. \n",
      "Ethanol decreases the elimination of <e1>abacavir</e1> causing an increase in overall exposure . The addition of <e2>methadone</e2> has no clinically significant effect on the pharmacokinetic properties of abacavir. \n",
      "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, <e1>warfarin</e1>, <e2>midazolam</e2>, clarithromycin, metronidazole, or amoxicillin. \n",
      "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), <e1>HIV protease</e1> or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., <e2>ketoconazole</e2>, itraconazole, voriconazole). \n",
      "Methscopolamine may interact with <e1>antidepressants</e1> (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), <e2>phenothiazines</e2> (e.g., chlorpromazine, promethazine).\n",
      "<e1>Hyaluronan lyase</e1> had a limited effect and <e2>collagenase</e2> was ineffective. \n",
      "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, <e1>erythromycin</e1> and <e2>multi minerals</e2>. \n",
      "<e1>Potassium</e1> Supplements and <e2>Potassium-Sparing Diuretics</e2>: UNIVASC    can increase serum potassium because it decreases aldosterone secretion. \n",
      "Dopamine antagonists, such as the neuroleptics (phenothiazines, <e1>butyrophenones</e1>, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a <e2>dopamine agonist</e2>); \n",
      "The action of <e1>Mecamylamine</e1> may be potentiated by anesthesia, other antihypertensive drugs and <e2>alcohol</e2>.\n",
      "In controlled clinical trials, <e1>ALOXI</e1> injection has been safely administered with corticosteroids, analgesics, antiemetics/antinauseants, antispasmodics and <e2>anticholinergic agents</e2>. \n",
      "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), <e1>calcium channel blockers</e1> (n=75), antidiabetics (n=21), <e2>nonsteroidal anti-inflammatory drugs</e2> (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15). \n",
      "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, <e1>isocarboxazid</e1>, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-<e2>pectin</e2>), phenothiazines (e.g., chlorpromazine, promethazine).\n",
      "Some examples of such drugs are erythromycin, itraconazole, <e1>ketoconazole</e1>, fluconazole, <e2>calcium channel blockers</e2> and cimetidine.\n",
      "Drugs that may decrease the effects of this medicine include: Rifampin <e1>barbiturates</e1> phenytoin (Dilantin) <e2>carbamazepine</e2> (Tegretol) Estrogens may decrease the effects of benzodiazepines (lorezepam oxezepam temezepam). \n",
      "Therefore, do not administer Myfortic with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral <e1>activated charcoal</e1>, because of the potential to reduce the efficacy of <e2>Myfortic</e2>. \n",
      "<e1>Macrolides</e1>: Clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on <e2>terfenadine</e2> metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent. \n",
      "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), <e1>nortriptyline</e1> (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or <e2>desipramine</e2> (Norpramin). \n",
      "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with <e1>narcotics</e1> (eg, <e2>morphine</e2>, meperidine, and fentanyl, etc.) \n",
      "Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (<e1>Tegretol</e1>) Estrogens may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). \n",
      "<e1>Sulfamethizole</e1> may increase the effects of barbiturates, <e2>tolbutamide</e2>, and uricosurics. \n",
      "- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)\n"
     ]
    }
   ],
   "source": [
    "test = open('datasets/ddi_corpus/test.tsv', 'r', encoding='utf-8')\n",
    "test.readline()  # skip header\n",
    "test_lines = test.readlines()\n",
    "\n",
    "dataset_lines = []\n",
    "for line in test_lines:\n",
    "    sentence = line.split('\\t')[-1][:-1]\n",
    "    print(sentence)\n",
    "    dataset_lines.append(sentence)\n",
    "dataset_lines.reverse()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6603\n"
     ]
    }
   ],
   "source": [
    "print(len(dataset_lines))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['- Antacids - Diarrhea medicine containing <e1>kaolin</e1> or attapulgite - Ketoconazole - Central nervous system (CNS) depressants - Other anticholinergics - Tricyclic antidepressants (e.g., Elavil, Asendin, Anafranil, Pertofrane, Sinequan, <e2>Tofranil</e2>, Aventyl, Surmontil) - Potassium chloride (e.g., Kay Ciel)', '<e1>Sulfamethizole</e1> may increase the effects of barbiturates, <e2>tolbutamide</e2>, and uricosurics. ', 'Drugs that may decrease the effects of this medicine include: Rifampin barbiturates phenytoin (Dilantin) carbamazepine (<e1>Tegretol</e1>) Estrogens may decrease the effects of benzodiazepines (lorezepam <e2>oxezepam</e2> temezepam). ', 'The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with <e1>narcotics</e1> (eg, <e2>morphine</e2>, meperidine, and fentanyl, etc.) ']\n"
     ]
    }
   ],
   "source": [
    "print(dataset_lines[:4])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "no_relation\tThe induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with <e1>narcotics</e1> (eg, <e2>morphine</e2>, meperidine, and fentanyl, etc.) \tno_relation\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(pair_type_to_label[predictive_classes[3]] + '\\t' + dataset_lines[3] + '\\t' + pair_type_to_label[ori_classes[3]] +'\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'0'"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "predictive_classes[3]"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.13"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
